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Burkholderia pseudomallei and Burkholderia cenocepacia are pathogenic bacteria that are 
the causative agents of the deadly diseases melioidosis and ‘cepacia syndrome’, 
respectively. Both species utilise extracytoplasmic function (ECF) sigma factors, alternative 
subunits of bacterial RNA polymerase, to transduce extracellular signals and drive the 
transcription of specific genes. MbaS, from Burkholderia pseudomallei, and OrbS, from 
Burkholderia cenocepacia, are two iron starvation (IS) sigma factors that regulate gene 
clusters associated with the iron-chelating siderophores mallebaction and ornibactin, 
respectively. 
Evidence has been presented in this study that these proteins contain on-board C-terminal 
regulatory extensions that transduce the presence of selected metal ions via cysteine thiol 
groups. Firstly, C-terminal trucnations of OrbS were assayed through colorimetric 
siderophore assays and promoter-reporter analyses to demonstrate that the C-terminal 
extension is required for sigma factor activity, and may be necessary for iron-dependent 
regulation. A series of gene deletions were also introduced into B. thailandensis, a safer 
surrogate species of B. pseudomallei, through allelic exchange to delete mbaS and the 
secondary siderophore pyochelin. Through use of these constructed mutants and promoter-
reporter analyses, the target promoters of MbaS have been identified and Fur regulation of 
the sigma factor has been established. Using further promoter-reporter analyses and in vitro 
techniques to assay transcription activity and protein-protein interaction, it has been 
demonstrated that the sigma factor activity of OrbS is inhibited in the presence of Fe(II), 
Cu(II) and Zn(II) ions, and the sigma factor activity of MbaS is inhibited in the presence of 
Zn(II). 
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1.1 The Burkholderia genus 
 
1.1.1 Characteristics of Burkholderia 
Burkholderia is a large, diverse and complex genus comprised of over 90 species. Recently, 
some of these species have undergone reclassification, which is expounded upon in section 
1.1.2. Burkholderia are Gram-negative β-proteobacteria and typically have large genomes of 
around 6-11 Mb with high GC content, normally organised into 2-3 chromosomes (Mannaa, 
Park and Seo, 2018; Depoorter et al., 2016). Burkholderia species can be found in a variety 
of contexts including as pathogens, phytopathogens, symbiotic and free-living non-
symbiotic strains. Identified strains are usually isolated from environmental (water, soil, 
fungi, plant) or clinical (animal and human) environments (Parke and Gurian-Sherman, 
2001). 
Species of Burkholderia are noted for their adaptability, accomplished through their large 
and gene-rich genomes containing a variety of different genes enabling survival in 
environments with stressful conditions (Mahenthiralingam, Urban and Goldberg, 2005; 
Duangurai, Indrawattana and Pumirat, 2018), resistances to many commonly used 
antibiotics (Rhodes and Schweizer, 2016), and genetic plasticity achieved through multiple 
transposable insertion sequence elements (Lessie et al., 1996). 
 
1.1.2 Taxonomy 
Initially described as a Pseudomonas species, Burkholderia was identified as a distinct genus 
with seven species by (Yabuuchi et al., 1992). The Burkholderia sensu lato now comprises at 
least 92 species and the splitting and reclassification of the genus into more closely defined 
groups is currently underway and may include the major genera Burkholderia, 
Paraburkholderia, Caballeronia, and the minor genera Trinickia, Mycetohabitans, and 




Figure 1.1. Phylogenetic tree of Burkholderia sensu lato 
Shown genera are based upon the 16S rRNA-based phylogenetic tree constructed by (Mannaa, Park 
and Seo, 2018) using data from the SILVA database (https://www.arb-silva.de/). Note that 
alternative phylogenetic analyses (for example (Estrada-de Los Santos et al., 2018)) may show 
different intergeneric relationships, but distinct groups remain consistent. The genus Burkholderia 
sensu stricto is expanded further to show the three intrageneric groups. Examples of representative 
strains are displayed next to each genus. Taxonomic positions and sizes of genus boxes are not to 
scale. 
 
The species of Burkholderia that are capable of causing human or animal infection all fall 
within the genus Burkholderia sensu stricto; this is one of the key characteristics of the 
group (Estrada-de los Santos et al., 2013). Compared to other Burkholderia sensu lato 
species, the Burkholderia sensu stricto species have genomes with higher GC content, 
contain genes for the virulence-associated Type III secretion system-3 (T3SS-3) and Type VI 
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secretion system-5 (T6SS-5) and do not have genes for Type IV secretion systems (T4SS) 
(Angus et al., 2014). Additionally, a second flagella system used in intracellular motility is 
only found in Burkholderia sensu stricto species (French et al., 2011). 
Members of the newly created genus Paraburkholderia are often associated with plants 
and/or fungi, either as symbionts, phytopathogens or as free-living/endophytic species 
(Sawana, Adeolu and Gupta, 2014). They are closely related to the newly created Trinickia 
genus (Estrada-de Los Santos et al., 2018) (can be legume nodulators or phytopathogenic) 
and the Caballeronia group (Dobritsa and Samadpour, 2016) (often free-living nitrogen-
fixing endosymbionts initially described as a clade between Burkholderia and 
Paraburkholderia). Much is shared in common with the Robbsia genus which also contains a 
plant-pathogenic ormer Burkholderia species – but the type species R. andropogonis has a 
single polar sheathed flagellum and can produce rhizobitoxine (Lopes-Santos et al., 2017). 
Finally, the Mycetohabitans genus currently containing two former Burkholderia sensu 
stricto species, is typified by the smaller genomes (3-4 Mb) of its member species and their 
lifestyle as fungal endosymbionts (Estrada-de Los Santos et al., 2018). 
 
1.1.3  The Burkholderia pseudomallei complex 
A sub-group of the Burkholderia genus, the Burkholderia pseudomallei complex (Bpc) 
currently contains six species. These are B. pseudomallei (Whitmore, 1913), B. mallei 
(Nierman et al., 2004), B. thailandensis (Brett, DeShazer and Woods, 1998), B. oklahomensis 
(Glass et al., 2006), B. humptydooensis (Tuanyok et al., 2017) and B. alba (Lee, Kim and Park, 
2018). 
The complex’s species are usually soil saprophytes. However, two species are also 
considered pathogenic. B. pseudomallei is the etiological agent of the human disease 
melioidosis (see section 1.2), and its clone B. mallei causes the disease glanders in equines 
(and in rare cases humans) (Van Zandt, Greer and Gelhaus, 2013). 
The remaining four species are closely related and are considered to be non-pathogenic. 
However, both B. thailandensis and B. oklahomensis have been observed to cause clinical 
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infections in humans under extreme and rare circumstances (Glass et al., 2006; Gee et al., 
2018). 
 
1.1.4 Burkholderia pseudomallei 
B. pseudomallei (Bps) is the causative agent of melioidosis (see section 1.2). Unlike the 
obligate parasite B. mallei (Bma), Bps is an environmental saprophyte that acts as an 
opportunistic pathogen of humans and other animals. It is often found in the soil in the 
tropics – in particular, rice paddy fields in South-East Asia. Bps has a large genome of 7.2 
Mb, split across two chromosomes of 4 Mb and 3.2 Mb, with a high GC content of around 
68% and encodes around 5,900 genes (Holden et al., 2004). 
Bps is considered a Category B agent for biosecurity and bioterrorism by the US Centers for 
Disease Control (CDC). A significant aspect of the virulence of Bps, and an important 
justification for its bioterror agent classification, is its multiple antibiotic resistances (Rhodes 
and Schweizer, 2016). Perhaps the most effective system of antibiotic resistance in Bps is 
through its ten multi-drug efflux pumps of the resistance-nodulation-division (RND) type, 
conferring resistance to six antibiotic classes (Podnecky, Rhodes and Schweizer, 2015). 
These are important due to their ability to export antibiotics across a combination of the 
cytoplasmic membrane, the periplasm and the outer membrane. Three RND family efflux 
pumps have been elucidated in Bps: AmrAB-OprA (contributing to macrolide, 
aminoglycoside and tetracycline resistance) (Trunck et al., 2009), BpeAB-OprB (contributing 
to macrolide, tetracycline, chloramphenicol and fluoroquinolone resistance) (Chan et al., 
2004; Mima and Schweizer, 2010) and BpeEF-OprC (contributing to tetracycline, 
trimethoprim, chloramphenicol, fluoroquinolone and sulphamethoxozole resistance) 
(Kumar, Chua and Schweizer, 2006; Podnecky et al., 2013). Further β-lactam resistance 
(more specifically carbapenems) is achieved via the type 2 metallo β-lactamase encoded 
from blaNDM-1 (González et al., 2016) and further trimethoprim resistance is conferred by 
mutations in the dihydrofolate reductase gene folA (Podnecky et al., 2013). Additional 
antibiotic resistances are achieved through expressing the PenA class A β-lactamase 
(providing resistance to β-lactams) (Randall et al., 2015), via the low permeability of the 
outer membrane (in particular due to the outer membrane porin Omp38 providing 
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resistance to polymyxin B) (Aunkham et al., 2014) and by encoding a mutated form of the 
GyrA DNA gyrase (providing resistance to fluoroquinolones) (Rhodes and Schweizer, 2016). 
Due to the hazardous nature of Bps, it must be handled in microbiological Containment 
Level 3 facilities. Therefore, it is common practice to use the closely-related but non-
pathogenic surrogate species Burkholderia thailandensis (Bth), which may be handled in 
Containment Level 2 laboratories (see section 1.1.5). 
 
1.1.5 Burkholderia thailandensis 
Bth was first identified as a Bps-like species, isolated in the same ecological niches, which 
displayed a decreased relative virulence (Brett, DeShazer and Woods, 1998). The species 
type strain Bth E264 shows a high degree of genomic synteny with Bps, with a similar 
number of coding regions, distributions of protein structural families and several shared 
genomic islands of unusually high GC-content or bacteriophage-related genes (Yu et al., 
2006). 
Unsurprisingly, there are several Bps virulence factors that are not found in the avirulent Bth 
E264. A major one of these is the bacterial cell capsule polysaccharide encoded by the 
wcbA-T genes; uncommon Bth strains that are able to produce a Bps-like capsule, such as 
strain E555, are also noteworthy displaying similar growth patterns to Bps in macrophages. 
However, they still cannot cause disease in murine models of disease and there are likely 
additional factors involved (Kovacs-Simon et al., 2019). 
Another important difference between Bth and Bps is the former’s ability to assimilate 
arabinose (Smith et al., 1997). The nine-gene operon conferring the ability to metabolise L-
arabinose found in Bth is not found in Bps, and the reintroduction of this operon into Bps 
has been demonstrated to reduce the pathogen’s virulence, most likely via the 





1.1.6 The Burkholderia cepacia complex 
Another sub-group of the Burkholderia genus is the Burkholderia cepacia complex (Bcc). 
Currently, this group contains 22 reported member species based upon homology of the B. 
cepacia recA gene (Devanga, Naveen and Veeraraghavan, 2019). Member species of the Bcc, 
including B. cencepacia (Bce), are noted for their ability to opportunistically infect and cause 
disease in immunocompromised individuals. This usually manifests as a pulmonary 
infection, and can lead to disease known as ‘Cepacia syndrome’ (more detail in section 1.3). 
Bcc species are also found interact non-pathogenically with plants, where their ability to 
perform nitrogen fixation and produce anti-fungal compounds could have useful 
applications in agriculture (Coenye and Vandamme, 2003). 
The significant aspect of Bcc species is the multiple antimicrobial resistances that can be 
employed. Bcc species can display resistances to carboxypenecillins, polymyxins and 1st-
generation cephalosporins (Mahenthiralingam, Urban and Goldberg, 2005). This 
antimicrobial resistance is brought about by a series of key factors. 
Firstly, the outer membrane of Bcc species is a major factor in antibiotic resistance. A 
decreased permeability of this membrane relative to other bacteria can be acquired and 
confers an inherent resistance to many aminoglycosides and β-lactams (Moore and 
Hancock, 1986). Additionally, the LPS of the outer membrane can be modified by the 
MrgS/MrgR two-component regulatory switch imparting polymyxin resistance (Kumar et al., 
2016). The LPS can also lack several binding sites, providing resistance to cationic antibiotics 
such as aminoglycosides. In cases of prolonged infection, Bcc species have been found to 
lose the O-antigen component of LPS, enabling evasion from host immune recognition 
(Hassan, Coutinho and Sa-Correia, 2019). 
As with Bps, many antibiotic resistances are conferred by the class A β-lactamase PenA and 
through multiple RND efflux pump systems (AmrAB-OprA, BpeEF-OprC and BpeAM-OprB) 
(Biot et al., 2011). All three efflux pumps provide resistance to tetracycline, AmrAB-OprA 
also provides resistances to aminoglycosides and macrolides, and BpeEF-OprC provides 






1.2.1 Symptoms and diagnosis 
Melioidosis is a disease caused by the bacterial pathogen Burkholderia pseudomallei (see 
section 1.1.4). Bps is able to infect and cause melioidosis in humans and several species of 
animals. The environmental bacterium is found in contaminated soil and water, and 
infection usually occurs through skin penetration, ingestion or inhalation (Limmathurotsakul 
et al., 2013). More details are provided in section 1.2.3. 
The symptoms of severity of melioidosis can vary depending on the route of infection, the 
bacterial load/strain, and if the patient has any disease risk factors. The most common 
clinical symptom of melioidosis is bacteraemia, which occurs in 40-60% of cases. Symptoms 
of pneumonia are also common, and occur in around 50% of cases. In 20% of cases septic 
shock can befall the patient. The infection can frequently spread to other key organs, in 
particular the liver, kidneys, spleen and prostate (Wiersinga et al., 2018).  
In most cases with immunocompetent individuals, infection of Bps does not lead to disease, 
as the pathogen can be cleared by the host’s humoral and cell-mediated immune response. 
However, infection can result in clinical symptoms of melioidosis with either acute or 
chronic disease (Currie, Ward and Cheng, 2010). Acute disease, which occurs in 85% of 
melioidosis cases, is associated with symptoms of sepsis, pneumonia and localised 
abscesses. On average, the incubation time of Bps in acute cases is nine days. The chronic 
disease, which occurs in 11% of cases, is a symptomatic infection that remains for more 
than two months. Additionally, less than 5% of cases may result in latency in which the 
disease is asymptomatic but not fully cleared; the symptoms of disease may occur much 
later than the original exposure and has been reported to be as long as 29 years (Chodimella 
et al., 1997). To complicate diagnosis of melioidosis, many cases of the disease do not 
display specific symptoms. This has led to the dubbing of melioidosis as ‘the great mimicker’ 
(Yee et al., 1988). 
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Diagnosis of melioidosis can be difficult for several reasons. These include the 
aforementioned occurrence of non-specific symptoms, a lack of awareness of the disease 
(particularly in non-endemic areas), and a lack of high-quality microbiology laboratories 
required for fast and specific identification of Bps (Wiersinga et al., 2018). In endemic areas 
that are familiar with the disease, melioidosis can be identified based upon the common 
clinical symptoms and the patient’s associated risk factors (Currie, 2015; Wiersinga, Currie 
and Peacock, 2012). In these cases, the disease can be pre-emptively treated with Bps-
targeting antibiotics. However, in many circumstances the disease does not show specific 
clinical symptoms and patients do not always display known risk factors, particularly in the 
case of paediatric patients (Hoffmaster et al., 2015). 
Bacterial culture is the main method used to identify Bps and melioidosis. Because Bps is not 
a commensal bacterium in humans, identification of the pathogen in patients is considered 
a positive test for incidence of melioidosis. Blood cultures are the chief method of sample 
collection due to the high frequency of bacteraemia. However, these samples often need to 
be repeated due to low sensitivity of identification (Limmathurotsakul et al., 2010a). 
Additionally, identification of Bps may be missed or mistaken by laboratory staff unfamiliar 
with the bacterium, or in lower-quality laboratories. Furthermore, bacterial culture 
techniques can take several days, which may take too long considering the potentially fast 
progression of melioidosis (Hoffmaster et al., 2015; Wiersinga et al., 2018). 
There are several standard biochemical and molecule-based tests that can be used to 
confirm the presence of Bps, but these can either lack specificity or only be available in 
research or defence laboratories. There are several more cost-effective and specific assays 
for the identification of Bps being developed, for example the use of a protein microarray, a 
duplex qPCR assay and specific selective media (Dance et al., 2019; Mohd Ali et al., 2019; 
Kohler et al., 2016). 
 
1.2.2 Epidemiology 
Bps and melioidosis is endemic to South-East Asia and Northern Australia. However, the 
disease is increasingly reported in more distant areas such as Colombia, Brazil and 
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equatorial Africa (Volpe-Chaves et al., 2019; Birnie et al., 2019; Rodriguez et al., 2019). It is 
likely that Bps and melioidosis is present across most tropical regions, and the distribution 
of the disease is likely to increase with increased diagnosis and awareness. The pathogenic 
bacterium is present in contaminated soil and surface water; it is most abundant at least 10 
cm below the soil surface. As a result, exposure to Bps can be increased during the rainy 
season, particularly during tropical storms, and through farming of the land, most 
commonly through rice farming in paddy fields (Kaestli et al., 2012; Limmathurotsakul et al., 
2016b). 
The major risk factor associated with melioidosis is diabetes mellitus, which is present in 23-
60% of melioidosis cases (Currie, 2015). Diabetes has been shown to ‘dampen’ the host cell-
mediated response through inhibiting the phagocytosis ability of macrophages, reducing the 
generation of CD4+ regulatory T cells via lipopolysaccharide induction (resulting in loss of 
cytotoxic T lymphocyte protein 4) (Jenjaroen et al., 2015), impairing MyD88 inflammatory 
signalling (specifically Toll-like receptor-mediated differentiation of myeloid cells), and 
dysregulation of NF-κB phosphorylation (Maniam et al., 2015). Diabetes mellitus has been 
predicted to confer a 12-fold increased risk of melioidosis infection (Limmathurotsakul et al., 
2010b). Another major risk factor is exposure to contaminated soil and water, which is 
increased through occupation (farmers, rice paddy workers) and environmental conditions 
(tropical storms) (Cheng and Currie, 2005). Additional risk factors include excess alcohol 
consumption and the associated liver damage, chronic lung and kidney disease, 
thalassaemia (Fong et al., 2015), prolonged steroid use and immunosuppression (Wiersinga 
et al., 2018). In a significant proportion of cases (>80% of children and approximately 20% of 
adults), sufferers of melioidosis possess no known risk factors (McLeod et al., 2015; Currie et 
al., 2004). 
A major modelling study from (Limmathurotsakul et al., 2016b) has predicted that 
worldwide there are around 165,000 cases of melioidosis in humans, around 89,000 (54%) 
of which are fatal. This estimated mortality is similar to the more well-known disease of 
measles (95,600 deaths per year) and greater than those of leptospirosis (50,000 deaths per 
year) and dengue fever (12,500 deaths per year). Under diagnosis or mistaken diagnosis of 
melioidosis may be a significant problem, particularly in areas where knowledge of the 
pathogen and disease are not as well established. This means the reported cases of 
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melioidosis are much lower than those predicted (Wiersinga et al., 2018; Limmathurotsakul 
et al., 2016a). 
 
1.2.3 Transmission and prevention 
Bps is found in contaminated soil and water, and there are three main routes of infection. 
The infection can occur through skin penetration through cuts or wounds, through ingestion 
of contaminated food or water, and through inhalation of disturbed contaminated soil or 
water. These routes of infection are particularly pertinent for farmers or other outdoor 
workers in endemic areas. Melioidosis is not contagious, and transmission between humans 
only occurs in very rare cases (Ashdown, 1979; Wiersinga et al., 2018). 
Depending on how the bacteria enters the host, upon initial infection Bps is able to invade 
and replicate in epithelial cells of the mucosa or broken skin. From there, Bps can spread to 
various cell types including both phagocytic and non-phagocytic cells. Infection most 
commonly occurs in the respiratory system or cardiovascular system (usually bacteraemia), 
but infection of the gastrointestinal system, musculoskeletal system, skin and soft tissue, 
and elsewhere in the body is also common (Wiersinga et al., 2018). 
A cost-effective approach for preventing the incidence of melioidosis is the increasing of 
awareness of the disease. Public health advice aims to educate those at risk to avoid 
exposure of contaminated soil and water (Bory et al., 2018; Chansrichavala et al., 2015). This 
is especially relevant at the start of the rainy season, where tropical storms and dust clouds 
can be prevalent. Additionally, those who may be in contact with contaminated soil and 
water can be encouraged to wear protective equipment such as boots and respiratory 
protection. Those at risk of infection, in particular sufferers of diabetes mellitus, may also be 
encouraged to cease smoking to reduce potential risk (Limmathurotsakul et al., 2013). 
Preventative measures targeting contaminated water have also been suggested. People 
may be urged to drink bottled water, or treat their water before consumption through 
boiling, chlorination or UV treatment (depending on the economic development of the area 
in question) (McRobb et al., 2013; Howard and Inglis, 2003). However, the effectiveness of 
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these measures has not been determined. A lack of awareness of melioidosis and those at 
risk finding themselves in underdeveloped areas may limit the impact of these approaches. 
Vaccination may be an effective approach for prevention of melioidosis. Currently, there are 
no human melioidosis vaccines available, but several are in development. Potential vaccines 
are either live attenuated vaccines (Titball et al., 2017; Khakhum et al., 2019), or subunit 
based vaccines (Muruato and Torres, 2016). An effective vaccine may utilise several antigens 
in order to combat Bps (Morici, Torres and Titball, 2019). Nonetheless, as a risk factor 
associated with melioidosis is immunosuppression, the effectiveness of a vaccine may be 
limited for this group. 
 
1.2.4 Treatment 
Antimicrobial therapy is the treatment used for melioidosis, and the initial diagnosis and 
start of antimicrobial therapy is critical. Where fast diagnosis and effective antibiotic 
therapy is applied, mortality rates are around 10%; where this treatment is less prompt and 
more limited, mortality rates increase to greater than 40% (Currie, 2015). 
Bps can be eliminated by some β-lactams (meropenem, imipenem, co-amoxiclav (a 
combination of amoxicillin and clavulanic acid) and ceftazidime), doxycycline, 
chloramphenicol and trimethoprim-sulphamethoxazole. However, as Bps is resistant to 
penicillin, ampicillin, gentamicin, cephalosporins, tobramycin, streptomycin, macrolides and 
polymyxins, the pathogen must be correctly identified in order to apply the correct 
antibiotic therapy (Rhodes and Schweizer, 2016). 
Initially, antibiotics are applied intravenously. Usually, meropenem or ceftazidime is used for 
10-14 days, but this can be increased to around four weeks for patients with severe disease. 
Once symptoms have improved, the patient receives oral antibiotics (usually trimethoprim-
sulphamethoxazole) for at least three months to eradicate the disease. This treatment 
duration can be increased for sufferers of neurological melioidosis or osteomyelitis. In cases 
where there are large abscesses in the liver, prostate or in muscle, or where septic arthritis 
or osteomyelitis has occurred, surgical drainage may be required (Wiersinga et al., 2018). 
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1.2.5 Virulence factors 
Bps possesses a large and varied array of virulence factors that enable it to infect, 
proliferate and avoid the immune response within a host. 
Bps possesses three type III secretion systems (T3SSs), the most well-characterised of which 
is T3SS-3 (also known as the Bsa system) (Vander Broek and Stevens, 2017). The T3SS-3 
needle tip and translocator protein components BipBCD are involved in cell invasion and 
intravesicular survival and escape upon contact with the host cell, the BopE effector induces 
actin rearrangement to assist cell invasion, and the CHBP/Cif effector inhibits cell 
maturation and apoptosis (Vander Broek and Stevens, 2017; Wiersinga et al., 2018). 
In addition to its T3SSs, Bps also has several type Va secretion systems (T5SSa), also known 
as autotransporters, that serve as virulence factors. These include BoaA and BoaB involved 
in cell attachment and invasion (Campos, Byrd and Cotter, 2013), BpaC required for cell 
adhesion (Lafontaine et al., 2014) and the BimA autotransporter implicated in actin tail 
formation and phagosome escape (Stevens et al., 2005). 
Furthermore, the Bps genome encodes six type VI secretion systems (T6SSs), involved in a 
variety of virulence-associated functions. The most well-studied example is T6SS-5, which 
can load and inject the specialised effector VgrG5 (also known as TssI). VgrG5 has been 
proposed to be responsible for the fusing of adjacent macrophages, leading to multi-
nucleate giant cell (MNGC) formation (Toesca, French and Miller, 2014; Shalom, Shaw and 
Thomas, 2007). MNGC formation is a hallmark feature of Bps infection, although its role in 
virulence is unclear (Burtnick et al., 2011). Interestingly, this system appears to be regulated 
by glutathione, cysteine, pH, iron and zinc (Burtnick and Brett, 2013; Wong, Chen and Gan, 
2015). 
Other virulence factors used by Bps include, but are not limited to: the Type IV pilin subunit, 
PilA (Essex-Lopresti et al., 2005), and the flagellin subunit FliC with functions in intracellular 
motility and cell adherence (DeShazer et al., 1997), the oxidative stress-associated enzymes 
SodC, KatG, AhpC and DpsA (Loprasert et al., 2004; Loprasert et al., 2003b; Loprasert et al., 
2003a; Vanaporn et al., 2011), the toxin BLF1 (Cruz-Migoni et al., 2011), and several genes 
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associated with  lipopolysaccharides that confer protection against the host immune 
response (Wiersinga et al., 2018; Norris, Schweizer and Tuanyok, 2017). 
 
1.3 Cepacia syndrome 
 
1.3.1 Symptoms and diagnosis 
‘Cepacia syndrome’ is a severe form of disease that can be caused by species of the Bcc 
(more detail in section 1.1.6). The symptoms that arise for Bcc infections can vary widely, 
ranging from no symptoms to severe respiratory decline, septicaemia and death 
(Mahenthiralingam et al., 1995). Sufferers of cystic fibrosis (CF) and chronic granulomatous 
disease are particularly susceptible to infection by the Bcc, although infections can occur in 
patients without these risk factors (Hauser and Orsini, 2015). 
In cases where symptoms develop to severe levels, Bcc infections may be referred to a 
‘Cepacia syndrome’. This disease is characterised by symptoms including rapid decline of 
lung and pulmonary functions, fever, septicaemia, necrotising pneumonia, leukocytosis, and 
increased inflammatory markers (Isles et al., 1984; Sfeir, 2018). However, more uncommon 
symptoms have been observed including but not limited to spontaneous bacterial peritonitis 
(in patients with liver cirrhosis), endophthalmitis (in patients after eye trauma and / or 
surgery) and genito-urinary infections (Sachdeva et al., 2011; Agochukwu et al., 2012; 
Taneja et al., 2017). 
Bcc infections and ‘Cepacia syndrome’ are diagnosed based on patient symptoms and 
identification of the Bcc bacteria. The bacteria can be identified using specific selective agar 
(Henry et al., 1999), recA specific PCR assays (Payne et al., 2005), MALDI-TOF mass 
spectroscopy (Fehlberg et al., 2013), and MLST (Spilker et al., 2009). Also, antibiotic 
susceptibility testing is often used to identify Bcc species using ceftazidime, meropenem, 





Much like Bps, Bcc species are found in contaminated water, soil and moist environments. 
They can also be found in hospital environments, usually in the Western hemisphere, and 
often in the sputum of CF patients (Mahenthiralingam, Urban and Goldberg, 2005). In 2016, 
it was estimated that 2.7 % of CF patients have Bcc infections. However, this number is 
gradually decreasing year-on-year as awareness and treatment of Bcc infections increases 
(Salsgiver et al., 2016). 
Humans can be exposed to Bcc species through contaminated water. Bcc species can be 
found naturally in water, where they display a high survival rate. Moreover, in some 
countries such as China, Bcc species are utilised in agriculture, where they suppress plant 
pathogens, and in bioremediation, where they assist in metabolising pesticides and 
herbicides (Ibrahim et al., 2012; McLoughlin et al., 1992).  
 
1.3.3 Transmission and prevention 
All species of the Bcc are able to opportunistically infect humans, and cause symptoms that 
lead to ‘Cepacia syndrome’. However, the most virulent of these species is Bce, followed by 
B. multivorans and B dolosa. Recently, B. multivorans appears to be found more commonly 
in infected patients than Bce, although with less severe symptoms (Zahariadis, Levy and 
Burns, 2003; Woods et al., 2004; Kalish et al., 2006; Miller et al., 2015). 
Unlike Bps, which does not show horizontal transmission between patients, Bcc species are 
able to transmit between patients via contact and / or water droplets. Patients with CF or 
chronic granulomatous disease are particularly vulnerable (Saiman et al., 2014). 
Transmission can also occur via contaminated medical equipment or medications, and can 
lead to outbreaks of disease (Sommerstein et al., 2017; Song et al., 2017). Correct 
sterilisation and hygiene techniques within hospitals and regarding medical products can 





The treatment of Bcc infections suffers from a lack of published data, and usually is 
approached on an individual basis depending on the severity and history of infection and in 
vitro antibiotic susceptibility data (Sfeir, 2018).  
Most commonly, either trimethoprim-sulphamethoxazole, ceftazidime, meropenem or 
doripenem is used in antibiotic therapy. The antimicrobials doxycycline and minocycline 
may also be used (Regan and Bhatt, 2019). However, certain antimicrobial resistance 
mechanisms can reduce the effectiveness of these antibiotics (more details are provided in 
section 1.1.6). Novel β-lactamase inhibitors can be used to overcome the effect of PenA. 
Avibactam (used in conjunction with ceftazidime) or vaborbactam (used in conjunction with 
meropenem) can support antibiotic therapy (Papp-Wallace et al., 2017). However, these 
inhibitors do not overcome the effect of multi-drug efflux pumps. Amiloride and verapamil 
have been shown to increase the effectiveness of tobramycin against these efflux pumps 
(Cohn, Rudzienski and Putnam, 1995). A combination of antibiotics appears to be an 
effective antibiotic treatment strategy. The cooperation of β-lactam-ciprofloxacin-
tobramycin has been demonstration to be the most consistent permutation, and shows 
effectiveness against the formation of biofilms, too. More recently, a novel polycationic 
glycopolymer has been shown to increase the effectiveness of tobramycin and meropenem 
against Bcc isolates (Narayanaswamy et al., 2017). 
 
1.4 Iron acquisition 
 
1.4.1 Iron in microbiology 
In almost all aerobic organisms, iron is an essential nutrient required for growth and 
survival. Iron is often incorporated in important proteins, including as a part of the haem 
cofactor, in iron-sulphur clusters, or an independent cofactor in mononuclear or dinuclear 
form. Its ability to transition between Fe(II), Fe(III) and Fe(IV) oxidation states make it ideal 
for the redox chemistry found in many metabolic processes and electron transport. 
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Biological iron is usually found in the oxidation states Fe(II) (ferrous) or Fe(III) (ferric) (Hider 
and Kong, 2010; Cassat and Skaar, 2013). 
Both the mammalian host and the bacterial pathogens must engage in an iron acquisition 
‘arms race’ in order obtain the iron each needs. 
In effect, the host organism makes iron unavailable by incorporating it in various proteins. 
Iron is incorporated in many enzymes, and also in prosthetic groups such as haem in 
haemoglobin and myoglobin. Excess iron is stored in ferritin and by lactoferrin, and 
transported by transferrin. Additionally, Fe(III) is highly insoluble and therefore difficult to 
obtain. These contribute to making the internal host environment an iron-limited 
environment. Bacteria can utilise different mechanisms to acquire extracellular iron during 
infection and aid survival. 
 
1.4.2 Siderophores 
One major mechanism used by many bacterial species to acquire extracellular iron for 
survival is the synthesis and secretion of iron-chelating compounds called siderophores. 
Siderophores are low molecular weight compounds of around 0.5-1.5 kDa that bind ferric 
iron with high specificity and affinity. They are able to form complexes with a single ion of 
Fe3+ using bidentate ligand groups, usually via a nucleophilic oxygen as a donor atom.  The 
most common groups found in siderophores are the bidentate catecholate, hydroxamate 
and hydroxycarboxylate groups, shown in Figure 1.2. The majority of ferric-siderophore 
complexes use three of these ligand groups to form hexadentate coordination complexes 
with Fe3+, with an overall octahedral geometry (Hider and Kong, 2010). Usage of 
siderophores is an important mechanism for solubilising the normally insoluble and 




Figure 1.2. Donor ligand group of bacterial siderophores 
Common bidentate ligand groups found in siderophores that are able to coordinate ferric iron. 
Adapted from (Hider and Kong, 2010). Note that derivatives of these functional groups may also act 
as metal-binding ligands in siderophores, such as with pyochelin (see section 1.4.5). 
 
In Gram-negative bacteria, ferric-siderophore complexes are transported across the 
bacterial outer membrane into the periplasmic space via specific TonB-dependent receptors 
(TBDRs). These TBDRs are gated receptors that are energised by the proton motive force 
(PMF), through the action of the TonB system consisting of the three inner membrane-
anchored proteins TonB, ExbB and ExbD (Bradbeer, 1993). The TBDR protein itself forms a β-
barrel structure and binds a specific ferric-siderophore complex with the high affinity 
necessary in the iron-scarce extracellular space. The β-barrel is ‘corked’ by a globular ‘plug’ 
domain that is ‘uncorked’ upon the binding of the ferric-siderophore complex and resulting 
in conformational change. Once within the periplasmic space, some systems have a 
periplasmic binding protein (PBP) to shuttle the ferric-siderophore complex to the 



























siderophore complex is then transported across into the bacterial cell cytoplasm by a 
cytoplasmic membrane transporter, usually acting in an ABC (ATP-binding cassette)-
dependent mechanism. These transporters can translocate either the ferric-siderophore 
complex, or the free ferric ion, depending on the system. When entering the cell cytoplasm, 
the ferric ion is released from the complex either by reduction to Fe(II) or by hydrolysis of 
the siderophore (Butt and Thomas, 2017). 
Most bacteria use one major siderophore to utilise extracellular iron. However, it is common 
to have additional secondary siderophores that may bind iron with lower affinity. These 
secondary siderophores may be useful under different environmental conditions, for iron 
storage, or for binding other metal ions (Hider and Kong, 2010). 
 
1.4.3 Ornibactin 
The major siderophore synthesised by all members of the Bcc (except for the recently 
identified strain B. paludis (Ong et al., 2016)) is ornibactin. Although ornibactin is predicted 
to be utilised by most Bcc members (Butt and Thomas, 2017), this has only been empirically 
demonstrated in B. cepacia, B. cenocepacia and B. vietnamensis (Meyer et al., 1995; 
Stephan et al., 1993; Agnoli et al., 2006; Darling et al., 1998). Ornibactin synthesis and 
utilisation is specified by the 14-15 gene orb cluster that is composed of three operons 
(Figure 1.3 a). 
Ornibactin is a tetrapeptide siderophore, formed from an L-ornithine-D-hydroxyaspartate-L-
serine-L-ornithine backbone and synthesised by the NRPSs OrbI and OrbJ (Figure 1.3 b). The 
N-terminal ornithine is modified at the δ-amino group by hydroxylation by the oxygenase 
PvdA, and OrbL/OrbK-dependent acylation by a β-hydroxy acid which may have chain 
lengths of four, six or eight carbons leading to synthesis of ornibatin-C4, -C6 or -C8, 
respectively. The C-terminal ornithine is also modified by hydroxylation by PvdA and by 
formylation at the same δ-amino group by the transformylase PvdF. It also and undergoes 
amidation at the α-carboxyl group with a single molecule of putrescine. These modifications 
result in the assembly of a mixed type siderophore containing two hydroxamate groups and 
one α-hydroxycarboxylate group that chelate Fe(III) in a 1:1 stoichiometry (Figure 1.3 b).  
 
Figure 1.3. orb gene cluster organisation, ornibactin biosynthesis and role in iron transport 
A. Organisation of orb genes responsible for production and utilisation of the siderophore ornibactin. Siderophore biosynthesis genes are shown in blue, 
siderophore transport/utilisation genes are shown in green, regulatory genes are shown in pink. The sites of the OrbS-dependent promoters are shown as 
curved arrows. B. Predicted chemical synthesis of pyochelin. Role of OrbH, an MbtH-like protein of unknown function, is not shown. C. Proposed ornibactin 
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The export of ornibactin through the cytoplasmic membrane is proposed to be performed 
by the ABC transporter OrbE (Figure 1.3 c). The ferric-ornibactin complex is transported 
across the outer membrane via the TonB-dependent receptor OrbA, then across the 
periplasm by the PBP OrbB, and finally across the inner membrane via the ABC transporter 
OrbCD. Once within the cytoplasm, the iron ion is proposed to be released from ornibactin 
via reduction to the ferrous form by OrbF. 
The orb gene cluster is regulated by the extracytoplasmic function (ECF) sigma factor OrbS 
(more detail in 1.7.2) and the global transcriptional regulator Fur (more detail in 1.5) (Agnoli 
et al., 2006). 
 
1.4.4 Malleobactin 
Malleobactin (to be precise, malleobactin E) is the major siderophore used by all members 
of the Bpc. Its structure is very similar to ornibactin, differing only by the presence of an 
additional formyl group on the α-amino nitrogen of the N-terminal ornithine and loss of an 
alkyl side chain and hydroxyl group (shown in Figure 1.4). 
Malleobactin is synthesised, exported and imported using genes of the mba gene cluster 
(Figure 1.4 a). The transcriptional control of these genes was demonstrated to act in the 
same way as the orb gene cluster, with the three transcriptional units regulated by a 
homologous ECF sigma factor, MbaS (Alice et al., 2006) (more detail in 1.7.2). Synthesis of 
malleobactin occurs very similarly to synthesis of ornibactin, with homologous enzymes and 
chemical precursors (Figure 1.4 b). However, there are the following differences: the mba 
operon lacks genes homologous to orbL/K, so that the N-terminal molecule of ornithine is 
acylated by formic acid rather than with a β-hydroxycarboxylic acid; the MbaI NRPS contains 
a different N-terminal adenylation domain to OrbI, so that this differently modified N-
terminal ornithine can be incorporated into the malleobactin structure; this peptide 
undergoes an additional formylation upon cyclisation by MbaI; the mba operon contains a 
hypothetical gene, mbaM, of unknown function (Franke, Ishida and Hertweck, 2014; Franke 
et al., 2013). 
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Additionally, the malleobactin biosynthetic apparatus shows greater flexibility in 
comparison that of ornibactin. Eight malleobactin congeners, A-H, have been identified. Not 
including malleobactin C (which is readily non-enzymatically transformed from malleobactin 
B), the malleobactin congeners A-H were isolated in the ratio of  30:11:9:2:6:2:20 by weight 
(Franke, Ishida and Hertweck, 2015; Franke et al., 2013). These diverse chemical structures 
are thought to arise due to the promiscuity of the adenylation domains of MbaI and MbaJ 
responsible for the incorporation diverse ornithine-derived precursors. Nonetheless, only 
malleobactin E contains the three bidentate ligand groups required for siderophore activity. 
Indeed, only this congener demonstrates siderophore activity similar to that of ornibactin by 
chrome azurol sulphonate (CAS) assay (Franke, Ishida and Hertweck, 2015). Another 
congener of malleobactin has been observed to be produced by B. xenovorans. In this case, 
the N-terminal N5-formyl-N5-hydroxyornithine does not undergo the additional formylation, 
giving rise to the malleobactin congener “malleobactin X” (Vargas-Straube et al., 2016; Butt 
and Thomas, 2017). 
The malleobactin import/export apparatus is homologous to the ornibactin apparatus, with 
homologous proteins corresponding to each of those encoded by the orb gene cluster 
(Figure 1.4c). 
First isolated from Bps, malleobactin was demonstrated to bind free iron in addition to host 
protein-bound iron and cell-derived iron (Yang, Kooi and Sokol, 1993; Yang, Chaowagul and 
Sokol, 1991). Additionally, this siderophore has been demonstrated not to be essential for 
virulence in mouse models (Kvitko et al., 2012). Interestingly, there is evidence that the 
malleobactin B congener may play a role in cell signalling, where it is used as a precursor in 
the biosynthesis of the antibiotic malleonitrone (Trottmann et al., 2019a). 
 
Figure 1.4. mba gene cluster organisation, malleobactin biosynthesis and role in iron transport 
A. Organisation of mba genes responsible for production of the siderophore malleobactin. Siderophore biosynthesis genes are shown in blue, siderophore 
transport / utilisation proteins are shown in green, regulatory genes are shown in pink. The sites of the MbaS-dependent promoters are shown as curved 
arrows. B. Predicted chemical synthesis of malleobactin. Role of MbaH is not shown, and is predicted to encode an MbtH-like protein of unknown function. 
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The secondary siderophore produced by most members of the Bcc, Bps and Bth (but not 
Bma) is pyochelin. It was first discovered in Pseudomonas aeruginosa (Liu and Shokrani, 
1978). Pyochelin is a tetradentate siderophore, with one bidentate 2-hydroxyphenyl 
thiazoline group and one bidentate N-methylthiazolidine-4-carboxylate group. Pyochelin can 
bind Fe3+ in a 1:1 ratio using all of its ligand groups, a 2:1 ratio using two additional ligand 
groups from the second pyochelin molecule to form an asymmetrical octahedral complex 
(Tseng et al., 2006), or a 1:1:1 ratio with a second siderophore, cepabactin, secreted by B. 
cepacia (Klumpp et al., 2005). The association constant for ferric iron is relatively low (2.4 x 
105 M) compared to ornibactin and malleobactin, although this value was obtained in 
ethanol and is likely to be higher in aqueous media (Cox and Graham, 1979). 
Pyochelin is synthesised from a salicylic acid molecule and two molecules of cysteine (see 
Figure 1.5) (Ronnebaum and Lamb, 2018). Salicylic acid is generated from chorismic acid by 
the isochorismate synthase PchA and the isochorimate pyruvate lyase PchB. Salicylate is the 
initiating hydroxy acid, which is activated by the standalone NRPS adenylase module of PchD 
and loaded upon the NRPS PchE. PchE integrates a thiazoline ring, derived from one cyclised 
L-cysteine molecule, into the nascent compound and epimerises the conjugate before 
passing it on to the second NRPS PchF. PchF integrates a second thiazoline ring, derived 
from a second cyclised L-cysteine molecule. The standalone NRPS tailoring module of PchG 
reduces this second thiazoline ring to thiazolidine, before PchF uses a ‘stuffed’ 
methyltransfersase domain to methylate the ring (Ronnebaum et al., 2019). Pyochelin is 
then released from the NRPS. 
The import and export of pyochelin from the cell is less well understood than synthesis of 
the siderophore. PchH and PchI are predicted to be cytoplasmic ABC transporters, but have 
been demonstrated to be non-essential for the export of pyochelin (Reimmann et al., 2001). 
Ferric-pyochelin is imported across the outer membrane by the TBDR FptA, and across the 
inner membrane by the transporter FptX. Unlike the ornibactin and malleobactin systems, 
the pyochelin import system appears to lack a PBP. The additional proteins FptB and FptC 
are also predicted to be involved in pyochelin transport, but appear to be dispensable for 
ferric-pyochelin uptake (Michel, Bachelard and Reimmann, 2007). 
 
Figure 1.5. pch gene cluster organisation, pyochelin biosynthesis and role in iron transport 
A. Organisation of pch genes responsible for production of the siderophore pyochelin. Siderophore biosynthesis genes are shown in blue, siderophore 
transport/utilisation proteins are shown in green, regulatory genes are shown in pink. The sites of the PchR-dependent promoters are shown as curved 
arrows. B. Predicted chemical synthesis of pyochelin. Role of PchC is not shown, and is predicted to encode a type II thioesterase that removes incorrectly 
charged substrates from the PchE-PchF NRPS complex. C. Proposed ferric-pyochelin uptake mechanism. Roles of the following proteins are not shown: 
PchH/PchI (predicted cytoplasmic membrane ABC transporters, but demonstrated not to have a role in pyochelin export (Reimmann et al., 2001)), FptB and 
FptC (predicted to be associated with pyochelin transport, but demonstrated not be necessary for ferric-pyochelin uptake (Michel, Bachelard and 
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Pyochelin has also been demonstrated to form complexes with other metal ions, including 
Cu(II), Zn(II), Ni(II), Co(II), Mo(VI), Al(III), V(IV) and V(V) (Cuppels et al., 1987; Visca et al., 
1992; Baysse et al., 2000). 
The pch gene cluster is regulated by both the Ferric uptake regulator Fur (more detail in 
section 1.5), and the AraC family transcription factor, PchR. PchR is activated upon direct 
binding of ferric-pyochelin, and recognises the 32 bp PchR-box DNA sequence located at the 
promoters of the pchDCBA, pchEFGHI and fptABCX operons. In the absence of ferric-
pyochelin, PchR is able to bind to these PchR-boxes and repress the expression of these 
operons. Additionally, these promoters and the pchR promoter are dominantly repressed by 




A third siderophore-type compound that can be synthesised by the Bpc is the cytotoxic 
secondary metabolite malleilactone (also known as burkholderic acid), encoded by the 
polyketide synthase (PKS) mal gene cluster. Malleilactone has been demonstrated to be 
cytotoxic and antiproliferative against some human cell lines and Gram positive bacteria in 
cell-based assays, through an unknown mode of action (Klaus et al., 2018; Trottmann et al., 
2019b). 
Bps and Bth lacking the ability to produce malleilactone have been shown to be less 
cytotoxic to Caenorhabditis elegans and Dictyostelium disoideum compared to those 
producing the metabolite. Malleilactone also displays iron-chelating properties in addition 
to this toxicity and therefore likely functions like a siderophore, despite not having ‘true’ 
siderophore ligand groups (Biggins, Ternei and Brady, 2012). 
MalR is a LuxR orphan (lacking a LuxI signal synthase partner) and is the regulatory 
transcription factor that controls the expression of the biosynthetic mal gene cluster and 
the production of malleilactone. Unlike most LuxR-type proteins, it does not bind acyl-
homoserine lactone (AHL) and it acts upon a lux box-containing promoter upstream of the 
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mal operon (Truong et al., 2015). Under regular laboratory conditions, the mal cluster is not 
expressed. But, activation of LuxR and therefore the mal gene cluster can be induced by 
sub-inhibitory levels of trimethoprim, fluoroquinolones, sulfamethoxazole, piperacillin and 
ceftazidime, and repressed by the AHLs N-octanoyl homoserine lactone, N-3-hydroxy-
octanoyl homoserine lactone and N-3-hydroxy-decanoyl homoserine lactone via the quorum 
sensing regulatory protein ScmR (Truong et al., 2015; Klaus et al., 2018). 
 
Figure 1.6. mal gene cluster organisation and the structure of malleilactone 
A. Organisation of mal genes responsible for production of the Bpc siderophore-like compound 
malleilactone. Siderophore biosynthesis genes are shown in green, hypothetical proteins are shown 
in orange, regulatory genes are shown in pink. The site of the MalR-dependent promoter is shown as 
a curved arrow. B. Predicted chemical structure of malleilactone (Klaus et al., 2018). 
 
As production of this siderophore is not observed under standard laboratory conditions, it 
has not been considered in these studies with the same importance as malleobactin and 
pyochelin. Additionally, recent studies suggest that the reactive precursors of malleilactone 
are more active virulence factors and may be the primary function of this biosynthetic 
pathway (Trottmann et al., 2019b). Additionally, it should be noted that despite being 
described as a siderophore-like compound, without the presence of a corresponding TBDR it 
does not share many of the characteristics of a siderophore. 
 
1.4.7 Alternative Burkholderia iron acquisition methods 
In addition to the usage of siderophores, Burkholderia have alternative mechanisms for 
acquiring iron during iron starvations conditions. 
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Haem is the most plentiful source of iron in the vertebrate host, making it an ideal source of 
iron for pathogenic bacteria. Haem can be released from haemoglobin via oxidation of the 
bound Fe(II) ion or proteolysis by host or pathogen proteases (Balla et al., 1993; Cosgrove et 
al., 2011). Several species of Burkholderia, including Bps and Bce, encode genes of the bhu 
(Burkholderia haem uptake) operon (Shalom, Shaw and Thomas, 2007). This five-gene 
operon encodes a TBDR (BhuR), a PBP (BhuT), a cytoplasmic ABC transporter formed of the 
membrane transporter (BhuU) and the ATPase component (BhuV), and a ‘shuttle’ protein 
(BhuS) predicted to have a role in the transport of cytoplasmic haem to haem-binding 
proteins and/or for degradation and release of iron (Figure 1.7). Recently, the chemo-
mechanical coupling mechanism of this haem transporter has been proposed, highlighting 
potential conformations that may occur during internalisation of haem (Tamura et al., 
2019). 
 
Figure 1.7. bhu gene operon organisation and haem uptake 
A. Organisation of bhu genes responsible for the uptake of exogenous haem. The site of the Fur-
dependent promoter is shown as a curved arrow. B. Proposed haem uptake mechanism. Further 
detail provided in main body of text. 
 
 1 kb 

















Another abundant source of iron during infection is the iron storage protein ferritin. Bce has 
been demonstrated to be able to acquire iron from ferritin in a proteolysis-dependent 
process (Whitby et al., 2006; Tyrrell et al., 2015). Surprisingly, in Bps, siderophores are not 
required for the acquisition of ferric iron bound by ferritin suggesting the presence of 
another alternative ferric iron acquisition process (Kvitko et al., 2012). 
An alternative iron uptake mechanism present in most Burkholderia species and 
investigated in Bce is the FtrABCD system (Figure 1.8), that is similar to systems also 
observed in Bordetella and Brucella (Brickman and Armstrong, 2012; Elhassanny et al., 2013) 
and the EfeUOB system of E. coli (Cao et al., 2007). This system encodes a ferrous iron 
transporter which oxidises ferrous iron and translocates the resulting ferric iron into the 
cytoplasm. FtrA is a putative periplasmic protein for the transport of Fe(II). This may carry 
the metal ion to both the cupredoxin component FtrB and the linked ferredoxin FtrD, which 
facilitate the oxidation of Fe(II), and pass the resulting electron to a suitable electron 
acceptor and the generated ferric ion is delivered  to the permease FtrC (Brickman and 
Armstrong, 2012; Mathew, Eberl and Carlier, 2014). The FtrABCD promoter has been shown 
to respond to iron, but not to low pH as is observed in Bordetella (Brickman and Armstrong, 




Figure 1.8. FtrABCD gene operon organisation and ferrous iron uptake 
A. Organisation of FtrABCD genes responsible for the uptake of ferrous iron. The site of the putative 
iron-dependent promoter is shown as a curved arrow. B. Proposed ferrous iron uptake system. 
Further details are provided in main body of text. 
 
Some species of Burkholderia, namely B. multivorans, B. pseudomultivorans and B. paludis, 
encode the FeoB component of the Feo ferrous iron uptake system. The Feo system is an 
inner membrane transport protein, used for uptake of ferrous iron into the cytoplasm. Most 
species of Burkholderia, including Bps and Bce, do not possess FeoA or FeoB (Butt and 
Thomas, 2017). It is not clear whether the single FeoB component present in these 
Burkholderia strains is involved in iron transport. 
Finally, it has been observed that Bps infecting macrophages is able to downregulate the 
host protein iron transporter ferroportin, resulting in reduction of iron transport and a 
greater availability of iron within macrophages (Schmidt et al., 2018). This increased iron 
pool may assist intracellular survival and proliferation during infection. 
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1.5 The Ferric Uptake Regulator (Fur) 
 
Although iron is an essential nutrient for most microorganisms, high concentrations of Fe(II) 
can lead to toxicity through the formation of highly reactive and toxic superoxide radicals 
via Fenton reactions (Imlay, Chin and Linn, 1988). Therefore, the intracellular pool of iron 
must be regulated. The ferric uptake regulator (Fur) is a global transcriptional repressor 
protein that is found in all Gram-negative and most Gram-positive bacteria. Fur responds to 
high intracellular concentrations of iron to repress iron-regulated genes and maintain 
acceptable intracellular iron concentrations. 
Initially identified in E. coli, Fur is a 17 kDa zinc metalloprotein (Schaffer, Hantke and Braun, 
1985). Binding of transition metals, including but not limited to Fe(II), induces dimerization 
of Fur (Mills and Marletta, 2005; Lee and Helmann, 2007). Fur dimerization has been shown 
to occur via dimerization domains, and DNA interaction via a DNA binding domains (Pohl et 
al., 2003). Additionally, Fur oligomerisation with DNA has been shown to occur, with 
tetramers (two Fur dimers) appearing to be particularly common (Perard et al., 2016). 
Fur binds DNA at specific sequences called Fur boxes, with the following consensus motif: 5′-
GATAATGATAATCATTATC-3′ (Baichoo and Helmann, 2002). However, Fur also displays some 
conformational plasticity that enable it to recognise this sequence with flexibility. These Fur 
boxes are located at the promoters of iron-regulated genes. Binding of the Fur dimer to this 
sequences occludes the promoter, preventing the association of RNAP with the DNA and 
repressing the transcription of the gene. 
The transcription of the ECF sigma factor OrbS, which regulates the transcription of orb 
cluster genes associated with ornibactin, has been demonstrated to be regulated by Fur 
(Agnoli et al., 2006). Additionally, the homologous sigma factor MbaS has been reported to 





1.6 ECF sigma factors 
 
1.6.1 Bacterial RNA polymerase 
Bacterial RNAP is the enzyme complex responsible for the transcription of bacterial DNA. 
The catalytic core of RNAP, which is capable of transcription elongation but unable to 
initiate transcription, is formed of five subunits: two identical α subunits, two non-identical 
β subunits (β and β’), and an ω subunit (Ishihama, 1969; Gruber and Gross, 2003)(Figure 
1.9). Only upon assembly with a sixth subunit, a σ factor, does core RNAP become the 
holoenzyme with the ability to initiate transcription. 
The α subunits (35 kDa approx. each) are formed of two domains. The N-terminal domains 
interact to enable α dimerization, and subsequently interaction with the β and β’ subunits; 
this is an essential step in assembly of the core enzyme. The C-terminal domains interact 
with DNA upstream of the gene promoter (the UP element) and can interact with a variety 




Figure 1.9. Three-dimensional Structure of E. coli RNA Polymerase 
3D Crystal structure of E. coli RNAP σ70 holoenzyme, 3.7 Å resolution (PDB: 4YG2). Protein subunits 
are coloured as indicated. Image created using CCP4MG. 
 
The large β and β’ subunits (approximately 151 kDa and 155 kDa in E. coli, respectively) form 
the catalytic ‘crab-claw’ structure of the enzyme complex. This structure consists of a DNA-
binding clamp, a channel for the DNA-RNA hybrid, and an RNA exit channel. The β’ subunit 
contains a conserved aspartic acid catalytic triad which binds to a Mg2+ cofactor, and also 
displays structural flexibility in forming channels for the access of free NTPs into the active 
site (Murakami, 2013; Vassylyev et al., 2002). 
The ω subunit (approximately 12 kDa) is an auxiliary factor with a variety of functions. These 
can include stabilisation of the RNAP complex and its component subunits, and binding 
ppGpp as part of the stringent response. 
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The σ subunit is responsible for the initiation of transcription – the core enzyme cannot 
begin transcription of double stranded DNA without it. The sigma factor has two key roles: it 
recruits the RNAP holoenzyme to the target genes by interacting with specific promoters, 
and separates the DNA strands at the promoter (DNA melting’) to generate the RNAP-
promoter open complex. Additionally, sigma factors can be a target for other transcription 
factors, providing a further degree of modulation.  
 
1.6.2 σ70 family and domain structure 
Based upon protein sequence similarity, sigma factors are split into two major classes: σ70 
and σ54 (or σN). 
The σ54 factors are alternative sigma factors, and can regulate the expression of genes with 
functions including nitrogen metabolism, cell motility, membrane biogenesis and 
pathogenesis. They differ from the σ70 family due to their dependence on enhancer proteins 
and ATP hydrolysis, as well as their highly different amino acid sequence and structure. The 
focus hereafter will be on the σ70 class of sigma factors and σ54 factors will not be discussed 
in further detail. 
Members of the σ70 sigma family are highly conserved across bacteria, and are further 
divided into four groups based upon their conserved domain architecture (Figure 1.10). 
Group 1 sigma factors are the archetypal housekeeping σ70, to which the three other groups 
2, 3 and 4 are related. Group 1 sigma factors are formed of four conserved helical-
structured domains: σ1.1, σ2, σ3 and σ4. These domains are connected by flexible linkers, and 
are themselves comprised of regions of conserved amino acid sequence. These regions are 




Figure 1.10. Domain structure of Group 1 and Group 4 σ70 factors. 
σ70 conserved domains are shown in coloured boxes. Conserved regions are represented by circles 
containing their region number. Group 1 sigma factors contain all four domains. The σ2 domain 
contains a non-conserved region (NCR) of variable length. A conserved 3.2 region acts as a linker 
between the σ3 and σ4 domains. Group 4 (ECF) sigma factors are smaller, containing only the σ2 and 
σ4 domains. The presence of region 1.2 in σECF is variable, denoted by a broken circle. 
 
Group 1 contains E. coli σ70 (RpoD), the primary sigma factor present in all bacteria, which is 
responsible for initiation of transcription at the majority of promoters in bacteria. It is 
largely responsible for transcription of ‘house-keeping’ genes. Group 1 sigma factors include 
all four of the σ domains. The alternative sigma factors in groups 2, 3 and 4 differ in their 
domain structure; they do not possess domain σ1.1, have variable presence of domain σ3 and 
can also differ in other aspects. Group 2 sigma factors, such as RpoS, lack the σ1.1 domain, 
but retain the σ3 domain, so overall show a close structural relationship to Group 1 sigma 
factors. Group 3 sigma factors, such as E. coli σ32, contain the σ2 and σ4 domains, and usually 
the σ3 domain. Sigma factors of this group are usually associated with (a) flagellum 
biosynthesis, (b) the heat shock response, (c) the general stress response and (d) 
sporulation. Group 4 sigma factors, also referred to as the extracytoplasmic function (ECF) 
sigma factors, are formed of only the σ2 and σ4 domains. They are discussed in more detail 






1.6.3 σ70 domain function 
Domain σ1.1, comprised solely of region 1.1, is an N-terminal domain of approximately 90 
amino acids attached to the rest of σ70 via a flexible linker. σ1.1 is present exclusively in 
group 1 sigma factors, has a high frequency of basic residues, and is formed of four α-
helices. Its natively disordered state has presented difficulties in generating a crystal 
structure, and it has only recently been elucidated (Murakami, 2013). It was initially thought 
to act solely at the transcription initiation process at promoters (Vuthoori et al., 2001). It is 
able to act as a DNA mimic and block entry into the DNA-binding channel of RNAP – its basic 
residues interact with the template DNA and ensure controlled entry into the complex. 
Further studies support that σ1.1 acts as an auto-inhibitory domain that interacts with 
binding elements to prevent free sigma-DNA binding until holoenzyme formation (Schwartz 
et al., 2008). 
Domain σ2, constructed of regions 1.2 to 2.4, forms an associative interface with RNAP 
mostly based on interactions between region 2.2 and the β’ subunit (Murakami, Masuda 
and Darst, 2002). σ2 also interacts with the -10 element of the promoter DNA. Regions 2.3 
and 2.4 selectively bind flipped bases from single-stranded non-template DNA of the -10 
promoter element using specific binding pockets, enabling stability of the opened DNA 
structure (Marr and Roberts, 1997). Specific interaction with the A-11 and T-7 flipped bases 
results from the action of conserved aromatic residues in σ70 (Juang and Helmann, 1994; 
Feklistov and Darst, 2011).  
Domain σ3 consists of regions 3.0 and 3.1, and is formed of three α helices. Region 3.0, 
previously known as region 2.5, is involved in the recognition and interaction with the 
‘extended’ or upstream region of the -10 box of promoter DNA (Barne et al., 1997). A 
conserved region, 3.2, forms a linker sequence between domains σ3 and σ4. Region 3.2 has 
been observed to fit into the RNA exit path in RNAP; part of this region (the “σ-finger”) is 
able to interact with the DNA template strand to aid its translocation into the enzyme 
complex. This region is displaced when greater than four nucleotides of the de novo RNA 
strand have been synthesised, allowing RNA exit (Zhang et al., 2012). 
Domain σ4, consisting of regions 4.1 and 4.2 plays at least three roles. Firstly, it forms a large 
interface with RNAP through interaction with the β subunit flap. Secondly, σ4 is formed of 
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four α helices which fold into a helix-turn-helix motif that specifically interacts with the -35 
box of the promoter DNA (Siegele et al., 1989; Gardella, Moyle and Susskind, 1989; 
Murakami et al., 2002). Thirdly, σ4 also shows roles in interaction with transcription 
activator proteins that bind upstream or downstream of the -35 box (Campbell et al., 2002). 
 
1.6.4 Extracytoplasmic function (ECF) sigma factors 
Group 4 sigma factors are also known as extracytoplasmic function (ECF) sigma factors. They 
constitute a wide and diverse family of sigma factors that frequently display a response to 
signals from the exterior of the cell cytoplasm (Mascher, 2013; Paget, 2015). 
ECF sigma factors contain only the σ2 and σ4 domains, and can even lack most or all of 
region 1.2 and the NCR from the σ2 domain. As a result, they are typically much smaller than 
group 1 sigma factors. 
ECF sigma factors normally regulate their own expression. An exception is a sub-group 
known as the iron-starvation σ factors (see section 1.6.6). The sigma factor recognises the 
promoter sequence elements of its own gene, thereby giving rise to a positive feedback 
system. Genes encoding ECF sigma factors are often located in operons or operon-like 
clusters with the gene their cognate anti-sigma factor. The anti-sigma factor inhibits the ECF 
sigma factor in absence of the sigma factor-activating environmental stress signal (see 
section 1.6.5). Often, the operon includes downstream target genes when the sigma regulon 
is small (Matsumoto et al., 2005). This ensures coordinated expression of the regulon genes. 
Group 4 sigma factors recognise -35 and -10 consensus sequences promoter elements that 
are different to those of typical primary sigma factors (Helmann, 2002). ECF sigma factors 
tend to have more stringent promoter sequence requirements; unlike a σ70 consensus 
sequence, single base substitutions may not be tolerated (Staron et al., 2009). The majority 
of ECF sigma factors also recognise promoters with an AAC motif in the -35 region, again 
suggesting that the diversity of gene targets results from more specific interaction 
elsewhere at the -10 box. At some promoters, a role for a segment of the spacer region 
immediately downstream of the -35 region has been implicated (Gaballa et al., 2018; Agnoli 
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et al., 2018). Increased stringency of promoter region selection by ECF sigma factors 
compared to σ70 is also achieved by alternative DNA promoter melting during transcription 
initiation. In the case of E. coli σE, the opening of the DNA helix is initiated by the flipping out 
of a single C-10 base accommodated by the ECF sigma factor region using a dynamic loop 
region. This single base specificity is not observed in σ70, and adds another level of 
stringency to promoter recognition, ensuring the redirected gene expression is restricted to 
the target regulons of ECF sigma factors (Campagne et al., 2014). 
The broad range of ECF sigma factors and their high level of diversity provide some difficulty 
in their categorisation. Bacterial species have on average six different ECF sigma factors, 
adding to the complexity. Nonetheless, ECF sigma factors were initially organised into at 
least 43 phylogenetically distinct major groups (Staron et al., 2009). However, this 
classification only used predicted ECF sigmas from well-studied bacterial phyla – although 
2,700 proteins were analysed, this is relatively small compared to the large range of 
potential ECF sigma factors. Moreover, many sigma factors were identified that could not be 
placed into the major groups – this issue will likely grow with the further identification of 
previously uncharacterised ECF sigma factor. Indeed, the number of major ECF sigma factors 
groups recognised has now increased to 50, yet this only encompasses roughly two thirds of 
all ECF sigma factor protein sequences identified (Jogler et al., 2012; Mascher, 2013). 
However, a small number of ECF sigma factors contain an additional domain fused to the C-
terminus of σ4. These C-terminal domains are thought to modulate the protein’s activity by 
acting as a sensory domain, an intra- or inter-molecular auto-inhibitory domain, or a protein 
interaction domain (Wecke et al., 2012). These C-terminal domains are not found in most 
ECF sigma factors. 
 
1.6.5 Anti-sigma factors 
One key characteristic of ECF sigma factors is their regulation by anti-sigma factors (Paget, 
2015; Staron et al., 2009). This usually occurs through inhibition of the abilty of the sigma 
factor to interact with core RNAP. Anti-sigma factors for ECF sigma factors are usually 
cytplasmic membrane-bound proteins that interact with ECF sigma factors to post-
translationally regulate their activity in a variety of ways. Such anti-sigma factors contain at 
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least three domains: (a) a cytoplasmic sigma protein interaction module, (b) a 
transmembrane domain, and (c) a sensory periplasmic/extracellular module which senses 
the stimulus to which the sigma factor responds (Yoshimura et al., 2004). Upon sensing of 
the specific signal (directly or indirectly via other interacting partners), the anti-sigma 
releases the sigma factor allowing it to associate with core RNAP. As the gene encoding the 
anti-sigma factor is often co-expressed with the sigma factor gene in an operon, this ensures 
that the sigma factor is expressed in an inactive form and with stoichiometric quantities of 
sigma:anti-sigma factor (Busche et al., 2012). Sigma factor/anti-sigma factor systems are 
important as they shape the third mechanism of signal transduction in bacteria, after one- 
and two-component signalling systems (Staron et al., 2009; Stock, Robinson and Goudreau, 
2000; Ulrich, Koonin and Zhulin, 2005).  
Anti-sigma factors possess a cytoplasmically-located N-terminal anti-sigma domain (ASD), 
forming a helical bundle which is able interact with the sigma factor to inhibit its activity. 
(Campbell et al., 2007). In one class of sigma factor, this helical bundle is stabilised by the 
addition of a zinc ion – this is termed a zinc-binding anti-sigma domain (ZASD) (Campbell et 
al., 2007). The ZASD domain contains a HX3CX2C motif which comprises three ligands, along 
with another cysteine or histidine residue elsewhere in the protein, which bind the zinc 
cation. Interestingly, the ZASD domain has been implicated in cytoplasmic sensing 
mechanisms, where it can act as a redox switch, initiating release of the sigma factor (Paget 
et al., 2001; Bae et al., 2004). 
Inhibition of the sigma factor though the ASD can occur either by disruption of the 
interaction with DNA and/or RNAP, or by stabilising the sigma factor in an inactive 
conformation. Anti-sigma factors inhibit sigma factors via three interaction classes (Figure 
1.11), although it is possible and probable that more as yet uncharacterised strategies exist. 
Class I anti-sigma factors insert the ASD between domains σ2 and σ4 of the ECF sigma factor 
and disrupt its binding to RNAP. This mechanism of inhibition is observed in the E. coli 
σE/RseA sigma:anti-sigma factor pair that regulates the response to cell envelope stress 
(Campbell et al., 2003). Another version of this mechanism using a ZASD is observed in the 
Rhodobacter sphaeroides σE:ChrR sigma:anti-sigma factor system that regulates the 
transcriptional response to reactive singlet oxygen (Campbell et al., 2007). 
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Class II anti-sigma factors can interact around sigma factor to stabilise the compact and 
inactive sigma structure (Sorenson, Ray and Darst, 2004; Maillard et al., 2014). This is the 
case in the σCnrH:CnrY sigma:anti-sigma factor system of Cupriavidus metallidurans than 
regulates nickel and cobalt resistance. In the inhibitory complex, CnrY stabilises the σCnrH 
conformation that buries its DNA interaction surfaces, thereby preventing σ2 interaction 
with the -10 promoter element. Furthermore, the anti-sigma factor CnrY occludes protein-
protein interaction surfaces of σCnrH to inhibit RNAP holoenzyme formation (Maillard et al., 
2014).  
A third way in which anti-sigma factors can act upon their ECF sigma factor partner is by the 
more recently discovered class III mechanism. These anti-sigma factors act simultaneously in 
two ways. Firstly, an ASD helix inserts between the σ2 and σ4 domains of the sigma factor 
blocking access of the DNA binding surfaces of the protein to the core promoter elements 
(more specifically, the σ4 domain from the -35 promoter element). This mechanism is similar 
to Class I anti-sigma factors. Secondly, the rest of the ASD can bind around the sigma factor, 
holding it in a compact and inactive conformation that is unable to interact with DNA or 
associate with RNAP. This is similar to the class II system. Class III anti-sigma factors are 
exemplified by the σBldN:RsbN sigma:anti-sigma factor system of Streptomyces venezuelae 
which regulates hyphae growth (Schumacher et al., 2018). All of these mechanisms are used 
by anti-sigma factors with no strong primary sequence similarity, suggesting they have 
arisen through convergent evolution. There are likely to be more undiscovered methods of 
ECF sigma factor inactivation by anti-sigma factors. 
Activation of the sigma factor via inactivation of the anti-sigma factor is also achieved in 
various ways. The most well studied mechanism is that of regulated proteolysis of the 
membrane-spanning anti-sigma factor by the process of regulated intermembrane 
proteolysis (RIP) (Heinrich and Wiegert, 2009). RIP consists of three proteolytic steps that 
result in: cleavage of the extracellular (-1) site of the anti-sigma factor, degradation of the 
transmembrane helix (-2) site, and further cytosolic proteolysis of the cytoplasmic domain 
by the ClpXP protease system to release the sigma factor. The proteases used in these steps 
can be fairly non-specific for the system, and several may be required at each step (Chaba et 
al., 2007; Ho and Ellermeier, 2012). In this mechanism, the proteases directly or indirectly 
respond to activating signals. For example, in Gram-negative bacteria, DegS acts as the 
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initial protease involved in the degradation of the anti-sigma factor RseA. DegS acts as a 
periplasmic stress sensor directly responding to misfolded outer membrane protein 
peptides. Its activation provides the rate limiting step for the downstream release of the 
RseA-bound σE, which drives the expression of genes associated with the adjustment 
response to cell envelope stress (Wilken et al., 2004). 
 
 
Figure 1.11. Inhibitory mechanisms of anti-sigma factors. 
Mechanisms employed by anti-sigma factors for inhibiting the function of sigma factors. Class I anti-
sigma factors (left) insert the anti-sigma domain (ASD) between the σ2 and σ4 domains of the sigma 
factor. Example shown is RseA interacting with σE of E. coli (PDB:1OR7). Class II anti-sigma factors 
(centre) bind around the σ2 and σ4 domains holding the sigma factor in an inactive conformation. 
Example shown is CnrY interacting with σCnrH of Cupriavidus metallidurans (PDB:4CXF). Class III anti-
sigma factors (right) insert between the σ2 and σ4 domains and bind around to hold the sigma factor 
in an inactive conformation. Example shown is RsbN interacting with σBldN of Streptomyces 
venezuelae (PDB:6DXO). 
 
Alternatively, anti-sigma factor inactivation can occur by allosteric means in anti-sigma 
factors which are not membrane bound. As discussed above, anti-sigma factors with ZASD 
motifs can act as direct redox sensors. In the case of the Streptomyces coelicolor anti-sigma 
factor RsrA, a ZASD-containing anti sigma factors that is not membrane bound, the ZASD 
motif of forms disulphide linkages between key cysteine residues when under disulphide 
stress. This results in the ejection the structurally significant zinc cation and stabilisises the 
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inactive reduced form of RsrA, resulting in release of its cognate sigma factor, σR. σR then 
drives the expression of thioredoxin and thioredoxin reductase genes to respond to the 
disulphide stress (Li et al., 2003). Anti-sigma factor suppression by conformational change 
can also occur indirectly. When the C. metallidurans outer membrane sensor protein CnrX 
detects extracellular cobalt or nickel ions, the metal binding induces allosteric changes that 
are transferred to the linked membrane-bound anti-sigma factor, CnrY, resulting in release 
of the ECF sigma factor CnrH, which then activates transcription of the appropriate metal 
ion resistance genes (Trepreau et al., 2011). 
Anti-sigma factor deactivation can also be achieved by sigma factor mimicry (Mascher, 
2013). In this method, the activating signal causes the anti-sigma factor to interact with a 
sigma-like protein with greater affinity than the sigma factor itself, thereby releasing the 
sigma factor. For example, in α-proteobacteria, sigma factor EcfG (σEcfG) is bound by its anti-
sigma factor, NepR, in the absence of signal (Campagne et al., 2012). However, stress 
conditions induce the action of Pak (PhyR-activating kinase) histidine kinases, which can 
phosphorylate the normally inactive unphosphorylated PhyR response regulator on its C-
terminal response domain. This activation induces an allosteric change in PhyR, presenting 
its N-terminal σEcfG-like domain, which causes NepR to undergo partner-switching to release 
active σEcfG (Campagne et al., 2012; Francez-Charlot et al., 2015). 
 
1.6.6 Iron starvation (IS) sigma factors and cell-surface signalling (CSS) 
Iron starvation (IS) sigma factors are sigma factors that belong to the groups ECF05-10, 
based upon the analysis of Staron et al (2009). IS sigma factors regulate the transcription of 
genes associated with iron acquisition. The transcription of these sigma factors are 
regulated by Fur (see section 1.5), and therefore the associated iron acquisition genes are 
only expressed under conditions of iron limitation (Baichoo and Helmann, 2002; Moraleda-
Munoz et al., 2019). A mechanism of sigma factor activation that is often implicated in ferric 
iron uptake, and regulates ECF sigma factors of the iron starvation (IS) class, is cell surface 
signalling (CSS)(Llamas et al., 2014). This mechanism occurs in Gram-negative bacteria and 
involves a protein interaction cascade that links extracellular signals to the cytoplasmic 
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sigma factor. Three examples of IS sigma factor systems, PvdS/FpvI, FecI and FoxI, are 
discussed below. 
The PvdS/FpvI sigma factor system of Pseudomonas aeruginosa is unusual in that one anti-
sigma factor, FpvR, acts as an inhibitory partner for two sigma factor, PvdS and FpvI (Llamas 
et al., 2014). P. aeruginosa produces a siderophore known as pyoverdine, and binding of 
iron-loaded pyoverdine (i.e. ferripyoverdine) to the TBDR FpvA initiates TonB-mediated 
active transport of the ferric-siderophore complex across the outer membrane. Binding of 
the ferric-siderophore complex to FpvA also stimulates the proteolytic cleavage of the linked 
FpvR anti-sigma factor by the RseP/MucP proteases (Visca, Imperi and Lamont, 2007), 
freeing the FpvI to direct further transcription of the fpvA gene, and PvdS to direct genes 
associated with pyoverdine synthesis (Edgar et al., 2017). 
Another IS sigma factor system is the Fec system found in many bacteria, comprising the 
sigma factors FecI and its anti sigma factor FecR (Braun and Mahren, 2005). In this system, 
the siderophore is citrate, and iron-loaded citrate is transported via the TBDR, FecA. Upon 
binding of extracellular ferric citrate to the FecA, an N-terminal domain of the TBDR 
interacts with the C-terminal domain of the linked anti-sigma factor FecR. This releases the 
sigma factor FecI. However, FecR appears to be essential for the activity of FecI, and thereby 
is more appropriately termed a sigma factor regulator (Mahren and Braun, 2003; Mettrick 
and Lamont, 2009). This may be due to FecR either (a) assisiting the association of FecI to 
core RNAP, or (b) stabilising the FecI sigma factor and/or protecting it from proteolysis 
(Braun, Mahren and Sauter, 2006). Thus, FecR acts as an inhibitor (anti-sigma factor) under 
non-inducing conditions and an activator (sigma factor) under inducing conditions. In these 
systems, the anti-sigma factor is referred to as a sigma factor regulatory protein. 
This regulator-dependent sigma factor activation is also observed in the P. aeruginosa FoxI-
FoxR system, and homologue of the Fec system (Bastiaansen et al., 2015a). This system 
regulated the utilisation of ferrioxamine B. Binding the ferric-ferrioxamine to the TBDR FoxA 
induces the interaction of a FoxA signalling domain with a periplasmic C-terminal domain of 
the sigma factor regulator FoxR. Self-cleavage of FoxR, via an N-O acyl rearrangement of 
residues Gly191 and The192, leads to the proteolysis by the Prc/RseP proteases. After this 
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cleavage, a cytoplasmic domain of the sigma factor regulator, termed a pro-sigma domain, 
remains bound to the sigma factor to mediate its activation (Bastiaansen et al., 2015b). 
Other anti-sigma factor-independent mechanisms of regulation include: direct regulation by 
transcription factors (Hong, Paget and Buttner, 2002; Lan et al., 2006), activation via 
phosphorylation by serine/threonine kinases (although this has not been empirically 
demonstrated) (Jogler et al., 2012), and some mechanisms which are completely 
uncharacterised (Mascher, 2013). 
 
1.7 Sigma factors with on-board regulatory 
domains 
 
1.7.1 ECF sigma factors with C-terminal regulatory domains 
Although the majority of ECF sigma factors are associated with an anti-sigma factor, there 
are several ECF groups which do not have a cognate anti-sigma factor. These sigma factors 
appear to be regulated in an anti-sigma factor-independent fashion (Mascher, 2013).  
Commonly, these ECF sigma factors have a fused regulatory C-terminal domain (CTD). 
Currently, there are over 15 ECF groups classified with such CTDs. However, only members 
of groups ECF41, ECF42, and ECF44 have been characterised. 
The ECF41 group contains over 400 different sigma factors across ten bacterial phyla 
including Acidobacteria, Actinobacteria, Cyanobacteria, Firmicutes, and Proteobacteria 
(Staron et al., 2009). They are hypothesised to have roles in redox homeostasis as they are 
often found in a genomic context with genes encoding oxioreductases, epimerases and 
carboxymuconolactone decarboxylases. ECF41 sigma factors have fused ~200 amino acid C-
terminal extensions with a conserved SnoaL_2-like domain. This domain may have a dual 
role, acting as an activator and inhibitor of the ECF sigma factor. The crystal structure of σJ 
from Mycobacterium tuberculosis suggests that the SnoaL_2 domain may act as a scaffold, 
holding the σ2 and σ4 domains in an inactive conformation under native conditions (Goutam, 
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Gupta and Gopal, 2017). Additionally, this regulatory CTD is also required for ECF sigma 
factor activity, so it also displays an activating role (Wecke et al., 2012). 
The ECF42 group consists of proteins that are mostly found in Actinobacteria and 
Proteobacteria, and are often situated near DGPF proteins (a highly-conserved but poorly-
characterised protein class with an D-G-P-F motif). The very large scale of the fused CTD 
means that ECF42 sigma factors are larger than most other ECF sigma factors. The fused CTD 
contains tetratrico peptide repeats (TPRs) which are hypothesised to have a role in protein-
protein interactions. Similarly to the ECF41 SnoaL_2 domain, the ECF42 TPR-containing CTD 
is required for the ECF sigma factor activity. However, there is less evidence demonstrating 
a regulatory function for the ECF42 CTD (Liu, Pinto and Mascher, 2018; Wu et al., 2019). 
ECF44 group sigma factors have a short cysteine-rich domain (CRD) of around 30-40 amino 
acids located at the C-terminus. These CRDs have been shown to act as metal-ion sensors, 
where the regulatory function of the CRD is activated in the presence of specific metal ions. 
The two characterised ECF44 sigma factors from Myxococcus xanthus, CorE and CorE2, have 
six cysteine residues within their CRDs. However, the arrangement of these cysteines is 
different, and this may confer different metal ion specificity. The CorE CRD has been 
demonstrated to interact with Cu+ ions (which inhibit CorE) and Cu2+ ions (which activate 
CorE) (Gomez-Santos et al., 2011). CorE2, with its different arrangement of cysteine 
residues, has been shown to be inactivated by Cd2+ and Zn2+ via its CRD (Marcos-Torres et 
al., 2016). However, the precise step of transcription initiation that is blocked by this 
mechanism has not been shown i.e. it is not clear whether metal binding inhibits (a) the 
association of the sigma factor with core RNAP, or (b) binding of the sigma factor to DNA (in 
association with core RNAP). 
There are examples of ECF groups that have been identified as lacking a cognate anti-sigma 
factor and containing a C-terminal domain that have not been characterised. In particular, 
the groups ECF58-62 found in Planctomycetes (formerly ECF01-Gob, ECF01-P, ECFSTK_01-
04) display these characteristics and it is possible that their CTDs display a regulatory 
function (Jogler et al., 2012; Pinto and Mascher, 2016). However, their signalling 




Figure 1.12. Domain architecture of characterised ECF sigma factors with putative regulatory C-
terminal regions 
All ECF sigma factors contain the conserved core ECF domains σ2 and σ4. Several classes of ECF sigma 
factors lack a cognate anti-sigma factor and contain a putative regulatory C-terminal region. The 
ECF09 sigma factors MbaS and OrbS have short C-terminal regions which constitute a C-terminal 
extension. ECF44 sigma factors have a short C-terminal region which constitutes a cysteine-rich 
domain (CRD) (Marcos-Torres et al., 2016; Gomez-Santos et al., 2011). ECF41 and ECF42 sigma 
factors have longer C-terminal regions; the ECF41 C-terminal region is a SnoaL_2-like domain, and 
the ECF42 C-terminal region contains tetratrico peptide repeats (TPRs) (Wu et al., 2019). Domains 
are not shown to scale. 
 
1.7.2 MbaS, OrbS, and the cysteine-rich extension (CRE) 
MbaS and OrbS Burkholderia sigma factors that are members of the ECF09 group, based on 
sequence similarity (Staron et al., 2009). Unlike other members of this group, they lack an 
anti-sigma factor and have a short extension at the C-terminus which may have a 
compensatory regulatory function. Similarly to the CRD found in ECF44 sigma factors, the C-
terminal extensions of MbaS and OrbS (and the homologous Paraburkholderia IS sigma 
factor PhmE) are rich in cysteine residues (Figure 1.13). This C-terminal extension could be 
considered a cysteine-rich extension (CRE). 
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Orbs part of the orb gene cluster responsible for the synthesis of ornibactin in Bce. It was 
demonstrated to be a sigma factor that acted upon three OrbS-dependent promoters (PorbH, 
PorbE and PorbI) by RT-PCR and transcription reporter analyses. Additionally, the orbS 
promoter was shown to regulated by Fur (Agnoli et al., 2006). Recently, the core elements 
OrbS-dependent promoters have been identified with greater precision, in addition to the 
transcription start site. The importance of the spacer region upon the activity of OrbS, and 
cross-activity between OrbS and PvdS, was also demonstrated (Agnoli et al., 2018). 
MbaS was  originally identified as the sigma factor responsible for the transcription of the 
mba gene cluster associated with malleobactin in Bth (see section 1.4.4). It was 
demonstrated to be induced under iron-limiting conditions, likely due to regulation by Fur at 
an identified Fur box sequence.  It was also shown to be necessary for the transcriptional 
activity from the mbaI promoter (Alice et al., 2006). Several studies have been published 
analysing the mba gene cluster and malleobactin, but these have not investigated MbaS 




Figure 1.13. Alignment of amino acid sequences of the C-terminal extensions of ECF group sigma factors RpoE, OrbS, MbaS, PvdS and PhmE. 
Sequences are aligned with Clustal-omega, amino acids that are identical in ≥70% of sequences are shown in white font highlighted in black, and amino 
acids that have similarity are shown in white font highlighted in grey. Conserved regions 4.1 and 4.2, based upon assignments of RpoE, are enclosed in blue 
and red boxes, respectively. The cysteine-rich extension (CRE) located at the C-terminus is enclosed in a yellow box, and cysteine residues in this region are 
highlighted in yellow. A conserved histidine residue within region 4.2 that is conserved across sigma factors containing a CRE is highlighted in red font. The 
iron starvation sigma factor sub-group to which sequnces belong is denoted on the left. Sequences were obtained from the following strains: E. coli 
MG1655, B. cenocepacia H111, Burkholderia ambifaria AMMD, Burkholderia lata 383, B. pseudomallei K96243, B. thailandensis E264, B. mallei ATCC23344, 
P. aeruginosa PA01, Pseudomonas putida KT2440, Pseudomonas fluorescens F113, Paraburkholderia phytofirmans PsJN, Paraburkholderia phymatum 







Bce encodes 13 annotated ECF sigma factors across two of its three chromosomes. One of 
these proteins is encoded by the gene annotated as BCAM0001. It is a member of the ECF13 
family, a small ECF sigma factor family found exclusively in Proteobacteria (Staron et al., 
2009). BCAM0001 is functionally uncharacterised. 
In the BCAM0001 system, the anti-sigma factor is encoded by the originally unannotated 
gene BCAM0001a. The BCAM0001a gene is located downstream of the sigma factor gene, 
and overlaps with the BCAM0001 gene by 23 bp, suggesting that these two genes may be 
co-transcribed. The unusual anti-sigma factors associated with ECF13 group sigma factors 
are typified by their possession of ZAS domains (described in section 1.6.5). Most interesting 
of all, these anti-sigma factors lack the central transmembrane region and periplasmic C-
terminal domains, indicating they act cytoplasmically. This group of anti-sigma factors are 
not well characterised. ZAS domains can act as redox sensors, with the thiol groups of 
conserved cysteine residues interacting with a zinc cation under favourable conditions, and 
forming disulphide bonds under stress conditions to eject the zinc cation and release the 
sigma factor. BCAM0001a also contains a ZAS domain, suggesting it could form a redox-
mediated interaction with its sigma factor (Figure 1.14). 
The adjacent genes to the sigma-anti-sigma factor pair, annotated as BCAM2840 and 
BCAM0002, are predicted to be involved in toxic metal resistance and show similarity to 
chromate reductases and arsenate reductases, respectively. Given that sigma factors often 
act on neighbouring genes, it is possible that sigma factor encoded by BCAM0001 regulates 






Figure 1.14. Sequence alignment of selected zinc-binding anti-sigma domains (ZASDs) and 
BCAM0001a. 
Residues with identity are shown in white font highlight in black, residues with similarity are shown 
in white font highlight in grey. The ZAS motif is aligned below sequences in bold font (Campbell et 
al., 2007). Sequences were obtained from the following species: BCAM0001a, Bce H111; NGO1943, 
Neisseria gonorrhoeae; NMB2145, Neisseria meningitidis; RsrA, Streptomyces coelicolor; ChrR, 
Rhodobacter sphaaroides. 
 
1.9 Hypotheses and aims 
 
1.9.1 Hypotheses and aims of MbaS- and OrbS-related studies 
Unlike the similar IS sigma factor PvdS, both MbaS and OrbS do not appear to have a 
cognate anti-sigma factor. Although the transcription of both mbaS and orbS has been 
demonstrated to be regulated by Fur, for stringent control of malleobactin/ornibactin 
synthesis post-translational regulation may be required. 
The cysteine-rich extension (CRE) present at the C-terminal region of MbaS/OrbS may play a 
role in this regulation. Cysteines often play a key role in binding metal ions. In particular, by 
binding iron ions via thiol functional groups to form iron-sulphur clusters. Thiols also often 
serves as ligands for zinc. Therefore, the cysteine residues of the CRE may directly respond 
to metal ions, which in turn induce an inactive conformation of the sigma factor. This would 
allow downregulation of the siderophore-associated genes under metal-replete conditions.  
This interacting metal ion is hypothesised to be Fe(II), due to the specificity of ornibactin 
and malleobactin for ferric iron. The bacterial cell is a reducing environment, so Fe(II) would 
be an appropriate signalling ion for the presence of high extracellular levels of Fe(III). 
BCAM0001a    1 -----MLPGKCTDVTRLL(13)LQVRVHLPTCSGCRAYRGQIALLRTAAKA 56 
NGO1943      1 -------MKKCRDIALLL(13)ISIYMHLLFCPHCREYKRQLQTIKISLAK 54 
NMB2145      1 -------MKKCRDIALLL(13)ISIYTHLLFCPYCREYKRQLQTIKRSLAK 54 
RsrA         1 MSCGEPHETDCSEILDHL(13)VKFEHHFEECSPCLEKYGLEQAVKKLVKR 61 
ChrR         1 -----MTIRHH-VSDALL(13)LVVATHLSLCDECRARAGALDAVGGSLME 55 
ZAS motif                                 HXXXCXXC 
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The activity of MbaS and OrbS in response to the presence of iron and other metal ions will 
be investigated. This will be compared to mutant forms of these proteins, with deleted or 
substituted residues, to examine the influence the C-terminal domain (and more specifically 
the cysteine residues of the CRE) has upon the regulation of the sigma factor activity. 
 
1.9.2 Hypotheses and aims of BCAM0001-related studies 
The function of the protein encoded by the gene annotated as BCAM0001 is unknown. The 
phenotype associated with deleting the BCAM0001 gene in Bce may provide some insights 
into the function. BCAM0001 and BCAM0001a are predicted to be a sigma-anti-sigma factor 
pair. This study aims to characterise this protein-protein interaction. Finally, in order to 
demonstrate the sigma factor activity of BCAM0001, its target promoters must be 



































2.1 Bacteriological methods 
 
2.1.1 Bacterial strains used in this study 
The bacterial strains used in this study are shown in Table 2.1. 
Table 2.1. Bacterial strains used in this study 
Strain Geneotype/Description[1] Reference 
E. coli Strains   




JM83 F- ara Δ(lac-proAB) rpsL φ80dlacZΔM15 (Smr) (Yanisch-Perron, 
Vieira and 
Messing, 1985) 
S17-1λpir thi proA hsdR recA RP4-2-tet::Mu-1 kan::Tn7 









BL21λDE3 F- ompT hsdS(rB- mB-) dcm+ gal endA (λDE3) (Tcr) (Studier and 
Moffatt, 1986) 
QC771 F- Δ(argF-lac)U169 rpsL (Smr) (Carlioz and 
Touati, 1986) 
QC1732 F- Δ(argF-lac)U169 rpsL Δfur::kan (Smr Kmr) (Touati et al., 
1995) 
BTH101 F- cya-99 araD139 galE15 galK16 rpsL1 hsdR2 mcrA1 
mcrB1 (Smr) 
Euromedex 
CC118λpir Δ(ara-leu) araD ΔlacX74 galE galK phoA20 thi-1 rpsE 




H1717 F- araD139 Δ(argF-lac)U169 rpsL150 relA1 deoC1 
ptsF25 flbB5301 aroB fhuF::λplac Mu 
(Hantke, 1987) 
   
B. thailandensis Strains   
E264 Environmental isolate; prototroph (Brett, DeShazer 
and Woods, 
1998) 
E264 ∆mbaS E264 with in-frame deletion within mbaS 
(BTH_II2426) 
This study 
E264 ∆pchE E264 with in-frame deletion within pchE 
(BTH_II1828) 
This study 
E264 ∆mbaS ∆pchE E264 ∆pchE with in-frame deletion within mbaS 
(BTH_II2426) 
This study 
   
B. cenocepacia Strains   
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OM3 KLF1-orbI::mini-Tn5Tp (orbI- derivative of 
spontaneous Pch- mutant of strain 715j) 
(Agnoli et al., 
2006) 
H111 CF isolate from Germany (Gotschlich et 
al., 2001) 
H111 ∆orbS H111 with in-frame deletion within orbS (BCAL1688) A. T. Butt 
(unpublished) 
H111 ∆BCAM0001a H111 with in-frame within BCAM0001a  This study 
H111 ∆BCAM0001-
BCAM0001a 
H111 with in-frame deletion through BCAM0001 
and BCAM0001a 
This study 
   
[1] Smr=streptomycin resistance; Tpr=trimethoprim resistance; Kmr=kanamycin resistance; 
Tcr=tetracycline resistance.  
 
2.1.2 Growth media 
All media were made up in 300 ml glass medicine bottles. For solid media, agar powder was 
added to the solution at 1.5% (w/v) prior to autoclaving where required. Solutions were 
autoclaved for 20 minutes (except for M9 minimal media containing p-chlorophenylalanine, 
see below). Media were allowed to cool to approximately 55oC before adding media 
supplements and, where agar was added, before pouring 25 ml per Petri dish. 
Luria-Bertani (LB) Medium 
The following were dissolved in d.H2O prior to autoclaving: 1.0% (w/v) tryptone, 0.5% (w/v) 
yeast extract, 1.0% (w/v) NaCl. 
Lennox (Lnx) Medium 
The following were dissolved in d.H2O prior to autoclaving: 1.0% (w/v) tryptone, 0.5% (w/v) 
yeast extract, 0.5% (w/v) NaCl. 
Environmental Broth (EB) Medium 
The following were dissolved in d.H2O prior to autoclaving: 0.33% (w/v) tryptone, 0.17% 





M9 Minimal Medium 
The following were added to d.H2O after autoclaving: 10X M9 salts solution (see below) to a 
final concentration of 10% (v/v), 1 M MgSO4 (filter sterilised) to a final concentration of 1 
mM, 100 mM CaCl2 (filter sterilised) to a final concentration of 100 µM. 
10X M9 salts solution was made up by dissolving the following: 60 g anhydrous Na2HPO4, 30 
g anhydrous KH2PO4, 5 g NaCl, 10 g NH4Cl in water to a final volume of 1 litre. 
Where each was desired, the following supplements were dissolved in d.H2O prior to 
autoclaving: casamino acids (CAA) at a final concentration of 1% (w/v), glucose at a final 
concentration of 0.5% (w/v), p-chlorophenylalanine (cPhe) at a final concentration of 0.1% 
(w/v) by mixing for approximately one hour (solutions containing cPhe had a reduced 
autoclaving time of 15 minutes). For blue/white screeing of E.coil JM83 transformants 
containing pSNUFF3Cm derivatives, the following were added to the medium containing 
0.1% (w/v) CAA after autoclaving: glycerol (final concentration of 0.5% (v/v)), thiamine (final 
concentration of 5 μg ml-1, made up at 5 mg ml-1 in d.H2O prior to addition), and 
trimethoprim (final concentration of 25 μg ml-1). 
CAS Medium 
In order to detect and determine the presence of siderophores produced by Bth, media 
containing chrome azurol S (CAS) was used, as per the protocol of (Schywyn and Neilands, 
1987). Two solutions, ‘CAS mix’ and Y minimal agar, were prepared and autoclaved 
separately. 
Y minimal agar was made up by dissolving the following in 90 ml d.H2O prior to autoclaving: 
169 mg glutamic acid (sodium salt), 0.3 g Tris base, 100 µl MgSO4·7H2O (10% (w/v), 100 µl 
CaCl2·6H2O (22% w/v), 100 µl K2HPO4·3H2O (22% w/v). The mixture was adjusted to pH 6.8, 
before the addition of agar powder for solid media. 
CAS mix was made up in the following way: 60.5 mg of CAS powder was added to 50 ml 
d.H2O until dissolved, followed by addition of 10 ml 1 mM FeCl3·6H2O (prepared by 
dissolution in 10 mM HCl), followed finally by addition of 40 ml 
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hexadecyltrimethylammonium bromide (HDTMA) solution (72.9 mg HDTMA dissolved in 40 
ml d.H2O) with stirring. 
Once autoclaved and cooled to ~50 oC, 90 ml of Y minimal medium was slowly combined 
with 10 ml CAS mix, and mixed until homogeneous. 
The resulting medium simulated iron-limiting conditions with ferric iron at a concentration 
of 10 µM. To prepare CAS medium with iron-replete conditions, FeCl3·6H2O was added 
immediately before pouring to give a final concentration of 60 µM. 
MacConkey Medium 
MacConkey agar (Difco) was dissolved into d.H2O at a final concentration of 4% (w/v) prior 
to autoclaving. Selected carbohydrates were added to the medium at a final concentration 
of 1% (w/v) after autoclaving. For Fur titration assays (see section 2.5.2), Fe(NH4)2(SO4)2 was 
added to the medium at a final concentration of 40 µM. 
 
2.1.3 Maintenance of bacterial cultures 
Escherichia coli 
E. coli cells were most commonly grown on LB-agar medium, although several other media 
were used where necessary for antibiotic selection or for agar plate-based assays. Agar 
plates harbouring E. coli were generally incubated overnight at 37 oC for approximately 16 
hours. Overnight liquid cultures of E. coli were grown in LB broth, with appropriate 
antibiotic where required. Single colonies of E. coli were picked by a sterile toothpick or 
loop. Cultures were incubated at 37 oC (200 rpm) with aeration, for approximately 16 hours. 
Burkholderia thailandensis and Burkholderia cenocepacia 
Bth and Bce were grown on similar media to E. coli. Where long-term storage was required, 
Bth and Bce were grown on M9 minimal media with 0.5% (w/v) glucose. EB media was used 
for the attempted selection of Bth fur mutants. Agar plates harbouring Bth and Bce strains 
were incubated at 37 oC for approximately 24-40 hours. Overnight liquid cultures of Bth and 
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Bce were made up in LB broth, with appropriate antibiotic where required. Single colonies 
of Bth and Bce were picked into sterile medium by sterile toothpick or loop. Cultures were 
incubated at 37 oC, 200 rpm, for approximately 16 hours. 
 
Storage of bacterial cultures 
For short-term storage, bacteria were routinely stored on parafilm-sealed agar plates. Agar 
plates harbouring E. coli and Bth were stored at 4oC, whereas agar plates harbouring Bce 
were stored at room temperature. Burkholderia strains were viable for considerably longer 
when stored on M9 minimal medium. E. coli strains were viable for up to one month of 
storage, Burkholderia strains were viable up to 10 days (increased when M9 minimal 
medium used). 
For long-term storage, bacterial suspensions were frozen in the presence of glycerol. 700 µl 
of overnight culture and 300 µl of 50% (v/v) glycerol were mixed in a cryovial and stored at -
80 oC. Strains were retrieved from glycerol stocks by scratching the surface of the frozen 
bacterial suspension with a wire loop and streaking onto a fresh agar plate to isolate single 
colonies. 
 
2.1.4 Plasmid transfer into bacteria 
Preparation of competent E. coli cells 
Competent E. coli cells capable of uptake of plasmid DNA via transformation were prepared 
by the method of (Hanahan, 1983). An overnight culture of the desired E. coli strain was 
grown in LB medium. 500 µl of this was inoculated into 50 ml of LB medium and grown at 37 
oC with aeration at 200 rpm until OD600≈0.5, whereupon the culture was stored on ice for 15 
minutes. Cells were collected by centrifugation at 3200x g for 10 minutes, and the cell 
pellets were resuspended in ice-chilled solution RF1 (100 mM KCl, 50 mM MnCl2·4H2O, 30 
mM potassium acetate, 10 mM CaCl2·2H2O, 15% (v/v) glycerol, adjusted to pH 5.8 with 200 
mM acetic acid) before storage on ice for 30 minutes. Cell were harvested by centrifugation 
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at 3200x g for 10 minutes, and resuspended in ice-chilled solution RF2 (200 µl MOPS [3-(N-
Morpholino)propanesulfonic acid] mixed with 9.8 ml 10 mM KCl, 75 mM CaCl2·2H2O, 15% 
(v/v) glycerol) followed by storage on ice for 15 minutes. 200-400 µl aliquots of these 
competent cells were transferred to in microcentrifuge tubes and stored immediately at -80 
oC. This method was used to create stocks of the following competent E. coli cells: JM83, 
BL21λDE3, MC1061, S17-1, SM10λpir, QC771, QC1732, BTH101, H1717, CC118λpir. 
Transformation 
Transformation was the preferred means of transferring plasmid DNA into E. coli cells. An 
aliquot of competent E. coli cells and the stock of plasmid DNA be transferred were 
defrosted on ice for 20 minutes. DNA-competent cell solutions were made up in individual 
microcentrifuge tubes. For transformation of plasmid miniprep DNA, 1-2 µl of DNA was 
added to 50 µl of cells. For transformation of ligation reactions, 10-20 µl of each solution 
(ligation, ligation control, and vector control) was each added to 50 µl of cells. Additionally, 
1-2 µl of supercoiled plasmid DNA (corresponding to the ligation reaction) was added to 50 
µl of competent cells as a cell control. As a control for the antibiotic selection agar plate 
and/or contamination of the competent cells, 50 µl of cells with no added DNA was also 
included. 
All DNA-competent cell suspensions were chilled on ice for 20 minutes prior to heat shock at 
42 oC in a water bath for 60 seconds. Following the heat shock, suspensions were returned 
to ice for two minutes, whereupom 500 µl of LB broth was added to each suspension, and 
the suspensions were incubated at 37 oC 200 rpm for 45 minutes. 100 µl of each cell 
suspension were spread on agar plates with appropriate antibiotic(s) to select for the 
transforming plasmid, and incubated at 37 oC overnight. The remainder of the cell 
suspensions were stored at 4 oC overnight as a contingency measure. 
Conjugation 
Conjugation, using E. coli donor cells, was the preferred means of transferring plasmid DNA 
into Burkholderia cells. The plasmid to be transferred was initially transformed into the E. 
coli donor strain, either S17-1 or SM10λpir (described in section 2.1.4: Transformation). 
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Overnight cultures of theplasmid-bearing E. coli donor strain and the recipient Burkholderia 
strain were grown in LB broth at 37 oC. 
1 ml of cells were taken from the E. coli donor culture (henceforth known as ‘donor’), and 
two 1 ml aliquots of the Burkholderia strain culture (henceforth known as ‘recipient’) were 
transferred to seperate microcentrifuge tubes. After centrifugation at 17,000x g for one 
minute, the cell pellets from the donor and recipient aliquots were resuspended in 200 µl 
phosphate-buffered saline (PBS). 100 µl from the donor cell suspension was taken and used 
to resuspend one of the recipient cell pellets. 100 µl of each of the cell suspensions was 
applied onto individual 0.45 µm nitrocellulose discs placed on separate agar plates (LB agar 
in most cases, EB agar when attempting to generate fur mutants) and incubated at 37 oC 
overnight. 
The nitrocellulose discs, with a lawn of bacterial growth on them, were each transferred to 
20 ml universal tubes containing 3-5 ml of PBS using sterile forceps, and the cells were 
resuspended by vigorous vortexing. 100-400 µl of undiluted or diluted cell suspensions were 
spread on selective agar plates containing appropriate antibiotics to select for the 
Burkholderia strain containing the transferred plasmid and ensuring the donor cells did not 
grow. Plates were incubated at 37 oC for 16-40 hours. 
Provided no colonies were formed on the donor or recipient control plates, colonies on the 
mix plate were accepted to be Burkholderia bearing the conjugated plasmid. 
 
2.1.5 Allelic exchange in Burkholderia 
For the in-frame marker-less deletion or mutation of genes in B. thailandensis and B. 
cenocepacia, two gene replacement vectors were used: pEX18Tp-pheS (Barrett et al., 2008) 
and pSNUFF3Cm (H. Spiewak, unpublished). These methods were particularly important 
when it was essential to avoid polar effects on downstream genes (such as in generating an 
mbaS mutant) and to allow multiple gene deletions to be introduced into a single strain 
without gaining antibiotic selectable markers and thereby restricting the ability to introduce 
plasmids. Additionally, for the attempted generation of marked mutants, such as the Bth 
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∆fur::TpTer mutant, the pSHAFT2 gene replacement vector was used (Shastri et al., 2017). 
This was necessary due to the strong selection for the restoration of the wild-type fur gene 
using marker-less gene deletion methods.  
Generation of DNA fragments that contained in-frame deletions within the target gene was 
achieved using SOE-PCR (see section 2.2.6). These DNA fragments contained ≥500 bp of 
identical sequence with the Burkholderia genome on either side of the gene deletion. In the 
case of the ∆fur::TpTer allele, a TpTer cassette was also inserted within the gene deletion. 
The SOE-PCR generated DNA fragments were then cloned into the MCS of the desired allelic 
exchange vector. 
The pEX18Tp-pheS and pSNUFF3Cm systems introduced allelic exchange using two rounds 
of homologous recombination. pEX18Tp-pheS and pSNUFF3Cm are able to introduce the 
mutant alleles into Burkholderia as the bacteria lack the ability to utilise the ColE1 origin of 
replication of the plasmids. Only homologous recombination between the chromosome and 
the plasmids, resulting in genomic integration of the plasmid, confers the specified 
antibiotic selection markers. The resulting co-integrant Burkholderia contains both the wild-
type allele and the deleted/modified allele. For the second homologous recombination, a 
counterselection that kills co-integrant cells was implemented. Two different methods for 
doing this were employed, for either pEX18Tp-pheS system or the pSNUFF3Cm system. 
For deletion of genes that were integrated into the genome using pEX18Tp-pheS (Figure 
2.1a)), co-integrant strains were grown on M9 minimal agar containing 0.1% (w.v) DL-4-
chlorophenylalanine (Sigma-Aldrich) (cPhe). Initially, the co-integrant strain was grown on 
M9-glucose agar containing 25 µg ml-1 trimethoprim. A single colony was taken, 
resuspended in PBS, and equal volumes of the cell solution spread on M9-glucose agar 
supplemented with: 25 µg ml-1 trimethoprim (control A); 25 µg ml-1 trimethoprim and 0.1% 
(w/v) cPhe (control B); and 0.1% (w/v) cPhe (recombination). Control A conditions should 
give rise to a high number of uniformly-sized colonies, control B conditions should give rise 
to no colonies, and the recombination conditions should give rise to a low number of 
variably-sized colonies. The B. pseudomallei mutant pheS gene, incorporated into the 
genome, is lethal when cPhe is present as it allows charging of tRNAPhe with cPhe. Therefore, 
only a second homologous recombination that results in plasmid excision enables survival. 
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The second crossover event resulted in either restoration of the wild-type gene, or 
introduction of the deleted/modified gene into the chromosome. cPhe-resistant 
recombinant strains were identified by parallel counter screening on agar containing 
chloramphenicol and trimethoprim, where sensitivity to the antibiotics indicated loss of the 
vector backbone. 
For the deletion of genes that were integrated into the genome using pSNUFF3Cm (Figure 
2.1b), the plasmid pDAI-SceI-pheS was introduced into the co-integrant strain by 
conjugation, and strains that had successfully taken up the plasmid were selected for with 
tetracycline resistance specified by pDAI-SceI-pheS. Strong expression of the I-SceI 
endonuclease on these plasmids introduces lethal DNA double strand breaks at the I-SceI 
site present on the intergrated pSNUFF3Cm plasmid, and only DNA excision via a second 
homologous recombination allowed survival. The second DNA crossover event resulted in 
either restoration of the wild-type gene, or introduction of the deleted/modified gene into 
the chromosome. Recombinant strains were verified by using the same means employed 
following application of cPhe counterselection. Mutants were then cured of the pDAI-SceI-
pheS plasmid by two rounds of streaking on M9 minimal medium containing 0.1% (w/v) 
cPhe. 
The pSHAFT2 system introduced allelic exchange using one round of concomitant double 
homologous recombination (Figure 2.1c). pSHAFT2 is able to introduce mutant alleles into 
Burkholderia as the bacteria lacks the ability to utilise the oriR6K origin of replication of the 
plasmid. Therefore, only homologous recombination between the chromosome and the 
plasmid confers the trimethoprim resistance. This recombination can occur by a single 
crossover event, resulting in integration of the plasmid and co-integrant formation, with 
both the wild-type allele and the mutant allele present. Alternatively, the recombination 
can occur by a double crossover event, resulting in the wild-type fur allele being replaced by 
the ∆fur::TpTer mutant allele. In this case, vector sequences are not permanently integrated 
into the genome. The desired latter case was screened for by a subsequent counter-
screening for chloramphenicol sensitivity. 
In all cases, PCR screening using the external primers upstream and downstream of the 
cloned gene fragment was used to confirm gene replacement. These PCR products also 
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underwent DNA sequencing and sequence analysis to verify correct gene 





Figure 2.1. Schematic representation of Burkholderia allelic exchange strategies. 
In all cases, allelic exchange vectors containing a mutant allele flanked by regions of Burkholderia DNA sequence were introduced into Bth or Bce by 
conjugation. Homologous recombination could occur upstream or downstream of the mutant allele. A. A second homologous recombination event was 
selected for by the presence of cPhe, which is toxic in combination with the mutant Bps PheS protein. B. A second homologous recombination event was 
selected for by the introduction of pDAI-SceI-pheS, which introduces lethal double-stranded DNA breaks. C. A double homologous recombination event was 
selected for by acquisition of trimethoprim resistance, but not ampicillin or chloramphenicol. Diagrams are not to scale. Genes are represented as 




2.1.6 Determination of bacterial growth rate 
To determine the growth rate of bacterial strains in different media and under different 
conditions, bacterial growth curves were utilised. Firstly, overnight cultures of the assayed 
bacterial strain were grown at 37 oC with aeration, 200 rpm, for approximately 16 hours. 
500 µl of this was inoculated into 50 ml of the desired medium. Where a single bacterial 
strain was assayed, these dilutions were made directly from the same overnight culture. 
Where different bacterial strains were assayed, the overnight cultures were first diluted 
with the same medium to a standard OD600 of 0.5 prior to inoculation. The cultures were 
grown at 37 oC 200 rpm. The bacterial growth rate was monitored by measuring the OD600 
from 1 ml samples, the first taken immediately after inoculation and then every 30 minutes 
thereafter. 
Data was plotted in GraphPad Prism to generate a growth curve, with OD600 values plotted 
on a logarithmic scale (GraphPad Prism version 7.03 for Windows, GraphPad Software, La 
Jolla California USA, www.graphpad.com) The growth curves were analysed by fitting to an 
exponential growth curve using the GraphPad Prism software (data points after the 
exponential growth phase were excluded), and the line of best fit was in the format: 
𝑦 = 𝑦 𝑒  
where  y0 = y when x = 0 
 k = rate constant 










2.2 Polymerase Chain Reaction (PCR) 
 
2.2.1 DNA primers 
Custom DNA oligonucleotides were supplied by Eurogentec. Where possible, primers were 
designed to have a region of 18-20 nucleotides that was complementary to the target, a GC 
content of 40-60%, and a melting temperature (Tm) in the range 50-65 oC. Pairs of primers 
were designed to have Tms within 5 oC of each other, and have no complementarity. Where 
selection of primers was limited by function, these parameters were adhered to where 
possible but was not always achievable. For ligation of amplicons to vectors, additional 
bases were added at the 5’ ends of the primers that specified a restriction enzyme cleavage 
site and a terminal GC ‘clamp’. 
Primer Tm was calculated using either of the two equations: 
For primers of 14-20 nucleotides in length (Wallace-Ikatura formula): 
𝑇𝑚 (℃) = 2(𝐴 + 𝑇) + 4(𝐺 + 𝐶) 
where A = number of adenine base pairs etc. 
For primers of >20 nucleotides in length: 




where n = total number of base pairs, %G = percentage of guanine bases in the primer etc. 
The optimum annealing temperature (Ta) of primers was determined by performing 
multiplex PCR using a gradient of annealing temperatures, or calculated as 5 oC below the 
mean Tm of the primers. Template DNA used was genomic DNA from boiled cell lysates, 





2.2.2 Annealing of oligonucleotides 
Where only short double-stranded DNA products were required for cloning, 
oligonucleotides were annealed to give the desired DNA fragment the requirement for PCR. 
Oligonucleotides were designed to be ≤59 nucelotides in length. Annealing was performed 
in a microcentrifuge tube. Where two oligonucleotides were to be annealed, 45 µl of each 
100 µM oligonucleotide was incubated with 10 µl of 10x annealing buffer (10 mM MgCl2, 
200 mM Tris pH 8.0, in d.H2O) at 90 oC for 10 minutes, followed by room temperature for 
one hour. DNA products were analysed by agarose gel electrophoresis. 
 
2.2.3 Primers used in this study 
The primers used in this study are shown in Table 2.2. 
Table 2.2. Primers used in this study 
Primer/oligonucleotide Sequence (5’-3’)[1] 






































































































































2.2.4 Q5 Hot Start High-Fidelity DNA Polymerase 
For amplification of DNA where high-fidelity of replication was required, i.e. cloning and 
splicing by overlap extension (SOE) PCR (see section 2.2.6), Q5 Hot Start High-Fidelity DNA 
Polymerase (New England Biolabs) was utilised. Reactions were made up on ice in PCR tubes 
with a 50 µl total volume per reaction (see Table 2.3). The DNA polymerase was the final 
reagent to be added shortly before PCR was initiated. PCRs were performed in either the T-
100 Thermal Cycler (Bio-Rad) or the G-Storm GS1 Thermal Cycler. Reactions conditions used 
were based upon the manufacturer’s recommended protocol (see Table 2.4).  
Table 2.3. Reaction setup for one PCR reaction using Q5 Hot Start High-Fidelity DNA Polymerase 
Reagent Volume per 50 µl reaction (µl) 
5x Q5 Reaction Buffer 10 
10 mM d.NTP Mix 1 
Template DNA Variable[1] 
10 µM Forward primer 2.5 
10 µM Reverse primer 2.5 
Q5 GC Enhancer 10 
Q5 Polymerase (2 U/µl) 0.5 
d.H2O To final volume of 50 µl 
Total 50 
[1] Approximately 1 ng-1 µg for genomic DNA, 1 pg- 1 ng for plasmid DNA 
 
Table 2.4. Reaction steps for PCR using Q5 Hot Start High-Fidelity DNA Polymerase 
Step Temperature (oC) Time (min:sec) 
Initial Denaturation 98 0:30 
Denaturation 98 0:10 
Annealing Variable[1] 0:30 
Elongation 72 0:30 per kb 
Final Elongation 72 2:00 
Storage 4 - 
[1] Calculated as 5oC below the mean primer Tm, or a gradient of Tas were used 
[2] Number of cycles 
 
2.2.5 GoTaq G2 DNA Polymerase 
For amplification of DNA where high-fidelity of replication was not paramount, i.e. 




Polymerase (Promega) was utilised. Reactions were made up on ice in PCR tubes with a 25 
µl total volume per reaction (see Table 2.5). The DNA polymerase was the final reagent to 
be added shortly before PCR was initiated. PCRs were performed in either the T-100 
Thermal Cycler (Bio-Rad) or the G-Storm GS1 Thermal Cycler. Reactions conditions used 
were based upon the manufacturer’s recommended protocol (see Table 2.6). In PCR 
screening experiments, no template DNA was added as a negative control, and 0.5 µl of 
appropriate plasmid or PCR product was added as template DNA as a positive control. For 
PCR screening of colonies, 2.5 µl of boiled lysate (as described in section2.3.3: Genomic 
DNA) was used as template DNA (originating from a picked single colony for E. coli and Bce, 
or from overnight culture for Bth). 
Table 2.5. Reaction setup for one PCR reaction using GoTaq G2 Flexi DNA Polymerase 
Reagent Volume per 25 µl reaction (µl) 
5x GoTaq Flexi Buffer 5 
25 mM MgCl2 1 
10 mM d.NTP Mix 0.5 
10 µM Forward primer 0.5 
10 µM Reverse primer 0.5 
DMSO 1 
GoTaq G2 Flexi Polymerase (5 U/µl) 0.25 
Template DNA Variable[1] 
d.H2O To final volume of 25 µl 
Total 25 
[1] Approximately <0.25 µg 
 
Table 2.6. Reaction steps for PCR using GoTaq G2 Flexi DNA Polymerase 
Step Temperature (oC) Time (min:sec) 
Initial Denaturation 95 2:00 
Denaturation 95 0:30 
Annealing Variable[1] 0:30 
Elongation 72 1:00 per kb 
Final Elongation 72 5:00 
Storage 4 - 
[1] Calculated as 5oC below the mean primer Tm, or a gradient of Tas were used 






2.2.6 Splicing by Overlap Extension (SOE) PCR 
SOE PCR was utilised to amplify DNA containing marker-less in-frame gene deletions or base 
substitutions to be cloned into the gene replacement vectors pEX18Tp-pheS, pSNUFF3Cm 
and pSHAFT2. A two-step process was used, and Q5 Hot Start High Fidelity DNA Polymerase 
(New England Biolabs) was used for both steps. For each SOE PCR process, four primers 
were used as shown in Table 2.7. 
Table 2.7. Primers used for general Splicing by Overlap Extension (SOE) PCR 
Primer Name Primer Description 
A Forward amplification primer. Contains a 5’ HindIII site [1] 
B Reverse mutagenic primer. Complementary to primer C. 
C Forward mutagenic primer. Complementary to primer B. 
D Reverse amplification primer. Contains a 5’ BamHI site. [1] 
[1] When making gene deletions, primers A and D annealed ≥500 bp upstream and downstream of 
the gene of interest 
 
In the first step, conventional PCR using genomic DNA as template was used. Primers A and 
B were used to amplify product AB, and primers C and D were used to amplify product CD. 
Products AB and CD were then combined in approximately equimolar amounts as template 
DNA (approximately 100 ng of the longest DNA product) for the second step in which 
amplification was carried out using primers A and D. Hybridisation at the overlapping region 
of single stranded DNA generated from products AB and CD and subsequent extension 
resulted in the generation of the full-length PCR product. Mutagenic primers were designed 
to produce a region of complementarity of 36 bp at the ends of PCR products AB and CD. 
For gene deletions, this 36 bp region contained 18 bp from the start of the gene, and 18 bp 
from the end of gene, to give a marker less in-frame gene deletion. For gene mutations, this 






2.2.7 Reverse transcriptase polymerase chain reaction (RT-PCR) 
Reverse transcription of RNA was performed using M-MLV Reverse Transcriptase (Promega), 
based upon the manufacturer’s recommended protocol. Approximately 2 µg of total RNA 
was used in each reaction. Custom primer pairs were designed to amplify a region of DNA 
approximately 300 bp in length. Only the reverse primer was included in the first strand 
cDNA synthesis step along with DMSO at a concentration of 10% (v/v) due to high GC 
content of Burkholderia DNA. 
For the second strand DNA synthesis, GoTaq G2 DNA Polymerase was used. 2.5 µl of cDNA 
was used as template DNA per reaction. For each RT-PCR reaction, a second reaction using 
0.5 µl of original RNA was used as a control of DNA contamination. Ta was selected based on 
the mean Tm of all primers used in the PCR. PCR products were visualised by agarose gel 
electrophoresis (see section 2.3.1).  
 
2.2.8 Purification of DNA from PCR reactions 
Purification of amplified DNA from PCR reactions and DNA fragments following other 
enzymatic reactions was achieved using the GeneJET PCR Purification Kit (Thermo-Fisher).  
Purification steps were followed as per the manufacturer’s recommended protocol. 
Centrifugations were performed at 17,000x g. 
 
2.3 Nucleic acids methods 
 
2.3.1 Agarose gel electrophoresis 
Agarose gel electrophoresis was used to visualise approximate molecular weight, purity, and 
concentration of DNA. 0.8-1.2% (w/v) agarose gels were prepared by dissolving agarose 
(Thermo-Fisher) in TAE buffer (0.04 M Tris, 0.1142% (w/v) acetic acid, 1 mM EDTA) and 
boiling using a microwave oven, then pouring the molten agarose solution into a gel cast 
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when cool. Conical flasks containing the gel solution were stoppered to reduce evaporation 
of solution. Gel volumes were 50-200 ml. Gels were allowed to set for approximately one 
hour prior to use. 
Gels were placed in a gel tank (BioRad), the well comb removed, and submerged in TAE 
buffer. Typically, 5 µl of DNA samples (mixed with 1 µl of 6x loading dye (Thermo-Fisher) 
prior to loading) were loaded per well. PCR products generated by GoTaq G2 DNA 
Polymerase (Promega) already contained DNA loading dye. Larger volumes of DNA solutions 
were loaded where necessary i.e. for gel extraction (see section 2.3.2). 
For linear DNA samples, 5 µl of GeneRuler 1 kb DNA Ladder (Thermo-Fisher) was loaded 
alongside samples. For supercoiled plasmid DNA, 0.5 µl of Supercoiled DNA Ladder (New 
England Biolabs), mixed with 4.5 µl d.H2O and 1 µl 6x loading dye prior to loading, was 
loaded alongside samples. 
Gel electrophoresis was performed at 80-110 V for 40-90 minutes, dependent on gel size 
and agarose concentration.  
A DNA pre-stain, Nancy-520 (Sigma-Aldrich) or Midori Green Advanced DNA Stain 
(Geneflow), was added to the gel before casting at a concentration of 0.01% (v/v). 
Alternatively, gels were post-stained by immersion in 5 µg ml-1 ethidium bromide solution 
for approximately 30 minutes with shaking.  
Gels were imaged using an EDAS 290 (Kodak) UV transilluminator. 
 
2.3.2 DNA extraction from agarose gels 
Where necessary due to the appearance of unwanted secondary PCR products or smearing 
following agarose gel electrophoresis, the DNA amplicon of the desired molecular weight 
was manually extracted from the agarose. In these situations, larger amounts of DNA were 
loaded, requiring larger wells to be cast in the agarose gel. Gel electrophoresis was 
performed as usual. Upon a UV transilluminator, the desired PCR product was manually cut 
from the gel with a sterile scalpel and transferred to a microcentrifuge tube. A blue light 
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transilluminator was used to limit UV exposure to prevent DNA damage. DNA in the excised 
gel slice was then extracted and purified using the QIAquick Gel Extraction Kit (QIAGEN) or 
the GeneJET Gel Extraction Kit (Thermo-Fisher). 
 
2.3.3 DNA/RNA extraction 
Genomic DNA 
Genomic/total DNA from E. coli was required for PCR screening during cloning experiments, 
and genomic DNA from Bth and Bce was required as template DNA in PCR to generate DNA 
fragments for cloning and for PCR screening during allelic replacement experiments. For E. 
coli and Bce, a single colony was picked and resuspended in 50 µl TE buffer (10 mM Tris, 1 
mM EDTA, pH 8.0). For Bth, a cell pellet from 1 ml of overnight culture was resuspended in 
100 µl TE buffer. Cell suspensions were boiled at approximately 100 oC for 10 minutes, and 
centrifuged to isolate cell debris. The supernatant was used as template DNA in PCR 
reactions. For long-term stocks of genomic DNA, supernatant was transferred to a 
microcentrifuge tube, and stored at -20 oC. 
Plasmid DNA 
Plasmid DNA was extracted using the GeneJET Plasmid Miniprep Kit (Thermo-Fisher). 
Extraction and purification steps were followed as per the manufacturer’s recommended 
protocol for centrifugation. Centrifugations were performed at 17,000x g. An additional 
wash step using 500 µl of PB buffer (QIAGEN) prior to the wash steps with the kit’s ‘wash 
buffer’ was used to inactivate endonucleases in the bacterial strains bearing the plasmid. 
Plasmid DNA was stored at -20 oC. 
For use in in vitro transcription assays, where high concentrations of RNase-free DNA were 
required, the QIAGEN Maxi Prep Kit was used according to the manufacturer’s 
recommended protocol. A 100 ml culture was used, and QIAGEN-tip 500 were used 
throughout. An additional purification step was included to completely remove RNase. An 
equal volume of phenol-chloroform-isoamyl alcohol (25:24:1) was added to the plasmid 
DNA solution after the QIAGEN Maxi Prep procedure, resuspended, centrifuged and the 
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aqueous phase containing the plasmid DNA transferred to a clean microcentrifuge tube. 
2.1x volumes of RNase-free precipitating solution (95% (v/v) ethanol, 1% (w/v) potassium 
acetate) was added to the DNA sample and briefly vortexed. After 10 minutes of incubation 
at room temperature and centrifugation for 10 minutes at 17,000x g, the DNA pellet was 
washed with 1 ml of RNase-free 70% (v/v) ethanol, incubated at room temperature for five 
minutes and centrifuged again for 10 minutes. The supernatant was removed, the pellet air-
dried, and then resuspended in 0.5 ml of RNase-free TE buffer (10 mM Tris, 1 mM EDTA, pH 
8.0). DNA purity and concentration was determined as described in section 2.3.5). 
RNA Extraction 
Extraction of RNA was performed using the NucleoSpin RNA kit (Machery-Nagel) based upon 
the manufacturer’s recommended protocol. Bacterial cell cultures of interest were grown in 
LB medium at 37 oC with aeration, 200 rpm, for approximately 16 hours, before being 
centrifuged at 4,000x g for 10 minutes to give a cell pellet with approximately 109 bacterial 
cells. The DNase reaction mixture (prepared from the manufactuer’s supplied reconstituted 
rDNase and Reaction Buffer for rDNase) was incubated at 37 oC for one hour, as this 
resulted in a superior removal of DNA contamination. Steps following the DNase reaction 
were performed with filter pipette tips. RNA solutions were maintained on ice trhougout 











2.3.4 Plasmids used in this study 
The plasmids used in this study are shown in Table 2.8. Several annotated plasmid maps of 
many of these plasmid constructs are shown in the Appendix. 
Table 2.8. Plasmids used in this study 
Plasmid Description[1] Reference 
pBBR1MCS Mobilisable BHR cloning 
vector (Cmr) 
(Kovach et al., 1994) 
pBBR1MCS-orbS pBBR1MCS containing orbS 
gene 
(Agnoli et al., 2006) 
pBBR1MCS-orbSCtetraA pBBR1MCS containing orbS 
gene with substitutions 
C196+199+203+209A 
(Agnoli, 2007) 
pBBR1MCS-orbS∆N pBBR1MCS containing orbS 
gene with residues 7-35 
deleted 
R. Lomax (unpublished) 
pBBR1MCS-orbS∆C1 pBBR1MCS containing orbS 
gene with residues 211-220 
deleted 
This study 
pBBR1MCS-orbS∆C2 pBBR1MCS containing orbS 
gene with residues 209-220 
deleted 
This study 
pBBR1MCS-orbS∆C3 pBBR1MCS containing orbS 
gene with residues 203-220 
deleted 
R. Lomax (unpublished) 
pBBR1MCS-orbS∆C4 pBBR1MCS containing orbS 
gene with residues 199-220 
deleted 
R. Lomax (unpublished) 
pBBR1MCS-orbS∆C5 pBBR1MCS containing orbS 
gene with residues 196-220 
deleted 
This study 
pBBR1MCS-orbS∆C6 pBBR1MCS containing orbS 
gene with residues 191-220 
deleted 
This study 
pBBR1MCS-orbS∆C7 pBBR1MCS containing orbS 
gene with residues 187-220 
deleted 
This study 
   
pBBR1MCS-2 Mobilisable BHR cloning 
vector (Cmr) 
(Kovach et al., 1995) 
pBBR1MCS2-orbS pBBR1MCS-2 containing 
orbS gene 
(Agnoli et al., 2018) 
pBBR1MCS2-orbSCtetraA pBBR1MCS-2 containing 






pBBR1MCS2-orbS∆N pBBR1MCS-2 containing 
orbS gene with residues 7-
35 deleted 
R. Lomax (unpublished) 
pBBR1MCS2-orbS∆C1 pBBR1MCS-2 containing 
orbS gene with residues 
211-220 deleted 
This study 
pBBR1MCS2-orbS∆C2 pBBR1MCS-2 containing 
orbS gene with residues 
209-220 deleted 
This study 
pBBR1MCS2-orbS∆C3 pBBR1MCS-2 containing 
orbS gene with residues 
203-220 deleted 
This study 
pBBR1MCS2-orbS∆C4 pBBR1MCS-2 containing 
orbS gene with residues 
199-220 deleted 
This study 
pBBR1MCS2-orbS∆C5 pBBR1MCS-2 containing 
orbS gene with residues 
196-220 deleted 
This study 
pBBR1MCS2-orbS∆C6 pBBR1MCS-2 containing 
orbS gene with residues 
191-220 deleted 
This study 
pBBR1MCS2-orbS∆C7 pBBR1MCS-2 containing 
orbS gene with residues 
187-220 deleted 
This study 
pBBR1MCS2-mbaS pBBR1MCS-2 containing 
mbaS and 30 bp upstream 
DNA 
This study 
pBBR1MCS2-mbaSCpentaA pBBR1MCS-2 containing 
mbaS with substitutions 
C203+206+216+220+230A 
and 30 bp upstream DNA 
This study 
pBBR1MCS2-pchE pBBR1MCS-2 containing 
pchE and 30 bp upstream 
DNA 
This study 
pBBR1MCS2-orbS∆P pBBR1MCS-2 containing 
orbS and 30 bp upstream 
DNA (no native promoter) 
This study 
pBBR1MCS2-orbSCtetraA-∆P pBBR1MCS-2 containing 
orbS with substitutions 
C196+199+203+209A and 
30 bp upstream DNA (no 
native promoter) 
This study 
pBBR1MCS2-∆fur::NdeI pBBR1MCS-2 containing 
∆fur with an internal NdeI 
site 
This study 
pBBR2MCS2-∆fur::TpTer pBBR1MCS-2 containing 




pBBR1MCS2-BCAM0001 pBBR1MCS-2 containing 




   
pBBR1MCS-5 Mobilisable BHR cloning 
vector (Gmr) 
(Kovach et al., 1995) 
pBBR1MCS5-orbS pBBR1MCS-5 containing 
orbS gene 
This study 
pBBR1MCS5-orbSCtetraA pBBR1MCS-5 containing 




pBBR1MCS5-orbS∆C1 pBBR1MCS-5 containing 
orbS gene with residues 7-
35 deleted 
This study 
pBBR1MCS5-orbS∆C2 pBBR1MCS-5 containing 
orbS gene with residues 
211-220 deleted 
This study 
pBBR1MCS5-orbS∆C3 pBBR1MCS-5 containing 
orbS gene with residues 
209-220 deleted 
This study 
pBBR1MCS5-orbS∆C4 pBBR1MCS-5 containing 
orbS gene with residues 
203-220 deleted 
This study 
pBBR1MCS5-orbS∆C5 pBBR1MCS-5 containing 
orbS gene with residues 
199-220 deleted 
This study 
pBBR1MCS5-orbS∆C6 pBBR1MCS-5 containing 
orbS gene with residues 
196-220 deleted 
This study 
pBBR1MCS5-orbS∆C7 pBBR1MCS-5 containing 
orbS gene with residues 
191-220 deleted 
This study 
pBBR1MCS5-mbaS pBBR1MCS-5 containing 
the mbaS gene and 30 bp 
upstream DNA 
This study 
pBBR1MCS5-mbaSCpentaA pBBR1MCS-5 containing 
the mbaS gene with 
substitutions 
C203+206+216+220+230A 
and 30 bp upstream DNA 
This study 
pBBR1MCS5-orbS∆P pBBR1MCS-5 containing 
the orbS gene and 30 bp 
upstream DNA (no native 
promoter) 
This study 
pBBR1MCS5-orbSCtetraA-∆P pBBR1MCS-5 containing 
the orbS gene with 
substitutions 
C196+199+203+209A and 
30 bp upstream DNA (no 
native promoter) 
This study 
   
pSRK-Km Broad host-range 
expression vector (Kmr)  
(Khan et al., 2008) 
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pSRK-Km-furFLAG pSRK-Km containing the 
Bth fur gene 
modified to encode a C-
terminal FLAG epitope 
This study 
pSRK-Km-BCAM0001FLAG pSRK-Km containing the 
BCAM0001 gene 
modified to encode a C-
terminal FLAG epitope 
This study 
pSRK-Km-BCAM0001aFLAG pSRK-Km containing the 
BCAM0001a gene 
modified to encode a C-
terminal FLAG epitope 
This study 
   
pET14b N-terminal His-tag fusion 
protein vector with T7 
promoter (Ampr) 
(Studier et al., 1990) 
pET14b-mbaS pET14b containing the 
mbaS gene 
This study 
pET14b-mbaSCpentaA pET14b containing the 




pET14b-orbS pET14b containing the orbS 
gene 
A. Butt and M. Thomas (unpublished) 




A. Butt and M. Thomas (unpublished) 
   
pKAGd4 Transcriptional fusion 
reporter vector derived 
from pPR9TT (Cmr Ampr) 
(Agnoli et al., 2006) 
pKAGd4-PorbHds6 pKAGd4 containing PorbH on 
a 42 bp DNA fragment 
(Agnoli et al., 2018) 
pKAGd4-PorbS pKAGd4 containing PorbS on 
DNA fragment 
(Agnoli, 2007) 
pKAGd4-PmbaS-L pKAGd4 containing PmbaS on 
a 186 bp DNA fragment 
This study 
pKAGd4-PmbaS-S pKAGd4 containing PmbaS on 
a 53 bp DNA fragment 
This study 
pKAGd4-PmbaH-L pKAGd4 containing PmbaH 
on a 274 bp DNA fragment 
This study 
pKAGd4-PmbaH-S pKAGd4 containing PmbaH 
on a 49 bp DNA fragment 
This study 
pKAGd4-PmbaE-L pKAGd4 containing PmbaE 
on a 308 bp DNA fragment 
This study 
pKAGd4-PmbaE-S pKAGd4 containing PmbaE 
on a 49 bp DNA fragment 
This study 
pKAGd4-PmbaI-L pKAGd4 containing PmbaI on 




pKAGd4-PmbaI-S pKAGd4 containing PmbaI on 
a 49 bp DNA fragment 
This study 
pKAGd4-PorbH-S pKAGd4 containing PorbH on 
a 49 bp DNA fragment 
This study 
pKAGd4-PBCAM0001 pKAGd4 containing 
PBCAM0001 on a 369 bp DNA 
fragment 
This study 
pKAGd4-PBCAM2840 pKAGd4 containing 
PBCAM2840 on a 369 bp DNA 
fragment 
This study 
pKAGd4-PBCAM0002 pKAGd4 containing 
PBCAM0002 on a 274 bp DNA 
fragment 
This study 
   
pRLG770 Transcription reporter 
vector used in in vitro 
transcription assays (Ampr) 
(Ross et al., 1990) 
pRLG770-PmbaH pRLG770 containg the 49 
bp PmbaH promoter 
This study 
pRLG770-PorbHds6 pRLG770 containing the 
PorbHds6 promoter (-36 to +6) 
A. Butt and M. Thomas (unpublished) 
pRLG770-PguaB pRLG770 containing the 
PguaB promoter (-133 to 
+36) 
(Husnain and Thomas, 2008) 
   
pEX18Tp-pheS Allelic replacement vector 
(Tpr) 
(Barrett et al., 2008) 
pEX18Tp-pheS-∆mbaS pEX18Tp-pheS containing a 
ΔmbaS allele with ≥500 bp 
of upstream and 
downstream DNA 
sequence identical to the 
Bth genome 
This study 
pEX18Tp-pheS-mbaSCpentaA pEX18Tp-pheS containing a 
mbaSCpentaA allele with ≥500 
bp of upstream and 
downstream DNA 
sequence identical to the 
Bth genome 
This study 
   
pSNUFF3Cm Allelic replacement vector 
(Tpr, Cmr) 
H. Spiewak, unpublished 
pSNUFF3Cm-∆mbaS pSNUFF3Cm containing a 
ΔmbaS allele with ≥500 bp 
of upstream and 
downstream DNA 
sequence identical to the 
Bth genome 
This study 
pSNUFF3Cm-∆pchE pSNUFF3Cm containing a 
ΔpchE allele with ≥500 bp 





sequence identical to the 
Bth genome 
pSNUFF3Cm-mbaSCpentaA pSNUFF3Cm containing a 
mbaSCpentaA allele with ≥500 
bp of upstream and 
downstream DNA 
sequence identical to the 
Bth genome 
This study 
pSNUFF3Cm-∆BCAM0001 pSNUFF3Cm containing a 
ΔBCAM0001 allele with 
≥500 bp of upstream and 
downstream DNA 
sequence identical to the 
Bce genome 
This study 
pSNUFF3Cm-∆BCAM0001a pSNUFF3Cm containing a 
ΔBCAM0001a allele with 
≥500 bp of upstream and 
downstream DNA 





pSNUFF3Cm containing a 
ΔBCAM0001-BCAM0001a 
allele with ≥500 bp of 
upstream and downstream 
DNA sequence identical to 
the Bce genome 
This study 
   
pDAI-SceI-pheS I-SceI meganuclease 
expression vector (Tcr) 
(Fazli et al., 2015) 
pDAI-SceI-pheS-Km Derivative of pDAI-SceI-
pheS with insterted 
kanamycin reistance 
cassette (Tcr Kmr) 
S. Hussain, unpublished 
p34E-TpTer Source of TpTer cassette (Shastri et al., 2017) 
   
pSHAFT2 Allelic replacement vector 
(Cmr Ampr)  
(Shastri et al., 2017) 
pSHAFT2-∆fur::TpTer pSHAFT2 containing a 
Δfur::TpTer allele with 
≥500 bp of upstream and 
downstream DNA 
sequence identical to the 
Bth genome 
This study 
   
pBluescript II KS E. coli-specific cloning 
vector (Ampr) 
(Stojiljkovic, Baumler and Hantke, 
1994) 
pBS-PmbaS pBluescript II KS containing 





pBS-PmbaH pBluescript II KS containing 
PmbaH on a 274 bp DNA 
fragment 
This study 
pBS-PmbaE pBluescript II KS containing 
PmbaE on a 308 bp DNA 
fragment 
This study 
pBS-PmbaI pBluescript II KS containing 
PmbaI on a 295 bp DNA 
fragment 
This study 
p3ZFBS pGEM3Z containing 
consensus E. coli Fur 
binding site (Ampr) 
(Vanderpool and Armstrong, 2001) 
   
pKT25 Low copy number BACTH 
vector, allows in-frame 
fusion of a gene to C-
terminal coding sequence 
of T25 adenylate cyclase 
domain (Kmr) 
(Karimova, Ullmann and Ladant, 
2001) 
pKT25-BCAM0001 pKT25 containing a protein 
fusion to the Bce 
BCAM0001 gene 
This study 
pKT25-BCAM0001-σ2 pKT25 containing a protein 
fusion to an N-terminal 
portion of the Bce 
BCAM0001 gene, including 
the σ2 domain 
This study 
pKT25-BCAM0001-σ4 pKT25 containing a protein 
fusion to an C-terminal 
portion of the Bce 
BCAM0001 gene, including 
the σ4 domain 
This study 
pKT25-BCAM0001a pKT25 containing a protein 
fusion to the Bce 
BCAM0001a gene 
This study 
pKNT25 Low copy number BACTH 
vector, allows in-frame 
fusion of a gene to N-
terminal coding sequence 
of T25 adenylate cyclase 
domain (Kmr) 
(Karimova, Ullmann and Ladant, 
2001) 
pKNT25-BCMA0001 pKNT25 containing a 
protein fusion to the Bce 
BCAM0001 gene 
This study 
pKNT25-BCAM0001-σ2 pKNT25 containing a 
protein fusion to an N-
terminal portion of the Bce 
BCAM0001 gene, including 
the σ2 domain 
This study 
pKNT25-BCAM0001-σ4 pKNT25 containing a 




terminal portion of the Bce 
BCAM0001 gene, including 
the σ4 domain 
pKNT25-BCAM0001a pKNT25 containing a 
protein fusion the Bce 
BCAM0001a gene 
This study 
pKT25-zip pKT25 containing a protein 
fusion to the leucine zipper 
domain of GNC4 
(Karimova, Ullmann and Ladant, 
2001) 
pUT18 High copy number BACTH 
vector, allows in-frame 
fusion of a gene to N-
terminal coding sequence 
of T18 adenylate cyclase 
domain (Ampr) 
(Karimova, Ullmann and Ladant, 
2001) 
pUT18-BCAM0001 pUT18 containing a protein 
fusion to the Bce 
BCAM0001 gene 
This study 
pUT18-BCAM0001-σ2 pUT18 containing a protein 
fusion to an N-terminal 
portion of the Bce 
BCAM0001 gene, including 
the σ2 domain 
This study 
pUT18-BCAM0001-σ4 pUT18 containing a protein 
fusion to an C-terminal 
portion of the Bce 
BCAM0001 gene, including 
the σ4 domain 
This study 
pUT18-BCAM0001a pUT18 containing a protein 
fusion the Bce BCAM0001a 
gene 
This study 
pUT18C High copy number BACTH 
vector, allows in-frame 
fusion of a gene to C-
terminal coding sequence 
of T18 adenylate cyclase 
domain (Ampr) 
(Karimova, Ullmann and Ladant, 
2001) 
pUT18C-BCAM0001 pUT18C containing a 
protein fusion to the Bce 
BCAM0001 gene 
This study 
pUT18C-BCAM0001-σ2 pUT18C containing a 
protein fusion to an N-
terminal portion of the Bce 
BCAM0001 gene, including 
the σ2 domain 
This study 
pUT18C-BCAM0001-σ4 pUT18C containing a 
protein fusion to an C-
terminal portion of the Bce 
BCAM0001 gene, including 




pUT18C-BCAM0001a pUT18C containing a 
protein fusion the Bce 
BCAM0001a gene 
This study 
pUT18C-zip pUT18C containing a 
protein fusion to the 
leucine zipper domain of 
GNC4 
(Karimova, Ullmann and Ladant, 
2001) 
Cmr=chloramphenicol resistance; Kmr=kanamycin resistance; Gmr=gentamicin resistance; 
Ampr=ampicillin resistance; Tpr=trimethoprim resistance; Tcr=tetracycline resistance 
 
2.3.5 DNA/RNA quantification 
The concentration and purity of DNA/RNA was measured by a NanoDrop 2000 
Spectrophotometer (Thermo Scientific). Purity of DNA and RNA was gauged by the ratio of 
the spectroscopic absorbance at 260/280 nm (𝐴 𝑛𝑚). To be considered sufficiently pure, 
this value was approximately 1.8 for DNA and 2.0 for RNA. 
 
2.3.6 Restriction enzyme digestion 
The digestion of DNA by restriction enzymes was performed based upon the manufacturer’s 
recommended protocol (New England Biolabs/Promega). The buffer used for the reaction 
was based upon the optimal activity for the selected restriction enzymes as determined by 
the manufacturer. Reactions were made up to 30 µl. After two hours of digestion at 37 oC, 
solutions underwent PCR purification (see section 0) and were visualised by agarose gel 
electrophoresis (see section 2.3.1) prior to further applications. 
Table 2.9. Reaction components for restriction digestion of DNA 
Reagent Volume (µl) 
DNA (Plasmid/PCR Product) [1] 10/20 
10x Restriction Enzyme Buffer 3 
Restriction Enzyme 1 (10 U/µl) 1 
Restriction Enzyme 2 (10 U/µl) 1 








2.3.7 DNA ligation 
The ligation of digested DNA was performed using T4 DNA Ligase (Promega) based upon the 
manufacturer’s recommended protocol. The concentration of digested DNA was measured 
(see section 2.3.5) and the vector DNA and DNA to be inserted into the vector was 
combined at a 1:3 molar ratio per reaction. Reactions were incubated at 16 oC in a heat 
block for approximately 16 hours. 
In cloning experiments, a ligation control (containing no DNA to be inserted into the vector) 
and a vector control (containing no DNA to be inserted into the vector and no T4 DNA 
ligase) were included to account for vector self-ligation and uncut vector, respectively (see 
Table 2.10). Ligation reactions were used directly for transformation into competent E. coli 
cells. 
Table 2.10. Reaction components for ligation of digested DNA 
Reagent 
Volume (µl) 
Ligation Ligation Control Vector Control 
Digested Vector DNA Variable[1] Variable[1] Variable[1] 
Digested PCR product Variable[2] 0 0 
T4 DNA ligase 1 1 0 
10x DNA ligase buffer 2 2 2 
d.H2O To final volume of 20 µl To final volume of 20 µl To final volume of 20 µl 
Total 20 20 20 
[1] Approximately 25 ng 
[2] Approximately 75 ng 
 
2.3.8 DNA sequencing and analysis 
All newly constructed plasmids, and some PCR products, had their nucleotide sequence 
verified by DNA sequencing. This was performed by the University of Sheffield Medical 
School Core Sequencing Facility. Analysis was performed using a combination of BioEdit 
software (Hall, 1999) and SnapGene© software (from GSL Biotech; available at 
snapgene.com). 
Genome sequencing was provided by MicrobesNG (http://www.microbesng.uk), which is 
supported by the BBSRC (grant number BB/L024209/1). Analysis was performed using 
Artemis software (Carver et al., 2012).  
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2.4 Protein methods 
 
2.4.1 Protein overexpression and extraction 
The pET14b expression vector constructs were introduced into E. coli BL21λDE3 by 
transformation, and the transformed bacteria were directly inoculated into either 50 ml or 
500 ml of autoinduction medium (50 mM anhydrous Na2HPO4, 25 mM anhydrous KH2PO4, 
0.5% (w/v) tryptone, 0.5% (w/v) yeast extract, 0.5% (w/v) NaCl, 0.5% (v/v) glycerol, 0.05% 
(w/v) glucose, 0.2% (w/v) lactose, supplemented with 100 µg ml-1 ampicillin) (Studier, 2005). 
Cultures were grown with aeration at 37 oC (250 rpm) to approximately OD600=1.0, then 
incubated at 20 oC with aeration (250 rpm) for approximately 24 hours. Cells were harvested 
by centrifugation at 4,000x g for 20 minutes at 4 oC. The resulting cell pellet was frozen at -
20 oC. 
Cell pellets were lysed in BugBuster Master Mix (Novagen) as per the manufacturer’s 
protocol. The insoluble protein fraction possessing the ECF sigma factor was isolated by 
centrifugation at 16,000 xg at 4 oC for 20 mins. In order to solubilise the protein, the pellet 
was re-suspended in HGD buffer (Table 2.11) containing N-lauroylsarcosine (Nguyen, Jensen 
and Burgess, 1993) overnight at 4 oC. After centrifugation at 16,000 xg at 4 oC for 20 mins, 
the soluble protein fraction was removed and taken for purification by nickel-affinity 
chromatography. 
 
2.4.2 Protein purification by nickel-affinity chromatography 
Solubilised ECF sigma factor was purified by nickel-affinity chromatography using a 1 ml 
HisTrapHP column (GE Healthcare) and an ÄKTApurifer system (GE Healthcare). The 
solubilised protein solution was manually loaded onto the HisTrap column, washed with 
binding buffer (Table 2.11) prior to and after loading. The protein was then eluted by means 
of a gradient with elution buffer (Table 2.11). The protein typically eluted at around 60-70% 
of elution buffer (308-356 mM imidazole). After analysis of eluted fractions by SDS-PAGE, 
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fractions containing the protein were pooled and diluted two-fold in elution buffer for 
dialysis into storage buffer. 
 
2.4.3 Buffer exchange of protein 
For the removal of imidazole and N-lauroylsarcosine, to decrease the NaCl concentration, 
and to increase the glycerol concentration to facilitate the long-term storage of the ECF 
sigma factor protein, the purified protein samples underwent sequential dialysis into a 
storage buffer (Table 2.11) (Nguyen, Jensen and Burgess, 1993). 
Protein samples were inserted into 8 kDa MWCO BioDesignDialysis Tubing (BioDesign Inc. of 
New York), and left to dialyse against 100 volumes of each buffer overnight at 4 oC with 
stirring. First, the protein sample was dialysed into the intermediate buffer ‘dialysis 1’ (Table 
2.11). This buffer contained EDTA to remove any leached nickel from the IMAC column that 
could interfere with downstream experiments. The protein sample was the diaylsed against 
‘dialysis 2’ buffer to remove any residual N-lauroylsarcosine, imidazole and EDTA. The 
protein samples were then concentrated to a total volume of 1-2 ml using the Amicon Ultra-
4 10K centrifugal filter (Merck-Millipore) with 10 kDa MWCO according to the 
manufacturer’s recommended protocol. A final dialysis against 50 volumes storage buffer 
was performed, and the purified protein was stored at -20 oC. These protein samples were 
analysed for purity and yield by SDS-PAGE (see section 2.4.4) and Bradford assay (see 
section 2.4.5). 
Table 2.11. Protein purification buffers 
 Buffer 
Reagents HGD Binding Elution Dialysis 1 Dialysis 2 Storage 
HEPES 50 mM pH 
7.4 
50 mM pH 
7.4 
50 mM pH 
7.4 
50 mM pH 
7.4 
50 mM pH 
7.4 
50 mM pH 
7.9 
Glycerol 5% (v/v) 
 
5% (v/v) 5% (v/v) 
 
5% (v/v) 5% (v/v) 50% (v/v) 
DTT[1] 1 mM 
 
1 mM 1 mM 1 mM 1 mM 1 mM 
NaCl 50 mM 300 mM 300 mM 50 mM 50 mM 50 mM 
N-lauroylsarcosine 0.25% (w/v) 0.25% (w/v) 0.25% (w/v) - - - 
Imidazole - 20 mM 500 mM - - - 
EDTA (pH 8.0) - - - 100 µM - - 
[1] Added fresh to buffer immediately before usage to avoid degradation 
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2.4.4 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
For the analysis of protein samples, sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) was used. 12% (w/v) SDS resolving gel was routinely used. The 
reagents used to make the resolving gel and stacking gel for two 8.3 cm x 7.3 cm x 0.75 mm 
SDS-PAGE gels are shown in Table 2.12. 
Table 2.12. Reagents for casting of two 12% SDS-PAGE gels 
Reagent 
Volume (µl) 
Resolving Gel Stacking Gel 
Acrylamide, 40% (Fisher Bioreagents)  3000 450 
1.5 M Tris-HCl pH 8.8 2500 - 
1.0 M Tris-HCl pH 6.8 - 187.5 
10% (w/v) SDS 100 30 
10% (w/v) APS[1] 100 30 
TEMED[1] 10 3 
d.H2O 4290 2299.5 
Total 10000 3000 
[1] Reagents added immediately before casting 
 
Gels were cast between two glass plates using the Mini-PROTEAN gel casting kit (BioRad). 
The resolving gel was cast first and levelled off with iso-butanol, allowed to polymerise for 
approximately 30 minutes, and the upper surface washed with d.H2O. This was followed by 
casting the stacking gel and applying the comb, and was allowed to set for approximately 30 
minutes. Gels were used immediately, or stored at 4 oC saturated in d.H2O and wrapped in 
clingfilm for short-to-medium-term storage. 
Protein samples were each prepared as a 1:1 mixture with 2x Laemmli buffer (4% (w/v) SDS, 
20% (v/v) glycerol, 10% (v/v) β-mercaptoethanol, 0.004% (w/v) bromophenol blue, 125 mM 
Tris-HCl pH 6.8). Protein samples were denatured by incubation in a heat block at 100 oC for 
10 minutes, followed by centrifugation at 17,000x g for 10 minutes. 
Gels were immersed in running buffer, diluted from a 10x stock solution (30.3 g Tris base, 
144g glycine, 10 g SDS, pH8.3 in one litre of d.H2O). Electrophoresis was performed at 100 V 
for 10 minutes, or until the dye had migrated through the stacking gel, and then the voltage 
was increased to 150 V for approximately one hour, or until the dye had migrated through 
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to the bottom of the resolving gel. The gel was removed from the apparatus and stained in 
Coomassie blue stain solution (0.25 g Coomassie Brilliant Blue R-250, 45 ml methanol, 10 ml 
glacial acetic acid, 45 ml d.H2O). Destaining was completed in destain solution (40 ml 
methanol, 10 ml glacial acetic acid, 50 ml d.H2O) for 16-24 hours. 
 
2.4.5 Measurement of protein concentration 
Protein concentration was calculated using either the Bradford protein assay or estimated 
using a NanoDrop 1000 Spectrophotometer (Thermo Scientific). 
Bradford protein assays were performed using the Bio-rad Protein Assay, using the 
manufactuer’s instructions for the microassay procedure. A standard curve using a stock 
BSA solution (Promega), diluted to final concentrations of 2, 4, 6, 8 and 10 µg ml-1 in the 
same buffer as the protein sample to be assayed, was set up prior to every new protein 
quantification assay. 
When using the Nanodrop to estimate protein concentrations, the molar extinction 
coefficient at 280 nm predicted using ProtParam (Gasteiger et al., 2005) was input for 
greater accuracy. 
 
2.4.6 Western blotting 
Protein analysis by Western blotting was used to identify protein samples containing 
hexahistidine tags and FLAG tags. 12% SDS-PAGE was used (see section 2.4.4), but using the 
EZ-Run Prestained Rec Protein Ladder (Thermofisher) in place of the EZ-Run Rec Protein 
Ladder (Thermofisher). After electrophoresis, proteins were transferred from the SDS-PA gel 
onto a PVDF membrane at 25 V for 30 mins (Trans-Blot Turbo, Biorad). The membrane was 
washed in Tris-buffered saline-Tween, TBS-T (50 ml 10x Tris-buffered saline, 0.5 ml Tween 
20, 449.5 ml d.H2O) with 5% (w/v) milk powder (Fluka), and incubated at 4 oC overnight. The 
membrane was then washed in a series of steps at room temperature. Firstly, in TBS-T 5% 
milk with the primary antibody for one hour, followed by three iterative washes in TBS-T for 
10 minutes each. Where required, this was followed by washing with TBS-T 5% milk with the 
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secondary antibody, and followed by three iterative washes in TBS-T for 10 minutes each. 
Chemiluminescence was initiated with EZ-ECL solutions (Biological Industries) as per the 
manufacturer’s recommended protocol, and analysed with the ChemiDoc XRS+ Systems 
Imager and Image Lab software (Bio-Rad). 
Table 2.13. Antibodies used for Western blot analysis 
Target Protein Tag Primary antibody Dilution[1] Secondary antibody Dilution[1] 
Hexahistidine HisProbe-HRP 
(ThermoFisher) 
1/5000 - - 
FLAG Polyclonal rabbit anti-
FLAG (Sigma) 
1/5000 HRP-labelled goat anti-
rabbit IgG (Vector) 
1/6000 
[1] Final concentration in TBS-T 5% milk 
 
2.5 Transcription regulation methods 
 
2.5.1 β-galactosidase assay 
To examine the interaction of proteins with their putative DNA targets, β-galactosidase 
assays were used based upon the method of (Miller, 1972). The Z buffer used in the assay 
was made by dissolving 16.1 g Na2HPO4·7H2O, 5.5 g NaH2PO4·H2O, 0.75 g KCl, 0.246 g 
MgSO4·7H2O in d.H2O to a final volume of 1 litre. Before use, 135 µl of β-mercaptoethanol 
was added per 50 ml Z buffer. This buffer was also used as the solvent to make the ONPG 
stock solution. 
Firstly, overnight cultures of the strains to be assayed were grown in either LB or M9 
medium at 37 oC for approximately 16 hours for E. coli or approximately 24 hours for 
Burkholderia. For each sample to be assayed, a small volume of each culture was diluted 
100-fold in 3 ml of appropriate medium; for metal-limited conditions 100 µM (M9) or 175 
µM (LB) 2,2-dipyridyl was added, for metal-replete conditions 50 µM of the the metal was 
added (more detail provided in the results sections). Three biological replicates were 
assayed for each strain, and for each condition. The diluted cultures were grown again at 37 
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oC until OD600 of 0.4 for E. coli or 0.6 for Burkholderia was reached. Cultures were the then 
transferred to ice for 25 minutes. 
For each individual cell suspension, the OD600 was measured using a spectrophotometer, 
and the volume to be used in the assay was calculated as follows: 
For E. coli:   𝐶𝑢𝑙𝑡𝑢𝑟𝑒 𝑣𝑜𝑙𝑢𝑚𝑒 𝑡𝑜 𝑏𝑒 𝑎𝑠𝑠𝑎𝑦𝑒𝑑 (𝜇𝑙) = . × 25 𝜇𝑙 
For Burkholderia: 𝐶𝑢𝑙𝑡𝑢𝑟𝑒 𝑣𝑜𝑙𝑢𝑚𝑒 𝑡𝑜 𝑏𝑒 𝑎𝑠𝑠𝑎𝑦𝑒𝑑 (𝜇𝑙) = . × 25 𝜇𝑙 
Test tubes were filled with 1 ml Z buffer (minus the volume of bacterial culture to be 
added), 30 µl chloroform and 30 µl of 0.1% (w/v) SDS. These solutions were added gently 
down the side of the test tube. Subsequently, the corresponding volume of culture was 
added in a likewise fashion. For each culture, two technical replicates were set up, as well as 
two control tubes with sterile medium in place of bacterial culture. Control tubes were set 
up for each condition used in the assay. Once all solutions were added, each tube was 
vortexed for 10 seconds and incubated at 30 oC for 15 minutes in a water bath. To initiate 
the β-galactosidase reaction, 200 µl of 4 mg ml-1 ONPG (dissolved in Z buffer with β-
mercaptoethanol) was added to each of the test tubes in regular recorded intervals, and the 
tubes immediately vortexed for one second before returning to the 30 oC water bath. When 
a yellow colour of sufficient intensity was judged to have developed (OD420 between 0.2 and 
0.7) the reaction was stopped by addition of 500 µl of 1 M Na2CO3, immediately vortexed 
for one second, and the total reaction time recorded. Stopped reactions were incubated at 
room temperature for 10 minutes before the OD420 and OD550 were measured by 
spectrophotometer. The control tubes were used as blanks.  
The β-galactosidase activity of each reaction was calculated, in Miller units (Mu), as: 
𝑀𝑖𝑙𝑙𝑒𝑟 𝑢𝑛𝑖𝑡𝑠 =
𝑂𝐷 − 1.75(𝑂𝐷 )
𝑇𝑖𝑚𝑒 (𝑚𝑖𝑛) × 𝐶𝑢𝑙𝑡𝑢𝑟𝑒 𝑣𝑜𝑙𝑢𝑚𝑒 (𝑚𝑙) × 𝑂𝐷
× 1000 
The mean of each pair of technical replicates was taken as one biological data point. The 
whole experiment was usually repeated on at least one more day to provide further 
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experimental replicates. The mean of biological replicates across all experiments was 
calculated.  
 
2.5.2 Fur titration assay (FURTA) 
The Fur titration assay (FURTA) was used to analyse binding of the ferric uptake repressor 
protein, Fur, to gene promoters in vivo (Stojiljkovic, Baumler and Hantke, 1994). Promoter 
DNA was cloned into the high-copy number plasmid pBluescript II SK and the plasmid 
constructs introduced by transformation into E. coli H1717. E. coli H1717 harbours a 
chromosomal fhuF-lacZ fusion; fhuF contains a Fur box, and Fur binding represses the 
promoter, thereby decreasing lacZ expression, resulting in a Lac- phenotype. If DNA 
containing another Fur-box is introduced into the bacterium on pBluescript II SK, this will 
titrate away Fur from the fhuF promoter, resulting in higher expression of the chromosomal 
lacZ gene, thereby resulting in a Lac+ phenotype. This was visualised in vivo by streaking E. 
coli H1717 on MacConkey agar supplemented with 1% (w/v) lactose, 40 µM Fe(NH4)2(SO4)2 
and 100 µg ml-1 ampicillin. Plates were incubated at 37 oC for approximately 16 hours. 
Introduction of a pBluescript II SK vector without a Fur box results in a Lac- phenotype and 
white colonies. Introduction of a pBluescript II SK vector with a Fur box results in a 
Lac+ phenotype and red colonies. As a negative control, pBluescript II SK lacking any cloned 
promoter DNA was used; as a positive control, the plasmid p3ZFBS containing the E. coli 
consensus Fur box was used. 
 
2.6 Protein-protein interaction methods 
 
2.6.1 in vitro transcription 
The in vitro transcription (ivT) assay was used to investigate the ability of ECF sigma factors 
to promote transcription of DNA to produce an RNA transcript using a template DNA 
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promoter under different conditions. It was also used to analyse the effect of metal ions 
upon the activity of the sigma factor. 
The ECF sigma factor proteins were produced in E. coli, purified by IMAC and maintained in 
storage buffer as in the protocols outlined in sections 2.4.1 to 2.4.3. Short promoter DNA of 
around 50 bp in length were cloned into the plasmid pRLG770 upstream of an rrnB 
terminator region, and the plasmid construct was purified by the maxiprep procedure 
outlined in section 2.3.3. E. coli core RNA polymerase (NEB) complexed with Burkholderia 
sigma factor or holo RNA polymerase incorporating E. coli σ70 (NEB) and NTPs (Agilent) were 
used to perform the transcription. Radiolabelled uridine 5’-triphosphate ([α-32P]UTP; 250 
µCi) (PerkinElmer) was used to label the RNA transcript. Throughout all stages of the ivT 
assay filter pipette tips, UltraPureTM distilled water (Invitrogen) and sterile RNase-free 
microcentrifuge tubes were used. Work surfaces were cleaned with RNaseZap (Invitrogen) 
prior to experimental activity.  
Each reaction (25 µl) contained 5 µl 5x E. coli RNA Polymerase Reaction Buffer (NEB), 1 µl 
holo or core RNA polymerase, 0.5 µl ECF sigma factor (at a typical concentration of 40-60 µg 
ml-1 in storage buffer, see section 2.4.3), d.H2O and any additional components (i.e. 
transition metal salts) were combined in reaction tubes and incubated at 30 oC for 15 
minutes to allow RNAP reconstitution. An NTP master mix was made up containing 0.5 µl 
each of dATP, dCTP and dGTP, 0.25 µl dUTP, and 0.25 µl [α-32P]UTP (when at 100% activity, 
volume corrected for radioactive decay) per reaction. To initiate the transcription reaction, 
1 µl of plasmid template containing the target promoter (at a typical concentration of 100-
200 ng µl-1) and 2 µl of NTP master mix (volume corrected for [α-32P]UTP radioactive decay) 
were added to each reaction, and incubation continued at 30 oC. The reaction was allowed 
to run for 5 minutes for reactions involving RNAP complexed with E. coli σ70, and 30 minutes 
for reactions involving core RNAP complexed with Burkholderia an ECF sigma factor. The 
reaction was stopped by addition of 25 µl of stop buffer (95% (v/v) formamide, 4% (v/v) 0.5 
M EDTA (pH 8.0), 0.01% (w/v) bromophenol blue), and 25 µl of each reaction solution was 




Table 2.14. Reagents for casting of a 7 M urea 5.5% polyacrylamide gel 
Reagent Quantity 
dd H2O 3.4 ml 
Acrylamide, 40% (Fisher Bioreagents) 1.372 ml 
Urea 4.2 g 
10X TBE buffer[1] 1 ml 
10% (w/v) APS[2] 100 µl 
TEMED[2] 10 µl 
Final Volume 10 ml [3] 
[1] Tris boric acid EDTA buffer (see Table 2.15) 
[2] Reagents added immediately before casting 
[3] Final volume is greater than the sum total volume of reagents due to solublisation of urea 
 
The urea polyacrylamide gels were cast using 1.5 mm glass spacer plates (Biorad), and 
electrophoresis was performed using 0.5x TBE running buffer. After samples migrated into 
the gel, the wells were washed thoroughly with 0.5x TBE buffer, and the buffer in the upper 
chamber of the gel tank was replaced in order to remove unincorporated [α-32P]UTP. 
Samples were electrophoresed until the bromophenol blue reached the bottom of the gel, 
which was cut off and discarded. 
Table 2.15. Reagents for making 10x TBE Buffer 
Reagent Quantity 
Tris base 54 g 
Boric acid 27 g 
EDTA 3.7 g 
dd H2O 500 ml 
 
The gel was exposed to an imaging plate at 4 oC overnight, and analysed using a Fujifilm 
FLA3000 phosphoimager. Band intensity was calculated using the Fujifilm FLA3000 software 
suite as photostimulated luminescence, corrected for background luminescence. 
 
2.6.2 Bio layer interferometry (BLI) 
Bio layer interferometry (BLI) analysis was used to determine the interaction kinetics 
between purified ECF sigma factors and E. coli core RNA polymerase (NEB), and the effect of 
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metal ions upon this interaction. This was performed using the BLItz System using BLItz Pro 
1.1 software with the ‘Advanced Kinetics’ mode (fortéBIO, Pall Corp., USA).  
Assays were performed in RNAP buffer (40 mM Tris-HCl (pH 7.5), 150 mM KCl, 10 mM 
MgCl2, 1 mM DTT, 0.01% (v/v) Triton X-100) made on the day of the assay. When included in 
the assay, metal solutions were also made on the same day as the assay. Ni-NTA Biosensors 
were used (fortéBIO, Pall Corp., USA), and were hydrated in RNAP buffer for a minimum of 
10 minutes before use. Each assay was performed according to the steps in Table 2.16.  
Table 2.16. Steps used in BLI assays 





1 Initial baseline 60 Tube RNAP buffer 
2 Baseline 60 Drop RNAP buffer 
3 Loading 300 Drop 200 µg ml-1 His-tagged sigma factor in RNAP buffer [2]† 
4 Baseline 60 Tube RNAP buffer 
5 Baseline 60 Drop RNAP buffer (+ 25 µM M2+) [3] † 
6 Association 300 Drop Core RNAP (+ 25 µM M2+) [4] † 
7 Dissociation 300 Tube RNAP buffer 
[1] The total volumes in each step were either 250 µl (tube) or 5 µl (drop) 
[2] 1.25 µl of sigma factor, 3.75 µl of RNAP buffer 
[3] 3.75 µl of RNAP buffer, 1.25 µl of either ddH2O or 100 µM M2+ solution 
[4] 3.75 µl of E. coli core RNAP (NEB) at varying concentrations, 1.25 µl of either ddH2O or 100 µM M2+ 
solution 
† Solutions were incubated at room temperature for approximately 10 minutes before assaying 
 
For each interaction, six assays were performed with a range of concentrations of core 
RNAP from 62.5 nM to 2000 nM diluted in RNAP buffer. 
Experimental data was analysed using the Data Analysis v9.0 software (fortéBIO, Pall Corp., 
USA). The dissociation rates (kd, s-1), association rates (ka, M-1 s-1) and the binding affinity 
constants (KD, M) were calculated using a global analysis of the six data runs across six 






2.6.3 Bacterial adenylate cyclase two-hybrid (BACTH) assay 
To examine the interaction of proteins in vivo using a bacterial two-hybrid assay, the 
Bacterial Adenylate Cyclase Two-Hybrid (BACTH) System kit (Euromedex) was used. Genes 
or gene fragments for putative interacting proteins or domains were cloned into the 
provided vectors (pKT25, pKNT25, pUT18, or pUT18C) to give gene fusions to one of two 
subunits, T25 or T18, of the Bordetella pertussis adenylate cyclase (CyaA). Interaction 
between the two studied proteins enables close proximity between the complementary 
subunits T25 and T18, and the functional complementation results in CyaA activity and cyclic 
AMP (cAMP) synthesis. cAMP in turn binds to the E. coli catabolite activator protein (CAP), 
also known as the cAMP receptor protein (CRP). The cAMP/CAP complex activates 
expression of reporter genes of the lac and mal operons; this enables a phenotypic 
visualisation of protein-protein interaction using indicator media. 
Genes or gene fragments were cloned between the XbaI and Acc65I restriction sites to give 
in-frame fusions to the T25 and T18 subunits. Plasmid constructs were co-transformed into 
the E. coli ∆cya strain BTH101, and the resulting strains were screened for their maltose 
phenotype on MacConkey-maltose IPTG medium following growth at 30 oC for 
approximately five nights. 
For negative controls, each plasmid construct was concurrently assayed against the relevant 
empty vector, and for a positive control the control plasmids pKT25-zip and pUT18C-zip 
(expressing the bona fide interacting protein partners of the leucine zipper component of 
GCN4) were used. An interaction between the two test proteins gave a deep pink colour, 














Deletion analysis of 
the extended N- and 
C-terminal domains of 
OrbS 
3.1 OverviewAs discussed in section Error! Reference source not 
found., the iron starvation (IS) sigma factors OrbS and MbaS have unusual extended 
C-terminal extensions that are rich in cysteine residues. These are referred to as 
cysteine-rich extensions (CREs). Given the lack of a cognate anti-sigma factor, the 
ability of cysteine residues to coordinate metals via their thiol group (Osman and 
Cavet, 2010), and the observation that the cysteine-rich extended C-terminal 
domains of the ECF44 group sigma factors bind various metals as part of a regulatory 
mechanism (Gomez-Santos et al., 2011; Marcos-Torres et al., 2016), it was 
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hypothesised that the CRE found in the ECF09 sigma factors OrbS and MbaS may 
play a role in binding iron. This may regulate the activity of the protein. 
In addition to the CRE of OrbS and MbaS, these atypical sigma factors also contain an 
extended N-terminal extension of 35 amino acids relative to the (IS) sigma factor 
homologue PvdS from P. aeruginosa (Figure 3.1). This, too, may play a role in the regulation 
of OrbS and MbaS. 
 
Figure 3.1. Amino acid sequence alignment of OrbS and PvdS 
Amino acid sequences were aligned using Clustal-Omega. Amino acids that are identical in the 
sequences are shown in white font highlighted in black, and amino acids that have similarity are 
highlighted in grey. Conserved sigma factor regions are denoted below sequences based upon 
previous assignments of RpoE (Gruber and Gross, 2003; Campagne et al., 2014). Cysteine residues 
within the C-terminal region are coloured in red. Sequences were obtained from the following 
strains: B. cenocepacia H111 and P. aeruginosa PA01. 
OrbS was the selected sigma factor used for the initial investigation into these extended N- 
and C-terminal extensions. Due to the high degree of homology between OrbS and MbaS, 
the working assumption is that most conclusions derived from OrbS should be transferrable 
to MbaS. 
The effect of deleting these terminal extensions was investigated, with the aims of 
determining what length of the domains are required for the function of OrbS, and whether 
they play a role in the ability of OrbS to respond to iron. 
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Additionally, a previous preliminary analysis of OrbS-dependent promoter affinity had 
suggested that the substitution of all four C-terminal cysteine residues in OrbS by alanine 
residues may reduce the sigma factor’s responsiveness to iron (Agnoli, 2007). This 
experiment was carried out in an E. coli strain harbouring an OrbS-dependent promoter-lacZ 
fusion and a plasmid expressing orbS. However, the function of the entire C-terminal 
extension upon the activity of OrbS has not been investigated. The cysteine-substituted 
mutant, OrbSCtetraA, was included in this analysis to assess the importance of the four 
cysteine residues, both in terms of the overall function of OrbS and the sigma factor’s ability 
to respond to iron. 
Objectives: 
 To construct mutant forms of OrbS containing deletions within to the extended 
terminal domains 
 To compare the ability of these OrbS variants to initiate transcription of genes within 
the target regulon in B. cenocepacia using a phenotypic assay for siderophore 
production 
 To compare the ability of these OrbS variants to initiate transcription of genes within 
the target regulon in E. coli using a transcription reporter assay to monitor OrbS-
dependent promoter activity 
 To compare the relative inhibitory effect of iron upon the OrbS variants using a 
transcription reporter assay to monitor OrbS-dependent activity 
3.2 Construction of orbS variants with C-
terminal truncations 
 
The overall contribution of the C-terminal CRE upon the activity of OrbS was investigated by 
construction of a series of C-terminally truncated derivatives, as shown in Figure 3.2. The 
end-points of the truncated variants were selected to sequentially delete one, two, three 
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and four putative iron-binding cysteine residues (OrbS∆C1-OrbS∆C5). Deletions were also 
extended into the C-terminal helix of region 4.2 (OrbS∆C6 and OrbS∆C7). Furthermore, 29 
residues of the extended NTD were deleted (OrbS∆N), as shown in Figure 3.2. This deletion 
removed an internal segment of the N-terminal extension that is common to OrbS and 
MbaS sigma factors, but not PvdS. Finally, the effect of four cysteine-to-alanine 




Figure 3.2. Sequences of OrbS deletion derivatives used for investigation of N-terminal and C-
terminal extensions. 
Top. The amino acid sequence of the N-terminal extension of OrbS and the truncated OrbS∆N. Amino 
acid residues 1-40 are shown. Bottom. The C-terminal sequences of C-terminally truncated OrbS 
derivatives (cysteine residues are shown in red font). The sequence of the OrbSCtetraA derivative is 
also shown (alanine-substituted cysteines are shown in orange font). Amino acid residues 183-220 
are shown. 
3.2.1 Construction of pBBR1MCS-orbS derivatives 
To investigate the effect of N- and C-terminal deletion on the activity of OrbS, the 
pBBR1MCS series of broad host-range expression vectors were used. These vectors have 
been shown to successfully express orbS in E. coli and Bce in previous work (Agnoli et al., 
2006; Agnoli et al., 2018). So, pBBR1MCS was used to express the orbS derivative in 
complementation assays performed in B. cenocepacia. 
117 
 
The plasmid constructs pBBR1MCS-orbS, pBBR1MCS-orbSCtetraA, pBBR1MCS-orbS∆N, 
pBBR1MCS-orbS∆C3 and pBBR1MCS-orbS∆C4 were previously constructed ((Agnoli et al., 
2006), (Agnoli, 2007), R. Lomax (unpublished data)). The forward primer orbSfor was used in 
conjunction with the following reverse primers to amplify the corresponding PCR products: 
orbSrevC1 (orbS∆C1, 862 bp PCR product), orbSrevC2 (orbS∆C2, 856 bp PCR product), 
orbSrevC5 (orbS∆C5, 817 bp PCR product), orbSrevC6 (orbS∆C6, 802 bp PCR product), and 
orbSrevC7 (orbS∆C7, 790 bp PCR product) (Figure 3.3a). These PCR products were cloned 
between the HindIII and BamHI sites of pBBR1MCS to give the plasmid constructs expressing 
orbS with C-terminal truncations (Figure 3.3b). These orbS variants contained 209 bp of 
upstream flanking sequence, and 97 bp of downstream flanking sequence. This included the 
native orbS promoter. The identities of these plasmid constructs was confirmed by PCR 
screening and DNA sequencing analysis with primers M13revBACTH and M13for2. 
 
Figure 3.3. Construction of pBBR1MCS derivatives containing orbS with C-terminal truncations. 
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Agarose gel electrophoresis analysis of DNA PCR products and plasmid DNA used in construction of 
pBBR1MCS expressing derivatives of orbS with different C-terminal truncations. A. PCR to amplify 
orbS with C-terminal truncations. Lane 1, GeneRuler 1 kb DNA Ladder (Thermofisher); lane 2, 
orbS∆C1, 862 bp PCR product; lane 3, orbS∆C2, 856 bp PCR product; lane 4, orbS∆C5, 817 bp PCR 
product; lane 5, orbS∆C6, 802 bp PCR product; lane 6, orbS∆C7, 790 bp PCR product. B. pBBR1MCS-
orbS derivatives encoding OrbS with C-terminal truncations. Lane 1, Supercoiled ladder (NEB); lane  
2, pBBR1MCS, 4.7 kb; lane 3, pBBR1MCS-orbS∆C1, 5.5 kb; lane 4, pBBR1MCS-orbS∆C2, 5.5 kb; lane 5, 
pBBR1MCS-orbS∆C5, 5.5 kb; lane 6, pBBR1MCS-orbS∆C6, 5.5 kb; lane 7, pBBR1MCS-orbS∆C7, 5.5 kb. 
 
3.2.2 Construction of pBBR1MCS2-orbS and pBBR1MCS5-orbS derivatives 
The activity of the OrbS deletion derivatives in directing transcription from the OrbS-
dependent promoter PorbH was also assayed. To achieve this, the orbS genes were sub-
cloned into pBBR1MCS-2 and pBBR1MCS-5 so that they could be used in conjunction with 
the transcriptional reporter vector pKAGd4-PorbHds6 in β-galactosidase assays (Agnoli et al., 
2018). The pBBR1MCS-5 vector was used to enable assays to be performed in E. coli QC1732 
(a kanamycin-resistant strain); the pBBR1MCS-2 vector was used as it shows greater levels 
of cloned gene expression compared to other vectors of the pBBR1MCS series, and 
therefore greater sigma factor activity in assays (however, these plasmid constructs were 
not used in this study). The following plasmid constructs were previously constructed: 
pBBR1MCS2-orbS (Agnoli et al., 2018), pBBR1MCS5-orbS and pBBR1MCS2-orbSCtetraA (Agnoli 
2007), pBBR1MCS2-orbS∆N (R. Lomax, unpublished). To construct the remaining plasmids, 
the pBBR1MCS plasmids underwent restriction digests with HindIII and BamHI and the 
released orbS DNA fragments were inserted between the same sites of pBBR1MCS-2 and 
pBBR5MCS-5 (Figure 3.4). The identities of these plasmid constructs were confirmed by PCR 








Figure 3.4. Construction of pBBR1MCS-2 and pBBR1MCS-5 derivatives containing orbS with 
terminal truncations. 
Agarose gel electrophoresis analysis of constructed pBBR1MCS-2 and pBBR1MCS-5 plasmid 
derivatives expressing orbS with different C-terminal truncations. A. pBBR1MCS2-orbS derivatives 
with C-terminal truncations. 1: Supercoiled ladder (NEB); 2: pBBR1MCS-2, 5.1 kb; 3: pBBR1MCS2-
orbS∆C1, 6.0 kb; 4: pBBR1MCS2-orbS∆C2, 6.0 kb; 5: pBBR1MCS2-orbS∆C3, 5.9 kb; 6: pBBR1MCS2-
orbS∆C4, 5.9 kb; 7: pBBR1MCS2-orbS∆C5, 5.9 kb; 8: pBBR1MCS2-orbS∆C6, 5.9 kb; 9: pBBR1MCS2-
orbS∆C7, 5.9 kb. B. pBBR1MCS5-orbS derivatives with terminal truncations. 1: Supercoiled ladder 
(NEB); 2: pBBR1MCS-5, 4.7 kb; 3: pBBR1MCS5-orbSCtetraA, 5.7 kb; 4: pBBR1MCS5-orbS∆N, 5.6 kb; 5: 
pBBR1MCS5-orbS∆C1, 5.6 kb; 6: pBBR1MCS5-orbS∆C2, 5.6 kb; 7: pBBR1MCS5-orbS∆C3, 5.6 kb; 8: 
pBBR1MCS5-orbS∆C4, 5.6 kb; 9: pBBR1MCS5-orbS∆C5, 5.5 kb; 10: pBBR1MCS5-orbS∆C6, 5.5 kb; 11: 







3.3 Comparison of OrbS derivatives to 
complement siderophore deficient 
phenotype by CAS assay 
 
Firstly, the relative activity of the truncated/substituted orbS derivatives was compared in a 
phenotypic assay. This was achieved via comparison of the ability of each orbS variant 
supplied in trans from pBBR1MCS to complement the KLF1 orbS mutant OM3, which does 
not produce ornibactin or pyochelin (Agnoli et al., 2006). This was assessed by comparing 
the size of the yellow halo surrounding the bacterial growth on agar containing chrome-
azurol sulphonate (CAS) (more detail in section 2.1.2). 
Each of the pBBR1MCS-orbS derivatives, and the parental plasmid pBBR1MCS, were 
introduced by conjugation into OM3 using E. coli S17-1 donor cells. 1 µl of normalised 
overnight cultures grown in M9 medium supplemented with 0.5% (w/v) glucose and 50 µg 
ml-1 chloramphenicol were spotted onto CAS agar plates in triplicate, and grown at 37 OC for 
24 hours. Both iron-limited (10 µM FeCl3) and iron-replete (60 µM FeCl3) CAS agar plates 
were used to see if any effect of iron upon the regulation of the N- and C-terminally deleted 




Figure 3.5. CAS assay of B. cenocepacia OM3 complemented with N- and C-terminally-modified 
OrbS derivatives. 
Cultures of OM3 containing pBBR1MCS-based plasmids spotted on iron-limited and iron-replete CAS 
agar. Plasmids are denoted as follows: -, pBBR1MCS; WT, pBBR1MCS-orbS; CtetraA, pBBR1MCS-
orbSCtetraA; ΔN, pBBR1MCS-orbSΔN; ΔC1-7, pBBR1MCS-orbSΔC1-pBBR1MCS-orbSΔC7 . A. CAS agar plate 
containing 10 μM FeCl3. B. CAS agar plate containing 60 μM FeCl3. C. Quantification of siderophore 
halo areas. The halo areas were calculated by measuring their diameters from CAS plates in 




The results presented in Figure 3.5 show that wild-type OrbS, OrbSΔN, OrbSCtetraA and 
OrbSΔC1-OrbSΔC4 were all capable of complementing the orbS- phenotype of OM3. However, 
the sigma factors with more extensive deletions, i.e.OrbSΔC5-OrbSΔ7, appeared unable to 
complement the mutant. 
Additionally, it was observed that OM3 containing OrbSΔC1, OrbSΔC2, OrbSΔC3 and OrbSCtetraA 
was able to produce a larger siderophore halo than OM3 containing wild-type OrbS. 
The effect of a high iron load upon the ability of these sigma factors to complement OM3 
was also investigated with iron-replete agar containing 60 μM FeCl3. The results show that 
all the complemented OM3 derivatives showed a consistent decrease in siderophore 
production.  
 
3.4 Determination of the activity of N- and C-
terminal deletion variants by promoter 
activity assays in vivo 
 
Although the CAS assay provides useful qualitative detail regarding the sigma factor activity 
of OrbS, OrbS-dependent promoter activity measurements were used for better 
quantitation of this activity. Additionally, these assays could be performed in a fur null 
mutant bacterial strain to enable investigation of direct iron regulation of OrbS activity. To 
assay OrbS-dependent promoter activity, a transcriptional fusion of the lacZ reporter gene 
to the orbH promoter was used, 
The pKAGd4-PorbHds6 promoter reporter vector (Agnoli et al., 2018) and pBBR1MCS5-based 
vectors expressing orbS and orbS mutants encoding truncated/substituted derivatives were 
co-introduced into E. coli QC1732 (fur-) by transformation. The assay was performed cells 
grown in M9 minimal salts medium supplemented with 0.5% (w/v) glucose, 0.1% (w/v) 
casamino acids, 50 µg ml-1 gentamicin, 25 µg ml-1 chloramphenicol and either 100 µM 2,2-
123 
 
dipyridyl (iron-limited conditions) or 50 µM FeCl3 (iron-replete conditions) and β-
galactosidase assays were performed according to the protocol outlined in section 2.5.1. 
The experiment was repeated twice. 
 
Figure 3.6. Activity of OrbS deletion derivatives at the orbH promoter in E. coli growing under iron-
replete and iron-limited conditions. 
β-galactosidase activity was measured in E. coli QC1732 harbouring pKAGd4-PorbHds6 and pBBR5-orbS, 
pBBR5-orbS∆N, pBBR5-orbS∆C1-pBBR5-orbS∆C7 or pBBR5-orbSCtetraA as denoted below data bars. All β-
galactosidase activities were corrected for the background vector activity by subtraction of activity 
derived from E. coli QC1732 harbouring the plasmids pKAGd4-PorbHds6 and pBBR1MCS-5. Growth 
medium was M9 minimal salts supplemented with 0.5% (w/v) glucose, 0.1% (w/v) casamino acids, 
50 µg ml-1 gentamicin, 25 µg ml-1 chloramphenicol and either 100 µM 2,2-dipyridyl (light grey) or 50 
µM FeCl3 (dark grey). Error bars show standard deviation (n=6). 
 
The results from the β-galactosidase assay conducted on cultures growing under iron-
limiting conditions concur with those from the CAS plate assay, in that all of the OrbS 
truncated mutants displayed functional activity with the exception of OrbS∆C5, OrbS∆C6 and 
OrbS∆C7. OrbS∆N and OrbSCtetraA both showed similarly high β-galactosidase activity as the 









































terminal cysteines of the CRE has no effect on the ability of OrbS to associate with RNAP or 
initiate transcription of target genes. Although OrbS∆C1-OrbS∆C3 were able to direct 
transcription from PorbH, the activity was approximately 32-43% lower than for wild-type 
OrbS under iron-limited conditions. OrbS∆C4 was also able to direct transcription from PorbH, 
but these activity was even lower – approximately 2% lower than for wild-type OrbS under 
iron-limited conditions. 
As this assay was performed in a fur null mutant, the effect of direct iron-dependent 
regulation of OrbS activity, independently of Fur, could be investigated. There are significant 
differences in β-galactosidase activity under iron-limited and iron-replete conditions for 
OrbS (P<0.0001), OrbS∆N (P<0.0001) and OrbS∆C1 (P<0.05), but not the others (one-way 
ANOVA, F=173.8, Sidak’s multiple comparisons test).  
Iron-replete conditions caused an approximately 43% decrease in the activity of wild-type 
OrbS. This provides initial verification that there may be a secondary mechanism for 
regulating OrbS in response to prevailing iron concentration, and supports previous data 
regarding this (Agnoli, 2007). 
The PorbH activity in the presence of OrbSΔN was similarly decreased (by approximately 31%) 
during growth under iron-replete conditions, indicating that the N-terminal extension may 
not play a role in the putative iron-regulation mechanism. Although OrbS∆C1 does also 
display a decrease in activity, it is a smaller decrease (approximately 35%) than that of wild-
type OrbS. OrbS derivatives with more extensive C-terminal deletion show no statistically 
significant difference between activities in cells growing under iron-limited and iron-replete 
conditions.  
Finally, it was observed that OrbSCtetraA gave rise to similarly high β-galactosidase activity in 
cells grown under both iron-limited and iron-replete conditions, with no statistically 







A series of pBBR1MCS-based plasmids expressing orbS and derivatives of orbS encoding C-
terminal truncations and an N-terminal deletion were constructed. All of these, with the 
exception of OrbS∆C5, OrbS∆C6, and OrbS∆C7, displayed functional ability both in terms of 
complementation of a ∆orbS phenotype and initiation of transcription from the PorbHds6 
target promoter. Therefore, the 29 residues of the N-terminus present in OrbS are not 
required for OrbS-dependent transcription. 
At the C-terminus, deletions extending as far as Cys199 (i.e. deletion of up to 21 amino acids 
from the C-terminus) also did not affect the ability of the sigma factor to initiate 
transcription. However, truncations extending N-terminally of Cys199 do abolish this ability, 
as demonstrated by the inability to complement the orbS mutant or initiate transcription 
from the orbH promoter. It is likely that the deleted amino acid residues in these cases 
provide a key role in the overall function of OrbS, particularly as they are located within the 
conserved region 4.2. 
Also, although the OrbS∆C4 mutant only has very low activity upon PorbHds6, it is sufficient to 
nearly fully complement to OM3 mutant. This would suggest that though the deletion 
extends up to the C-terminal boundary of region 4.2, but not beyond it, there may be some 
destabilisation of the helix-turn-helix required for engagement with the -35 DNA element. 
The residues positioned N-terminally of Cys199 are either functionally important (i.e. they 
are specifically required for interaction with promoter DNA and/or core RNAP) or 
structurally important (i.e. deletion of these residues results in an incorrectly folded sigma 
factor with loss-of-function). Protein structure modelling using the Phyre2 server (Kelley et 
al., 2015) was carried out in an attempt to rationalise the effect of these N-terminal and C-
terminal deletions. The overall structure of wild-type OrbS was modelled upon known 
structures of similar sigma factors bound by their anti-sigma factors (more specifically RpoE 
and NepR, among others) (Figure 3.7). Therefore, the structure shown is likely to be that of 
the putative inactive form, and not the structure of free OrbS or OrbS in complex with core 
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RNAP and/or promoter DNA. Although the core of the protein is highly conserved and 
modelled with relatively high reliability, the terminal extensions are not, and the reliability 




Figure 3.7. Predicted structure of OrbS. 
Predicted model 3D structure of OrbS, generated using Phyre2 (Kelley et al., 2015) and analysed with 
CCP4MG (McNicholas et al., 2011). The protein structure is displayed in ribbon format. Based upon 
previous assignments of RpoE, domains have been coloured as follows: N-terminal extension (Arg7-





Firstly, in the predicted structure of OrbS, both the N-terminal extension and the C-terminal 
extension have been modelled to be in close proximity to each other. If OrbS, when 
inactivated, forms the same conformation as related sigma factors when they are 
inactivated by anti-sigma factors, the association between these termini may correlate to 
the inhibition of the sigma factor. The modelling suggests that the N- and C-terminal 
extensions are largely unstructured and each contain a very short α-helical region. The N-
terminal extension is rich in proline residues which is consistent with its modelling as a 
region lacking secondary structure. The terminal extensions may adopt a different structure 
upon iron-binding. Nonetheless, there is a low reliability of the predicted structure of these 
terminal extensions. No specific conclusions can be drawn apart from the fact that the N-
terminal extension is very likely to lack secondary structural elements, such as α-helices. 
Next, the effect of deletion of the most of the N-terminal extension was modelled to predict 
what effect this may have had on the activity of OrbS (Figure 3.8). 
The deletion of the N-terminal extension is predicted to have no large-scale effect on the 
overall fold of the protein. This affirms the data presented in Figure 3.5 and Figure 3.6, 
which show OrbS∆N displays very similar activity to wild-type OrbS. However, an interesting 
difference is predicted to occur at the C-terminus in the absence of the N-terminal 
extension. Without the N-terminal region, the C-terminal extension is predicted to become 
disordered (Figure 3.8). This is not consistent with the empirical data presented in Figure 
3.6, which demonstrates that OrbS∆N retains the ability respond to iron, whereas OrbS∆C2- 





Figure 3.8. Effect of N-terminal deletion upon the predicted protein structure of OrbS. 
Predicted superimposed model 3D structures of OrbS and OrbS∆N, generated using Phyre2 (Kelley et 
al., 2015) and analysed with CCP4MG (McNicholas et al., 2011). The core protein structures of OrbS 
(gold) and OrbS∆N (ice blue) are displayed in worm format. The N-terminal extension of OrbS (Met1-
Ser35) is displayed in ribbon format and coloured red. 
 
In the presented promoter reporter analysis, there was a progressive decrease in the 
activity of OrbS as deletions at the C-terminus were extended (Figure 3.9). The effect of C-
terminal deletion was also modelled to rationalise this data. In particular, the large 10 
residue deletion of OrbS∆C1 compared to OrbS has been predicted to have a significant 
effect upon the C-terminal extension. Not only is the predicted C-terminal α-helix lost, the 
peptide backbone is directed outwards at a markedly different angle.  This structural 
disparity may account for the decrease in sigma factor activity observed in Figure 3.6. 
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Furthermore, successive deletion from OrbS∆C1 to OrbS∆C5 have the effect of shortening the 
C-terminal helix of region 4.2, although these deletions do not directly impinge on the helix 
Figure 3.1 and Figure 3.2. This may account for the decreased activity of OrbS∆C1-OrbS∆C5. In 
particular, the ΔC5 deletion that terminates immediately adjacent to the C-terminus of 
region 4.2 results in a much shorter α-helix and abolishes OrbS activity (Figure 3.2, Figure 
3.5, Figure 3.6 and Figure 3.9). Deletion beyond ΔC5 removes key RNAP/DNA interacting 
residues or disrupt the structure of the helix, resulting in loss-of-function. Importantly, none 
of the C-terminal truncated variants are predicted to have a global effect on the overall 
structure of OrbS. Therefore, differences in the activity of these proteins should be specific 
to alterations in the structure of the C-terminal extension. 
In this chapter, experiments were performed with the aim analyse the effect of iron upon 
the activity of OrbS and its N- and C-terminally truncated variants. This was first performed 
in OM3 Figure 3.5 However, this is a Fur+ system. OM3 produces Fur which is able to repress 
the transcription of orbS by interacting with the Fur box sequence present in the promoter 
regions of the cloned orbS variants. Therefore, it is assumed that the action of Fur may mask 
any iron-dependent inhibition specific to the terminal extensions. Therefore, this decrease 
in siderophore production is not unexpected. This was also demonstrated with promoter 
reporter analysis in an E. coli fur null mutant Figure 3.6. In this experiment, it was observed 
that OrbS activity was regulated in response to prevailing iron. There was loss of this iron-
dependent regulation of the activity of OrbS variants with C-terminal deletions. This could 
point to the CTE having a role in the iron-dependent regulation mechanism. Interestingly, 
the difference between OrbS∆C1, which displays some iron regulation, and OrbS∆C2, which 
does not display iron regulation, is the deletion of the Cys209 and Pro210 residues. This 
could imply that these residues, most likely the cysteine residue, have a role in this iron 
regulation. 
Furthermore, this loss of iron regulation was observed upon the activity of OrbSCtetraA. This 
observation strongly suggests that the four cysteine residues of the CRE play a significant 
role in the putative direct iron-regulation mechanism of OrbS. The predicted effect of the 
four cysteine-to-alanine substitutions in OrbSCtetraA was modelled (Figure 3.10). Overall, 
there is predicted to be little difference in the overall protein structure of OrbS and 
OrbSCtetraA. This prediction is in accordance with the presented empirical data, in which both 
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OrbS and OrbSCtetraA display similar levels of functional activity. However, there is some 
structural variation in the C-terminal 15-20 residues. If this modelling is accurate, it means it 
is difficult to determine whether any difference between the response of OrbS and 
OrbSCtetraA to iron is specifically due to iron binding by the cysteine residues, or due to an 
incorrectly folded domain resulting from the substitution of the cysteines. It is also 
noteworthy that Cys196, Cys199 and Cys203 are predicted to be positioned in proximity to 
one another. The inter-atom distances are possibly viable for cooperative coordination of a 
metal ion such as Fe(II), although may be considered too distant. For example, in the Fur 
protein of Magnetospirillum gryphiswaldense MSR-1, bond distances between Mn(II) and 
coordinating amino acids are around 2.2 Å, and the distances between the amino acids are 
around 3-4 Å (Deng et al., 2015). However, it should be noted again that (a) the modelling in 
this region is very unreliable, and (b) the CRE cysteines can be expected reorientate to 
chelate the metal ion 
In conclusion, the results from these investigations into the terminal extensions have 
provided justification to investigate the C-terminal region of OrbS as a possible iron sensor, 
in particular the four conserved cysteine residues. Although the role of the N-terminal 
extension remains elusive, it does not appear to have a direct role in iron-dependent 
regulation. Therefore, the N-terminal extension will not be investigated further. 
Nonetheless, further examination of the role of this domain could provide interesting 
insights into the regulation of OrbS. Due to the high degree of similarity between OrbS and 
MbaS (Figure 1.13), some of the conclusions drawn here may be applicable to MbaS. More 
specifically, that some or all of the five cysteine residues found in the CRE of MbaS may play 
a role in an iron-dependent regulation mechanism. This is the focus of the investigation as 





Figure 3.9. Effect of C-terminal truncation upon the predicted structure of the OrbS C-terminal 
extension. 
Predicted superimposed 3D structural models of OrbS and OrbS∆C1-OrbS∆C7, generated using Phyre2 
(Kelley et al., 2015) and analysed using CCP4MG (McNicholas et al., 2011). Amino acid residues from 
the region 4.2 helix-turn-helix to the C-terminus are shown (Thr170-Arg220). Structures are 





Figure 3.10. Effect of four cysteine-to-alanine substitutions upon the predicted protein structure of 
the OrbS C-terminal extension. 
Predicted superimposed model 3D structures of OrbS and OrbSCtetraA, generated using Phyre2 (Kelley 
et al., 2015) and analysed using CCP4MG (McNicholas et al., 2011). Amino acid residues of the CTD 
are shown. Peptide backbones are displayed in worm format, and are coloured as indicated. Alanine 
or cysteine residues at positions 196, 199, 203 and 209 are displayed in cylinder format, and atoms 
coloured as follows: carbon, grey (OrbS) or green (OrbSCtetraA); oxygen, red; nitrogen, blue; sulphur, 
yellow. Distances between sulphur atoms of Cys196, Cys199, Cys203 and Cys209 of OrbS are shown 























For the analysis of the activity of MbaS in vivo, a series of gene mutations were required in 
the model organism B. thailandensis E264. Firstly, a ∆mbaS mutant was required to remove 
the genomic copy of MbaS, and allow Fur-independent MbaS (and mutant forms of MbaS) 
to be supplied in trans. Additionally, the secondary siderophore pyochelin was predicted to 
interfere with in vivo assays where the production of malleobactin was to be assayed. 
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Therefore, the pyochelin NRPS pchE gene was to be deleted. The transcription of mbaS is 
regulated by the ferric uptake regulator Fur (Alice et al., 2006); therefore, the fur gene was 
also selected for deletion to remove the masking effect of Fur-dependent iron regulation. 
Finally, for the purpose of investigating the effect of the five conserved cysteine residues of 
the CRE of MbaS, mutant forms of the mbaS gene with selected cysteine-to-alanine 
substitutions were produced. These mbaS substitution mutants were also intended to be 
introduced into Bth E264. 
Mutant alleles were amplified by SOE-PCR (described in 2.2.6) and cloned into selected 
allelic exchange vectors. Allelic exchange has been demonstrated to be effective at 
generating mutants in several species of Burkholderia (Barrett et al., 2008; Shastri et al., 
2017). However, several allelic exchange vectors were employed with varying levels of 
success in Bth E264. Attempts with several different methods of allelic exchange were 
required to generate mutants, and these were isolated with low efficiency. For the 
generation of mbaSCpentaA and fur mutants, usage of these allelic exchange vectors was 
unsuccessful and it was not possible to isolate the desired mutants. 
The phenotypes of isolated mutants were analysed using a variety of methods, including 
growth curves (see section 2.1.1), β-galactosidase assays (see section 2.5.1) and CAS assays 




 To use SOE-PCR to synthesise mutant alleles of ∆mbaS, ∆pchE, ∆fur and mbaSCpentaA 
 To introduce these mutant alleles into Bth E264, and phenotypically characterise the 
isolated mutants 





For the analysis of MbaS in vivo in Bth, an mbaS deletion mutant was sought after. This 
would enable in trans complementation with MbaS (and any MbaS mutants). Due to the 
genomic location of mbaS within the mba gene cluster, a marker-less in-frame deletion was 
required to avoid polar effects. 
 
4.2.1 Construction of pEX18Tp-pheS-∆mbaS 
For the introduction of ∆mbaS, the pEX18Tp-pheS allelic exchange vector was used (Barrett 
et al., 2008). The ∆mbaS mutant allele, with ≥500 bp of upstream and downstream flanking 
DNA, was amplified by SOE-PCR using primers ∆mbaS-A, ∆mbaS-B, ∆mbaS-C, and ∆mbaS-D 
to produce a 1099 bp PCR product (Figure 4.1a,b). The ∆mbaS allele was cloned between 
the HindIII and BamHI sites of the MCS of pEX18Tp-pheS to give pEX18Tp-pheS-∆mbaS 
(Figure 4.1c). The identity of the plasmid construct was confirmed by PCR screening and 




Figure 4.1. Construction of pEX18Tp-pheS-∆mbaS 
Agarose gel electrophoresis analysis of DNA PCR products and plasmid DNA used in construction of 
pEX18Tp-pheS-∆mbaS. A. First round SOE PCR to amplify ∆mbaS with upstream and downstream 
flanking DNA. Lanes 1 and 4, GeneRuler 1 kb DNA Ladder (Thermofisher); lane 2, ∆mbaS ‘left’ flank, 
554 bp PCR product; lane 3, ∆mbaS ‘right’ flank, 581 bp PCR product. B. Second round SOE PCR to 
amplify ∆mbaS with upstream and downstream flanking DNA. Lane 1, GeneRuler 1 kb DNA Ladder 
(Thermofisher); lane 2, ∆mbaS, 1099 bp PCR product. C. pEX18Tp-pheS-∆mbaS. Lane 1, Supercoiled 
ladder (NEB); lane 2, pEX18Tp-pheS, 4.5 kb; lane 3, pEX18Tp-pheS-∆mbaS, 5.6 kb. 
 
4.2.2 Introduction of ∆mbaS into wild-type B. thailandensis by allelic 
exchange 
E. coli SM10λpir transformed with pEX18Tp-pheS-∆mbaS was used as the donor strain for 
transfer of the mutant allele by conjugation into wild-type Bth E264. Resolution products 
were selected on M9 agar containing 25 µg ml-1 trimethoprim. Plasmid integration was 
further verified by PCR screening using the mbaS-specific primers ∆mbaS-A and ∆mbaS-D, 
and the vector specific primers pEX18Tpfor2 and pEX18Tprev2 (Figure 4.2). 
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The verified co-integrant strain, harbouring both mbaS and ∆mbaS, was then grown on M9-
glucose agar containing 0.1% (w/v) cPhe and supplemented with 10 µM FeCl3 and counter-
screened on trimethoprim according to section 2.1.5 to isolate recombinant strains. 
Additionally, colonies were screened on CAS agar with 10 µM FeCl3 to identify colonies 
exhibiting loss of yellow halo, indicative of loss of malleobactin production (colonies still 
exhibited small orange halo when grown at 30 oC, indicative of retention of pyochelin 
production). Positive clones underwent PCR screening with the primer pairs ∆mbaS-out-
fwd/∆mbaS-out-rev, ∆mbaS-A/∆mbaS-D, and pEX18Tpfor2/pEX18Tprev2, to identify 




Figure 4.2. Verification of Bth E264 ∆mbaS deletion mutant by PCR screen 
Agarose gel electrophoresis analysis of DNA products from PCR screening of strains during 
introduction of mutant ∆mbaS allele into Bth E264. The bacterial strain or plasmid from which the 
template DNA is extracted is denoted by brackets below. The primer pairs used in each PCR reaction 
are indicated by letters above lanes: A, ∆mbaS-A/∆mbaS-D (expected molecular weights: mbaS = 
1746 bp, ∆mbaS = 1092 bp); B, pEX18Tpfor2/pEX18Tprev2 (expected molecular weight 1368 bp); C, 
∆mbaS-out-fwd/∆mbaS-out-rev (expected molecular weights: mbaS = 1797 bp, ∆mbaS = 1131 bp). 






Figure 4.3. Schematic representation of mbaS gene deletion deletion PCR screening strategy. 
Genes are shown as block arrows, and annotated with gene names below. Primer pairs, with resulting PCR product sizes, are shown above genes as arrows: 
black, ∆mbaS-A/∆mbaS-D; red, ∆mbaS-out-fwd/∆mbaS-out-rev. All genomic sizes and positions are to scale, except for the pEX18Tp-pheS plasmid 
backbone. The co-integrant strain shown results from the first homologous recombination occurring upstream of mbaS, but could also occur downstream 
and result in a different gene organisation, but the same PCR product sizes.
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4.3 Construction of ∆pchE gene deletion 
mutant 
 
Several in vivo experiments were planned to analyse the production of malleobactin by Bth 
as a way of evaluating the regulation of MbaS. However, Bth also produces a secondary 
siderophore, pyochelin, which was likely to interfere with the analysis of malleobactin 
production. Therefore, in order to remove pyochelin production, the pyochelin NRPS gene 
pchE was deleted in Bth by construction of a ∆pchE allele and allelic exchange. 
 
4.3.1 Construction of pSNUFF3Cm-∆pchE 
For the introduction of ∆pchE, the pSNUFF3Cm allelic exchange vector was used (Spiewak, 
unpublished). The ∆pchE mutant allele, with ≥500 bp of upstream and downstream flanking 
DNA, was amplified by SOE-PCR using primers ∆pchE-A, ∆pchE-B, ∆pchE-C and ∆pchE-D to 
produce a 1088 bp PCR product (Figure 4.4a,b). The ∆pchE allele was cloned between the 
HindIII and BamHI sites of the MCS of pSNUFF3Cm to give pSNUFF3-Cm-∆pchE (Figure 4.4c). 
The identity of the plasmid construct was confirmed by PCR screening and DNA sequencing 




Figure 4.4. Construction of pSNUFF3Cm-∆pchE 
Agarose gel electrophoresis analysis of DNA PCR products and plasmid DNA used in construction of 
pSNUFF3Cm-∆pchE. A. First round SOE PCR to amplify ∆pchE with upstream and downstream 
flanking DNA. Lanes 1 and 4, GeneRuler 1 kb DNA Ladder (Thermofisher); lane 2, ∆pchE ‘left’ flank, 
556 bp PCR product; lane 3, ∆pchE ‘right’ flank, 568 bp PCR product. B. Second round SOE PCR to 
amplify ∆pchE with upstream and downstream flanking DNA. Lane 1, GeneRuler 1 kb DNA Ladder 
(Thermofisher); lane 2, ∆pchE, 1088 bp PCR product. C. pSNUFF3Cm-∆pchE. Lane 1, Supercoiled 




4.3.2 Introduction of ∆pchE into wild-type B. thailandensis by allelic 
exchange 
E. coli S17-1λpir transformed with pSNUFF3Cm-∆pchE was used as the donor strain for 
transfer of the mutant allele by conjugation into wild-type Bth E264. Resolution products 
were selected on Lnx agar containing 50 µg ml-1 kanamycin and 50 µg ml-1 chloramphenicol. 
Plasmid integration was further verified by PCR screening using the pchE-specific primers 
∆pchE-A and ∆pchE-D, and the vector specific primers pEX18Tpfor2 and pEX18Tprev2. 
The I-SceI endonuclease was then introduced into the verified co-integrant strain, 
harbouring both pchE and ∆pchE, in order to select for a second recombination event. This 
was achieved by introduction of pDAI-SceI-pheS via conjugation with E. coli S17-1λpir donor 
cells. Strains that had successfully taken up pDAI-Sce-pheS were selected for on Lnx agar 
containing 50 µg ml-1 gentamicin and 50 µg ml-1 tetracycline. Positive clones underwent PCR 
screening with the primer pairs ∆pchE-out-fwd/∆pchE-out-rev and 
pEX18Tpfor2/pEX18Tprev2, to identify recombinants with the pchE gene deletion and loss 
of the vector backbone (Figure 4.5). 
 
Figure 4.5. Verification of Bth E264 ∆pchE deletion mutant by PCR screen 
Agarose gel electrophoresis analysis of DNA products from PCR screening of strains during 
introduction of mutant ∆pchE allele into Bth E264. The bacterial strain or plasmid from which the 
template DNA is extracted is denoted below the gel image. The primer pair used in each PCR 
reaction are indicated by letters above lanes: A, ∆pchE-out-fwd/ ∆pchE-out-rev (expected molecular 
weights: pchE = 5568 bp (PCR products were too large to be amplified and could not be observed), 
∆pchE = 1224 bp). B, pEX18Tpfor2/ pEX18Tprev2 (expected molecular weight 1368 bp); MW 
indicates GeneRuler 1 kb DNA Ladder (Thermofisher). 
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4.4 Construction of ∆mbaS ∆pchE gene 
deletion mutant 
 
To analyse the effect activity of MbaS supplied in trans in Bth, a mutant unable to produce 
pyochelin and with an mbaS deletion was sought after. This would enable complementation 
with MbaS (and any MbaS mutants), and enable the analysis of malleobactin production 
without the interference of pyochelin production. Again, a marker-less in-frame deletion 
was required to avoid polar effects. This mutant was generated by introduction of pEX18Tp-
pheS-∆mbaS (see section 4.2.1) into Bth E264 ∆pchE (see section 4.3). 
 
4.4.1 Introduction of ∆mbaS into B. thailandensis ∆pchE by allelic 
exchange 
E. coli SM10λpir transformed with pEX18Tp-pheS-∆mbaS (section 4.2.1) was used as the 
donor strain for transfer of the mutant allele by conjugation into Bth E264 ∆pchE (section 
4.3). Resolution products were selected on M9 agar containing 25 µg ml-1 trimethoprim. 
Plasmid integration was further verified by PCR screening using the mbaS-specific primers 
∆mbaS-A and ∆mbaS-D, and the vector specific primers pEX18Tpfor2 and pEX18Tprev2. 
The verified co-integrant strain, harbouring both mbaS and ∆mbaS (and ∆pchE), was then 
grown on M9-glucose agar containing 0.1% (w/v) cPhe and supplemented with 10 µM FeCl3 
and counter-screened on trimethoprim according to section 2.1.5 to isolate recombinant 
strains. Additionally, colonies were screened on CAS agar with 10 µM FeCl3 to identify 
colonies exhibiting loss of yellow halo, indicative of loss of malleobactin production. Positive 
clones underwent PCR screening with the primer pair ∆mbaS-out-fwd/∆mbaS-out-rev to 





Figure 4.6. Verification of Bth E264 ∆mbaS ∆pchE deletion mutant by PCR screen 
Agarose gel electrophoresis analysis of DNA products from PCR screening of strains during 
introduction of mutant ∆mbaS allele into Bth E264 ∆pchE using the primer pair ∆mbaS-out-
fwd/∆mbaS-out-rev (expected molecular weights: mbaS = 1797 bp, ∆mbaS = 1131 bp). Lanes 1 and 
6, GeneRuler 1 kb DNA Ladder (Thermofisher). The bacterial strain from which the template DNA is 
extracted is as follows: lane 2, Bth E264 ∆pchE (original strain); lane 3, Bth E264 ∆pchE-pEX18Tp-
pheS-∆mbaS (co-integrant); lane 4, Bth E264 ∆pchE (exogonjugant restoring the wild-type mbaS 
allele); lane 5, Bth ∆mbaS ∆pchE (resolution product with desired gene deletion). 
 
4.5 Attempts at construction of mbaSCpentaA 
gene substitution mutants 
 
MbaS encodes five conserved cysteine residues within its C-terminal region, which have 
been hypothesised to play a role in the regulation of the sigma factor via direct binding of 
Fe(II) (see section Error! Reference source not found.). To investigate the influence of these 
five C-terminal cysteine residues of MbaS, five cysteine-to-alanine substitutions were 
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introduced to construct a mutant allele, MbaSCpentaA. This allele was attempted to be 
introduced into Bth by allelic exchange. 
 
4.5.1 Construction of pEX18Tp-pheS-mbaSCpentaA 
For the introduction of ∆mbaS, the pEX18Tp-pheS allelic exchange vector was found to be 
successful. Therefore, this vector was initially selected for the introduction of an mbaS 
mutant allele with cysteine-to-alanine substitutions within the CRE, at positions C203, C206, 
C216, C220 and C230. The mutant allele was to be introduced into both Bth E264 ∆mbaS 
and Bth E264 ∆mbaS ∆pchE. This ‘knock-in’ mutagenesis would make the screening of 
potential mutants simpler, as the primers ∆mbaS-out-fwd/∆mbaS-out-rev are expected to 
amplify a markedly larger PCR product from Bth containing the mbaSCpentaA allele compared 
to the ΔmbaS allele. Additionally, replacing MbaS with MbaSCpentaA is not expected to be 
associated with a strong phenotype change that can be screened for. 
SOE-PCR was used to produce the mbaSCpentaA mutants allele. Initially, this was attempted 
using a single pair of long mutagenic primers, in conjugation with the primers ΔmbaS-A and 
ΔmbaS-D. This pair of mutagenic primers would introduce all five cysteine-to-alanine 
substitutions. However, attempts at producing mbaSCpentaA in the way were not successful. 
Therefore, it was decided to approach the five cysteine-to-alanine substitutions in three 
‘clusters’: cluster 1 comprised the substitutions C203+206A, cluster 2 comprised the 
substitutions C216+220A, and cluster 3 comprised the substitution C230A. 
Firstly, the mbaSC230A allele was amplified from Bth E264 genomic DNA by SOE-PCR using the 
primers ΔmbaS-A, mbaS-C230A-B, mbaS-C230A-C, and ΔmbaS-D to produce a 1765 bp PCR 
product (Figure 4.7a,b). This mbaSC230A allele was cloned between the HindIII and BamHI 
sites of the MCS of pEX18Tp-pheS to give pEX18Tp-pheS-mbaSC230A. The identity of this 
plasmid construct was confirmed by PCR screening and DNA sequencing analysis with 
primers M13revBACTH and M13for2. 
Next, the mbaSC203+206+230A allele was amplified by SOE-PCR, using pEX18Tp-pheS-mbaSC230A 
as template DNA, with the primers ΔmbaS-A, mbaS-C203+206A-B, mbaS-C203+216A-C, and 
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ΔmbaS-D to produce a 1765 bp PCR product (Figure 4.7c,d). This mbaSC203+206+230A allele was 
cloned between the HindIII and BamHI sites of the MCS of pEX18Tp-pheS to give pEX18Tp-
pheS-mbaSC203+206+230A. The identity of this plasmid construct was confirmed by PCR 
screening and DNA sequencing analysis with primers M13revBACTH and M13for2. 
Finally, the mbaSC203+206+216+220+230A (or mbaSCpentaA) allele was amplified by SOE-PCR, using 
pEX18Tp-pheS-mbaSC203+206+230A as template DNA, with the primers ΔmbaS-A, mbaS-
C216+220A-B, mbaS-C216+220A-C, and ΔmbaS-D to produce a 1765 bp PCR product (Figure 
4.7e,f). This mbaSCpentaA allele was cloned between the HindIII and BamHI sites of the MCS of 
pEX18Tp-pheS to give pEX18Tp-pheS-mbaSC230A (Figure 4.7g). The identity of this plasmid 
construct was confirmed by PCR screening and DNA sequencing analysis with primers 
M13revBACTH and M13for2. 
Although this was the process by which pEX18Tp-pheS-mbaSCpentaA was constructed, 
attempts to introduce the cysteine-to-alanine substitutions also resulted in the construction 
of mbaS mutant alleles with other arrangements of the cysteine-to-alanine substitutions. 
For instance, this process also yielded the alleles mbaSC203+206A (or mbaSCdiA) and 
mbaSC203+206+216+220A (or mbaSCtetraA), both of which were also inserted into pEX18Tp-pheS, 
and their cloning confirmed by PCR screening and DNA sequencing analysis with the primers 




Figure 4.7. Construction of pEX18Tp-pheS-mbaSCpentaA 
Agarose gel electrophoresis analysis of DNA PCR products and plasmid DNA used in construction of 
pEX18Tp-pheS-mbaSCpentaA. A. First round SOE PCR to amplify mbaSC230A with upstream and 
downstream flanking DNA. Lane 1, mbaSC230A ‘left’ flank, 1232 bp PCR product; lane 2, mbaSC230A 
‘right’ flank, 561 bp PCR product; lane 3, GeneRuler 1 kb DNA Ladder (Thermofisher). B. Second 
round SOE PCR to amplify mbaSC230A with upstream and downstream flanking DNA. Lane 1, 
GeneRuler 1 kb DNA Ladder (Thermofisher); lane 2, mbaSC230A, 1765 bp PCR product. C. First round 
SOE PCR to amplify mbaSC203+206+230A with upstream and downstream flanking DNA. Lane 1, 
GeneRuler 1 kb DNA Ladder (Thermofisher); lane 2, mbaSC203+206+230A ‘left’ flank 1156 bp PCR product; 
lane 3, mbaSC203+206+230A ‘right’ flank 637 bp PCR product. D. Second round SOE PCR to amplify 
mbaSC203+206+230A with upstream and downstream flanking DNA. Lane 1, GeneRuler 1 kb DNA Ladder 
(Thermofisher); lane 2, mbaSC203+206+230A 1765 bp PCR product. E. First round SOE PCR to amplify 
mbaSCpentaA with upstream and downstream flanking DNA. Lanes 1 and 4, GeneRuler 1 kb DNA 
Ladder (Thermofisher); lane 2, mbaS::CpentaA ‘left’ flank 1196 bp PCR product; lane 3, mbaSCpentaA 
‘right’ flank 597 bp PCR product. F. Second round SOE PCR to amplify mbaSCpentaA with upstream and 
downstream flanking DNA. Lane 1, GeneRuler 1 kb DNA Ladder (Thermofisher); lane 2, mbaSCpentaA 
1765 bp PCR product.  G. pEX18Tp-pheS-mbaSCpentaA plasmid DNA. Lane 1, Supercoiled ladder (NEB); 
lane 2, pEX18Tp-pheS, 4.5 kb; lane 3, pEX18Tp-pheS-mbaSCpentaA, 6.2 kb. 
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4.5.2 Attempts at the introduction of mbaSCpentaA into B. thailandensis by 
allelic exchange 
Many attempts were made at introducing the mbaSCpentaA allele into Bth E264 ΔmbaS and 
Bth E264 ΔmbaS ΔpchE by allelic exchange. Initially, this was attempted using pEX18Tp-
pheS-mbaSCpentaA. E. coli SM10λpir transformed with pEX18Tp-pheS-mbaSCpentaA was used as 
the donor strain for transfer of the mutant allele by conjugation into Bth E264 ∆mbaS and 
Bth E264 ∆mbaS ΔpchE. Resolution products were selected on M9 agar containing 25 µg ml-
1 trimethoprim. Plasmid integration was further verified by PCR screening using the vector 
specific primers pEX18Tpfor2 and pEX18Tprev2. 
The verified co-integrant strains, harbouring both ∆mbaS and mbaSCpentaA, were then grown 
on M9-glucose agar containing 0.1% (w/v) cPhe and counter-screened on trimethoprim 
according to methods to isolate recombinant strains. Additionally, colonies were screened 
on CAS agar containing 10 µM FeCl3 to identify colonies exhibiting gain of a yellow halo, 
indicative of restoration of the Mba+ phenotype. Positive clones underwent PCR screening 
with the primer pair ∆mbaS-out-fwd/∆mbaS-out-rev to identify recombinants with the 
mbaSCpentaA gene insertion and loss of the vector backbone. 
Several hundred potential resolution products were screened in this way. However, most of 
the screened colonies did not have genomic DNA which gave rise to a PCR product of a size 
corresponding to a second homologous recombination event i.e. these colonies were cPhe 
resistant, but had not excised the integrated plasmid backbone. 
Therefore, the I-SceI endonuclease method, which proved successful in inducing the second 
recombination event for the mutagenesis of Bth E264 ΔpchE (see section 4.3.2), was 
attempted. The mbaSCpentaA allele was subcloned by restriction digest with HindIII and BamHI 
from pEX18Tp-pheS to pSNUFF3Cm, to produce pSNUFF3Cm-mbaSCpentaA. This was plasmid 
construct introduced into Bth E264 ΔmbaS and Bth E264 ΔmbaS ΔpchE by conjugation using 
E. coli SM10λpir donor cells. Resolution products were selected on LB agar containing 50 μg 
ml-1 gentamicin and 50 μg ml-1 chloramphenicol. Plasmid integration was further verified by 
PCR screening using the vector specific primers pEX18Tpfor2 and pEX18Tprev2. 
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The I-SceI endonuclease was then introduced into the verified co-integrant strain, 
harbouring both ΔmbaS and mbaSCpentaA, in order to select for a second recombination 
event. This was attempted by introduction of pDAI-SceI-pheS via conjugation with E. coli 
S17-1λpir donor cells. Strains that had successfully taken up pDAI-Sce-pheS were selected 
for on Lnx agar containing 50 µg ml-1 gentamicin and 50 µg ml-1 tetracycline. Positive clones 
underwent PCR screening with the primer pair ∆mbaS-out-fwd/∆mbaS-out-rev to identify 
recombinants with the mbaSCpentaA gene insertion and loss of the vector backbone (an 
example is show in Figure 4.8). 
 
Figure 4.8. A representative example of PCR screening for introduction of the mbaSCpentaA allele 
into Bth. 
Agarose gel electrophoresis analysis of DNA products from PCR screening of strains during an 
attempted introduction of mutant mbaSCpentaA allele into Bth E264 ∆mbaS, using the primer pair 
∆mbaS-out-fwd/∆mbaS-out-rev (expected molecular weights: mbaSCpentaA = 1797 bp, ∆mbaS = 1131 
bp, shown to the left of the gel image). The bacterial strain from which the template DNA is 
extracted is denoted above the gel image. Screened colonies were selected as detailed in text. MW 
denotes GeneRuler 1 kb DNA Ladder (Thermofisher). 
 
Again, several hundred potential resolution products were screened in this way. However, 
all of the screened colonies gave rise to a PCR product of a size corresponding to a second 




An analogous method of isolating the mbaSCpentaA mutant by the I-SceI endonuclease using 
M9 minimal agar (supplemented with 0.5% (w/v) glucose and 0.1% (w/v) casamino acids) in 
place of Lnx agar was attempted. The rationale for this was that, on iron-limited media, 
there would be a selective advantage for Bth to maintain the mbaSCpentaA allele (and gain an 
Mba+ phenotype) over retention of the ΔmbaS allele. Nonetheless, the resolution product 
strains that were isolated appeared to contain the ΔmbaS allele. 
No explanation could be found for the perceived incompatibility for the mbaSCpentaA allele 
and Bth E264. However, it is possible that the cysteine-to-alanine substitutions introduced 
changes in either the genomic DNA sequence of the protein sequence that conferred a 
detrimental effect upon the organism. In particular, the C230A substitution introduces base 
substitutions within the mbaH promoter. Therefore, mbaS alleles with different cysteine-to-
alanine substitutions were attempted to be introduced into Bth (see section 4.5.3). 
 
4.5.3 Further attempts at the introduction of mbaS with cysteine-to-
alanine substitutions into B. thailandensis by allelic exchange 
Due to the problems encountered in generating mutants with the mbaSCpentaA allele, 
attempts were made at introducing both the mbaSCdiA allele (substituting cysteine 203 and 
cysteine 206 for alanines in mbaS) and mbaSCtetraA allele (substituting cysteines 203, 206, 
216 and 220 for alanines in mbaS) that were generated in section 4.5.1. The pSNUFF3Cm 
vector was selected to be used for this mutagenesis ahead of pEX18Tp-pheS, due to the 
greater number of colonies that had undergone a second homologous recombination event. 
Both mbaSCdiA and mbaSCtetraA were subcloned into pSNUFF3Cm between the HindIII and 
BamHI sites of the MCS. As an additional control, the 1765 bp mbaS wild-type allele was 
amplified from Bth E264 genomic DNA by PCR using the primers ∆mbaS-A and ∆mbaS-D, 
and this was also cloned into pSNUFF3Cm (verified by PCR screening and DNA sequencing 
analysis with the primers M13revBACTH and M13for). 
In parallel, the four plasmids pSNUFF3Cm-mbaS, pSNUFF3Cm-mbaSCdiA, pSNUFF3Cm-
mbaSCtetraA and pSNUFF3Cm-mbaSCpentaA were introduced into Bth E264 ∆mbaS ∆pchE by 
conjugation using E. coli S17-1 donor cells. Resolution products were selected on LB agar 
150 
 
containing 50 µg ml-1 gentamicin and 50 µg ml-1 chloramphenicol. Plasmid integration was 
further verified by PCR screening using the vector specific primers pEX18Tpfor2 and 
pEX18Tprev2. 
An additional PCR screening step using the primers mbaSmeroscreen-fwd and 
mbaSmeroscreen-rev was introduced to determine the location of the recombination event 
that led to the plasmid integration. If the recombination event occurred at the region of 
identical sequence upstream of the ∆mbaS allele, PCR using the co-integrant template DNA 
produces a 1012 bp product; if the recombination event occurred at the region of identical 
sequence downstream of the ∆mbaS allele, PCR using the co-integrant template DNA 
produces a 1678 bp product (an example is shown in Figure 4.9). For each mutant allele two 
co-integrants were selected, in which either an ‘upstream’ or a ‘downstream’ recombination 
had occurred. 
The I-SceI endonuclease was then introduced into the co-integrant strains, harbouring both 
ΔmbaS and either mbaS, mbaSCdiA, mbaSCtetraA or mbaSCpentaA. This was achieved by 
introduction of pDAI-SceI-pheS via conjugation with E. coli S17-1λpir donor cells. Strains that 
had successfully taken up pDAI-Sce-pheS were selected for on Lnx agar containing 50 µg ml-1 
gentamicin and 50 µg ml-1 tetracycline. To screen for loss of the integrated vector backbone, 
clones were counter-screened by growth (or lack, thereof) on LB agar containing 50 µg ml-1 
chloramphenicol. In each case, around 50 colonies were selected. However, PCR screening 
with the primer pair ∆mbaS-out-fwd/∆mbaS-out-rev did not identify any recombinants with 
the desired mbaSCdiA, mbaSCpentaA or mbaSCpentaA gene mutations (‘knock-in’ mutagenesis 
with the mbaS allele was not screened for). 
Ultimately, the mbaSCpentaA allele, or a similar allele with other C-terminal cysteine-to-





Figure 4.9. A representative example of PCR screening to the determine the location of the first 
homologous recombination event for introduction of the mbaSCpentaA allele into Bth. 
Agarose gel electrophoresis analysis of DNA products from PCR screening of strains during an 
integration pSNUFF3Cm-mbaSCpentaA into Bth E264 ∆mbaS ∆pchE, using the primer pair 
mbaSmeroscreen-fwd/mbaSmeroscreen-rev (expected molecular weights: ‘upstream’ 
recombination = 1012 bp, ‘downstream’ recombination = 1678 bp, shown to the left of the gel 
image). PCR positive controls using pSNUFF3Cm-mbaSCpentaA and Bth E264 ∆mbaS ∆pchE as template 
DNA were used (denoted above lanes). Screened colonies were selected as detailed in text. MW 







4.6 Attempts at construction of ∆fur gene 
deletion mutants 
 
With the aim of investigating the iron regulation of the sigma factor MbaS in vivo, specific to 
its cysteine-rich extension (see section 1.7.2), it was necessary to remove the iron-
dependent transcriptional regulation of MbaS accomplished by the ferric uptake regulator, 
Fur (see section 1.5). Although Fur is a global transcriptional repressor and its deletion is 
likely to have widespread effects upon Bth, mutagenesis performed in Bce (A. Butt, 
unpublished data) and Pseudomonas aeruginosa (Pasqua et al., 2017) has suggested that a 
Bth fur null mutant could be generated and be used in in vivo studies. This would remove 
the masking effect of iron-dependent Fur regulation, and enable direct iron regulation of 
MbaS to be investigated. 
 
4.6.1 Construction of pSNUFF3Cm-∆fur 
For the introduction of ∆fur, the pSNUFF3Cm allelic exchange vector was used. The ∆fur 
mutant allele, with ≥500 bp of upstream and downstream flanking DNA, was amplified by 
SOE-PCR using primers ∆fur-A, ∆fur-B, ∆fur-C and ∆fur-D to produce a 1090 bp PCR product 
(Figure 4.10a,b). The ∆fur allele was cloned between the HindIII and BamHI sites of the MCS 
of pSNUFF3Cm to give pSNUFF3-Cm-∆fur (Figure 4.10c). The identity of the plasmid 
construct was confirmed by PCR screening and DNA sequencing analysis with primers 




Figure 4.10. Construction of pSNUFF3Cm-∆fur 
Agarose gel electrophoresis analysis of DNA PCR products and plasmid DNA used in construction of 
pSNUFF3Cm-∆fur. A. First round SOE PCR to amplify ∆fur with upstream and downstream flanking 
DNA. Lanes 1 and 4, GeneRuler 1 kb DNA Ladder (Thermofisher); lane 2, ∆fur ‘left’ flank, 554 bp PCR 
product; lane 3, ∆fur ‘right’ flank, 572 bp PCR product. B. Second round SOE PCR to amplify ∆fur with 
upstream and downstream flanking DNA. Lane 1, GeneRuler 1 kb DNA Ladder (Thermofisher); lane 2, 
∆fur, 1090 bp PCR product. C. pSNUFF3Cm-∆fur. Lane 1, Supercoiled ladder (NEB); lane 2, 
pSNUFF3Cm, 5.1 kb; lane 3, pSNUFF3Cm-∆fur, 6.1 kb. 
 
4.6.2 Construction of pSHAFT3-∆fur::TpTer and pSHAFT2-∆fur::TpTer 
Due to difficulties encountered using pSNUFF3Cm-∆fur to introduce the unmarked ∆fur 
allele into Bth (see section 4.6.3), a different approach using a marked mutant was 
attempted. A similar ∆fur allele was made, but with the insertion of an internal TpTer 
antibiotic selection marker. 
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SOE-PCR was used to produce a ∆fur mutant allele. This mutant allele contained an internal 
NdeI site, preceded by an in-frame stop codon, into which the TpTer cassette from p34E-
TpTer (Shastri et al., 2017) would be inserted. This ∆fur::NdeI allele was amplified from Bth 
E264 genomic DNA by SOE-PCR using the primers Δfur-A, Δfur-NdeI-B, Δfur-NdeI-C, and 
Δfur-D to produce a 1099 bp PCR product (Figure 4.11a,b). After gel extraction, this 
∆fur::NdeI allele was cloned between the HindIII and BamHI sites of the MCS of pBBR1MCS-
2 to give the intermediate plasmid pBBR1MCS2-∆fur (Figure 4.11c). The identity of this 
plasmid construct was confirmed by PCR screening and DNA sequencing analysis with the 
primers M13revBACTH and M13for2. Next, the TpTer cassette from p34E-TpTer was 
removed by restriction digest with NdeI, and inserted within the NdeI site of pBBR1MCS2-
∆fur to give pBBR1MCS2-∆fur::TpTer (Figure 4.11d). Finally, the ∆fur::TpTer cassette from 
this plasmid was subcloned into pSHAFT3 using the restriction enzymes Acc65I and XbaI to 
construct pSHAFT3-∆fur::TpTer (Figure 4.11e). The identity of this plasmid construct was 
confirmed by DNA sequencing analysis with the primers catendout and pUTcatrev. 
The ∆fur::TpTer cassette was also subcloned in the same way into pSHAFT2 to give 
pSHAFT2-∆fur::TpTer. The identity of this plasmid was also confirmed by DNA sequencing 




Figure 4.11. Construction of pSHAFT3-∆fur::TpTer 
Agarose gel electrophoresis analysis of DNA PCR products and plasmid DNA used in construction of 
pSHAFT3-∆fur::TpTer. A. First round SOE PCR to amplify ∆fur with ≥500 bp upstream and 
downstream flanking DNA, and an internal NdeI site. Lanes 1 and 4, GeneRuler 1 kb DNA Ladder 
(Thermofisher); lane 2, ∆fur ‘left’ flank, 563 bp PCR product; lane 3, ∆fur ‘right’ flank, 581 bp PCR 
product. B. Second round SOE PCR to amplify ∆fur. Lane 1, GeneRuler 1 kb DNA Ladder 
(Thermofisher); lane 2, ∆fur, 1099 bp PCR product. C. pBBR1MCS2-∆fur. Lane 1, Supercoiled ladder 
(NEB); lane 2, pBBR1MCS2-∆fur, 6.2 kb. D. Insertion of TpTer cassette into pBBR1MCS2-∆fur. Lane 1, 
Supercoiled ladder (NEB); lane 2, pBBR1MCS2-∆fur::TpTer, 7.1 kb. E. Subcloning of ∆fur::TpTer into 
pSHAFT3. Lane 1, Supercoiled ladder (NEB); lane 2, pSHAFT3, 4.5 kb; lane 3, pSHAFT3-∆fur::TpTer, 
6.5 kb. 
 
4.6.3 Attempts at the introduction of ∆fur into B. thailandensis by allelic 
exchange 
Initially, E. coli S17-1λpir transformed with pSNUFF3Cm-∆fur was used as the donor strain 
for transfer of the mutant allele by conjugation into wild-type Bth E264. Resolution products 
were selected on Lnx agar containing 50 µg ml-1 kanamycin and 50 µg ml-1 chloramphenicol. 
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Plasmid integration was further verified by PCR screening using the vector specific primers 
pEX18Tpfor2 and pEX18Tprev2. 
The I-SceI endonuclease was then introduced into the verified co-integrant strain, 
harbouring both fur and ∆fur, in order to select for a second recombination event. This was 
achieved by introduction of pDAI-SceI-pheS via conjugation with E. coli S17-1λpir donor cells. 
Strains that had successfully taken up pDAI-Sce-pheS were selected for on EB agar 
containing 50 µg ml-1 gentamicin and 50 µg ml-1 tetracycline. Positive clones underwent PCR 
screening with the primer pairs ∆fur-out-fwd/∆fur-out-rev to identify recombinants with 
the fur gene deletion. Approximately 200 colonies were screened in this way. However, no 
successful ∆fur strains were identified. Where a second recombination event was found to 
have occurred, cells had favoured retaining the wild-type fur allele ahead of the fur deletion, 
as judged by the presence of a 1688 bp PCR product rather than a 1312 bp PCR product. 
This suggested that there was a strong selective disadvantage for the loss of fur in Bth. 
Therefore, attempts were made using the ∆fur::TpTer allele. Initially, this was attempted 
using pSHAFT3-∆fur::TpTer. However, there were unexplained difficulties in introducing this 
plasmid into E. coli SM10λpir and S17-1λpir and pSHAFT2-∆fur::TpTer was used instead. 
Additionally, research in Pseudomonas aeruginosa had suggested that the fur deletion may 
not be lethal in conjunction with a Pch- phenotype. Therefore, the ∆fur::TpTer allele was 
attempted to be introduced into Bth E264 ∆mbaS (see section 4.2), Bth E264 ∆pchE (see 
section 4.3) and Bth E264 ∆mbaS ∆pchE (see section 4.4) in addition to wild-type Bth E264. 
pSHAFT2-∆fur::TpTer vector was introduced into the Bth strains by conjugation via E. coli 
SM10λpir donor cells, and cells that had undergone homologous recombination with the 
plasmid were selected for on EB agar containing 50 µg ml-1 gentamicin and 50 µg ml-1  
trimethoprim. As Bth lacks the ability to utilise the oriR6K origin of replication of the 
plasmid, only homologous recombination between the chromosome and the plasmid 
confers trimethoprim resistance. This recombination can occur by a single crossover event, 
resulting in integration of the plasmid and co-integrant formation, with both the wild-type 
fur allele and the ∆fur::TpTer allele present. Alternatively, the recombination can occur by a 
double crossover event, resulting in the wild-type fur allele being replaced by the 
∆fur::TpTer mutant allele. In this case, vector sequences are not permanently integrated 
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into the genome. The desired latter case was screened for by a subsequent counter-
screening for chloramphenicol and/or ampicillin sensitivity. Approximately 1,000 colonies 
were screened in this way. However, in all cases, the bacteria displayed resistance to 50 µg 
ml-1 chloramphenicol and/or 100 µg ampicillin, indicating the occurrence of a single 
homologous recombination event, rather than the desired double recombination. PCR 
screening of selected colonies with the primer pair ∆fur-out-fwd/∆fur-out-rev confirmed 
the retention of the wild-type fur gene (Figure 4.12). Ultimately, it was not possible to 
generate a Bth E264 fur null mutant in this study. 
 
Figure 4.12. A representative example of PCR screening for introduction of the ∆fur::TpTer allele 
into Bth. 
Agarose gel electrophoresis analysis of DNA products from PCR screening of strains during 
introduction of mutant ∆fur::TpTer allele into Bth E264 using the primer pair ∆fur-out-fwd/∆fur-out-
rev (expected molecular weights: fur = 1688 bp, ∆fur::TpTer = 2189 bp, shown to the left of the gel 
image). The bacterial strain from which the template DNA is extracted is denoted above the gel 
image (WT denoted Bth E264, screened colonies were selected as detailed in the main body of text). 
MW denotes GeneRuler 1 kb DNA Ladder (Thermofisher). 
 
4.7 Phenotypic characterisation of B. 
thailandensis mutants 
 
The three successfully generated mutant strains of Bth E264 harbouring ∆mbaS and/or 
∆pchE gene deletions were further verified and characterised via a series of phenotypic 
assays. These included growth on CAS medium to analyse production of siderophores, 
monitoring the growth of culture under iron-limited and iron-replete conditions, and 
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promoter reporter analysis using selected target promoters. These experiments also 
required the construction of plasmids that express corresponding protein to complement 
the mutants, and transcriptional reporter plasmids, which are discussed forthwith. 
 
4.7.1 Construction of pBBR1MCS2-mbaS, pBBR1MCS2-mbaSCpentaA and 
pBBR1MCS2-pchE 
For the expression of the MbaS protein and MbaSCpentaA mutant proteins in vivo and to 
complement the ∆mbaS mutants, the mbaS and mbaSCpentaA genes were cloned into the 
broad host range expression vector pBBR1MCS-2 (Kovach et al., 1995). The mbaS gene was 
amplified by PCR from Bth E264 genomic template DNA, and the mbaSCpentaA was amplified 
by PCR from the plasmid pSNUFF3-Cm-mbaSCpentaA (see section 4.5.1) using the primers 
mbaS-fwd-HindIII and mbaS-rev-BamHI to produce a 774 bp PCR product in each case 
(Figure 4.13a,b). This included 30 bp immediately upstream of the translation start codon 
that contained the Shine-Dalgarno sequence, but not the native mbaS promoter. An in-
frame stop codon was incorporated into the 5’ end of the forward primer to terminate 
translation of the upstream lacZα gene segment of the vector to eliminate the possibility of 
generating a LacZα-MbaS protein fusion. The mbaS and mbaSCpentaA genes were cloned 
between the HindIII and BamHI sites of the MCS of pBBR1MCS-2 to give pBBR1MCS2-mbaS 
and pBBR1MCS2-mbaSCpentaA (Figure 4.13c). The identities of the plasmid constructs were 





Figure 4.13. Construction of pBBR1MCS2-mbaS and pBBR1MCS2-mbaSCpentaA. 
Agarose gel electrophoresis analysis of DNA PCR products and plasmid DNA used in construction of 
pBBR1MCS2-mbaS pBBR1MCS2-mbaSCpentaA. A. PCR to amplify mbaS. Lane 1, GeneRuler 1 kb DNA 
Ladder (Thermofisher); lane 2, mbaS PCR product, 774 bp. B. PCR to amplify mbaSCpentaA. Lane 1, 
GeneRuler 1 kb DNA Ladder (Thermofisher); lane 2, mbaSCpentaA PCR product, 774 bp. C. pBBR1MCS2-
mbaS and pBBR1MCS2-mbaSCpentaA plasmid DNA. Lane 1, Supercoiled DNA Ladder (NEB); lane 2, 




Likewise, for the expression of PchE and complementation of ∆pchE mutants in vivo, the 
pchE gene was also cloned into pBBR1MCS-2. The pchE gene was amplified by PCR from Bth 
E264 genomic DNA using the primers pchE-fwd-HindIII and pchE-rev-BamHI to produce a 
4464 bp PCR product. As with mbaS and mbaSCpentaA, the cloned pchE gene was preceded by 
an in-frame stop codon. pchE was cloned between the HindIII and BamHI sites of the MCS of 
pBBR1MCS-2 to give pBBR1MCS2-pchE (Figure 4.14). The identity of the plasmid was 
confirmed by PCR screening analysis with primers M13revBACTH and M13for2. 
 
Figure 4.14. Construction of pBBR1MCS2-pchE. 
Agarose gel electrophoresis analysis of DNA PCR products and plasmid DNA used in construction of 
pBBR1MCS2-pchE. A. PCR to amplify pchE. Lane 1, GeneRuler 1 kb DNA Ladder (Thermofisher); lane 
2, pchE PCR product, 4464 bp. B. pBBR1MCS2-pchE plasmid DNA. Lanes 1 and 4, Supercoiled DNA 





4.7.2 Comparison and complementation of siderophore production CAS 
agar 
The deletion of both the mbaS and pchE genes was verified in vivo by complementation of 
their phenotypes using the plasmids constructed in section 4.7.1. The plasmids pBBR1MCS-
2, pBBR2-mbaS or pBBR2-pchE were introduced into wild-type Bth E264, Bth E264 ∆mbaS, 
Bth E264 ∆pchE or Bth E264 ∆mbaS ∆pchE via conjugation with E. coli S17-1λpir donor cells. 
Bth strains harbouring the plasmids were selected on Lnx medium containing 50 µg ml-1 
gentamicin and 250 µg ml-1 kanamycin. Overnight cultures of these plasmid-harbouring 
strains were grown in M9 minimal medium supplemented with 0.5% (w/v) glucose and 250 
µg ml-1 kanamycin. Additionally, overnight cultures of wild-type Bth E264, Bth E264 ∆mbaS, 
Bth E264 ∆pchE and Bth E264 ∆mbaS ∆pchE were also grown in M9 minimal medium 
supplemented with 0.5% (w/v) glucose. After normalisation, 1 µl of each bacterial culture 
was spotted onto CAS agar plates containing 10 µM FeCl3, and incubated at 30 oC for 
approximately 48 hours. 
Firstly, Bth E264 wild-type and ΔmbaS strains were grown on CAS agar to verify and analyse 
the effect of the mbaS deletion in Bth E264 ∆mbaS. This gene deletion was complemented 
in cells harbouring pBBR2-mbaS (Figure 4.15). 
Both areas of growth of the wild-type Bth and the ∆mbaS mutant grown on CAS medium 
were surrounded by a distinctive halo, indicating the secretion of an iron-chelating molecule 
(Figure 4.15, left). The wild-type strain was surrounded by a yellow halo, and the ∆mbaS 
strain was surrounded by an orange halo. Bce strains that are to produce ornibactin, but not 
pyochelin, also display a large yellow/orange halo around their area of bacterial growth on 
CAS medium. Due to the high structural similarity between ornibactin and malleobactin, it is 
highly likely the yellow colour observed in Figure 4.15 derives from metal chelation by 
malleobactin. The loss of the mbaS gene, and therefore the assumed loss of malleobactin 
synthesis, is the most likely explanation for the loss of this yellow halo in the ∆mbaS mutant. 
An orange halo can be obseverved around the growth of the ∆mbaS mutant strain. It is 
likely that this orange colour derives from the secondary siderophore pyochelin. Bce grown 





Figure 4.15. Burkholderia thailandensis E264 ∆mbaS grown on CAS agar 
Bacterial cultures of Bth grown on CAS agar containing 10 µM FeCl3. Cultures were incubated at 30 oC 
for approximately 48 hours (more detail provided in text). Left. Bth E264 (WT) and Bth E264 ∆mbaS. 
Right. Bth E264/pBBR2 (WT/-), Bth E264/pBBR2-mbaS (WT/mbaS+), Bth E264 ∆mbaS/pBBR2 
(∆mbaS/-); Bth E264 ∆mbaS/pBBR2-mbaS (∆mbaS/mbaS+). 
 
Providing further verification that the yellow halo colour on CAS agar is due to malleobactin, 
complementation of Bth with the plasmid pBBR2-mbaS gives rise to large yellow halos 
produced around the bacterial growth. These halos are larger than are observed for Bth that 
are not harbouring plasmid DNA. This suggests that pBBR2-mbaS is able to express and 
produce MbaS in much greater quantities than is achieved from the chromosomal copy of 
the gene, and that this has increased the MbaS-dependent transcription of the mba gene 
cluster. Hence, more malleobactin has been produced and secreted, giving rise to a greater 
yellow area due to iron-chelation and release of CAS dye. 
Bth E264 wild-type and ΔpchE strains were grown on CAS agar to verify and analyse the 
effect of the pchE deletion in Bth E264 ∆pchE. This gene deletion was complemented in cells 




Figure 4.16. Burkholderia thailandensis E264 ∆pchE grown on CAS agar 
Bacterial cultures of Bth grown on CAS agar containing 10 µM FeCl3. Cultures were incubated at 30 oC 
for approximately 48 hours (more detail provided in text). Left. Bth E264 (WT) and Bth E264 ∆pchE. 
Right. Bth E264/pBBR2 (WT/-), Bth E264/pBBR2-pchE (WT/pchE+), Bth E264 ∆pchE/pBBR2 (∆pchE/-); 
Bth E264 ∆pchE/pBBR2-pchE (∆pchE/pchE+). 
 
The Bth strains grown in Figure 4.16 ubiquitously displayed yellow halos around their 
bacterial growth on CAS medium regardless of whether pchE is deleted. This yellow halo is 
assumed to be due to the metal-chelation by malleobactin. In isolation, this makes it 
difficult to judge whether the ∆pchE allele has been successfully introduced. 
However, the ∆mbaS was introduced into Bth E264 ∆pchE to generate Bth E264 ∆mbaS 
∆pchE. Therefore, assuming there were no secondary site mutations co-introduced during 
the mbaS mutagenesis, the Pch- phenotype of Bth E264 ∆mbaS ∆pchE should be consistent 
with the Pch- phenotype of Bth E264 ∆pchE. 
Bth E264 wild-type and Bth E264 ∆mbaS ∆pchE strains were grown on CAS agar to verify 
and analyse the effect of the mbaS and pchE deletions in Bth E264 ∆mbaS ∆pchE. These 





Figure 4.17. Burkholderia thailandensis E264 ∆mbaS ∆pchE grown on CAS agar 
Bacterial cultures of Bth grown on CAS agar containing 10 µM FeCl3. Cultures were incubated at 30 oC 
for approximately 48 hours (more detail provided in text). Left. Bth E264 (WT) and Bth E264 ∆mbaS 
∆pchE. Right. Bth E264/pBBR2 (WT/-), Bth E264/pBBR2-mbaS (WT/mbaS+), Bth E264/pBBR2-pchE 
(WT/pchE+), Bth E264 ∆mbaS ∆pchE/pBBR2 (∆mbaS ∆pchE/-), Bth E264 ∆mbaS ∆pchE/pBBR2-mbaS 
(∆mbaS ∆pchE/mbaS+), Bth E264 ∆mbaS ∆pchE/pBBR2-pchE (∆mbaS ∆pchE/pchE+). 
 
The area of growth of Bth E264 ∆mbaS ∆pchE mutant did not show a distinctive halo in CAS 
agar (Figure 4.17. left). This was consistent with an Mba- Pch- phenotype, as there should be 
no iron-chelating siderophores produced by these strains. This strongly suggested that both 
mbaS and pchE have successfully been deleted. To verify this further, this Bth strain was 
complemented using pBBR2-mbaS and pBBR2-pchE (Figure 4.17, right). Both the Mba+ 
phenotype was restored (as judged by a large yellow halo), and the Pch+ phenotype was 
restored (as judged by a small orange halo). Taken together, the phenotypes of these Bth 
strains, and their in trans complementation, suggest it is very likely that both the ∆mbaS 
and ∆pchE alleles have been successfully introduced, and that they display the Mba- and 
Pch- phenotypes, respectively. 
The phenotypes of the constructed Bth mutants grown on CAS agar are compared in Figure 
4.18. Growth of wild-type Bth E264 and Bth E264 ∆pchE on CAS medium are surrounded by 
a yellow halo. This is assumed to be due to chelation of exogenous ferric iron by secreted 
malleobactin. Growth of Bth E264 ∆mbaS on CAS medium is surrounded by an orange halo. 
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This is assumed to be due to the chelation of exogenous ferric iron by secreted pyochelin. 
No such halos were observed around growth of Bth E264 ∆mbaS ∆pchE. This is assumed to 
be due to inability to produce either malleobactin or pyochelin, hence no chelation of 
exogenous ferric iron is observed. 
 
Figure 4.18. Burkholderia thailandensis E264 mutant strains grown on CAS agar 
Bacterial cultures of Bth grown on CAS agar containing 10 µM FeCl3. Cultures were incubated at 30 oC 
for approximately 48 hours (more detail provided in text). Bacterial cultures grown are Bth E264 
(WT), Bth E264 ∆mbaS, Bth E264 ∆pchE and Bth E264 ∆mbaS ∆pchE.  
 
4.7.3 Effect of temperature upon production of pyochelin 
During the phenotypic characterisation of the Bth E264 siderophore deficient mutants, it 
was observed that the presence and area of the siderophore halo resulting from the 
secretion of pyochelin varied depending on incubation temperature. More specifically, 
plates grown at 37 oC appeared to show smaller halo areas due the secretion of iron 
chelating compounds (pyochelin) than those grown at 30 oC, and the pyochelin-derived halo 




This phenomenon was investigated further by growing Mba- Pch+ Bth strains on CAS agar. 
Bth E264 ∆mbaS was grown in M9 minimal medium supplemented with 0.5% (w/v) glucose, 
and Bth E264 ∆mbaS ∆pchE/pBBR2-pchE was grown in the same medium supplemented 
with 250 µg ml-1 kanamycin. After normalisation, 1 µl of each bacterial culture was spotted 
onto CAS agar plates containing 10 µM FeCl3, and incubated at a range of temperatures. 
Images of the cultures were taken at a range of time points (Figure 4.19). 
 
Figure 4.19 Effect of temperature upon production of pyochelin in Burkholderia thailandensis E264 
Bacterial cultures of Bth grown on CAS agar containing 10 µM FeCl3. Cultures were incubated at 25 
oC, 30 oC or 37 oC. Each agar plate was imaged after approximately 16, 24, 40 and 48 hours of 
incubation. In each image, the bacterial cultures grown are: Left: Bth E264 ∆mbaS, Right: Bth E264 
∆mbaS ∆pchE/pBBR2-pchE. 
 
The halos visible around these cultures suggest that pyochelin was secreted in greater 
quantities when grown at 30 oC, compared to when grown at 25 oC and 37 oC. Even when 
grown at 25 oC, the Bth cultures secreted more pyochelin then when grown at 37 oC. 
Furthermore, it typically took around 16 hours at 30 oC for the appearance of a yellow halo 
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(derived from malleobactin-mediated iron chelation) of considerable area to be observed 
around the growth of Bth. It took around 48 hours at 30oC for the appearance of an orange 
halo (derived from pyochelin-mediated iron chelation) of a similar area to be observed 
around the growth of Bth. 
 
4.7.4 Comparison of bacterial growth rates of Bth mutants 
To determine the effect that the mbaS and pchE gene deletions had upon the growth of B. 
thailandensis grown in minimal medium, the growth curves and rates of the strains were 
compared. Additionally, to demonstrate the complementation of the ∆mbaS and ∆pchE 
mutants, pBBR2-mbaS and pBBR2-pchE were introduced into these strains, and the growth 
curves and rates also compared. Bacterial growth curves were generated, and growth rates 
were calculated, according to the protocol in section 2.1.1. 
The effect of the ∆mbaS deletion was investigated by comparison of wild-type Bth E264 and 
Bth E264 ∆mbaS. Both of these strains, harbouring either pBBR1MCS-2 or pBBR2-mbaS, 
were grown in M9 minimal medium containing 0.5% (w/v) glucose, 0.1% (w/v) casamino 
acids, and 250 µg ml-1 kanamycin (Figure 4.20). The OD600 of these bacterial cultures was 
recorded every 30 minutes once the cultures were judged to have reached log phase. 
The ∆mbaS mutant displays a lower growth rate compared to the wild-type. However, this 
appears to be somewhat alleviated by the in trans addition of MbaS. This confirms that 
MbaS, and by extension malleobactin, are factors for the growth of Bth under iron-limited 
conditions. It also provides further verification the ∆mbaS allele was implemented as 
intended. 
The effect of the ∆pchE deletion was also investigated using the same conditions by 
comparison of wild-type Bth E264 and Bth E264 ∆pchE. These strains harboured either 
pBBR2 or pBBR2-pchE, and were grown in M9 minimal medium containing 0.5% (w/v) 





Figure 4.20. Burkholderia thailandensis E264 ∆mbaS growth curve 
Burkholderia thailandensis E264 wild-type and ∆mbaS strains complemented with pBBR1MCS-2-
mbaS grown in M9 minimal salts medium supplemented with 0.5% (w/v) glucose, 0.1% (w/v) 
casamino acids and 250 µg ml-1 kanamycin (n=1). 
 
Table 4.1. Growth rate of Bth E264 and Bth E264 ΔmbaS supplied with mbaS in trans. 
Strain 
Growth rate (doubling hr-1) [1] 
pBBR1MCS-2 [2] pBBR2-mbaS [2] 
Bth E264 1.16 0.99 
Bth E264 ΔmbaS 1.07 0.86 
[1] Growth rates for the indicated strains were calculated as described in section 2.1.1, using the 
curves shown in Figure 4.20. 



















Figure 4.21. Burkholderia thailandensis E264 ∆pchE growth curve 
Burkholderia thailandensis E264 wild-type and ∆pchE strains complemented with pBBR2-pchE grown 
in M9 minimal salts medium supplemented with 0.5% (w/v) glucose, 0.1% (w/v) casamino acids and 
250 µg ml-1 kanamycin. Error bars show SEM (n=2). 
 
Table 4.2. Growth rate of Bth E264 and Bth E264 ΔpchE supplied with pchE in trans. 
Strain 
Growth rate (doubling hr-1) [1] 
pBBR1MCS-2 [2] pBBR2-pchE [2] 
Bth E264 0.97 0.85 
Bth E264 ΔpchE 0.82 0.79 
[1] Growth rates for the indicated strains were calculated as described in section 2.1.1, using the 
curves shown in Figure 4.21. 



















This mutation appears less significant compared to the loss of mbaS, as there is no 
significant difference between the growth curves of the grown bacterial cultures. This is 
consistent with previous assertions that malleobactin is the major siderophore used by Bth 
and pyochelin is less significant to the bacteria’s survival. 
Aditionally, the growth rates of all of the generated Bth strains, including Bth E264 ΔmbaS 
ΔpchE, were investigated. These strains were grown in M9 minimal medium containing 0.5% 
(w/v) glucose, 0.1% (w/v) casamino acids. The effect of further iron starvation was examined 
by supplementing the growth medium with 100 µM 2,2-dipyridyl (Figure 4.22). 
 
Figure 4.22. Burkholderia thailandensis E264 ∆mbaS ∆pchE growth curve 
Burkholderia thailandensis E264 wild-type, ∆mbaS, ∆pchE and ∆mbaS ∆pchE strains grown in M9 
minimal salts medium supplemented with 0.5% (w/v) glucose and 0.1% (w/v) casamino acids, and 



























Table 4.3. Growth rate of Bth E264, Bth E264 ΔmbaS, Bth E264 ΔpchE and Bth E264 ΔmbaS ΔpchE. 
Strain 
Growth rate (doubling hr-1) [1] 
0 μM DP 100 μM DP 
Bth E264 0.78 0.80 
Bth E264 ΔmbaS 0.88 0.69 
Bth E264 ΔpchE 0.81 0.81 
Bth E264 ΔmbaS ΔpchE 0.92 3.54 
[1] Growth rates for the indicated strains were calculated as described in section 2.1.1, using the 
curves shown in Figure 4.22. 
 
There are only small differences in the growth rates of all of the grown bacteria cultures, in 
the absence and presence 100 μM 2,2-dipyridyl. The exception to this is the growth of Bth 
E264 ΔmbaS ΔpchE grown with 100 μM 2,2-dipyridyl, which has a significantly slower 
growth rate than the other strains. The effect of deleting both siderophores appears to have 
a greater effect than deleting either malleobactin or pyochelin individually. 
In all of the Bth E264 growth curves, any difference due to the effect of deleting either mbaS 
or pchE appears to take place at the lag phase of growth. Furthermore, given that the 
secretion of pychelin is lower at 37 oC than at 30 oC (Figure 4.19), and in these experiments 
the bacteria were grown at 37 oC, the analysis of the effect of deleting pchE may be limited. 
 
4.7.5 Comparison of mbaS-dependent promoter activity in ∆mbaS 
mutants 
In order to confirm the loss of the mbaS gene in the mutants ∆mbaS and ∆mbaS ∆pchE, the 




The DNA fragments containing the putative MbaS target promoter PmbaH and the mbaS 
promoter PmbaS were cloned into the transcriptional lacZ reporter plasmid pKAGd4 (Agnoli et 
al., 2006). The promoter DNA was cloned into the MCS upstream of the promoter-less lacZ 
gene, allowing the promoter activity of the cloned DNA to be assayed by performing β-
galactosidase assays. For each promoter, a ‘long’ DNA fragment of ~250 bp was cloned (to 
be distinguished from the ‘short’ promoters in section 5.2.2). 
The ‘long’ mbaS promoter, PmbaS-L, was amplified using primers pmbaS-long-fwd and pmbaS-
long-rev to produce a 186 bp PCR product, and the ‘long’ mbaH promoter, PmbaH-L, was 
amplified using primers pmbaH-long-fwd and pmbaH-long-rev to produce a 274 bp PCR 
product, by PCR from Bth E264 genomic template DNA. The cloned DNA was inserted 
between the HindIII and BamHI sites of pKAGd4 to give the plasmids pKAGd4-PmbaS-L and 
pKAGd4-PmbaH-L. The identity of each plasmid construct was confirmed by PCR screening and 
DNA sequencing analysis using the primer AP10. 
pKAGd4-PmbaS-L and pKAGd4-PmbaH-L were introduced into Bth E264, Bth E264 ∆mbaS and Bth 
E264 ∆mbaS ∆pchE by conjugation via E. coli S17-1 donor cells. The β-galactosidase assay 
was performed on cultures grown in M9 minimal medium, supplemented with 0.1% (w/v) 
casamino acids, 0.5% (w/v) glucose and 50 µg ml-1 chloramphenicol, according to the 
protocol outlined in section 2.5.1. The experiment was performed a total of three times 




Figure 4.23. β-galactosidase assay of PmbaS and PmbaH in B. thailandensis E264 ∆mbaS mutants 
β-galactosidase activity was measured in Bth E264 wild-type, ∆mbaS and ∆mbaS ∆pchE (denoted 
below data bars). Cells harboured either pKAGd4-PmbaS-L (light grey) or pKAGd4-PmbaH-L (dark grey). All 
β-galactosidase activities were corrected for the background vector activity by subtraction of activity 
derived from the same Bth E264 strain harbouring the parental plasmid pKAGd4. Error bars show 
standard deviation (n=9). Growth medium was M9 minimal salts medium supplemented with 0.5% 
(w/v) glucose, 0.1 % (w/v) casamino acids and 50 µg ml-1 chloramphenicol. 
 
The activity from the mbaS remained at a consistent level in all of the assayed bacteria. 
However, the activity of the mbaH promoter was high in the wild-type strains, and 
completely abolished in the strains with the mbaS gene deletion. These observations are 
consistent with the hypothesis that mbaS promoter is acted upon by σ70, and that the mbaH 
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4.8 Identification of B. thailandensis E264 
strain variant 
 
During the process of this research, it was discovered there were two strain variants of Bth 
E264 in use. The strain used first, hereafter denoted as E264a, showed many key differences 
in comparison to the reference strain, hereafter denoted as E264b. These differences 
include colony morphology, antibiotic resistance, secretion of siderophores and sigma factor 
activity. Many DNA products were amplified by PCR from Bth E264a genomic DNA, but 
cloned DNA showed no difference from the reference Bth E264 genome. In the following 
section, figures and data are presented that uses Bth E264a – this has been clearly denoted. 
In all other experiments in this thesis, where the particular strain is not specified, the Bth 
E264b strain has been used. 
 
4.8.1 Morphological distinction 
The most striking difference between Bth E264a and Bth E264b is their colony morphology 
(Figure 4.24). Bth E264a produces smaller, circular, opaque colonies, whereas Bth E264b 
produces larger, circular, translucent colonies. This was observed when the bacteria were 




Figure 4.24. Burkholderia thailandensis E264 Strains Colony Formation 
Burkholderia thailandensis E264 strains on M9 minimal agar supplemented with 0.5% (w/v) glucose 
and 0.1% (w/v) casamino acids. A: Bth E264a; B: Bth E264b. 
 
4.8.2 Malleobactin secretion and transcriptional control of associated 
genes 
In promoter reporter assays performed in Bth E264a, lower promoter activities than 
expected were consistently observed, irrespective of the DNA fragment containing putative 
promoters. This was explored further by direct comparison with Bth E264b. The relative 




The pKAGd4 reporter vectors pKAGd4-PmbaS-F and pKAGd4-PmbaH-F (described in section 
4.7.5) were introduced into Bth E264a and Bth E264b by conjugation via E. coli S17-1 donor 
cells. The β-galactosidase assay was performed in LB medium, supplemented with 100 µg 
ml-1 ampicillin according to the protocol outlined in section 2.5.1. The experiment was 
performed a total of three times across different days (Figure 4.25). 
 
Figure 4.25. β-galactosidase assay of B. thailandensis E264a and E264b upon PmbaS and PmbaH 
β-galactosidase assays were performed in the Bth strains E264a and E264b (denoted below data 
bars). Cells harboured either pKAGd4-PmbaS-F (light grey) or pKAGd4-PmbaHF (dark grey). All β-
galactosidase activities were corrected for the background vector activity by subtraction of activity 
derived from the same Bth E264 strain harbouring the parental plasmid pKAGd4. Growth medium 
was LB medium supplemented with 100 µg ml-1 ampicillin. Error bars show standard deviation (n=9).  
 
In the promoter reporter assays shown in Figure 4.25, there was a statistically significant 
difference between groups (one-way ANOVA, F=174.8, P<0.0001). Tukey’s multiple 
comparisons post hoc tests reveal that Bth E264a displays significantly lower transcriptional 
activity than Bth E264b. The activity from PmbaS was approximately 93% lower for E264a than 





































than for E264b (P<0.0001). The low activity of the PmbaH promoter is likely due to the same 
factors that result in the low activity of the PmbaS promoter, as these would have an 
accumulative effect on the amount of MbaS present in the cell. 
Furthermore, the activity of the MbaS regulon, and the production of malleobactin, was 
compared by growing the two strains of Bth E264 on CAS agar. Overnight cultures of both 
Bth E264a and Bth E264b were grown in LB medium, and 1 µl of normalised cultures of each 
were spotted on CAS medium containing 10 µM FeCl3 (Figure 4.26). 
 
Figure 4.26. Burkholderia thailandensis E264 Strains Colony Formation 
Burkholderia thailandensis E264 strains on CAS agar containing 10 µM FeCl3. A: Bth E264a; B: Bth 
E264b. 
 
Comparing the halos observed around growth of each bacterial strain on CAS agar, it is clear 
that Bth E264a produces a much smaller halo around the area of bacterial growth compared 
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to the large yellow halo produced around Bth E264b. This suggest that E264a produces less 
iron-chelating compound (likely predominantly malleobactin) than E264b. This could be 




In this chapter, the gene deletion mutant alleles ∆mbaS, ∆pchE and ∆fur (plus ∆fur::TpTer), 
and the substitution mutants alleles mbaSC203+206A (mbaSCdiA), mbaSC203+206+216+220A 
(mbaSCtetraA) and mbaSC203+206+216+220+230A (mbaSCpentaA), were constructed using SOE-PCR. The 
mutant alleles were cloned into allelic exchange vectors to enable in-frame gene deletions 
or substitutions to be introduced into Bth. 
The ∆mbaS and ∆pchE deletion alleles were successfully introduced to generate Bth E264 
∆mbaS, Bth E264 ∆pchE and Bth E264 ∆mbaS ∆pchE. These mutant strains were 
phenotypically characterised to verify the gene deletions and demonstrate the resulting loss 
of malleobactin and pyochelin production. However, attempts at introducing the 
∆fur/∆fur::TpTer and mbaSCdiA/mbaSCtetraA/mbaSCpentaA alleles was not achieved. All three of 
the allelic exchange vectors pEX18Tp-pheS, pSNUFF3Cm and pSHAFT2, containing the 
mutant alleles, successfully integrated into Bth chromosomal DNA to generate co-integrant 
strains. However, the stimulation of a second recombination event that excised the 
integrated plasmid and gave the desired gene deletion proved to be difficult. For the 
introduction of the ∆pchE allele using pSNUFF3Cm-∆pchE, of the 50 candidate colonies that 
displayed tetracycline resistance (specified by pDAI-SceI-pheS) and chloramphenicol 
sensitivity (due to loss of the pSNUFF3Cm vector backbone), only one candidate colony had 
resolved the co-integrant state and retained the desired ∆pchE allele. For the introduction 
of the ∆mbaS allele into Bth using pEX18Tp-pheS-∆mbaS, 600 candidate colonies in total 
(300 colonies each for the generation of Bth E264 ∆mbaS and Bth E264 ∆mbaS ∆pchE) 
displayed cPhe resistance (due to loss of the pEX18Tp-pheS vector backbone). Of these 600 
colonies, only three colonies that had resolved the co-integrant state and retained the 
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desired ∆mbaS allele (two for Bth E264 ∆mbaS, one for Bth E264 ∆mbaS ∆pchE). Several 
hundred candidate colonies for the introduction of the fur deletion and the mbaSCpentaA 
replacement were isolated, but none possessed the desired mutant allele. These allelic 
exchange vectors have been shown to be effective in several species of Burkholderia 
(Barrett et al., 2008; Shastri et al., 2017)(H. Spiewak, unpublished). Indeed, pSNUFF3Cm was 
used to introduce gene deletions successfully in Bce (see Chapter VI). Therefore, it appears 
these allelic exchange vectors have poor efficiency in Bth. It is unclear what factors specific 
to Bth may affect this efficiency of mutant generation, but problems arose at the stage of 
resolving the co-integrant state of the Bth cells. It is likely that this was not specific to the 
mutant allele being introduced, as introduction of the mbaSCpentaA allele into Bth E264 
∆mbaS (which should introduce a relative advantageous phenotype) also proved to be 
difficult. 
With regards to attempts to introduce the ∆fur mutation, the potentially essential nature of 
the global repressor may have contributed to the inability to isolate a gene deletion mutant.  
Efforts were made to overcome this in several ways. Mutagenesis was performed using EB 
agar, a partially nutrient-limited medium that has been demonstrated to support growth of 
a Burkholderia multivorans fur mutant (Yuhara et al., 2008). Additionally, usage of a marked 
mutant allele conferring trimethoprim resistance was attempted in order introduce a 
selective advantage to fur null mutants. This was performed in Bth Mba- and Pch- strains, 
which could have decreased the excess of intracellular iron that may have been toxic for a 
fur mutant. Although none of these attempts worked, the choice of medium may have a 
significant effect upon the viability of fur null Bth mutants. Efforts could be made in the 
future to rationally select a different growth medium to generate a Bth ∆fur mutant, in 
which the fur gene is not essential. Despite this, it cannot be precluded that Fur is an 
essential protein in Bth. 
The Bth E264 ∆mbaS, ∆pchE and ∆mbaS ∆pchE strains had their specific gene deletions 
verified in vivo by complementation with pBBR2-mbaS and pBBR2-pchE. However, Bth E264 
∆pchE displayed no observable phenotypic difference to the wild-type, making it difficult to 
confirm the pchE deletion and the complementation of this gene deletion. However, in 
combination with the phenotypic characterisation of the Bth E264 ∆mbaS and Bth E264 
∆mbaS ∆pchE it is unlikely that the gene deletions were not introduced as expected. 
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Additionally, when Bth was grown on CAS agar, the large yellow halo was assigned as being 
produced due to the secretion of malleobactin, and the large orange halo was assigned as 
the result of pyochelin production. This is assumption is based upon the known functions of 
the mbaS and pchE genes. However, empirical identification of these siderophores could be 
achieved by siderophore cross-feeding assays and/or isolation of the siderophore and mass 
spectroscopic analysis. 
Assuming that the orange halo produced around Bth cultures when grown on CAS agar is 
due to the activity of pyochelin, there appears to be an effect of temperature upon 
pyochelin production. Two different Pch+ Bth cells cultures were used – the first produced 
pyochelin using a chromosomal copy of PchE (Bth E264 ∆mbaS), and the second produced 
pyochelin using the plasmid-based copy of PchE (Bth E264 ∆mbaS ∆pchE/pBBR2-pchE). Both 
strains display similar patterns of halo production on CAS agar. The explanation for this 
effect of temperature upon the production of pyochelin is unclear, and may be worthy of 
further investigation. 
Finally, during the course of this study a strain variant of Bth E264 was discovered. Using a 
Bth strain (now designated as Bth E264a) originating from the Titball research group at the 
University of Exeter, attempts were made to analyse the production of siderophores by 
growing the bacteria on CAS agar. The failure of this strain to produce a large halo due to 
siderophore secretion prompted comparison with another Bth E264 strain (now designated 
as Bth E264b) originating from the Hertweck research group at the Leibniz Institute for 
Natural Product Research and Infection Biology. This second Bth E264 strain was able to 
produce a much larger halo due to siderophore secretion when grown on CAS agar, 
indicating the presence of two strain variants. Many experiments were performed in Bth 
E264a, until it was recognised as a strain variant. These experiments were repeated in Bth 
E264b. The discovery of this strain variant perhaps demonstrates the extent to which there 














regulation of MbaS 










As previously discussed in section Error! Reference source not found., the Burkholderia ECF 
sigma factors MbaS and OrbS both contain extended C-terminal extensions that are rich in 
conserved cysteine residues. Within these cysteine-rich extensions (CREs), MbaS contains 
five cysteine residues (amino acid positions 203, 206, 216, 220 and 230) and OrbS contains 
four cysteine residues (amino acid positions 196, 199, 203 and 209) (Figure 1.13). 
It is hypothesised that these residues perform a key role in the post-translational regulation 
of the sigma factors. The most likely possibility is that ferrous iron could bind to the cysteine 
thiol groups, conferring a conformational change which inhibits the activity of the sigma 
factor. 
In the experiments described in this chapter, this hypothesis is tested through assaying the 
effect of iron and alternative metals upon the activity of MbaS and OrbS. Through 
comparison with constructed cysteine-to-alanine substitution mutants, the involvement of 
the CRE in metal-dependent regulation was also examined. 
Objectives: 
 To verify that MbaS is an ECF sigma factor, and to identify its target promoters 
 To verify Fur-dependent regulation of mbaS transcription and the location of the Fur-
regulated DNA binding region 
 To investigate cross-activity between MbaS and OrbS with respect to promoter 
recognition 
 To investigate metal-dependent inhibition of MbaS and OrbS activity via their 
cysteine-rich extensions 
 
5.2 Identification of MbaS-dependent 




A significant body of work regarding the OrbS regulon has been published. The target 
promoters of OrbS, PorbH, PorbE and PorbI, have been experimentally verified via a transcription 
reporter analysis (Agnoli et al., 2006), and their transcription start sites have been identified 
by primer extension analysis (Agnoli et al., 2018). Furthermore, the precise -35 and -10 
promoter elements of PorbH have been elucidated single base pair substitution analysis in 
vivo (Agnoli et al., 2018). Additionally, it has been demonstrated that OrbS does not, as is 
the case with most ECF sigma factors, act upon its own promoter in an auto-regulatory 
fashion (Agnoli et al., 2006). 
There is a high degree of sequence identity between the genes of the orb gene cluster and 
the mba gene cluster. Therefore, it is highly likely that MbaS recognises the homologous 
promoters PmbaH, PmbaE and PmbaI, and does not interact with its own promoter. However, 
this has not been empirically demonstrated. Therefore, steps were taken to confirm these 
assumptions and characterise the MbaS regulon. 
 
5.2.1 in silico identification of MbaS-dependent target promoters 
Three MbaS-dependent promoters have been predicted in the Bps malleobactin gene 
cluster based upon DNA sequence similarity with the empirically determined and 
homologous PvdS-dependent promoter motifs, and RNAse protection assays (Alice et al., 
2006). These predicted MbaS-dependent promoter sequences have been used to predict 
the position of the MbaS-dependent promoters in the genome sequence of Bth E264, and to 
generate a consensus sequence motif using the predicted promoter sequences from several 
Bth, Bps and Bma strains that encode MbaS (Figure 5.1). Given the homology between the 
PvdS, OrbS and MbaS systems, it is highly likely that the sequences identified correspond to 





Figure 5.1. Sequences and consensus sequence motif of predicted MbaS-dependent promoters 
A. DNA sequences predicted to be recognised by MbaS. Top. The consensus sequence motifs 
recognised by PvdS (Wilson, McMorran and Lamont, 2001) and OrbS (Agnoli et al., 2018). Bottom. 
Aligned DNA sequences found upstream of the Bth E264 genes mbaH, mbaE and mbaI. Identified 
bases in all five sequences are shown with white font upon black background. B. The consensus 
sequence motif of the predicted MbaS-dependent promoter. Generated using WebLogo (Crooks et 
al., 2004) with DNA upstream of the mbaH, mbaE and mbaI genes from the following species: Bth 
E264, Bth E254, Bth 34. Bps K96243, Bps TSV48, Bps 1710b, Bma FMH and Bma ATCC23344. 
 
5.2.2 Construction of MbaS-dependent promoter-reporter fusion 
plasmids 
The DNA fragments containing putative MbaS target promoters, and the mbaS promoter, 
were cloned into the transcriptional lacZ reporter plasmid pKAGd4 (Agnoli et al., 2006). The 
promoter DNA was cloned into the MCS upstream of the promoter-less lacZ gene, allowing 
the promoter activity of the cloned DNA to be assayed by performing β-galactosidase 
assays. The promoters for the genes mbaS, mbaH, mbaE and mbaI were all to be assayed. 
For each promoter, a ‘long’ DNA fragment of ~250 bp, and a ‘short’ DNA fragment of 49 or 
53 bp (both containing the putative -35 and -10 promoter elements) were cloned ( 
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Table 5.1). ‘Long’ promoters were cloned by PCR amplification, whereas ‘short’ promoters 
were cloned by annealing of long single-stranded oligonucleotides to form double-stranded 
DNA fragments with sticky ends. 
The cloning of the ‘long’ mbaS promoter, PmbaS-L, and the ‘long’ mbaH promoter, PmbaH-L, are 
described in section 4.7.5. The ‘short’ mbaS promoter, PmbaS-S, was generated by annealing 
oligonucleotides pmbaS-short-fwd and pmbaS-short-rev to produce a 63 bp DNA product. 
The ‘short’ mbaH promoter, PmbaH-S, was annealed using oligonucleotides pmbaH-short-fwd 
and pmbaH-short-rev to produce a 59 bp DNA product. The ‘long’ mbaE promoter, PmbaE-L, 
was amplified by PCR from Bth E264 genomic template DNA using primers pmbaE-long-fwd 
and pmbaE-long-rev to produce a 308 bp DNA product. The ‘short’ mbaE promoter, PmbaE-S, 
was generated by anneal oligonucleotides pmbaE-short-fwd and pmbaE-short-rev to 
produce a 59 bp DNA product. The ‘long’ mbaI promoter, PmbaI-L, was amplified by PCR from 
Bth E264 genomic template DNA using primers pmbaI-long-fwd and pmbaI-long-rev to 
produce a 295 bp DNA product. The ‘short’ mbaI promoter, PmbaI-S, was annealed using 
oligonucleotides pmbaI-short-fwd and pmbaI-short-rev to produce a 59 bp DNA product. All 
promoter DNA fragments were inserted between the HindIII and BamHI sites of pKAGd4 to 
give the corresponding plasmid derivatives (excluding PmbaI-L, cloned between HindIII and 
XbaI). The identity of each plasmid construct was confirmed by PCR screening and DNA 
sequencing analysis using the primer AP10. 
Table 5.1. Cloned putative promoter endpoints from the malleobactin gene cluster 
Promoter Upstream endpoint[1] Downstream endpoint[1] 
PmbaS-L -141 +25 
PmbaS-S -45 +8 
PmbaH-L -193 +57 
PmbaH-S -43 +6 
PmbaE-L -150 +138 
PmbaE-S -43 +6 
PmbaI-L -202 +73 
PmbaI-S -43 +6 
[1] Endpoint distances are given relative to the experimentally determined transcription start site of 




Figure 5.2. Cloned putative promoter sequences from the malleobactin gene cluster 
Full sequences shown correspond to the sequences of the ‘long’ cloned promoters. The sequences 
of the corresponding ‘short’ promoters are underlined. DNA bases enclosed in boxes correspond to 
the predicted -35 and -10 promoter elements, and bases in bold red font correspond to the 
predicted transcription start site, based upon the homologous orb system (Agnoli et al., 2018). 
Predicted Shine-Dalgarno sequences are shown in bold black font. Bases with identity to the Fur 
consensus sequence (Baichoo and Helmann, 2002) at the predicted Fur binding site of PmbaS are 
highlighted in yellow. 
 
5.2.3 Activity of MbaS-dependent promoters in E. coli 
The pBBR1MCS2-mbaS expression plasmid and the pKAGd4 promoter reporter plasmids 
were co-introduced into E. coli MC1061 (∆lac) by transformation, in addition to the parental 
plasmids as negative controls, in different combinations. The β-galactosidase assay was 
























cultures grown in LB broth, supplemented with 100 µg ml-1 ampicillin and 50 µg ml-1 
kanamycin, and the experiment was performed a total of four times on different days. 
The results shown in Figure 5.3 demonstrate that both PmbaS derivatives are active even 
without the introduction of MbaS. Furthermore, the addition of MbaS does not significantly 
increase the β-galactosidase activity. This is consistent with the assumption that PmbaS is a 
σ70-dependent promoter, as the high degree of conservation between the E. coli and Bth σ70 
proteins results in β-galactosidase activity when the promoter-reporter is present. The 
absence of significantly increased β-galactosidase activity for either promoter fragment with 
the introduction of MbaS also verifies that, like OrbS, MbaS does not have auto-regulatory 
activity and PmbaS is not an MbaS-dependent promoter. This is the first demonstration of the 
σ70-dependency of PmbaS. These results localised the PmbaS core elements to a 53 bp DNA 
region and the PmbaH, PmbaE and PmbaI core elements to a 49 bp region. 
The results also demonstrate that PmbaH, PmbaE and PmbaI are all MbaS-dependent promoters. 
For each of the promoters, there is no β-galactosidase activity when there is no MbaS 
present, indicating that they are not activated directly by E. coli σ70 is the same way that 
PmbaS is. When mbaS is introduced on a plasmid, each of the promoters gives rise to a high β-
galactosidase activity, indicating that they are activated directly by MbaS. Interestingly, the 
‘long’ PmbaH and PmbaE promoters give rise to lower β-galactosidase activities compared to 
the ‘short’ promoters. The ‘long’ and ‘short’ PmbaI promoters show no significant disparity. 
This possibly points towards an inhibitory regulatory element upstream of the PmbaH and 
PmbaE promoters that is present in the ‘long’ promoter variants, and an unknown factor of E. 




Figure 5.3. β-galactosidase assay of MbaS-dependent promoters in E. coli MC1061. 
β-galactosidase activity was measured in E. coli MC1061 harbouring a) pBBR1MCS-2 (denoted by ‘-‘) 
or pBBR1MCS-2-mbaS (denoted by ‘+’), and b) pKAGd4 or pKAGd4 derivatives containing PmbaS, PmbaH, 
PmbaE, or PmbaI (denoted below data bars). All β-galactosidase activities were corrected for the 
background vector activity by subtraction of activity derived from E. coli MC1061 harbouring both 
parental plasmids pBBR1MCS-2 and pKAGd4. Error bars show standard deviation (n=12). Growth 
medium was LB supplemented with 100 µg ml-1 ampicillin and 50 µg ml-1 kanamycin. 
 
5.2.4 Activity of MbaS-dependent promoters in B. thailandensis 
After identification of the MbaS-dependent promoters in E. coli, the pKAGd4 promoter 
reporter plasmids (and the parental pKAGd4 plasmid as a negative control) were introduced 
into Bth E264 by conjugation to verify their activity in Bth. MbaS protein was provided by 
the chromosomal copy of the gene in Bth. The β-galactosidase assay was performed 
according to the protocol outlined in section 2.5.1 on cells grown in M9 minimal salts 
medium supplemented with 0.5% (w/v) glucose, 0.1 % (w/v) casamino acids and 50 µg ml-1 





Figure 5.4. β-galactosidase assay of MbaS-dependent promoters in B. thailandensis E264. 
β-galactosidase activity was measured in Bth E264 harbouring pKAGd4 derivatives containing PmbaS, 
PmbaH, PmbaE, or PmbaI (denoted below data bars). All β-galactosidase were activities corrected for 
background vector activity by subtraction of activity derived from Bth E264 harbouring the parental 
plasmid pKAGd4. Error bars show standard deviation (n=9). Growth medium was M9 minimal salts 
supplemented with 0.5% (w/v) glucose, 0.1 % (w/v) casamino acid and 50 µg ml-1 chloramphenicol. 
 
The results from Figure 5.4 show that the assayed promoters are active in Bth E264. From 
this experiment alone, it is unclear what factor in Bth E264 acts upon the promoters, but 
taken in conjunction with the results in Figure 5.3 and Figure 4.23 it is highly likely that the 
factor acting upon PmbaH, PmbaE and PmbaI is the chromosomally-expressed MbaS sigma factor, 
and the factor acting upon PmbaS is the Bth E264 σ70 protein. The β-galactosidase activity for 
specified by the ‘short’ and ‘long’ PmbaS variants is lower than that of the activities for ‘full’ 




5.3 Identification of an MbaS-dependent 
promoter by in vitro transcription assay 
 
In addition to the in vivo methods used to verify the characterisation of MbaS as a sigma 
factor and the identities of the MbaS-dependent promoters, in vitro transcription (ivT) was 
also used. This method allows confirmation of MbaS as a sigma factor as there are no other 
protein factors present apart from core RNAP. This method required the purification of the 
MbaS and the cloning of a target promoter into a transcription reporter vector compatible 
with ivT. As MbaS stimulated high levels of transcription in E. coli, it was decided to use the 
E. coli core RNAP for ivT assays as it was commercially available. 
 
5.3.1 Construction of pET14b-mbaS and pET14b-mbaSCpentaA 
To overexpress the MbaS and MbaSCpentaA sigma factor for protein-based assays, the 
corresponding genes were cloned into the bacterial expression vector pET14b (Novagen). 
Both the mbaS gene and the mbaSCpentaA genes were amplified using the primers mbaS-fwd-
NdeI and mbaS-rev-BamHI to produce 740 bp PCR products (Figure 5.5a,b). The mbaS gene 
was amplified from Bth E264 genomic template DNA, whereas the mbaSCpentaA gene was 
amplified from the plasmid construct pSNUFF3Cm-mbaSCpentaA (see section 4.5.1) as 
template DNA. Both PCR products were cloned between the NdeI and BamHI sites of the 
MCS of pET14b to give pET14b-mbaS and pET14b-mbaSCpentaA (Figure 5.5c). In both cases, 
the cloned genes were under the transcriptional control of a T7 promoter, and the 
translated product included an N-terminal hexahistidine tag followed by a thrombin 
cleavage site giving a total N-terminal tag length of 20 amino acids. The identities of the 
plasmid constructs were confirmed by PCR screening and DNA sequencing analysis with 




Figure 5.5. Construction of pET14b-mbaS and pET14b-mbaSCpentaA 
Agarose gel electrophoresis analysis of DNA PCR products and plasmid DNA used in construction of 
pET14b-mbaS and pET14b-mbaSCpentaA. A. PCR to amplify mbaS. Lane 1, GeneRuler 1 kb DNA Ladder 
(Thermofisher); lane 2, mbaS PCR product, 740 bp. B. PCR to amplify mbaSCpentaA. Lane 1, GeneRuler 
1 kb DNA Ladder (Thermofisher); lane 2, mbaSCpentaA PCR product, 740 bp. C. pET14b plasmid 
constructs. Lane 1, pET14b-mbaS, 5.4 kb; lane 2, pET14b-mbaSCpentaA, 5.4 kb; lane 3, Supercoiled DNA 
Ladder (NEB). 
 
5.3.2 Purification of MbaS and MbaSCpentaA 
The constructed plasmids pET14b-mbaS and pET14b-mbaSCpentaA were used to overexpress 
the corresponding ECF sigma factors in E. coli BL21(DE3). The overexpressed proteins were 
purified from cell lysates as described in sections 2.4.1 to 2.4.3. Typically, the MbaS and 
MbaSCpentaA proteins were extracted from cell pellets generated from 50 ml of culture. As 
with many ECF sigma factors, the proteins were found to be insoluble and required 
solubilisation with N-lauroylsarcosine (also referred to as sarkosyl). Examples of SDS-PAGE 
for analysis of the protein purification process are shown for MbaS (Figure 5.6) and 




Figure 5.6. Purification of MbaS 
SDS-PAGE analysis of protein samples from overexpression and purification of MbaS. Expected MW 
of MbaS is 27.7 kDa. Volume of sample loaded shown below in brackets. Lane 1, EZ-run Rec Protein 
Ladder (Fisher Bioreagents); lane 2, un-induced protein (5 µl); lane 3, total induced protein (5 µl); 
lane 4, total soluble protein (5 µl); lane 5, total protein post-sarkosyl treatment (10 µl); lane 6, total 
soluble protein post-sarkosyl treatment (10 µl); lane 7, protein unbound to IMAC column (10 µl); 
lane 8, flow-through of wash through protein-loaded IMAC column (10 µl); lane 9, eluted protein (10 




Figure 5.7. Purification of MbaSCpentaA 
SDS-PAGE analysis of protein samples from overexpression and purification of MbaSCpentaA. Expected 
MW of MbaSCpentaA is 27.5 kDa. Volume of sample loaded shown below in brackets. Lane 1, EZ-run 
Rec Protein Ladder (Fisher Bioreagents); lane 2, un-induced protein (5 µl); lane 3, total induced 
protein (5 µl); lane 4, total soluble protein (5 µl); lane 5, total protein post-sarkosyl treatment (10 µl); 
lane 6, total soluble protein post-sarkosyl treatment (10 µl); lane 7, protein unbound to IMAC 
column (10 µl); lane 8, flow-through of wash through protein-loaded IMAC column (10 µl); lane 9, 
eluted protein (10 µl); lane 10, final dialysed protein (5 µl). 
 
During the stages of dialysis into the storage buffer, the purified proteins would occasionally 
precipitate; this was corrected by titrating with N-lauroylsarcosine at final concentrations of 
0.05-0.25% until resolubilisation was achieved. Although it was unclear whether ECF sigma 
factor treated in this way would refold into the native state, the proteins functioned 
identically in ivT (see section 5.3.4) and bio layer interferometry (see section 5.9.4) 
regardless of resolubilisation procedure. Typically, the final concentration of purified ECF 
sigma factor purified in storage buffer was 1.5-3.0 mg ml-1. These proteins were then diluted 





5.3.3 Construction of pRLG770-derived transcription assay vector for 
analysis of MbaS-dependent transcription in vitro 
A plasmid harbouring an MbaS-dependent promoter was required to serve as template DNA 
in the ivT assay. As the transcription assay procedure uses supercoiled DNA, the plasmid 
template must have a strong transcription terminator located downstream of the cloning 
site for the promoter DNA. pRLG770 is an in vitro transcription reporter vector that contains 
the tandem rrnB T1T2 terminator (Ross et al., 1990). This would give an RNA transcript of an 
expected length that can be detected through incorporation of 32P-UTP and thereby used as 
a probe for MbaS/MbaSCpentaA transcription activity. The mbaH promoter was selected as a 
representative MbaS-dependent promoter for cloning into pRLG770. 
The 49 bp PmbaH promoter DNA fragment was made by annealing the oligonucleotides 
pBTHI2426-EcoRI-fwd an pBTHI2426-HindIII-rev, and ligated between the EcoRI and HindIII 
sites of pRLG770 to give the plasmid pRLG770-PmbaH (Figure 5.8). The identity of the 
plasmid construct was confirmed by PCR screening and DNA sequencing analysis with the 
primers 1204 and RLG1620. 
For use in ivT assays, the plasmid was prepared by maxiprep as described in section 2.3.3. 






Figure 5.8. Construction of pRLG770-PmbaH 
Agarose gel electrophoresis analysis of DNA products and plasmid DNA used in construction of 
pRLG770-PmbaH. Lane 1, Supercoiled DNA Ladder (NEB); lane 2, pRLG770-PmbaH, 5.1 kb. 
 
5.3.4 Verification of MbaS as a sigma factor by in vitro transcription assay 
Once all of the components of the ivT assay were prepared, a series of control reactions 
were performed (Figure 5.9). These reactions were set up to confirm that (a) E. coli σ70 does 
not direct synthesis of RNA from PmbaH, (b) MbaS/MbaSCpentaA do not direct synthesis of RNA 
from the PmbaH promoter in the absence of E. coli core RNAP, and (c) MbaS/MbaSCpentaA are 
able to direct synthesis of RNA from PmbaH when E. coli core RNAP is present. As a positive 
control, pRLG770-PguaB containing the σ70-dependent guaB promoter was included in the 
assays. For the assays involving MbaS/MbaSCpentaA, a 15-minute pre-incubation step was 
employed to allow for association of the σ factor with E. coli core RNAP. However, for σ70-




Figure 5.9. in vitro transcription assay controls 
RNA transcripts were resolved in a 5.5% acrylamide, 7 M urea gel following an in vitro transcription 
assay. E. coli core RNA polymerase (NEB), in association with a sigma factor, was used to synthesise 
RNA from DNA fragments containing the promoters PguaB, PmbaH or PorbH cloned into pRLG770 as 
indicated. The location of the transcripts originating from each promoter are indicated on the left of 
the image: the guaB promoter (186 nt transcript), the mbaH or orbH promoter (156 nt transcript). 
The location of the replicon-derived RNAI 108 nt transcript is also indicated. More detail is included 
within the text. 
 
As expected, the reaction containing the E. coli σ70 holoenzyme and pRLG770-PguaB produces 
two RNA transcripts: one 186 nt product initiated from the cloned guaB promoter, and one 
108 nt product initiated from the RNAI site within pRLG770. When pRLG770-PmbaH was used 
as template in place of pRLG770-PguaB, only the RNAI transcript was produced, consistent 
with the hypothesis that the PmbaH is not a σ70-dependent promoter. This was confirmed 
further when E. coli σ70 was not included in the reaction, and there is complete shutdown of 
transcription. Both MbaS and MbaSCpentaA are not able to stimulate RNA synthesis originating 
from the mbaH promoter in the absence of E. coli core RNAP, confirming there was no 
contaminating RNAP in the preparations of these sigma factors. Finally, it was observed that 
both MbaS and MbaSCpentaA, when in association with core RNAP, can initiate transcription 
from PmbaH and produce a 156 nt RNA transcript. Both of these sigma factors show 




5.4 Demonstration of Fur-dependent 
regulation of mbaS 
 
In order to investigate the putative iron-dependent regulation of MbaS sigma factor activity 
in vivo, it was necessary to empirically demonstrate that Fur acts upon PmbaS, but not upon 
the MbaS-dependent promoters PmbaH, PmbaE and PmbaI. Doing so ensures that any observed 
iron-regulation of the activity of MbaS upon a target promoter is due solely to effects upon 
MbaS activity and/or abundance, and not upon the MbaS target promoters. 
In the homologous orbS system of Bce, it has been demonstrated by bioinformatic 
prediction, Fur titration assay (FURTA) and EMSAs, that PorbS contains a Fur box, but PorbH 
and PorbI/PorbE do not (Agnoli et al., 2006). Additionally, in the mbaS system of Bps, a putative 
Fur box was identified at PmbaS bioinformatically and by FURTA (Alice et al., 2006). In the 
latter experiment, the length of the PmbaS DNA fragment that was assayed was not specified 
and the precise location of the Fur box is yet to be identified experimentally. Therefore, 
investigations using both FURTA and transcriptional reporter fusions were performed to 
demonstrate Fur regulation of MbaS, and identify the Fur box with greater precision.  
 
5.4.1 Construction of pBluescript II KS-derived Fur box probe vectors 
The same ‘long’ promoter DNA fragments of ~200-300 bp from the malleobactin gene 
cluster that were cloned used to construct pKAGd4-PmbaS-L, pKAGd4-PmbaH-L, pKAGd4-PmbaE-L 
and pKAGd4-PmbaI-L were cloned into the high copy-number reporter plasmid pBluescript II 
KS to examine Fur binding by FURTA. The amplified DNA fragments containing the 
promoters are shown in Figure 5.10a-d. The PmbaS, PmbaH, and PmbaE DNA fragments were 
cloned between the HindIII and BamHI sites of the pBluescript II SK MCS to give pBS-PmbaS, 
pBS-PmbaH and pBS-PmbaE, respectively (Figure 5.10e). The PmbaI DNA fragment was cloned 
between the HindIII and XbaI sites of the MCS of pBluescript II SK to give pBS-PmbaI (Figure 
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5.10e). The identities of the plasmid constructs were confirmed by PCR screening and DNA 
sequencing analysis with primers M13for2 and M13revBACTH. 
 
Figure 5.10. Construction of pBluescript II SK derivatives containing putative promoter DNA. 
Agarose gel electrophoresis analysis of DNA PCR products and plasmid DNA used in construction of 
pBluescript II SK derivatives containing promoter DNA for the genes mbaS, mbaH, mbaE and mbaI. 
A. PCR to amplify PmbaS. Lane 1, GeneRuler 1 kb DNA Ladder (Thermofisher); lane 2, PmbaS, 186 bp PCR 
product. B. PCR to amplify PmbaH. Lane 1, GeneRuler 1 kb DNA Ladder (Thermofisher); lane 2, PmbaH, 
274 bp PCR product. C. PCR to amplify PmbaE. Lane 1, GeneRuler 1 kb DNA Ladder (Thermofisher); 
lane 2, PmbaE, 308 bp PCR product. D. PCR to amplify PmbaI. Lane 1, GeneRuler 1 kb DNA Ladder 
(Thermofisher); lane 2, PmbaI, 295 bp PCR product. E. pBluescript II SK plasmid constructs. Lanes 1 and 
6, Supercoiled DNA ladder (NEB); lane 2, pBS-PmbaS, 3.1 kb; lane 3, pBS-PmbaH, 3.2 kb; lane 4, pBS-
PmbaE, 3.2 kb, lane 5, pBS-PmbaI, 3.2 kb. 
 
5.4.2 Identification of Fur binding sites by FURTA 
The pBluescript II KS derivatives containing PmbaS, PmbaH, PmbaE and PmbaI, in addition to 
pBluescript II KS and p3FZBS (positive control harbouring the E. coli consensus Fur box) were 
introduced into E. coli H1717 by transformation. These strains were streaked out onto 
MacConkey agar containing 1% (w/v) lactose and 40 µM Fe(NH4)2(SO4)2, and grown at 37 oC 




Figure 5.11. Identification of Fur-binding sites in MbaS-associated promoters by FURTA 
E. coli H1717 transformants grown on a MacConkey agar plate, supplemented with 1% (w/v) lactose, 
40 µM Fe(NH4)2(SO4)2 and 100 µM ampicillin. Plasmids harboured by E. coli H1717 are pBluescript II 
KS (-), p3ZFBS (+), and pBluescript II KS derivatives containing the promoters PmbaS, PmbaH, PmbaE, and 
PmbaI, as indicated. 
 
The results from the FURTA indicate that the 186 bp DNA region located upstream of the 
mbaS translation initiation codon contains a Fur box, whereas the 274, 308 and 295 bp DNA 
regions upstream of mbaH, mbaE and mbaI, respectively, do not contain a Fur box. 
Therefore, analogous to the orb system, only the transcription of mbaS is directly regulated 






5.4.3 Determination of optimum 2,2-dipyridyl concentration to induce 
iron-limited conditions 
In order to simulate iron-deplete conditions, the metal ion-chelating molecule 2,2-dipyridyl 
(DP) was added to minimal salts medium to sequester any trace amounts of iron. DP is able 
to enter bacterial cells and bind Fe2+, where three molecules of the bidentate ligand DP 
coordinate one ion of Fe2+ with high affinity. 
A suitable concentration of DP in conjunction with Bth had to be determined for use in 
bacterial growth curves and transcription reporter analyses; this would be the highest 
concentration of metal chelator that did not significantly affect the bacterial growth rate. A 
concentration of DP that impacts bacterial growth may lead to physiological changes that 
could interfere with or mask iron regulatory mechanisms. Conversely, a concentration of DP 
too low may not induce iron-depleted conditions. The suitable concentration of DP to be 
used was determined by growing Bth E264 in medium containing different concentrations of 
DP (Figure 5.12). 
 
Figure 5.12. Growth curves of Bth E264 growth with different concentrations of 2,2-dipyridyl. 
Growth curves carried out in M9 minimal salts medium supplemented with 0.5% (w/v) glucose, 0.1% 
(w/v) casamino acids and varying concentrations of 2,2-dipyridyl (DP). Concentration of DP is 




Figure 5.12 suggests that a concentration of 100 µM DP is sufficient to induce iron-depleted 
conditions for Bth in M9 minimal salts medium supplemented with 0.5% (w/v) glucose and 
0.1% (w/v) casamino acids, as this is the highest concentration of DP that results in only a 
small decrease in growth rate. This concentration was used in all subsequent experiments 
where iron starvation conditions were required. 
 
5.4.4 Demonstration of Fur-dependent regulation of MbaS by 
transcription reporter analysis 
It has previously been demonstrated that the expression of mbaS occurs in a Fur-dependent 
manner (see section 5.4.2) (Agnoli et al., 2006), and therefore the transcription of the mbaS 
gene and its downstream target genes will be regulated by iron. Under iron-replete 
conditions, mbaS is downregulated; under iron-limiting conditions, mbaS is upregulated 
(Alice et al., 2006). Although this has been observed in Bps K96243, it has not previously 
been shown in vivo in Bth. 
To confirm that mbaS and its malleobactin-associated target genes are regulated by iron, 
the pKAGd4 reporter plasmids bearing the ‘long’ PmbaS, PmbaH, PmbaE and PmbaI promoters (and 
the parental pKAGd4 plasmid as a negative control) were introduced into Bth E264 by 
conjugation. β-galactosidase assays were performed on cells growing in M9 minimal salts 
medium supplemented with 0.5% (w/v) glucose, 0.1% casamino acids and 50 µg ml-1 
chloramphenicol according to the protocol outlined in section 2.5.1. To induce iron-limiting 
conditions, cultures were supplemented with 100 µM 2,2-dipyridyl (see section 5.4.3). To 
induce iron-replete conditions, cultures were supplemented with 50 µM FeCl3, as this 
concentration is regularly used to induce iron-replete conditions for many bacteria across 




Figure 5.13. β-galactosidase assay of MbaS-dependent promoters in B. thailandensis E264 under 
iron-replete and iron-limited conditions. 
Results of β-galactosidase assay investigating iron-dependent regulation of promoters mbaS and its 
target genes. β-galactosidase activity was measured in Bth E264 harbouring pKAGd4 derivatives 
containing PmbaS, PmbaH, PmbaE, or PmbaI (denoted below data bars). All β-galactosidase activities were 
corrected for the background vector activity by subtraction of activity derived from Bth E264 
harbouring the parental plasmid pKAGd4 under identical conditions. Growth medium was M9 
minimal salts supplemented with 0.5% (w/v) glucose, 0.1 % (w/v) casamino acid, 50 µg ml-1 
chloramphenicol and either 100 µM 2,2-dipyridyl (iron-limited, light grey) or 50 µM FeCl3 (iron-
replete, dark grey). Error bars show standard deviation (n=9). There is a significant difference in β-
galactosidase activity between cultures grown under iron-limited and iron-replete conditions for the 
promoters PmbaS (P=0.03), PmbaH (P<0.0001), PmbaE (P<0.0001) and PmbaI (P<0.0001) (one-way ANOVA, 
F=79.78, Tukey’s multiple comparison’s test). 
 
The results in Figure 5.13 show that all four of the promoters are regulated by iron, with 
significantly higher activity in cells grown under iron-limited conditions compared to iron-
replete conditions. The addition of iron results in an approximately 88% decrease in activity 
from the mbaS promoter (P=0.03), an approximately 86% decrease in activity from the 
mbaH promoter (P<0.0001), an approximately 82% decrease in activity from the mbaE 








































5.5 Construction of Fur-independent MbaS 
and OrbS expression vectors 
 
To investigate the possibility of direct iron regulation of MbaS and OrbS activity in vivo, 
expression vectors to supply the sigma factors in trans were constructed, without their 
native promoters so that Fur-dependent regulation of sigma factor gene transcription was 
eliminated from the in vivo assay system. The effect of iron on the activity of these sigma 
factors could then be ascertained using a transcription reporter system. Fur-independent 
expression of mbaS and orb Seas achieved using pBBR1MCS-2 and pBBR1MCS-5 plasmids 
containing the genes for mbaS, mbaSCpentaA, orbS and orbSCtetraA. 
 
5.5.1 Construction of pBBR1MCS2-orbS and pBBR1MCS2-orbSCtetraA 
expression vectors 
Both the orbS and orbSCtetraA genes have been cloned into pBBR1MCS-based expression 
plasmids by previous researchers ((Agnoli et al., 2006), A. Butt unpublished). However, in 
these constructs orbS and orbSCtetraA were cloned together with the native PorbS promoter, 
and so are therefore regulated by Fur. To express the OrbS protein and OrbSCtetraA mutant 
proteins in vivo, independently of Fur, these genes were cloned in an analogous manner as 
for construction of pBBR2-mbaS and pBBR2-mbaSCpentaA (see section 4.7.1). 
The orbS gene was amplified from Bce H111 genomic template DNA and the orbSCtetraA gene 
was amplified from the plasmid pBBR1MCS-orbSCtetraA (Agnoli, 2007), using the primers orbS-
fwd-HindIII and orbS-rev-BamHI to produce a 723 bp PCR product in each case (Figure 
5.14a,b). This included 30 bp immediately upstream of the translation start codon that 
contained the Shine-Dalgarno sequence, but not the native orbS promoter. An in-frame stop 
codon was incorporated into the 5’ end of the forward primer to terminate translation of 
the upstream lacZα gene segment of the vector to eliminate the possibility of generating a 
LacZα-OrbS protein fusion. The orbS and orbSCtetraA genes were cloned between the HindIII 
and BamHI sites of the MCS of pBBR1MCS-2 to give pBBR1MCS2-orbSΔP and pBBR1MCS2-
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orbSCtetraA-ΔP (Figure 5.14c). The identities of the plasmid constructs were confirmed by PCR 
screening and DNA sequencing analysis with primers M13revBACTH and M13for2. These 
plasmid constructs were given ΔP nomenclature to distinguish them previously constructed 
plasmids in which the the genes were cloned together with the native PorbS promoter. 
 
Figure 5.14. Construction of pBBR1MCS2-orbSΔP and pBBR1MCS2-orbSCtetraA-ΔP. 
Agarose gel electrophoresis analysis of DNA PCR products and plasmid DNA used in construction of 
pBBR1MCS2-orbSΔP and pBBR1MCS2-orbSCtetraA-ΔP. A. PCR to amplify orbS. Lane 1, GeneRuler 1 kb 
DNA Ladder (Thermofisher); lane 2, orbS PCR product, 723 bp. B. PCR to amplify orbSCtetraA. Lane 1, 
GeneRuler 1 kb DNA Ladder (Thermofisher); lane 2, orbSCtetraA PCR product, 723 bp. C. pBBR1MCS2-
orbS and pBBR1MCS2-orbSCtetraA. Lane 1, Supercoiled DNA Ladder (NEB); lane 2, pBBR1MCS-2, 5.1 kb; 
lane 3, pBBR1MCS2-orbSΔP, 5.8 kb, lane 4, pBBR1MCS2-orbSCtetraA-ΔP, 5.8 kb. 
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5.5.2 Construction of pBBR1MCS5-based expression vectors 
To investigate Fur-dependent regulation of MbaS, the E. coli fur mutant strain QC1732 
(Touati et al., 1995) and its parent strain QC771 (Carlioz and Touati, 1986) were used. 
However, QC1732 contains a kanamycin antibiotic resistance cassette that was used to 
inactivate the fur gene, and so could not be used in conjunction with the pBBR1MCS2-based 
plasmid constructs (see section 4.7.1 and 5.5.1). Therefore, these genes were cloned into 
another plasmid of the pBBR1MCS series: pBBR1MCS-5 (Kovach et al., 1995). This plasmid 
has an antibiotic selection marker that specifies gentamicin resistance, and could be used in 
conjunction with E. coli QC1732. As with the pBBR1MCS-2 based plasmid constructs (section 
5.5.1), the plasmids that contained orbS and orbSCtetraA were given ΔP nomenclature. 
The mbaS, mbaSCpentaA, orbS, and orbSCtetraA genes were obtained by restriction digestion 
with HindIII and BamHI from the plasmid constructs pBBR2-mbaS, pBBR2-mbaSCpentaA, 
pBBR2-orbSΔP and pBBR2-orbSCtetraA-ΔP, respectively, and ligated into the MCS of pBBR1MCS-
5 between the HindIII and BamHI sites to give pBBR1MCS5-mbaS, pBBR1MCS5-mbaSCpentaA, 
pBBR1MCS5-orbSΔP and pBBR1MCS5-orbSCtetraA (Figure 5.15). The identities of the plasmid 
constructs were confirmed by PCR screening and DNA sequencing analysis with primers 





Figure 5.15. Construction of pBBR1MCS-5 vectors expressing MbaS, MbaSCpentaA, OrbS and 
OrbSCtetraA. 
Agarose gel electrophoresis analysis of constructed plasmid DNA pBBR1MCS5-mbaS, pBBR1MCS5-
mbaSCpentaA, pBBR1MCS5-orbSΔP and pBBR1MCS2-orbSCtetraA-ΔP. Lane 1, Supercoiled DNA Ladder 
(NEB); lane 2, pBBR1MCS-5, 4.8 kb; lane 3, pBBR1MCS5-mbaS, 5.5 kb, lane 4, pBBR1MCS5-
mbaSCpentaA, 5.5 kb; lane 5, pBBR1MCS5-orbSΔP, 5.4 kb; lane 6, pBBR1MCS5-orbSCtetraA-ΔP, 5.4 kb. 
 
5.5.3 Construction of pKAGd4-PorbH-S 
Although pKAGd4 constructs containing PorbH have previously been constructed, a new 
variant of pKAGd4-PorbH was constructed that contained a promoter that corresponded in 
length and base pair coordinates to pKAGd4-PmbaH-S (-43 to +6 with respect to the predicted 
transcription start site) to allow direct comparison. The corresponding orbH promoter was 
assembled by annealing the oligonucleotides porbH-fwd-HindIII and porbH-rev-BamHI to 
produce a 59 bp DNA product. This was cloned between the HindIII and BamHI sites of 
pKAGd4 to produce pKAGd4-PorbH-S. The identity of this plasmid construct was confirmed by 




5.5.4 Demonstration of loss of Fur-dependent regulation of mbaS and 
orbS expression on pBBR1MCS5-derived expression vectors lacking 
the native mbaS and orbS promoters 
To confirm that by cloning the mbaS and orbS genes without their native promoter results in 
Fur-independent expression, the activity of the sigma factors expressed from pBBR5-mbaS 
and pBBR5-orbSΔP upon their target promoters was compared in both an E. coli fur+ strain 
(QC771) and an E. coli fur- strain (QC1732). As positive controls for Fur dependency, the Fur-
regulated promoters PmbaS and PorbS were also assayed. 
Firstly, either pKAGd4, pKAGd4-PmbaS-S, or pKAGd4-PorbS (Agnoli et al., 2006) were introduced 
into each of E. coli QC771 or QC1732 by transformation. Also, a combination of (a) pKAGd4-
PmbaH-S or pKAGd4-PorbH-S and (b) pBBR1MCS-5, pBBR5-mbaS or pBBR5-orbSΔP were 
introduced into either E. coli QC771 or QC1732 by co-transformation. β-galactosidase assays 
were performed on cells growing in M9 minimal salts medium supplemented with 0.5% 
(w/v) glucose, 0.1% casamino acids, and 25 µg ml-1 chloramphenicol, according to the 
protocol outlined in section 2.5.1. The medium was supplemented with 50 µg ml-1 
gentamicin for bacteria harbouring pBBR1MCS-5 and its derivatives. To induce iron-limiting 
conditions, cultures were supplemented with 100 µM 2,2-dipyridyl (see section 5.4.3). To 




Figure 5.16. β-galactosidase assay demonstrating loss of Fur-dependent regulation of constructed 
ECF sigma factor expression plasmids under iron-replete and iron-limited conditions. 
Results of β-galactosidase assay investigating iron-dependent regulation of the σ70-dependent 
promoters PmbaS and PorbS, and the loss of iron-dependent regulation upon the expression of MbaS and 
OrbS measured via their activity upon their target promoters. β-galactosidase activity was measured 
in either E. coli QC771 (fur+) or E. coli QC1732 (fur-) (denoted as ‘+’ or ‘-‘ below data bars). The bacteria 
harboured either pKAGd4-PshortmbaS (PmbaS), pKAGd4-PorbS (PorbS), pBBR5-mbaS and pKAGd4-PshortmbaH 
(MbaS/PmbaH) or pBBR5-orbS and pKAGd4-PorbH (OrbS/PorbH), as denoted below data bars. All β-
galactosidase activities are corrected against background by subtraction of activity derived from either 
E. coli QC771 or E. coli QC1732 harbouring pKAGd4, or harbouring pBBR5 with pKAGd4-PshortmbaH or 
pKAGd4-PorbH, as appropriate, under identical conditions. Growth medium was M9 minimal salts 
supplemented with 0.5% (w/v) glucose, 0.1 % (w/v) casamino acid, 25 µg ml-1 chloramphenicol, 50 µg 
ml-1 gentamicin for pBBR5-containing strains, and either 100 µM 2,2-dipyridyl (iron-limited, light grey) 
or 50 µM FeCl3 (iron-replete, dark grey). Error bars show standard deviation (n=2). There are significant 
differences of β-galactosidase activity between iron-limited and iron-replete conditions for PmbaS in 
QC771 (P=0.03), PorbS in QC771 (P=0.03), and OrbS/PorbH in both QC771 (P=0.0008) and QC1732 
(P=0.03) (unpaired t-tests). 
 
In this assay, there is clear Fur dependent iron regulation of both PmbaS and PorbS in the fur+ 
strain (P=0.03 for both, unpaired t-tests), which has been abolished in the fur-strain (no 
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mbaS is being expressed from the vector lacZ promoters but not its native promoter, there 
is no iron regulation in the fur+ strain (no significant difference, unpaired t tests). This 
demonstrates that MbaS expressed from pBBR1MCS-5 is no longer under the regulatory 
control of Fur. For the pBBR5-orbS/pKAGd4-PorbH system, there is some iron regulation of 
PorbH present. However, this is assumed to not be due to Fur, as this regulation is present in 
both the fur+ and fur- strains of E. coli (P=0.0008 and P=0.03, respectively, unpaired t tests). 
Therefore, the pBBR1MCS-based expression plasmids containing mbaS, mbaSCpentaA, orbS 
and orbSCtetraA were used to investigate the effect of regulation upon the sigma factors 
independently of Fur. 
 
5.6 Demonstration of cross-activity between 
MbaS and OrbS 
 
Due to the homology between MbaS and OrbS, and their target promoters, the degree to 
which they show cross-activity was investigated. Although this may not occur in nature, this 
would demonstrate the high conservation shown by these IS sigma factors found in 
different Burkholderia species. 
 
5.6.1 Cross-activity by CAS assay 
The plasmids pBBR1MCS-2, pBBR1MCS2-mbaS and pBBR1MCS2-orbSΔP were introduced by 
conjugation into the strains Bth E264 ΔmbaS and Bce H111 ΔorbS to compare the ability of 
the expressed sigma factors to complement the malleobactin/ornibactin-deficient 
phenotypes. This was assayed using the observed production of siderophore observed on 
CAS agar. Although pyochelin is still produced by both strains of Burkholderia, the 
production is much lower compared to that of malleobactin/ornibactin (in the case of Bth 
E264 ΔmbaS it is not seen after 16 hours at 37 oC) and can be clearly distinguished by its 
orange/red colour compared to the yellow of malleobctin/ornibactin. 
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Overnight cultures of each strain were grown in M9 minimal medium supplemented with 
0.5% (w/v) glucose and 250 μg ml-1 (for Bth) or 50 μg ml-1 (for Bce) kanamycin. Cultures were 
normalised according to their OD600 and 1 μl spotted onto CAS agar containing 10 μM FeCl3 
in triplicate. The areas of the siderophore halos was calculated manually. 
 
Figure 5.17. CAS assay demonstrating cross activity of MbaS and OrbS. 
Bth E264 ΔmbaS and Bce H111 ΔorbS containing pBBR2 expression plasmids harbouring pBBR2, 
pBBR2-mbaS or pBBR2-orbSΔP grown on CAS agar plates supplemented with 10 μM FeCl3. Strain and 
plasmid harboured denoted above spotted culture. B. Area of siderophore halos produced. Error bars 
show standard deviation (n=3). 
 
Both MbaS and OrbS expressed from the pBBR1MCS-2 plasmid are able to complement the 
Mba- and Orb- phenotypes of both Bth and Bce, respectively. This occurs irrespective of 
which sigma factor is present i.e. MbaS from Bth is able to complement the ΔorbS deletion 
of Bce and regulate the production of ornibactin, and OrbS from Bce is able to complement 
the ΔmbaS deletion of Bth and regulate the production of malleobactin. OrbS appears to 
show a greater ability to complement the Mba- and Pch- phenotypes, but this is small and 





5.6.2 Cross-activity by transcription reporter analysis 
To quantify the in vivo cross activity observed in section 5.6.1 further, a combination of the 
expression vectors pBBR1MCS-2, pBBR2-mbaS and pBBR2-orbSΔP and the transcriptional 
reporter vectors pKAGd4-PmbaH-S and pKAGd4-PorbH-S were introduced into E. coli MC1061 by 
transformation. The β-galactosidase assay was performed according to the protocol 
outlined in section 2.5.1, and performed on cells grown in Lnx medium supplemented with 
50 µg ml-1 kanamycin and 100 µg ml-1 ampicillin. 
 
Figure 5.18. β-galactosidase assay demonstrating cross activity of MbaS and OrbS. 
Results of β-galactosidase assay cross-activity of MbaS and OrbS upon their target promoters. β-
galactosidase activity was measured in E. coli MC1061 harbouring (a) the transcriptional reporter 
vectors pKAGd4-PmbaH-S (light grey) or pKAGd4-PorbH-S (dark grey), and (b) the expression vector pBBR2-
mbaS or pBBR2-orbSΔP (denoted below data bars). All β-galactosidase activities were corrected against 
background vector activity by subtraction of activity derived from E. coli MC1061 harbouring both the 
parental plasmid pBBR2 and either pKAGd4-PmbaH-S or pKAGd4-PorbH-S. Strains were grown in Lnx 
medium supplemented with 50 µg ml-1 kanamycin and 100 µg ml-1 ampicillin. Error bars show standard 
deviation (n=6). There is a significant difference between the activities of MbaS and OrbS upon PmbaH 
(P<0.0001), but no significant different between the activities of MbaS and OrbS upon PorbH (one-way 








































Again, it can be observed that both sigma factors are able to recognise and initiate 
transcription from the other’s target promoter. Both MbaS and OrbS display similar activity 
upon the orbH promoter (no significant difference), but OrbS displays a smaller activity upon 
the mbaH promoter compared to MbaS (P<0.0001). 
 
5.6.3 Purification of OrbS and OrbSCtetraA 
The previously constructed plasmids pET14b-orbS (Agnoli, 2007) and pET14b-orbSCtetraA (A. 
Butt unpublished data) were used to overexpress the corresponding ECF sigma factors in E. 
coliBL21(DE3). The overexpressed proteins were purifiedfrom cell lysates in an analogous 
manner to MbaS and MbaSCpentaA (section 5.3.2) and as described in sections 2.4.1 to 2.4.3. 
Protein yields were typically lower for OrbS/OrbSCtetraA. To overcome this, proteins were 
extracted from cell pellets generated from 500 ml of cell culture, supplemented with 100 μg 
ml-1 carbenicillin. Examples of SDS-PAGE for analysis of the protein purification process are 






Figure 5.19. Purification of OrbS 
SDS-PAGE analysis of protein samples from overexpression and purification of OrbS. Expected MW of 
OrbS is 26.8 kDa. Volume of sample loaded shown below in brackets. Lane 1, EZ-run Rec Protein Ladder 
(Fisher Bioreagents); lane 2, un-induced protein (5 µl); lane 3, total induced protein (5 µl); lane 4, total 
soluble protein (5 µl); lane 5, total protein post-sarkosyl treatment (10 µl); lane 6, total soluble protein 
post-sarkosyl treatment (10 µl); lane 7, protein unbound to IMAC column (10 µl); lane 8, flow-through 
of wash through protein-loaded IMAC column (10 µl); lane 9, eluted protein (10 µl); lane 10, final 





Figure 5.20. Purification of OrbSCtetraA 
SDS-PAGE analysis of protein samples from overexpression and purification of OrbSCtetraA. Expected 
MW of OrbSCtetraA is 26.7 kDa. Volume of sample loaded shown below in brackets. Lane 1, EZ-run Rec 
Protein Ladder (Fisher Bioreagents); lane 2, un-induced protein (5 µl); lane 3, total induced protein (5 
µl); lane 4, total soluble protein (5 µl); lane 5, total protein post-sarkosyl treatment (10 µl); lane 6, 
total soluble protein post-sarkosyl treatment (10 µl); lane 7, protein unbound to IMAC column (10 µl); 
lane 8, flow-through of wash through protein-loaded IMAC column (10 µl); lane 9, eluted protein (10 
µl); lane 10, final dialysed protein (5 µl). 
 
5.6.4 Cross-activity by in vitro transcription assay 
To further examine this cross-activity further, both the MbaS and OrbS sigma factors were 
used in ivT assays in combination with E. coli core RNAP (NEB) and the pRLG770 plasmids 
containing either PmbaH or PorbH. Reactions were set up with core RNAP in conjunction with 
(a) pRLG770-PmbaH with MbaS, OrbS, or the absence of sigma factor, and (b) pRLG770-PorbHds6 




Figure 5.21. in vitro transcription assay demonstrating cross-activity of MbaS and OrbS upon their 
target promoters. 
RNA transcripts were resolved in a 5.5% acrylamide, 7 M urea gel following an in vitro transcription 
assay. E. coli core RNA polymerase (NEB), in association with either MbaS, OrbS or no sigma factor 
(denoted above gel image), was used to synthesise RNA from a DNA fragments containing the 
promoters PmbaH or PorbH cloned into pRLG770 (denoted below gel image). RNA transcripts were 
synthesised from the mbaH or orbH promoter (156 nt transcripts). 
 
Both MbaS and OrbS, when present with E. coli core RNAP, can initiate transcription to 
synthesise an RNA product from both the PmbaH and PorbH promoters. Again, this 
demonstrates the homology between both these ECF sigma factors and their target 
promoters. 
 
5.7 Investigation of iron-dependent 
regulation of MbaS and OrbS in vivo 
 
It has been observed in previous work, and in experimental data presented here (see 
Chapter III), that there appears to be a Fur-independent iron regulation of OrbS activity. It 
has been hypothesised that this regulation occurs via the four cysteine residues found 
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within the CRE of OrbS. Experimental work using OrbSCtetraA, and mutant form of OrbS with 
four cysteine-to-alanine substitutions within the CRE, also provides some evidence that this 
iron regulation is lost when the cysteine residues are not present (see section 3.3-3.4). The 
homologous protein MbaS also contains a CRE, with five cysteine residues. So far, 
preliminary experiments (Figure 5.16) have not demonstrated any iron regulation. 
The putative regulatory effect of iron, independent of Fur, upon both MbaS and OrbS was 
investigated further. If iron regulation is observed, the dependency of the cysteine residues 
of the CREs was examined by comparison of the wild-type sigma factors with their cysteine-
to-alanine substitution mutants. Firstly, in vivo transcription reporter analysis and growth of 
Bth cultures on CAS medium were used to investigate this iron regulation. 
 
5.7.1 Effect of iron availability upon MbaS and OrbS independent of Fur 
in E. coli MC1061 
Using the Fur-independent expression vectors pBBR2-mbaS and pBBR2-mbaSCpentaA (see 
section 4.7.1), and the MbaS-dependent promoter contained within the transcriptional 
reporter vector pKAGd4-PmbaH-S (see section 5.2.2), it was possible to investigate the effect 
of iron upon the activity of MbaS via the five cysteine residues of its CRE through 
transcription reporter analysis. As the sigma factors genes are expressed independently of 
Fur (see section 5.5.4) it was possible to use the fur+ E. coli MC1061 strain. A combination of 
the plasmids pKAGd4 or pKAGd4-PmbaH-S and pBBR1MCS-2, pBBR2-mbaS or pBBR2-
mbaSCpentaA were introduced into E. coli MC1061 by transformation. β-galactosidase assays 
were performed in cells grown in M9 minimal salts medium supplemented with 0.5% (w/v) 
glucose, 0.1% (w/v) casamino acids, 100 µg ml-1 ampicillin and 50 µg ml-1 kanamycin, 
according to the protocol outlined in section 2.5.1. Iron-limited conditions were introduced 
by the addition of 100 µM 2,2-dipyridyl, and iron-replete conditions were introduced by the 






Figure 5.22. β-galactosidase assay of MbaS and MbaSCpentaA upon PmbaH in E. coli MC1061 under 
iron-limited and iron-replete conditions. 
Results of β-galactosidase assay investigation iron-dependent regulation of MbaS and MbaSCpentaA 
upon an MbaS-dependent promoter. β-galactosidase activity was measured in E. coli MC1061 
harbouring (a) pKAGd4, (-)  or pKAGd4-PmbaH-S (+), and (b) pBBR1MCS-2 (-), pBBR2-mbaS or pBBR2-
mbaSCpentaA, as denoted below data bars. All β-galactosidase activities were corrected against 
background vector activity by subtraction of activity derived from E. coli MC1061 harbouring both 
parental plasmids pBBR2 and pKAGd4. Growth medium was M9 minimal salts supplemented with 
0.5% (w/v) glucose, 0.1% (w/v) casamino acids, 100 µg ml-1 ampicillin and 50 µg ml-1 kanamycin and 
either 100 µM 2,2-dipyridyl (iron-limited, light grey) or 50 µM FeCl3 (iron-replete, dark grey). Error 
bars show standard deviation (n=6). There are no significant differences between the activities of 
MbaS and MbaSCpentaA upon the mbaH promoter under iron-limited and iron-replete conditions (one-
way ANOVA, Tukey’s multiple comparisons test). 
 
The β-galactosidase activity from the fused mbaH promoter remained high regardless of 
whether MbaS or MbaSCpentaA were included, and whether conditions were iron-limited or 
iron-replete. This strongly suggests there is no iron-regulation of MbaS. As a positive control 
for iron-dependent regulation of the sigma factors, it was decided to include OrbS and 






































an analagous way, but included pBBR2-orbSΔP or pBBR2-orbSCtetraA-ΔP, in combination with 
pKAGd4-PorbH-S, introduced into E. coli MC1061 by transformation. The experiment was 
performed a total of two times on two days. 
 
Figure 5.23. β-galactosidase assay of MbaS, MbaSCpentaA, OrbS and OrbSCtetraA upon their target 
promoters in E. coli MC1061 under iron-limited and iron-replete conditions. 
Results of β-galactosidase assay investigation iron-dependent regulation of MbaS and MbaSCpentaA 
upon an MbaS-dependent promoter, and OrbS and OrbSCtetraA upon an OrbS-dependent promoter. β-
galactosidase activity was measured in E. coli MC1061 harbouring (a) pKAGd4-PmbaH-S for MbaS and 
MbaSCpentaA or pKAGd4-PorbH-S for OrbS and OrbSCtetraA, and (b) pBBR2-mbaS, pBBR2-mbaSCpentaA, pBBR2-
orbSΔP or pBBR2-orbSCtetraA-ΔP as denoted below data bars. All β-galactosidase activities were corrected 
for background vector activity by subtraction of activity derived from E. coli MC1061 harbouring both 
plasmids pBBR2 and pKAGd4-PmbaH-S (for MbaS and MbaSCpentaA) or pKAGd4-PorbH-S (for OrbS and 
OrbSCtetraA). Growth medium was M9 minimal salts supplemented with 0.5% (w/v) glucose, 0.1% (w/v) 
casamino acids, 50 µg ml-1 chloramphenicol and 50 µg ml-1 kanamycin and either 100 µM 2,2-dipyridyl 
(iron-limited, light grey) or 50 µM FeCl3 (iron-replete, dark grey). Error bars show standard deviation 
(n=6). There is a significant difference between the activity of OrbS under iron-limited and iron-replete 













































Again, there appears to be no regulation of MbaS by iron. However, with OrbS there is a 
approximately 29% reduction in activity under iron-replete conditions compared to iron-
limited conditions (P<0.0001, one-way ANOVA, Sidak’s multiple comparisons test). The four 
cysteine residues of the CRE appear to be integral to this regulation mechanism, as there is 
no reduction of activity observed for OrbSCtetraA. 
 
5.7.2 Effect of iron availability upon MbaS and OrbS independently of Fur 
in E. coli QC1732 
Although it has been demonstrated that the pBBR1MCS-based plasmids containing the 
mbaS and orbS genes are not regulated by Fur (see section 5.5.4), it is possible that the Fur 
protein may still influence the results when performing β-galactosidase assays investigating 
the effect of iron in the E. coli fur+ strain MC1061. For instance, under iron-replete 
conditions, the Fur repressor may regulate chromosomal genes of the E. coli MC1061 host 
strain that could ultimately impact the β-galactosidase activity measured from the LacZα-
fused promoters cloned into pKAGd4. To overcome this potential issue, the β-galactosidase 
assays performed in section 5.7.1 were repeated in the E. coli fur- QC1732 strain. 
Additionally, to demonstrate the loss of Fur regulation in parallel, pKAGd4 containing the 
σ70-dependent, Fur-regulated, PmbaS was included. 
A combination of the plasmids pKAGd4, pKAGd4-PmbaS-L or pKAGd4-PmbaH-L and pBBR1MCS-5, 
pBBR5-mbaS or pBBR5-mbaSCpentaA were introduced into E. coli QC1732 by transformation. 
The β-galactosidase assay was performed in cells grown in M9 minimal salts medium 
supplemented with 0.5% (w/v) glucose, 0.1% (w/v) casamino acids, 100 µg ml-1 ampicillin 
and 50 µg ml-1 gentamicin, according to the protocol outlined in section 2.5.1. Iron-limited 
conditions were introduced by the addition of 100 µM 2,2-dipyridyl, and iron-replete 
conditions were introduced by the addition of 50 µM FeCl3. The experiment was performed 





Figure 5.24. β-galactosidase assay of MbaS and MbaSCpentaA upon PmbaS and PmbaH in E. coli QC1732 
under iron-limited and iron-replete conditions. 
Results of β-galactosidase assay investigation iron-dependent regulation of MbaS and MbaSCpentaA 
upon the PmbaS and PmbaH promoters. β-galactosidase activity was measured in E. coli QC1732 
harbouring (a) pBBR1MCS-5 (-), pBBR5-mbaS or pBBR5-mbaSCpentaA, and (b) pKAGd4 (-), pKAGd4-PmbaS-
L or pKAGd4-PmbaH-L, as denoted below data bars. All β-galactosidase activities were corrected for 
background vector activity by subtraction of activity derived from E. coli QC1732 harbouring both 
parental plasmids pBBR1MCS-5 and pKAGd4. Growth medium was M9 minimal salts supplemented 
with 0.5% (w/v) glucose, 0.1% (w/v) casamino acids, 100 µg ml-1 ampicillin and 50 µg ml-1 gentamicin 
and either 100 µM 2,2-dipyridyl (iron-limited, light grey) or 50 µM FeCl3 (iron-replete, dark grey). Error 
bars show SEM (n=6). There are no significant differences between the activities of the mbaS promoter 
or the activities of MbaS and MbaSCpentaA upon the mbaH promoter under iron-limited and iron-replete 
conditions (one-way ANOVA, F=0.58, P=0.63, Tukey’s multiple comparisons post-hoc test). 
 
As with the assay performed in E. coli MC1061, there is no iron-dependent inhibition effect 
upon MbaS. The β-galactosidase activity from the Fur-regulated σ70-dependent mbaS 
promoter remains high regardless of the iron conditions, confirming that there no Fur-
regulation is present in this system. 
As with E. coli MC1061 in section 5.7.1, OrbS and OrbSCtetraA were included as a positive 
control for Fur-independent iron regulation. The assay was performed in an analogous 
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PorbH-S, introduced into E. coli QC1732 by transformation. The experiment was performed a 
total of two times on two days. 
 
Figure 5.25. β-galactosidase assay of MbaS, MbaSCpentaA, OrbS and OrbSCtetraA upon their target 
promoters in E. coli QC1732 under iron-replete and iron-limited conditions. 
Results of β-galactosidase assay investigation iron-dependent regulation of MbaS and MbaSCpentaA 
upon an MbaS-dependent promoter, and OrbS and OrbSCtetraA upon an OrbS-dependent promoter. β-
galactosidase activity was measured in E. coli QC1732 harbouring (a) pKAGd4-PmbaH-S for MbaS and 
MbaSCpentaA or pKAGd4-PorbH-S for OrbS and OrbSCtetraA, and (b) pBBR5-mbaS, pBBR5-mbaSCpentaA, pBBR5-
orbSΔP or pBBR5-orbSCtetraA-ΔP as denoted below data bars. All β-galactosidase activities were corrected 
for background vector activity by subtraction of activity derived from E. coli QC1732 harbouring both 
plasmids pBBR1MCS-5 and pKAGd4-PmbaH-S (for MbaS and MbaSCpentaA) or pKAGd4-PorbH-S (for OrbS and 
OrbSCtetraA). Growth medium was M9 minimal salts supplemented with 0.5% (w/v) glucose, 0.1% (w/v) 
casamino acids, 50 µg ml-1 chloramphenicol and 50 µg ml-1 gentamicin and either 100 µM 2,2-dipyridyl 
(iron-limited, light grey) or 50 µM FeCl3 (iron-replete, dark grey). Error bars show standard deviation 
(n=6). There is a significant difference between the activity of OrbS under iron-limited and iron-replete 











































As previously observed, there appears to be no regulation of MbaS by iron. This remains the 
case regardless of whether E. coli MC1061, QC771 or QC1732 is used. However, OrbS 
displays an approximately 38% reduction in activity upon PorbH-S under iron-replete 
conditions compared to iron-limited conditions (P=0.0002, one-way ANOVA, Sidak’s multiple 
comparisons test). Further evidence is provided that this is due to the four cysteine residues 
of the CRE, as there is no reduction of activity observed for OrbSCtetraA. 
 
5.7.3 Effect of iron availability upon MbaS by transcription reporter 
analysis in B. thailandensis ∆mbaS 
The transcription reporter analyses from sections 5.7.1 and 5.7.2 were performed in 
heterologous E. coli systems. However, there may be factors present in Bth, which are not 
found in E. coli, that could be involved in the iron-dependent regulation of MbaS. Therefore, 
the β-galactosidase assays were also performed using a Bth host strain. Ideally, these assays 
would be performed in a Bth fur- strain to remove Fur-regulation of the chromosomal copy 
of MbaS. However, there were many difficulties in isolating a Bth E264 ∆fur mutant. Instead, 
the Fur-independent pBBR2-mbaS and pBBR2-mbaSCpentaA were utilised in a Bth E264 ∆mbaS 
host strain (to remove interference from chromosomally-encoded MbaS). However, this 
strain still possessed the Fur repressor, so PmbaS was assayed in parallel with PmbaH to 
examine the effect Fur-regulation may have on the system. 
A combination of pKAGd4, pKAGd4-PmbaS-L and pKAGd4-PmbaH-L were introduced into Bth 
E264 ∆mbaS by conjugation using E. coli S17-1 donor cells. Subsequently, either pBBR1MCS-
2, pBBR2-mbaS or pBBR2-mbaSCpentaA were introduced into these strains by conjugation, 
also using E. coli S17-1 donor cells. β-galactosidase assays were performed in M9 minimal 
salts medium supplemented with 0.5% (w/v) glucose, 0.1% (w/v) casamino acids, 50 µg ml-1 
chloramphenicol and 250 µg ml-1 kanamycin according to the protocol outlined in section 
2.5.1. Iron-limited conditions were introduced by the addition of 100 µM 2,2-dipyridyl, and 
iron-replete conditions were introduced by the addition of 50 µM FeCl3. The experiment 




Figure 5.26. β-galactosidase assay of MbaS and MbaSCpentaA upon PmbaS and PmbaH in B. thailandensis 
E264 ∆mbaS under iron-limited and iron-replete conditions. 
Results of β-galactosidase assay investigation iron-dependent regulation of MbaS and MbaSCpentaA 
upon the PmbaS and PmbaH promoters. β-galactosidase activity was measured in Bth E264 ∆mbaS 
harbouring (a) pBBR1MCS-2 (-), pBBR2-mbaS or pBBR2-mbaSCpentaA, and (b) pKAGd4 (-), pKAGd4-PmbaS-
L or pKAGd4-PmbaH-L, as denoted below data bars. All β-galactosidase activities were corrected for 
background vector activity by subtraction of activity derived from Bth E264 ∆mbaS harbouring both 
parental plasmids pBBR1MCS-2 and pKAGd4. Growth medium was M9 minimal salts supplemented 
with 0.5% (w/v) glucose, 0.1% (w/v) casamino acids, 50 µg ml-1 chloramphenicol and 250 µg ml-1 
kanamycin and either 100 µM 2,2-dipyridyl (iron-limited, light grey) or 50 µM FeCl3 (iron-replete, dark 
grey). Error bars show SEM (n=9). There is a significant difference between the activities of MbaS upon 
the mbaH promoter under iron-limited and iron-replete conditions (unpaired t-test, P=0.04), and no 
significant difference between the activities of MbaSCpentaA upon the mbaH promoter under iron-
limited and iron-replete conditions (unpaired t-test, P=0.40). 
 
In Figure 5.26, it can be observed that the Fur repressor is active in the Bth E264 ∆mbaS 
host. This is seen in the reduction of activity from the PmbaS promoter under iron-replete 
conditions compared to iron-limited conditions. However, it is unlikely that this has had an 
effect upon the expression of MbaS/MbaSCpentaA from pBBR1MCS-5, or their activity upon 
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or pBBR5-mbaSCpentaA does not display this magnitude of inhibition. A small, but significant, 
approximately 19% decrease in activity by MbaS upon PmbaH under iron-replete conditions 
compared to iron-limited conditions is observed (P=0.04, unpaired t-test). This inhibition is 
not observed in the parallel MbaSCpentaA system (P=0.40, unpaired t-test). This is the first 
indication that MbaS may respond to iron via its five cysteine residues present in its CRE. 
However, it should be noted that this inhibition effect is smaller than the effect seen with 
OrbS. 
 
5.7.4 Effect of iron upon MbaS and OrbS-regulated siderophore 
production in B. thailandensis ∆mbaS and B. cenocepacia ∆orbS 
grown on CAS agar 
In addition to the transcription reporter analyses in sections 5.7.1 to 5.7.3, Burkholderia 
strains were grown on CAS agar to investigate the effect of iron upon the regulation of 
MbaS and OrbS. Rather than judging the activity of the sigma factors via their target 
promoter expression, this in vivo method analysed the activity of the sigma factors via the 
production of siderophores. 
To examine the iron-regulation of MbaS, the plasmids pBBR1MCS-2, pBBR2-mbaS and 
pBBR2-mbaSCpentaA were each introduced into Bth E264 ∆mbaS by conjugation using E. coli 
S17-1 donor cells. Likewise, to examine the iron-regulation of OrbS, the plasmids 
pBBR1MCS-2, pBBR2-orbSΔP and pBBR2-orbSCtetraA-ΔP were each introduced into Bce H111 
∆orbS (A. Butt, unpublished) using E. coli S17-1 donor cells. Strains were grown overnight in 
M9 minimal medium containing 0.5% (w/v) glucose, 0.1% (w/v) casamino acids and either 
250 µg ml-1 kanamycin (for Bth) or 50 µg ml-1 kanamycin (for Bce). Cultures were normalised 
according to their OD600 and 1 μl spotted onto CAS agar containing either 10 μM FeCl3 or 60 
µM FeCl3 in quadruplicate (Figure 5.27 and Figure 5.28). The areas of the siderophore halos 




Figure 5.27. Comparison of Bth E264 ∆mbaS grown on iron-limited and iron-replete CAS medium 
supplied in trans with MbaS or MbaSCpentaA 
A. Bth E264 ΔmbaS containing either pBBR1MCS-2 (-), pBBR2-mbaS or pBBR2-mbaSCpentaA (indicated 
by white text above bacterial growth) grown on CAS agar plates supplemented with either 10 μM FeCl3 
(green plate, left) or 60 µM FeCl3 (blue plate, right). B. Calculated areas of siderophore halos produced. 






Figure 5.28. Comparison of Bce H111 ∆orbS grown on iron-limited or iron-replete CAS medium 
supplied in trans with OrbS or OrbSCtetraA 
A. Bce H111 ΔorbS containing either pBBR1MCS-2 (-), pBBR2-orbS or pBBR2-orbSCtetraA (indicated by 
white text above spotted culture) grown on CAS agar plates supplemented with either 10 μM FeCl3 
(green plate, left) or 60 µM FeCl3 (blue plate, right). B. Calculated areas of siderophore halos produced. 




In the Bth E264 ΔmbaS CAS assay (Figure 5.27), introduction of both MbaS and MbaSCpentaA 
complement the ΔmbaS gene deletion and initiate transcription of the malleobactin-
associated genes, as judged by the production of a large yellow halo surrounding the 
bacterial growth. The halo observed due to the production of malleobactin is similar for 
both the wild-type and mutant sigma factors. Additionally, this malleobactin-induced halo is 
slightly smaller when the cultures are grown on the 60 μM FeCl3 CAS agar, compared to 
when grown on 10 μM FeCl3 CAS agar. However, these halos are relatively large, indicating 
that there is no Fur-regulation of the plasmid-supplied sigma factor. Furthermore, 
regardless of whether they are grown in iron-limited or iron-replete medium, the relative 
size of the halos produced by cultures harbouring pBBR2-mbaS and pBBR2-mbaSCpentaA 
remains the same i.e. they both decrease in area by approximately 48% and 49%, 
respectively. This suggests that, although there is some non-specific iron regulation 
occurring, it is not specific to the regulation of MbaS via the cysteine residues of the CRE. 
Likewise, in the Bce H111 ΔorbS CAS assay (Figure 5.28), both OrbS and OrbSCtetraA can 
complement the Orb- phenotype and give rise to the production of ornibactin, observed 
through the production of a large yellow halo. Where no sigma factor has been supplied in 
trans, halos produced through the secretion of pyochelin can be observed (orange on CAS 
agar containing 10 μM FeCl3, violet on CAS agar containing 60 μM FeCl3). As with the Bth 
experiment, there appears to be a non-specific reduction of the production of siderophores 
on CAS agar containing 60 μM FeCl3 compared to 10 μM FeCl3. However, there is a larger 
reduction of the area of the yellow ornibactin halo when OrbS is introduced to the system 
(approximately 91%) compared to when OrbSCtetraA is introduced (approximately 70%). This 
provided further evidence that OrbS bears an iron regulation mechanism specific to the four 






5.8 Investigation of alternative metal ions 
upon regulation of MbaS and OrbS in vivo 
 
As there was no observable effect of iron upon the activity of MbaS compared to 
MbaSCpentaA in vivo, except the small effect seen in Bth E264 ∆mbaS, the inhibitory effect of 
alternative metal ions that could interact with the CRE were investigated. The biologically-
relevant metals copper (a cofactor of cytochrome c oxidase), zinc (a cofactor in RNA and 
DNA polymerases and many DNA-binding proteins), nickel (found in most hydrogenases), 
manganese (an activator of a range of enzymes) and cobalt (a cofactor of vitamin B12) were 
tested. As it was initially hypothesised that MbaS and OrbS interacted with Fe(II) via their 
CRE, the selected metals were assayed using ions with an oxidation state of 2+ i.e. Cu(II), 
Zn(II) etc. Again, transcription reporter analysis and growth on CAS agar was used to 
investigate the effect of these metals upon the activity of MbaS and OrbS compared to their 
cysteine-to-alanine substitution mutant forms. 
 
5.8.1 Effect of alternative metal ions upon MbaS by transcription reporter 
analysis in E. coli 
Using the same E. coli QC1732 strains used in section 5.7.2, a β-galactosidase assay was 
repeated using other biologically important transition metal ions. The metals copper, zinc, 
nickel, manganese and cobalt were selected. 50 µM of each of these metals was used in the 
β-galactosidase assay to parallel the concentration used for iron with the exception of 
copper: 10 µM was used as copper displays toxicity at higher concentrations (Mathew et al., 
2016). 
Firstly, the effect of the metal ions upon MbaS and MbaSCpentaA was investigated. The E. coli 
QC1732 strain harbouring pKAGd4-PmbaH-S and either pBBR1MCS-5, pBBR5-mbaS or pBBR5-
mbaSCpentaA, (see section 5.7.2) were used. β-galactosidase assays were performed in cells 
grown in M9 minimal salts medium supplemented with 0.5% (w/v) glucose, 0.1% (w/v) 
casamino acids, 100 µg ml-1 ampicillin and 50 µg ml-1 gentamicin according to the protocol 
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outlined in section 2.5.1. Metal-limited conditions were introduced by the addition of 100 
µM 2,2-dipyridyl, iron-replete conditions by the addition of 50 µM FeCl3, copper-replete 
conditions by the addition of 10 μM CuCl2, zinc-replete conditions by the addition of ZnCl2, 
nickel-replete conditions by the addition of 50 μM NiSO4, manganese-replete conditions by 
the addition of 50 μM MnCl2, and cobalt-replete conditions by the addition of 50 μM CoCl2. 
 
 
Figure 5.29. β-galactosidase assay of MbaS and MbaSCpentaA upon a target promoter in E. coli 
QC1732 with a selection of biologically-relevant metals. 
Results of β-galactosidase assay investigation metal-dependent regulation of MbaS and MbaSCpentaA 
upon an MbaS-dependent promoter. β-galactosidase activity was measured in E. coli QC1732 
harbouring pKAGd4-PmbaH-S and pBBR5-mbaS (light grey) or pBBR5-mbaSCpentaA (dark grey). All β-
galactosidase activities were corrected for background vector activity by subtraction of activity 
derived from E. coli QC1732 harbouring both plasmids pBBR1MCS-5 and pKAGd4-PmbaH-S. Growth 
medium was M9 minimal salts supplemented with 0.5% (w/v) glucose, 0.1% (w/v) casamino acids, 
25 µg ml-1 chloramphenicol and 50 µg ml-1 gentamicin and either 100 µM 2,2-dipyridyl (DP), 50 µM 
FeCl3 (Fe), 10 µM CuCl2 (Cu), 50 µM ZnCl2 (Zn), 50 µM NiSO4 (Ni), 50 µM MnCl2 (Mn) or 50 µM CoCl2 
(Co). Error bars show standard deviation (n=3). There are no significant differences between MbaS 
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Again, no iron-dependent regulation of MbaS was demonstrated in this analysis. Moreover, 
it appears none of the other metals assayed exhibit any regulatory activity upon MbaS. The 
β-galactosidase activities for cultures grown in 50 μM CoCl2 display lower activity than for 
the other metals, but this is observed in both the addition of MbaS and MbaSCpentaA. 
Therefore, it is likely that this is a non-specific effect, possibly a result of cobalt toxicity upon 
the E. coli cells. 
 
5.8.2 Effect of alternative metal ions upon MbaS by transcription reporter 
analysis in B. thailandensis ∆mbaS 
Although no metal regulation upon MbaS could be observed in the heterologous E. coli 
QC1732 system, the β-galactosidase assay was repeated in the Bth E264 ΔmbaS system. 
Given that a small iron-inhibition effect was observed in this system previously (Figure 5.26), 
it could be that regulation by other metal ions may also be observed. 
The assay was performed using the same Bth E264 ΔmbaS strains from section 5.7.3, 
harbouring pKAGd4-PmbaH-S and either pBBR1MCS-5, pBBR5-mbaS or pBBR5-mbaSCpentaA. 
Bacterial cultures were grown in analogous conditions as in section 5.8.1, with the exception 
of the antibiotics used: the medium was supplemented with 50 μg ml-1 chloramphenicol and 




Figure 5.30. β-galactosidase assay of MbaS and MbaSCpentaA upon a target promoter in B. 
thailandensis E264 ∆mbaS with a selection of biologically-relevant metals. 
Results of β-galactosidase assay investigation metal-dependent regulation of MbaS and MbaSCpentaA 
upon an MbaS-dependent promoter. β-galactosidase activity was measured in B. thailandensis E264 
∆mbaS harbouring pKAGd4-PmbaH-S and pBBR5-mbaS (light grey) or pBBR5-mbaSCpentaA (dark grey). All 
β-galactosidase activities were corrected for background vector activity by subtraction of activity 
derived from B. thailandensis E264 ∆mbaS harbouring both plasmids pBBR1MCS-5 and pKAGd4-
PmbaH-S. Growth medium was M9 minimal salts medium supplemented with 0.5% (w/v) glucose, 0.1% 
(w/v) casamino acids, 50 µg ml-1 chloramphenicol and 250 µg ml-1 kanamycin and either 100 µM 2,2-
dipyridyl (DP), 50 µM FeCl3 (Fe), 10 µM CuCl2 (Cu), 50 µM ZnCl2 (Zn), 50 µM NiSO4 (Ni), 50 µM MnCl2 
(Mn) or 50 µM CoCl2 (Co). Error bars show standard deviation (n=3). There are no significant 
differences between MbaS and MbaSCpentaA under each metal condition (one-way ANOVA, Sidak’s 
multiple comparisons test). 
 
However, again it can be observed that there are no significant differences between the β-
galactosidase activities resulting from the addition of MbaS or MbaSCpentaA in the presence of 
metal ions. It appears none of the selected metals exhibit an inhibition effect upon MbaS 
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5.8.3 Effect of alternative metal ions upon OrbS by transcription reporter 
analysis in E. coli 
Although an iron inhibition effect has been demonstrated upon OrbS, the effect of 
alternative metals ions was also assayed. The assay was performed using the E. coli QC1732 
strains used in section 5.7.2, harbouring pKAGd4-PorbH-S and either pBBR1MCS-5, pBBR5-
orbSΔP or pBBR5-orbSCtetraA-ΔP. The β-galactosidase assay was performed in an analogous 
manner as described in section 5.8.1. 
 
Figure 5.31. β-galactosidase assay of OrbS and OrbSCtetraA upon a target promoter in E. coli QC1732 
with a selection of biologically-relevant metals. 
Results of β-galactosidase assay investigation metal-dependent regulation of OrbS and OrbSCtetraA 
upon an OrbS-dependent promoter. β-galactosidase activity was measured in E. coli QC1732 
harbouring pKAGd4-PorbH-S and pBBR5-orbSΔP (light grey) or pBBR5-orbSCtetraA-ΔP (dark grey). All β-
galactosidase activities were corrected for background vector activity by subtraction of activity 
derived from E. coli QC1732 harbouring both plasmids pBBR1MCS-5 and pKAGd4-PorbH-S. Growth 
medium was M9 minimal salts medium supplemented with 0.5% (w/v) glucose, 0.1% (w/v) casamino 
acids, 25 µg ml-1 chloramphenicol and 50 µg ml-1 gentamicin and either 100 µM 2,2-dipyridyl (DP), 50 
µM FeCl3 (Fe), 10 µM CuCl2 (Cu), 50 µM ZnCl2 (Zn), 50 µM NiSO4 (Ni), 50 µM MnCl2 (Mn) or 50 µM 
CoCl2 (Co). Error bars show standard deviation (n=3). There are significant differences between the 
activities of OrbS and OrbSCtetraA under iron-replete conditions (P=0.0002), copper-replete conditions 
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As previously observed, there is a significant difference in the β-galactosidase activities 
resulting from the activity of OrbS and OrbSCtetraA in the presence of iron (P=0.0002). In 
addition, there appears to be differences in these activities in the presence of copper and 
zinc, too (P=0.0044 and P<0.0001, respectively, one-way ANOVA, Sidak’s multiple 
comparisons test). There are no differences in these β-galactosidase activities in the 
presence of nickel, manganese, or cobalt (again, a non-specific reduction of β-galactosidase 
activity in the presence of cobalt is observed). This data suggests that in addition to Fe(II), 
both Cu(II) and Zn(II) ions could interact with the putative key cysteine residues of the CRE 
to regulate the activity of OrbS. 
 
5.8.4 Effect of alternative metal ions upon OrbS by transcription reporter 
analysis in B. cenocepacia ∆orbS 
To explore the effect of metal ions upon OrbS further, the β-galactosidase assay was 
repeated in the Bce H111 ΔorbS system. The assay was performed using the same Bce H111 
ΔorbS harbouring pKAGd4-PorbH-S and either pBBR1MCS-2, pBBR2-orbSΔP or pBBR2-
mbaSCtetraA-ΔP, introduced by sequential conjugation using E.coli S17-1 donor cells. Bacterial 
cultures were grown in analogous conditions as in section 5.8.1, with the exception of the 






Figure 5.32. β-galactosidase assay of OrbS and OrbSCtetraA upon a target promoter in B. cenocepacia 
E264 ∆orbS with a selection of biologically-relevant metals. 
Results of β-galactosidase assay investigation metal-dependent regulation of OrbS and OrbSCtetraA 
upon an OrbS-dependent promoter. β-galactosidase activity was measured in B. cenocepacia H111 
∆orbS harbouring pKAGd4-PorbH-S and pBBR2-orbSΔP (light grey) or pBBR2-orbSCtetraA-ΔP (dark grey). All 
β-galactosidase activities were corrected for background vector activity by subtraction of activity 
derived from B. cenocepacia H111 ∆orbS harbouring both plasmids pBBR1MCS-2 and pKAGd4-PorbH-S. 
Growth medium was M9 minimal salts medium supplemented with 0.5% (w/v) glucose, 0.1% (w/v) 
casamino acids, 50 µg ml-1 chloramphenicol and 250 µg ml-1 kanamycin and either 100 µM 2,2-
dipyridyl (DP), 50 µM FeCl3 (Fe), 10 µM CuCl2 (Cu), 50 µM ZnCl2 (Zn), 50 µM NiSO4 (Ni), 50 µM MnCl2 
(Mn) or 50 µM CoCl2 (Co). Error bars show standard deviation (n=3). There are significant differences 
between the activities of OrbS and OrbSCtetraA under iron-replete conditions (P<0.0001), copper-
replete conditions (P=0.0012) and zinc-replete conditions (P=0.0033) (one-way ANOVA, Sidak’s 
multiple comparisons test). 
 
As was observed in E. coli, there are significant differences in the β-galactosidase activities 
from the orbH promoter between when OrbS or OrbSCtetraA are supplied in trans in the 
presence of iron (P<0.0001), copper (P=0.0012) and zinc (P=0.0033, one-way ANOVA, Sidak’s 
multiple comparisons test). There are no differences in the presence of nickel, manganese 
or cobalt. This corroborates the finding that Fe(II), Cu(II) and Zn(II) may interact with and 
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5.8.5 Effect of alternative metal ions upon siderophore production in B. 
thailandensis ∆mbaS and B. cenocepacia ∆orbS grown on CAS agar 
As a further attempt to assay the regulatory effect of metal ions upon the sigma factors 
MbaS and OrbS, specific to their CREs, selected Bth and Bce cultures were grown in CAS agar 
supplemented with different metal ions. Different CAS agar recipes have been used to 
demonstrate the production of siderophore analogues that chelate non-iron metal ions, for 
example the copper-binding chalkophores produced by several methanotroph species (Yoon 
et al., 2010). However, CAS agar was desired that contained alternative metal ions (to 
analyse their effect upon the regulation of siderophore production) in addition to iron (to 
colormetrically identify and quantify siderophore production). No research literature could 
be found that described such CAS medium, therefore it was unclear whether this dual-metal 
CAS agar would be viable. 
Overnight cultures of Bth E264 ∆mbaS harbouring pBBR2-mbaS or pBBR2-mbaSCpentaA, and 
cultures of Bce H111 ∆orbS harbouring pBBR2-orbSΔP or pBBR2-orbSCtetraA-ΔP, were grown in 
M9 minimal medium supplemented with 0.5% (w/v) glucose and 250 μg ml-1 (for Bth) or 50 
μg ml-1 (for Bce) kanamycin. Cultures were normalised according to their OD600 and 1 μl 
spotted, in triplicate, onto CAS agar containing either 10 μM FeCl3, 60 µM FeCl3, 10 μM FeCl3 
and 50 µM ZnCl2, 10 μM FeCl3 and 10 µM CuCl2, 10 μM FeCl3 and 50 µM NiSO4, and 10 μM 
FeCl3 and 50 µM MnCl2. Cultures were grown at 37 oC for 24 hours. Burkholderia cultures 
were also attempted to be grown on CAS agar containing 10 μM FeCl3 and 50 µM CoCl2, but 




Figure 5.33. Comparison of Bth E264 ∆mbaS, supplied in trans with MbaS or MbaSCpentaA, and Bce H111 ∆orbS, supplied in trans with OrbS or OrbSCtetraA, 
grown on iron-limited CAS medium further supplemented with iron, zinc, copper, nickel and manganese. 
Bth and Bce grown on CAS agar plates supplemented with 10 μM FeCl3 (-) in addition to a further 50 µM FeCl3 (Fe(III)), 50 µM ZnCl2 (Zn(II)), 10 µM CuCl2 
(Cu(II)), 50 µM NiSO4 (Ni(II)) or 50 µM MnCl2 (Mn(II)), denoted at the top left of each plate image. The Burkholderia cultures were as follows: A: Bth E264 
∆mbaS/pBBR1MCS-2; B: Bth E264 ∆mbaS/pBBR2-mbaSCpentaA; C: Bth E264 ∆mbaS/pBBR2-mbaS; D: Bce H111 ∆orbS/pBBR1MCS-2; E: Bce H111 ∆orbS/pBBR2-
orbSCtetraA-ΔP; F: Bce H111 ∆orbS/pBBR2-orbSΔP. Cultures were grown at 37 oC for 24 hours (n=4).
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On all of the dual-metal CAS agar used in Figure 5.33, halos resulting from the removal of 
Fe(III) from CAS-HDTMA can be observed. In all cases, it is likely that this results from the 
secretion of the siderophores malleobactin and ornibactin. On CAS agar containing 60 µM 
FeCl3, an inhibition of ornibactin production initiated by OrbS, but not OrbSCtetraA, is 
observed (similar to as seen in Figure 5.28). Based upon the results of Figure 5.31 and Figure 
5.32, it could also be expected that a similar pattern of ornibactin regulation would be 
observed for CAS agar containing 10 µM FeCl3 and 50 µM ZnCl2, and 10 µM FeCl3 and 10 µM 
CuCl2. However, this is not the case; the Bce H111 ∆orbS cultures produce similar sized halos 
on all of the dual-metal CAS media, relative to those observed on CAS agar containing only 
10 µM FeCl3. This is also the case for all of the Bth E264 ∆mbaS cultures grown on these CAS 
media. 
 
5.9 Investigation of metal-dependent 
regulation of MbaS and OrbS in vitro 
 
Following on from in vivo data investigating the effect of metal regulation upon MbaS and 
OrbS, in vitro methods were also employed to analyse the influence of Fe(II) and Zn(II) upon 
the activity of MbaS and OrbS, and their association with core RNAP. The recombinant 
proteins MbaS, MbaSCpentaA, OrbS and OrbSCtetraA (produced and purified using the methods 
described in sections 2.4.1 to 2.4.3, and shown in sections 5.3.2 and 5.6.3) were used in 
these experiments. A combination of in vitro transcription (ivT) assays (see section 2.6.1), 
examining the RNA synthesis performed by core RNAP is association with the Burkholderia 
sigma factors, and bio layer interferometry (BLI) (see section 2.6.2), examining the binding 





5.9.1 Determination of optimum Fe(II) concentration to be used in in vitro 
transcription 
Preliminary experiments examining the effect of Fe(II) on the association of E. coli core 
RNAP with the heterologous Burkholderia sigma factors presented the issue of non-specific 
iron-inhibition. Therefore, it was necessary to determine the optimum concentration of 
Fe(II) to use. This would be the highest concentration at which there is no non-specific 
inhibition effect upon the transcription reaction. To do this, E. coli holo RNAP (NEB) 
(comprising E. coli σ70) was used in conjunction with pRLG770-PguaB containing the σ70-
dependent guaB promoter. The synthesis of RNA was examined by performing the ivT assay 
in the presence of different concentrations of Fe(NH4)(SO4) (Figure 5.34). 
 
Figure 5.34. in vitro transcription assay to determine the optimum concentration of Fe(NH4)2(SO4)2. 
RNA transcripts were resolved in a 5.5% acrylamide, 7 M urea gel following an in vitro transcription 
assay. RNA transcripts were synthesised by E. coli holo σ70 RNA polymerase (NEB). The location of the 
RNA transcript originating from the cloned guaB promoter (186 nt) and from the replicon-derived 
RNAI transcript (108 nt) is indicated to the left of the image. The concentrations of Fe(NH4)2(SO4)2 in 
the the transcription reaction is denoted above the image.  
 
From this data, it can be concluded that the efficiency of the transcription reactions 
decreases in the presence of higher concentrations of Fe(NH4)2(SO4)2. This appears to take 
effect at concentrations from 15 µM onwards. Therefore, it was decided to use 10 µM 






5.9.2 Effect of Fe(II) upon MbaS and OrbS in in vitro transcription 
The influence of Fe(II) upon the RNA transcription achieved by E. coli core RNAP in 
association with the Burkholderia sigma factors, upon their target promoters, was 
investigated. Transcription reactions were prepared containing (a) E. coli core RNAP, (b) 
MbaS, MbaSCpentaA, OrbS or OrbSCtetraA, and (c) pRLG770-PmbaH (for MbaS/MbaSCpentaA) or 
pRLG770-PorbHds6 (for OrbS/OrbSCtetraA). Reactions contained either 0 µM or 10 µM 
Fe(NH4)2(SO4)2. This ivT assays was performed in duplicate (Figure 5.35). 
The amount of RNA transcribed by core RNAP in association with MbaSCpentaA and OrbSCtetraA 
remains the same, regardless of the addition of Fe(II) (P=0.17 and P=0.88, respectively, one-
way ANOVA, Sidak’s multiple comparisons test). In the presence of 10 µM Fe(II), there is a 
statistically significant approximately 61% decrease in the amount of RNA produced by 
RNAP in association with MbaS (P=0.02), and a non-statistically significant approximately 
85% decrease in the amount of RNA produced by RNAP in association with OrbS (P=0.07, 
one-way ANOVA, Sidak’s multiple comparisons test). It appears Fe(II) may have a specific 
effect, via the cysteine residues of their respective CREs, upon the activity of MbaS and OrbS 





Figure 5.35. in vitro transcription assay examining the effect of 10 µM Fe(NH4)2(SO4)2 upon 
transcription initiated by MbaS, MbaSCpentaA, OrbS and OrbSCtetraA in association with core RNA 
polymerase. 
A. RNA transcripts were resolved in a 5.5% acrylamide, 7 M urea gel following an in vitro transcription 
assay. E. coli core RNA polymerase (NEB), in association with either MbaS, MbaSCpentaA, OrbS or 
OrbSCtetreA (denoted below gel image) was used to synthesise 156 nt RNA from a DNA fragments 
containing promoters PmbaH (for MbaS and MbaSCpentaA) or PorbH (for OrbS and OrbSCtetraA) cloned into 
pRLG770. The reaction was performed in the absence (-) or in the presence (+) of 10 µM Fe(NH4)2(SO4)2 
(denoted above the gel image). B. Quantification RNA transcripts from the in vitro transcription assays. 
The sigma factors used in the reactions are denoted below data bars. Reactions were performed in 
the presence of 0 µM Fe(NH4)2(SO4)2 (light grey) or 10 µM Fe(NH4)2(SO4)2 (dark grey). Error bars show 
standard deviation (n=2). P value results from one-way ANOVA, Sidak’s multiple comparisons test, are 
shown above corresponding pairs of data bars. 
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5.9.3 Effect of Zn(II) upon MbaS and OrbS in in vitro transcription 
In an analogous method as was performed in section 5.9.2, the influence of Zn(II) upon the 
RNA transcription achieved by E. coli core RNAP in association with the Burkholderia sigma 
factors was investigated. Preliminary experiments using MbaS and MbaSCpentaA suggested 
that there was no non-specific inhibition effect of Zn(II) upon the transcription reaction. 
Therefore, a concentration of 25 µM ZnCl2 was selected to be used in these ivT assays (to be 
consistent with metal concentrations used in BLI, see section 5.9.4). The experiment was 
performed identically to those in section 5.9.2, with the exception that reactions contained 
either 0 µM or 25 µM ZnCl2. The ivT assay was performed in triplicate. Although, these 
assays displayed qualitative consistency, 32P-UTP decay resulted in large quantitative 
discrepancies between data sets. Therefore, only one set of data is presented (Figure 5.36). 
There appears to be a large decrease in the amount of RNA transcribed by core RNAP in 
association with MbaS in the presence of zinc (72%), whereas there is only a small decrease 
when core RNAP is in association with MbaSCpentaA in the presence of zinc (25%). In the 
transcription reactions containing OrbS or OrbSCtetraA, there appears to be a non-specific 
inhibition of transcription in the presence of zinc which masks any specific inhibition of the 
sigma factors. Nonetheless, the reduction in RNA synthesis by core RNAP in the presence of 
zinc is greater when the enzyme is in association with OrbS (99.5%) than it is for in 
association with OrbSCtetraA (93.8%). This data requires much greater statistical power, yet 






Figure 5.36. in vitro transcription assay examining the effect of 25 µM ZnCl2 upon transcription 
initiated by MbaS, MbaSCpentaA, OrbS and OrbSCtetraA in association with core RNA polymerase. 
A. RNA transcripts were resolved in a 5.5% acrylamide, 7 M urea gel following an in vitro transcription 
assay. E. coli core RNA polymerase (NEB), in association with either MbaS, MbaSCpentaA, OrbS or 
OrbSCtetreA (denoted below gel image) was used to synthesise 156 nt RNA from a DNA fragment 
containing the promoters PmbaH (for MbaS and MbaSCpentaA) or PorbH (for OrbS and OrbSCtetraA) cloned 
into pRLG770. The reaction was performed in the absence (-) or in the presence (+) of 25 µM ZnCl2 
(denoted above the gel image). B. Quantification RNA transcripts from the in vitro transcription assays. 
The sigma factors used in the reactions are denoted below data bars. Reactions were performed in 




5.9.4 Effect of selected metals upon the binding affinity of core RNAP for 
MbaS and OrbS 
In the putative metal-responsive regulatory mechanism for MbaS and OrbS, it has been 
hypothesised that the sigma factors are inhibited by interaction with metal ions via the 
cysteine residues within their CRE. This could regulate the activity of the sigma factor either 
by (a) inhibiting the association of the sigma factor with core RNAP, or (b) by inhibiting the 
interaction of the sigma factor with its target promoter. Previous work using EMSAs (A. Butt, 
unpublished) has suggested that it may be the former mechanism. Therefore, the effect of 
metals upon the association of the Burkholderia sigma factors and E. coli core RNAP 
polymerase was investigated using bio layer interferometry (BLI). 
BLI provides binding kinetics data about protein-protein interactions, enabling 
quantification of the interaction between a sigma factor and core RNAP. This binding 
interaction was compared in the presence of the metal ions FeCl2, CuCl2, ZnCl2 and MnCl2. 
The assays were performed according to the protocol outlined in section 2.6.2, and a 
representative examples using real data (for the interaction between MbaS and core RNAP 
in the presence of 25 µM Mn(II)) is presented in Figure 5.37. Optimisation and development 
of the assays was performed by Dr. Srdjan (Guta) Vitovski, whom also obtained the data for 
the association of OrbS with core RNAP in the absence of metal, the presence of Fe(II), Cu(II) 
and Zn(II), and of OrbSCtetraA with core RNAP in the absence of metal, the presence of Fe(II) 
and Zn(II). All of the binding affinities of the ECF sigma factors MbaS, MbaSCpentaA, OrbS and 
OrbSCtetraA for core RNAP in the absence of metal ions, or in the presence of 25 µM Fe(II), 
Cu(II), Zn(II) or Mn(II), are shown in Table 5.2. 
All four of the Burkholderia sigma factors display a strong binding affinity, in the nanomolar 
range, for core RNAP in the absence of metal. There is some variation in the binding affinity 
between sigma factors, and in the presence of different metal ions. Based upon the data 
presented, a subjectively significant change in the binding affinity was judged to have 
occurred in cases where the relative fold decrease in binding affinity is greater than two 
orders of magnitude i.e. a 100-fold change or higher. 
For MbaS and MbaSCpentaA, the presence of Fe(II), Cu(II) or Mn(II) ions has no large scale 
effect on the binding of the sigma factors to core RNAP. However, when Zn(II) is present, 
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MbaS displays a 77,544-fold decrease in binding affinity for core RNAP, whereas MbaSCpentaA 
displays only a 2-fold decrease. This strongly suggests that Zn(II) is able to inhibit the 
interaction of MbaS and core RNAP via the C-terminal cysteine residues. 
For OrbS and OrbSCtetraA, both the presence of Fe(II) ions and Zn(II) ions exhibit 435-fold and 
934-fold decreases in binding affinity for core RNAP, respectively. This large decrease in 
binding affinity is not observed for OrbSCtetraA under identical conditions. Additionally, the 
presence of Cu(II) and Mn(II) does not appear to significantly affect the binding of either 




Figure 5.37. Representative example of binding kinetics data for a bio layer interferometry experiment using core RNAP and MbaS. 
Time course of BLI experiment investigating the binding affinity (KD) of ECF sigma factors for core RNA polymerase in the presence of different metal ions. For 
the determination of the KD for each protein-protein interaction in the presence of metal ions, six concentrations of core RNAP were used (right). The numbers 
in grey boxes are positioned above the distinct steps of the BLI assay, corresponding to those described in Table 2.16. ECF sigma factor is loaded upon the 
biosensor to form a bio layer in step 3, core RNAP associates to the bio layer in step 6, and core RNAP dissociates from the bio layer in step 7. The association 


































Table 5.2 Binding affinity of ECF sigma factors for core RNA polymerase in the presence of different metal ions. 
 Sigma factor 
 MbaS MbaSCpentaA OrbS OrbSCtetraA 
Metal KD (M) Kd (s-1)/ 
Ka (M-1 s-1) 
Fold 
change[1] 
KD (M) Kd (s-1)/ 
Ka (M-1 s-1) 
Fold 
change[1] 
KD (M) Kd (s-1)/ 
Ka (M-1 s-1) 
Fold 
change[1] 
KD (M) Kd (s-1)/ 
Ka (M-1 s-1) 
Fold 
change[1] 
None 1.71 ×10-8 2.98 ×10-4/ 
1.74 ×104 
 1.97 ×10-8 7.54 ×10-4/ 
3.82 ×104 
 8.38 ×10-8 4.50 ×10-4/ 
5.37 ×103 
 1.96 ×10-8 3.02 ×10-4/ 
1.54 ×104 
 
Fe(II) 1.58 ×10-7 1.47 ×10-3/ 
9.28 ×103 
9 4.28 ×10-8 7.23 ×10-4/ 
1.69 ×104 
2 3.65 ×10-5 2.43 ×10-4/ 
6.67 ×100 
435 8.40 ×10-8 7.64 ×10-4/ 
9.09 ×103 
4 
Cu(II) 1.56 ×10-7 1.37 ×10-3/ 
8.79 ×103 
9 4.41 ×10-7 5.40 ×10-3/ 
1.23 ×104 




1 1.18 10-7 8.83 ×10-4/ 
7.04 ×103 
6 
Zn(II) 1.33 ×10-3 1.33 ×10-2/ 
1.00 ×101 
77,544 3.39 ×10-8 4.74 ×10-3/ 
1.40 ×105 
2 7.82 ×10-5 3.02 ×10-4/ 
3.86 ×100 
934 2.98 ×10-8 4.67 ×10-4/ 
1.57 ×104 
2 
Mn(II) 7.82 ×10-8 6.94 ×10-4/ 
8.87 ×103 
5 2.65 ×10-7 4.38 ×10-3/ 
1.65 ×104 




1 8.76 ×10-8 5.29 ×10-4/ 
6.04 ×103 
4 
[1] The relative fold decrease in the binding of each sigma factor to E. coli RNAP in the presence of each metal, to the nearest integer, is calculated as the 
ratio of the KD value in the presence of the metal to the KD in the absence of metal. 
[2] Note that these values were measured using a different protein preparation of OrbS than other values. 





In this chapter, it has been empirically demonstrated that MbaS is a sigma factor. This has 
been shown through its capacity to stimulate transcription from target gene promoters in 
promoter reporter assays and in vitro transcription assays in the presence of core RNAP. 
Additionally, the association of MbaS and core RNAP has been demonstrated by bio layer 
interferometry, and a binding affinity for this association has been determined. Although 
the designation of MbaS as an ECF sigma factor has been established for some time (Alice et 
al., 2006), this study presents the first empirical demonstration of this. 
Furthermore, the target promoters of MbaS have been formally identified. Again, based 
upon homology with the orb gene cluster and RNase protection assays of MbaS-regulated 
genes, the PmbaH and PmbaE promoters were assumed to be transcribed in an MbaS-
dependent manner. A 562 bp DNA region containing the PmbaI promoter DNA was shown to 
be activated in an MbaS-dependent manner by an in vivo promoter reporter assay (Alice et 
al., 2006). Through further in vivo promoter reporter assays presented in this study, this has 
been empirically demonstrated for all three promoters. Moreover, these promoters have 
been identied with precision to a 49 bp DNA region. It is very likely that the core promoter 
elements are present within this region, and that they correspond to those precisely 
identified in the orbH promoter (see Figure 5.2) (Agnoli et al., 2018). 
The mbaS promoter has also been characterised to a greater degree. Through in vivo 
promoter reporter assays, it has been established that activity from the mbaS promoter 
does not increase in the presence of MbaS, and therefore it can be concluded MbaS does 
not autoregulate its own promoter. It is highly likely that the mbaS promoter is regulated in 
a σ70-dependent manner, although this has not been demonstrated unequivocally. Previous 
work identified that transcription of mbaS was downregulated under high-iron conditions, 
likely due to a Fur box sequence identified in silico in a DNA region upstream of the 
translation start codon (Alice et al., 2006). It was also reported that this was demonstrated 
by FURTA (although the data was not shown and the length of DNA assayed was not 
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specified). Using FURTA, this study has limited the location of the Fur box to an 186 bp DNA 
of region. Nonetheless, this could be identified with greater precision in the future. 
Cross-activity between MbaS and OrbS has also been demonstrated. Due to the homology 
between the two IS sigma factors, it was likely that they would recognise target promoters 
of a similar sequence. MbaS was shown to stimulate transcription from the orbH promoter, 
and OrbS shown to stimulate transcription from the mbaH promoter. This cross-activity is 
unlikely to occur in nature, but it demonstrates that these two sigma factors likely possess 
highly similar mechanisms of DNA binding. 
Evidence has been presented that supports the hypothesis that MbaS and OrbS possess on-
board metal-responsive regulatory domains. A series of methods were developed and 
employed to investigate the influence that the presence of metal ions had on MbaS and 
OrbS activity upon dependent promoters, and upon association with core RNAP. Through 
comparison with the cysteine-to-alanine substitution mutants MbaSCpentaA and OrbSCtetraA, 
the dependency of the conserved cysteine residues of the CRE upon this metal regulation 
could be inferred.  
In in vivo promoter reporter analyses, inhibition of the activity of OrbS could be observed in 
the presence of 50 μM iron chloride, copper chloride and zinc chloride. The presence of 10 
μM Fe(II) and 25 μM Zn(II) was also demonstrated to inhibit the OrbS-dependent 
transcription of a target promoter in vitro. Finally, the presence of 25 μM Fe(II) and Zn(II) 
decreased the binding affinity of core RNAP and OrbS by 435-fold and 934-fold, respectively. 
This strongly suggests that OrbS is able to respond to the presence of Fe(II), Zn(II), and 
possibly Cu(II) ions. In the same experiments performed upon MbaS in vivo, the presence of 
the selected metal showed no effect upon the activity of MbaS upon its target promoter. 
However, in vitro transcription assays demonstrated that presence of 25 μM Zn(II) and 10 
μM Fe(II) resulted in reduced MbaS-dependent transcription from a target promoter, and 
presence of 25 μM Zn(II) decreased the binding affinity between MbaS and core RNAP 
77,544-fold. This suggests that MbaS is able to respond to the presence of Zn(II), and 
possibly Fe(II) ions. 
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Importantly, these metal inhibition effects were not observed to occur to the same degree 
upon the activity of MbaSCpentaA OrbSCtetraA. Therefore, it is highly likely that this influence 
the metal ions exhibit upon the sigma factor activity and association with core RNAP occurs 
via the thiol groups of some or all of the conserved cysteine residues of the CREs present in 
both OrbS and MbaS. Nonetheless, direct binding of iron to these sigma factors has not 
been demonstrated. 
It is unclear why, despite displaying a strong inhibitory effect upon the association of MbaS 
and core RNAP in vitro, presence of Zn(II) does not demonstrate this inhibition of MbaS 
activity in in vivo promoter reporter analyses. It could possibly be due that the intracellular 
concentration of zinc is very low, and MbaS does not sense or interact with Zn(II). Also, the 
effect of six common metals found in biology were investigated. However, it cannot be 
discounted that additional metals, or other moieties, could regulate the activity of MbaS 




















Characterisation of B. 





BCAM0001 is a putative uncharacterised ECF13 group sigma factor. The gene annotated as 
BCAM0001 is located upstream of a gene annotated as BCAM0001a, encoding a putative 
anti-sigma factor. These genes overlap by 25 bp, suggesting that they are co-transcribed. 
No work has previously been performed upon this sigma factor system, and therefore it was 
important to demonstrate that BCAM0001 displays sigma factor activity. It is unclear what 
genes could be regulated by BCAM0001 are, or what their function is. However, most ECF 
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sigma factors act upon the own promoter, so BCAM0001 was predicted to stimulate 
expression of its own promoter. Additionally, ECF sigma factors are often located in 
proximity to the genes that they regulate (Figure 6.1). Therefore, the neighbouring genes 
annotated as BCAM2840 and BCAM0002 were predicted to be to be transcribed from 
BCAM0001-dependent promoters. 
 
Figure 6.1. Schematic representation of the DNA region around BCAM0001. 
Genes are shown as block arrows, and are annotated above with their gene annotation and below 
with their protein homologies and/or predicted functions. Genes are as follows: BCAM2839 (blue), 
hybrid sensor histidine kinase/ response regulator; BCAM2840 (orange), NAD(P)H reductase and/or 
chromate reductase; BCAM0001 (pink), RNA polymerase ECF sigma factor; BCAM0001a (green), zinc-
finger domain containing anti-sigma factor; BCAM0002 (orange), arsenate reductase; BCAM0003 
(blue), AAA family ATPase and/or ParA-like protein. Genes predicted to be regulated by BCAM0001 




 To demonstrate a protein-protein interaction between BCAM0001 and BCAM0001a 
 To introduce gene deletions of BCAM0001 and BCAM0001a in Bce H111 and 
characterise the mutant phenotypes 
 To demonstrate that BCAM0001 has sigma factor activity, identify the BCAM0001-




6.2 Investigating the protein-protein 
interaction between BCAM0001 and 
BCAM0001a 
 
The protein-protein interaction between the ECF sigma factor BCAM0001 and its anti-sigma 
factor BCAM0001a was analysed in vivo using the bacterial adenylate cyclase two-hybrid 
assay (more detail in section 2.6.3). This was performed to investigate the protein-protein 
interaction between the anti-sigma factor and the full-length sigma factor, and additionally 
the individual sigma domains domain 2 and domain 4. Furthermore, the self-interaction of 
the anti-sigma factor BCAM0001a was investigated. 
 
6.2.1 Construction of BACTH assay plasmids 
The ECF sigma factor gene BCAM0001 was amplified by PCR using the primers BACTH-
BCAM1-Fwd and BACTH-BCAM1-Rev to produce a 617 bp product (Figure 6.2a). This was 
cloned between the Acc65I and XbaI restriction sites of the MCS of all four BACTH assay 
plasmids to give adenylate cyclase domain protein fusions resulting from the plasmids 
pUT18-BCAM0001, pUT18C-BCAM0001, pKT25-BCAM0001 and pKNT25-BCAM0001 (Figure 
6.2b). The identity of the plasmids was verified by PCR screening and DNA sequencing 
analysis with the primers M13revBACTH and BACTH-BCAM1-rev. 
The N-terminus of BCAM0001, from Pro2-Thr82 and comprising the σ2 domain, was 
amplified by PCR using the primers BACTH-BCAM1-Fwd and BACTH-BCAM1r2-Rev to 
produce a 266 bp product (Figure 6.3a). This was cloned between the Acc65I and XbaI 
restriction sites of the MCS of all four BACTH assay plasmids to give adenylate cyclase 
domain protein fusions resulting in the plasmids pUT18-BCAM0001σ2, pUT18C-
BCAM0001σ2, pKT25-BCAM0001σ2 and pKNT25-BCAM0001σ2 (Figure 6.3b). The identity of 
the plasmids was verified by PCR screening and DNA sequencing analysis with the primers 




Figure 6.2. Construction of BACTH plasmids expressing BCAM0001 
Agarose gel electrophoresis analysis of PCR products and constructed bacterial two-hybrid assay 
plasmid DNA expressing BCAM0001. A. PCR to amplify bcam0001. Lane 1, GeneRuler 1 kb DNA 
Ladder (Thermofisher); lane 2, bcam0001, 617 bp PCR product. B. BACTH plasmid DNA. Lanes  1 and 
10, Supercoiled ladder (NEB); lane 2, pUT18, 3.0 kb; lane 3, pUT18-bcam0001, 3.6 kb; lane 4, 
pUT18C, 3.0 kb; lane 5, pUT18C-bcam0001, 3.6 kb; lane 6, pKT25, 3.4 kb; lane 7, pKT25-bcam0001, 
4.0 kb; lane 8, pKNT25, 3.5 kb; lane 9, pKNT25-bcam0001, 4.1 kb. Note the pKNT25 is only observed 
in the concatenated form. 
 
The C-terminus of BCAM0001, from Gln122-Tyr199, comprising the σ4 domain, was 
amplified by PCR using the primers BACTH-BCAM1r4-Fwd and BACTH-BCAM1-Rev to 
produce a 257 bp product (Figure 6.4a). This was cloned between the Acc65I and XbaI 
restriction sites of the MCS of all four BACTH assay plasmids to give adenylate cyclase 
domain protein fusions resulting in the plasmids pUT18-bcam0001σ4, pUT18C-bcam0001σ4, 
pKT25-bcam0001σ4 and pKNT25-bcam0001σ4 (Figure 6.4b). The identity of the plasmids 
was verified by PCR screening and DNA sequencing analysis with the primers M13revBACTH 
and BACTH-BCAM1-rev. 
The anti-sigma factor gene BCAM0001a was amplified by PCR using the primers BACTH-
BCAM1a-Fwd and BACTH-BCAM1a-Rev to produce a 233 bp product (Figure 6.5a). This was 
cloned between the Acc65I and XbaI restriction sites of the MCS of all four BACTH assay 
plasmids to give adenylate cyclase domain protein fusions resulting from the plasmids 
pUT18-bcam0001a, pUT18C-bcam0001a, pKT25-bcam0001a and pKNT25-bcam0001a 
(Figure 6.5b). The identity of the plasmids was verified by PCR screening and DNA 






Figure 6.3. Construction of BACTH plasmids expressing BCAM0001σ2 
Agarose gel electrophoresis analysis of PCR products and constructed bacterial two-hybrid assay 
plasmid DNA expressing BCAM0001σ2. A. PCR to amplify bcam0001σ2. Lane 1, GeneRuler 1 kb DNA 
Ladder (Thermofisher); lane 2, bcam0001σ2, 266 bp PCR product. B. BACTH plasmid DNA. Lane 1, 
Supercoiled ladder (NEB); lane 2, pUT18, 3.0 kb; lane 3, pUT18-bcam0001σ2, 3.3 kb; lane 4, pUT18C, 
3.0 kb; lane 5, pUT18C-bcam0001σ2, 3.3 kb. C. BACTH plasmid DNA. Lane 1, Supercoiled ladder 
(NEB); lane 2, pKT25, 3.4 kb; lane 3, pKT25-bcam0001σ2, 3.7 kb; lane 4, pKNT25, 3.5 kb; lane 5, 





Figure 6.4. Construction of BACTH plasmids expressing BCAM0001σ4 
Agarose gel electrophoresis analysis of PCR products and constructed bacterial two-hybrid assay 
plasmid DNA expressing BCAM0001σ4. A. PCR to amplify bcam0001σ4. Lane 1, GeneRuler 1 kb DNA 
Ladder (Thermofisher); lane 2, bcam0001σ4, 257 bp PCR product. B. BACTH plasmid DNA. Lanes 1 
and 10, Supercoiled ladder (NEB); lane 2, pUT18, 3.0 kb; lane 3, pUT18-bcam0001σ4, 3.3 kb; lane 4, 
pUT18C, 3.0 kb; lane 5, pUT18C-bcam0001σ4, 3.2 kb; lane 6, pKT25, 3.4 kb; lane 7, pKT25-
bcam0001σ4, 3.7 kb; lane 8, pKNT25, 3.5 kb; lane 9, pKNT25-bcam0001σ4, 3.7 kb. Note that both 
pKNT25 and pKNT25-bcam0001σ4 are only observed in the concatenated form. 
 
 
Figure 6.5. Construction of BACTH plasmids expressing BCAM0001a 
Agarose gel electrophoresis analysis of PCR products and constructed bacterial two-hybrid assay 
plasmid DNA expressing BCAM0001a. A. PCR to amplify bcam0001a. Lane 1, GeneRuler 1 kb DNA 
Ladder (Thermofisher); lane 2, bcam0001a, 233 bp PCR product. B. BACTH plasmid DNA. Lanes 1 and 
10, Supercoiled ladder (NEB); lane 2, pUT18, 3.0 kb; lane 3, pUT18-bcam0001, 3.2 kb; lane 4, 
pUT18C, 3.0 kb; lane 5, pUT18C-bcam0001, 3.2 kb; lane 6, pKT25, 3.4 kb; lane 7, pKT25-bcam0001, 





6.2.2 Demonstration of BCAM0001-BCAM0001a interaction in vivo 
The interaction between the BCAM0001 and BCAM0001a was investigated using the 
bacterial two-hybrid assay (see section 2.6.3). Proteins or protein domains are fused to the 
complementary subunits T25 or T18 of Bordetella pertussis adenylate cyclase (CyaA) in the 
constructed plasmids described in section 6.2.1. If a protein-protein interaction occurs, a 
distinctive deep pink colony colour can be observed on indicator medium. 
The phenotype consistent with a protein-protein interaction occurring is observed between 
full-length BCAM0001 and BCAM0001a when BCAM0001 is fused to both T25 and T18 via its 
N-terminus (Figure 6.6) and via its C-terminus (Figure 6.7). A phenotype consistent with a 
protein-protein interaction with BCAM0001 is not observed when BCAM0001 containing 
only its σ2 domain or only its σ4 domain are assayed, regardless of the terminal location of 
the protein fusion (Figure 6.6 and Figure 6.7). 
Additionally, a phenotype suggesting a self-interaction by BCAM0001a is not observed in the 




Figure 6.6. Bacterial two-hybrid analysis of interaction N-terminally linked BCAM0001, and its 
domains, and C-terminally linked BCAM0001a  
BTH101 cells were grown on MacConkey medium containing 1% (w/v) maltose, 0.5 mM IPTG, 100 µg 
ml-1 ampicillin and 50 µg ml-1 kanamycin at 30 oC for five nights. The combinations assayed are 
denoted by the box representations: T18 domain, black; T25 domain, white; full-length BCAM0001, 
linked red and blue boxes; BCAM0001σ2, red; BCAM0001σ2, blue; BCAM0001a, green; the leucine 





Figure 6.7. Bacterial two-hybrid analysis of interaction C-terminally linked BCAM0001, and its 
domains, and C-terminally linked BCAM0001a  
BTH101 cells were grown on MacConkey medium containing 1% (w/v) maltose, 0.5 mM IPTG, 100 µg 
ml-1 ampicillin and 50 µg ml-1 kanamycin at 30 oC for five nights. The combinations assayed are 
denoted by the box representations: T18 domain, black; T25 domain, white; full-length BCAM0001, 
linked red and blue boxes; BCAM0001σ2, red; BCAM0001σ2, blue; BCAM0001a, green; the leucine 





Figure 6.8. Bacterial two-hybrid analysis of BCAM0001a-BCAM0001a interaction 
BTH101 cells were grown on MacConkey medium containing 1% (w/v) maltose, 0.5 mM IPTG, 100 µg 
ml-1 ampicillin and 50 µg ml-1 kanamycin at 30 oC for five nights. The combinations assayed are 
denoted by the box representations: T18 domain, black; T25 domain, white; BCAM0001a, green; the 
leucine zipper component of GNC4, yellow. 
 
6.3 Attempts a construction of a ∆BCAM0001 
gene deletion mutant 
 
To investigate function of the genes regulated by BCAM0001, a gene deletion was 
attempted in Bce H111. This was attempted by introduction of in-frame marker-less 
∆BCAM0001 allele using the allelic exchange vector pSNUFF3Cm (H. Spiewak, unpublished). 
 
6.3.1 Construction of pSNUFF3Cm-∆bcam0001 
The in-frame marker-less ∆bcam0001 mutant allele was amplified by SOE-PCR using primers 
∆bcam1-A, ∆bcam1-B, ∆bcam1-C and ∆bcam1-D to produce a 1073 bp PCR product (Figure 
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6.9a,b). This gene deletion maintained the start of the bcam0001a gene and the 25 bp 
immediately upstream of its start codon, which overlaps with the bcam0001 gene. The 
∆bcam0001 allele was cloned between the BamHI and HindIII sites of the MCS of 
pSNUFF3Cm to give pSNUFF3Cm-∆bcam0001 (Figure 6.9c). The identity of the plasmid 
construct was confirmed by PCR screening and DNA sequencing analysis with primers 
M13revBACTH and M13for2. 
 
Figure 6.9. Construction of pSNUFF3Cm-∆bcam0001 
Agarose gel electrophoresis analysis of DNA PCR products and plasmid DNA used in construction of 
pSNUFF3Cm-∆bcam0001. A. First round SOE PCR to amplify ∆bcam0001 with upstream and 
downstream flanking DNA. Lanes 1 and 4, GeneRuler 1 kb DNA Ladder (Thermofisher); lane 2, 
∆bcam0001 ‘left’ flank, 543 bp PCR product; lane 3, ∆bcam0001 ‘right’ flank, 565 bp PCR product. B. 
Second round SOE PCR to amplify ∆bcam0001 with upstream and downstream flanking DNA. Lane 1, 
GeneRuler 1 kb DNA Ladder (Thermofisher); lane 2, ∆bcam0001, 1073 bp PCR product. C. 
pSNUFF3Cm-∆bcam0001 plasmid DNA. Lane 1, Supercoiled ladder (NEB); lane 2, pSNUFF3Cm, 5.1 




6.3.2 Attempts to introduce ∆bcam0001 into B. cenocepacia by allelic 
exchange 
E. coli SM10λpir transformed with pSNUFF3Cm-∆bcam0001 was used as the donor strain for 
transfer of the mutant allele by conjugation into wild-type Bce H111. Resolution products 
were selected on LB agar containing 100 µg ml-1 ampicillin and 50 µg ml-1 chloramphenicol. 
Plasmid integration was further verified by PCR screening using the bcam0001-specific 
primers ∆bcam1-A and ∆bcam1-D, and the vector specific primers pEX18Tpfor2 and 
pEX18Tprev2. 
E. coli SM10λpir transformed with pDAI-SceI-pheS was used to introduce the constitutively-
expressed I-SceI endonuclease into the verified co-integrant strain, harbouring both 
bcam0001 and ∆bcam0001, via a second conjugation. Strains that had successfully 
undergone a second recombination event to remove the vector backbone were selected for 
on Lnx agar containing 100 µg ml-1 ampicillin and 125 µg ml-1 tetracycline. However, no 
clones that contained the desired gene deletion were identified by PCR screening with the 
primer pair ∆bcam1-1a-out-fwd/∆bcam1-1a-out-rev. 
 
6.4 Construction of ∆bcam0001a gene 
deletion mutant 
 
As another approach to investigate the function of the genes regulated by BCAM0001, a 
gene deletion of its putative anti-sigma factor, BCAM0001a, was attempted in Bce H111. 
Without the its inhibitory partner, the BCAM0001 may be free to associated with core RNAP 
and stimulate the expression of genes of its regulon. This was attempted by introduction of 






6.4.1 Construction of pSNUFF3Cm-∆bcam0001a 
The in-frame marker-less ∆bcam0001a mutant allele was amplified by SOE-PCR using 
primers ∆bcam1a-A, ∆bcam1a-B, ∆bcam1a-C and ∆bcam1a-D to produce a 1056 bp PCR 
product (Figure 6.10a,b). The ∆bcam0001a allele was cloned between the BamHI and HindIII 
sites of the MCS of pSNUFF3Cm to give pSNUFF3Cm-∆bcam0001a (Figure 6.10c). The 
identity of the plasmid construct was confirmed by PCR screening and DNA sequencing 
analysis with primers M13revBACTH and M13for2. 
 
Figure 6.10. Construction of pSNUFF3Cm-∆bcam0001a 
Agarose gel electrophoresis analysis of DNA PCR products and plasmid DNA used in construction of 
pSNUFF3Cm-∆bcam0001a. A. First round SOE PCR to amplify ∆bcam0001a with upstream and 
downstream flanking DNA. Lanes 1 and 4, GeneRuler 1 kb DNA Ladder (Thermofisher); lane 2, 
∆bcam0001a ‘left’ flank, 532 bp PCR product; lane 3, ∆bcam0001a ‘right’ flank, 555 bp PCR product. 
B. Second round SOE PCR to amplify ∆bcam0001a with upstream and downstream flanking DNA. 
Lane 1, GeneRuler 1 kb DNA Ladder (Thermofisher); lane 2, ∆bcam0001a, 1056 bp PCR product. C. 
pSNUFF3Cm-∆bcam0001a plasmid DNA. Lane 1, Supercoiled ladder (NEB); lane 2, pSNUFF3Cm, 5.1 
kb; lane 3, pSNUFF3Cm-∆bcam0001a, 6.1 kb. 
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6.4.2 Introduction of ∆BCAM0001a into B. cenocepacia by allelic 
exchange 
E. coli SM10λpir transformed with pSNUFF3Cm-∆bcam0001a was used as the donor strain 
for transfer of the mutant allele by conjugation into wild-type Bce H111. Resolution 
products were selected on LB agar containing 100 µg ml-1 ampicillin and 50 µg ml-1 
chloramphenicol. Plasmid integration was further verified by PCR screening using the 
bcam0001a-specific primers ∆bcam1a-A and ∆bcam1a-D, and the vector specific primers 
pEX18Tpfor2 and pEX18Tprev2. 
E. coli SM10λpir transformed with pDAI-SceI-pheS was used to introduce the constitutively-
expressed I-SceI endonuclease into the verified co-integrant strain, harbouring both 
bcam0001a and ∆bcam0001a, via a second conjugation. Strains that had successfully 
undergone a second recombination event to remove the vector backbone were selected for 
on Lnx agar containing 100 µg ml-1 ampicillin and 125 µg ml-1 tetracycline. Positive clones 
underwent PCR screening with the primer pairs ∆bcam1-1a-out-fwd/ ∆bcam1-1a-out-rev, 
∆bcam1a-A/ ∆bcam1a-D, and pEX18Tpfor2/ pEX18Tprev2, to identify recombinants with 
the bcam0001a gene deletion and loss of the vector backbone (Figure 6.11). Mutants were 





Figure 6.11. Verification of Bce H111 ∆BCAM0001a deletion mutant by PCR screen 
Agarose gel electrophoresis analysis of DNA products from PCR screening of strains during 
introduction of mutant ∆BCAM0001a allele into Bce H111 using the primer pair ∆bcam1-1a-out-fwd/ 
∆bcam1-1a-out-rev (expected molecular weights: BCAM0001a = 1869 bp, ∆BCAM0001a = 1703 bp). 
Lane 1, GeneRuler 1 kb DNA Ladder (Thermofisher). The bacterial strain from which the template 
DNA is extracted is as follows: lane 2, Bce H111; lane 3, Bce H111-pSNUFF3Cm-∆BCAM0001a (co-
integrant); lane 4, Bce H111 ∆BCAM0001a. 
 
6.5 Construction of ∆bcam0001-bcam0001a 
gene deletion mutant 
 
6.5.1 Construction of pSNUFF3Cm-∆bcam0001-bcam0001a 
The in-frame marker-less ∆bcam0001-bcam0001a mutant allele was amplified by SOE-PCR 
using primers ∆bcam1-A, ∆bcam1-1a-B, ∆bcam1-1a-C and ∆bcam1a-D to produce a 1064 bp 
PCR product (Figure 6.12a,b). This mutant allele deletes both the bcam0001 and bcam0001a 
genes, and leaves a small fused gene formed of the first eight codons of bcam0001 and the 
last eight codons of bcam0001a. The ∆bcam0001-bcam0001a allele was cloned between 
the BamHI and HindIII sites of the MCS of pSNUFF3Cm to give pSNUFF3Cm-∆bcam0001-
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bcam0001a (Figure 6.12c). The identity of the plasmid construct was confirmed by PCR 
screening and DNA sequencing analysis with primers M13revBACTH and M13for2. 
 
Figure 6.12. Construction of pSNUFF3Cm-∆bcam0001-bcam0001a 
Agarose gel electrophoresis analysis of DNA PCR products and plasmid DNA used in construction of 
pSNUFF3Cm-∆bcam0001-bcam0001a. A. First round SOE PCR to amplify ∆bcam0001-bcam0001a 
with upstream and downstream flanking DNA. Lanes 1 and 4, GeneRuler 1 kb DNA Ladder 
(Thermofisher); lane 2, ∆bcam0001-bcam0001a ‘left’ flank, 544 bp PCR product; lane 3, ∆bcam0001-
bcam0001a ‘right’ flank, 555 bp PCR product. B. Second round SOE PCR to amplify ∆bcam0001-
bcam0001a with upstream and downstream flanking DNA. Lane 1, GeneRuler 1 kb DNA Ladder 
(Thermofisher); lane 2, ∆bcam0001-bcam0001a, 1064 bp PCR product. C. pSNUFF3Cm-∆bcam0001-
bcam0001a plasmid DNA. Lane 1, Supercoiled ladder (NEB); lane2, pSNUFF3Cm-∆bcam0001-




6.5.2 Introduction of ∆bcam0001-bcam0001a into B. cenocepacia by 
allelic exchange 
E. coli SM10λpir transformed with pSNUFF3Cm-∆bcam0001-bcam0001a was used as the 
donor strain for transfer of the mutant allele by conjugation into wild-type Bce H111. 
Resolution products were selected on LB agar containing 100 µg ml-1 ampicillin and 50 µg ml-
1 chloramphenicol. Plasmid integration was further verified by PCR screening using the 
bcam0001-0001a-specific primers ∆bcam1-A and ∆bcam1a-D, and the vector specific 
primers pEX18Tpfor2 and pEX18Tprev2. 
E. coli SM10λpir transformed with pDAI-SceI-pheS was used to introduce the constitutively-
expressed I-SceI endonuclease into the verified co-integrant strain, harbouring both 
bcam0001-bcam0001a and ∆bcam0001-bcam0001a, via a second conjugation. Strains that 
had successfully undergone a second recombination event to remove the vector backbone 
were selected for on Lnx agar containing 100 µg ml-1 ampicillin and 125 µg ml-1 tetracycline. 
Positive clones underwent PCR screening with the primer pairs ∆bcam1-1a-out-fwd/ 
∆bcam1-1a-out-rev, ∆bcam1-A/ ∆bcam1a-D, and pEX18Tpfor2/ pEX18Tprev2, to identify 
recombinants with the bcam0001-bcam0001a gene deletion and loss of the vector 
backbone (Figure 6.13). Mutants were then cured of the pDAI-SceI-pheS plasmid by growth 




Figure 6.13. Verification of Bce H111 ∆BCAM0001-BCAM0001a deletion mutant by PCR screen 
Agarose gel electrophoresis analysis of DNA products from PCR screening of strains during 
introduction of mutant ∆BCAM0001-BCAM0001a allele into Bce H111 using the primer pair ∆bcam1-
1a-out-fwd/ ∆bcam1-1a-out-rev (expected molecular weights: BCAM0001-BCAM0001a = 1869 bp, 
∆BCAM0001-BCAM001a = 1125 bp). The bacterial strain from which the template DNA is extracted 
is as follows: lane 1, Bce H111 ∆BCAM0001-BCAM0001a; lane 3, Bce H111-pSNUFF3Cm-
∆BCAM0001-BCAM0001a (co-integrant); lane 4, Bce H111. Lane 4, GeneRuler 1 kb DNA Ladder 
(Thermofisher). 
 
6.6 Identification of BCAM0001-dependent 
promoters 
 
6.6.1 Construction of pBBR1MCS-2-bcam0001 
For the analysis of the BCAM0001 ECF sigma factor in vivo, the bcam0001 gene was cloned 
into the broad host range expression vector pBBR1MCS-2 (Kovach et al., 1995). The 
bcam0001 gene was amplified by PCR from Bce H111 genomic template DNA using the 
primers bcam1-fwd-HindIII and bcam1-rev-BamHI to produce a 672 bp PCR product (Figure 
6.14a). This included 30 bp immediately upstream of the start codon containing the Shine-
Dalgarno sequence, and preceded by an in-frame stop codon to terminate translation of the 
upstream lacZα gene of the vector to eliminate LacZα-BCAM0001 fusion. The bcam0001 
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gene was cloned between the HindIII and BamHI sites of the MCS of pBBR1MCS-2 to give 
pBBR1MCS-2-bcam0001 (Figure 6.14b). The identity of the plasmid construct was confirmed 
by PCR screening and DNA sequencing analysis with primers M13revBACTH and M13for2. 
 
Figure 6.14. Construction of pBBR1MCS-2-bcam0001. 
Agarose gel electrophoresis analysis of DNA PCR products and plasmid DNA used in construction of 
pBBR1MCS-2-bcam0001. A. PCR to amplify bcam0001. Lane 1, GeneRuler 1 kb DNA Ladder 
(Thermofisher); lane 2, bcam0001 PCR product, 672 bp. B. pBBR1MCS-2-bcam0001 plasmid DNA. 
Lane 1, Supercoiled DNA Ladder (NEB); lane 2, pBBR1MCS-2, 5.1 kb; lane 3, pBBR1MCS-2-bcam0001, 
5.8 kb. 
 
6.6.2 Construction of pKAGd4-derived transcriptional reporter plasmids 
To investigate the activity of BCAM0001 upon its putative target promoters by β-
galactosidase assay, the promoters Pbcam2840, Pbcam0001 and Pbcam0002 were cloned into the 
transcription reporter plasmid pKAGd4 (Agnoli et al., 2006). All promoters were amplified by 
PCR from Bce H111 genomic template DNA. The primers p-bcam2840-fwd and p-bcam2840-
rev were used to produce a 388 bp PCR product, containing 368 bp of the 5’-UTR of the 
bcam2840 gene (Figure 6.15a); the primers p-bcam0001-fwd and p-bcam0001-rev were 
used to produce a 388 bp PCR product, containing 368 bp of the 5’-UTR of the bcam0001 
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gene (Figure 6.15b); the primers p-bcam0002-fwd and p-bcam0002-rev were used to 
produce a 294 bp PCR product, containing 274 bp of the 5’-UTR of the bcam2840 gene 
(Figure 6.15c). All promoter DNA was cloned between the HindIII and BamHI sites of the 
MCS of pKAGd4, upstream of the lacZα gene, to give pKAGd4-Pbcam2840, pKAGd4-Pbcam0001 and 
pKAGd4-Pbcam0002 (Figure 6.15d). The identities of the plasmid constructs were confirmed by 






Figure 6.15. Construction of pKAGd4 derivatives containing putative promoter DNA. 
Agarose gel electrophoresis analysis of DNA PCR products and plasmid DNA used in construction of 
pKAGd4 derivatives containing putative promoter DNA for the genes bcam2840, bcam0001 and 
bcam0002. A. PCR to amplify Pbcam2840. Lane 1, GeneRuler 1 kb DNA Ladder (Thermofisher); lane 2, 
Pbcam2840 PCR product, 388 bp. B. PCR to amplify Pbcam0001. Lane 1, GeneRuler 1 kb DNA Ladder 
(Thermofisher); lane 2, Pbcam0001 PCR product, 388 bp. C. PCR to amplify Pbcam0002. Lane 1, GeneRuler 1 
kb DNA Ladder (Thermofisher); lane 2, Pbcam0002 PCR product, 294 bp. D. pKAGd4 derivatives plasmid 
DNA. Lanes 1 and 6, Supercoiled DNA Ladder (NEB); lane 2, pKAGd4, 9.60 kb; lane 3, pKAGd4-





6.6.3 Promoter reporter analyses of putative BCAM0001-dependent 
promoters 
The pBBR1MCS2-BCAM0001 expression plasmid and the pKAGd4 promoter reporter 
plasmids containing the putative BCAM0001-dependent promoters were co-introduced into 
E. coli MC1061 (∆lac) by transformation, in addition to the parental plasmids as negative 
controls, in different combinations. The β-galactosidase assay was performed according to 
the protocol outlined in section 2.5.1. The assay was performed on cultures grown in LB 
broth, supplemented with 100 µg ml-1 ampicillin and 50 µg ml-1 kanamycin. However, none 
of the three assayed promoters displayed any activity in the presence of BCAM0001 (data 
not shown). 
This could be explained by the lack of a Bce specific factor necessary for the activity of the 
sigma factor. Therefore, the pKAGd4 promoter reporter plasmids (and the parental pKAGd4 
plasmid as a negative control) were introduced into Bce H111 by conjugation to verify their 
activity in Bce. The β-galactosidase assay was performed according to the protocol outlined 
in section 2.5.1 on cells grown in LB medium supplemented with 50 µg ml-1 
chloramphenicol. However, again, none of the three assayed promoters displayed any 




In this chapter, the start of an investigation into characterising the BCAM0001 sigma factor 
of Bce has been described. The protein-protein interaction between BCAM0001 and its 
putative anti-sigma factor has be demonstrated in vivo. Although this does not verify that 
these two protein constitute a sigma-anti-sigma factor pair in isolation, it strongly suggests 
that their activity is linked. This could be explored further with in vitro experiments.  
Attempts were made to generate a BCAM0001 gene deletion mutant. However, this proved 
to be difficult. However, a deletion of the anti-sigma factor BCAM0001a, and a tandem 
deletion of the BCAM0001-BCAM0001a pair were introduced into Bce H111. These strains 
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could be used to determine the function of the genes regulated by BCAM0001. This could 
take the form of experiments to characterise the phenotypes of the mutant strains grown in 
the presence of different stressors.  
Finally, the identification of the BCAM0001-dependent promoters was undertaken. 
Although it was predicted that the DNA fragments upstream of the translation start codon 
of the genes located proximal to BCAM0001 would contain BCAM0001-dependent 
promoters, these regions of DNA showed no activity in promoter reporter analyses. As with 
the phenotypic characterisation of the Bce H111 mutant strains, analysing the activities of 
these promoters in the presence of different stressors may be necessary to activate the 
BCAM0001-dependent promoters. As the predicted functions of BCAM2840 are an NAD(P)H 
reductase or chromate reductase, and the predicted function of BCAM0002 is an arsenate 

























7.1 Final discussion and remarks 
 
The body of research presented in this thesis has provided several new insights into the 
OrbS, MbaS and BCAM0001 sigma factor systems of Burkholderia, and their metal-
responsive regulatory domains. In adition to delivering novel information about these 
systems, and new tools whith which to study them, this research has also generated new 
questions to pursue. 
Firstly, the regulation of MbaS has been elucidated in greater detail. It has been 
demonstrated that, like OrbS, MbaS is regulated by the ferric uptake regulator, Fur, and the 
location of the Fur-binding DNA element has been limited to a 186 bp region of DNA (shown 
in Figure 5.2. Within this region of DNA, is a sequence that shows similarity to the 19-mer 
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Fur box consensus sequence. It is highly likely that this the Fur site in PmbaS, but further 
FURTA experiments or promoter-reporter analyses with base substitions could be 
performed to identify this site beyond doubt. Additionally, three MbaS-dependent 
promoters have been validated. 
An mbaS deletion mutant has also been constructed in B. thailandensis, a useful tool for the 
study of the sigma factor and its function. This work enabled the investigation of the 
regulatory mechanism or MbaS, alongside its homologue OrbS. Further gene deletions and 
insertions using a variety of techniques were attempted, but proved to be unsuccessful. It is 
unclear why this was the case, but it may by that the allelic exchange vectors used have low 
effectiveness when used in conjunction with Bth, and different methods may need to be 
used. With respect to the introduction of the mbaSCpentaA allele, a potential solution may be 
directly replacing the wild-type mbaS with mbaSCpentaA (rather than the ‘knock-in’ 
mutagenesis attempted). This would require the use of specific screening primers that bind 
to the mutated CRE region of mbaSCpentaA, but not mbaS, or vice versa. 
An interesting observation that arose though the deletion of mbaS and the NRPS gene pchE 
in Bth was the effect of temperature upon the secretion of pyochelin. It appears that a 
greater amount of pyochelin is produced and/or secreted by Bth at 30 oC, compared to at 37 
oC. It is unclear why this may be the case, but could be linked to the utilisation of more than 
one siderophore by Bth and many other siderophore-producing bacteria. Perhaps the 
secondary siderophore pyochelin is the favoured siderophore of use, over malleobactin, 
under some environmental conditions. When found in its soil environment, temperatures 
are around 30 oC and pyochelin production could be increased; during infection of 
mammalian hosts, temperatures are around 37 oC and the pyochelin production could be 
decreased. Therefore, the regulation of dual-siderophore systems may be pertintent to 
infection, and this temperature regulation effect of pyochelin is worthy of future 
investigation. 
In the course of this research, a strain variant of Bth E264 was discovered. Although 
obstensibly the same as the reference strain Bth E264, this strain differed in some key 
aspects, particularly the loss of malleobactin production. This suggests that the usage of 
malleobactin is not essential to Bth E264 under laboratory conditions. This could also imply 
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that the siderophore system provides a selective advantage to Bth in its soil environment 
and/or during infection, given that this system is retained in other strains of the bacterium. 
The identification of this strain also raise the possibility that there is large variation between 
Bth E264 strains widely used across many laboratories, which could have profound 
implications upon the research performed upon hypothetically identical bacterial strains. 
Examination of the N-terminal extension of OrbS was performed through analysis of an OrbS 
variant encoding a deletion of the N-terminal region. However, this N-terminally deleted 
OrbS variant appeared to act identically to the wild-type protein, and was not studied 
further. It is unclear what the function of this N-terminal extension, present in both MbaS 
and OrbS, is. More experimental work could be carried out on this variant. In particular, 
examining the effect of the N-terminal deletion in conjunction with the C-terminal deletion, 
or substitutions of the C-terminal cysteines, could investigate any cooperativity between the 
two terminal regions. 
Examination of the function of the C-terminal extension in OrbS by sequential truncations of 
the C-terminus revealed that this extension contributed to the activity of the sigma factor. 
When short C-terminal deletions were made in OrbS, the resulting activity from a target 
promoter was decreased. However, this activity was not completely lost, suggesting the C-
terminal extension only confers a partial influence upon the sigma factor’s activity. 
Additionally, when C-terminal truncation impinged upon the C-terminal helix-turn-helix of 
region 4.2, there was abolition of the sigma factor’s activity. 
These preliminary studies also provided evidence of iron regulation upon the activity of 
OrbS, independently of Fur. The presence of iron was shown to result in lower activity from 
an OrbS-dependent promoter. The C-terminally truncated variants displayed a loss of this 
iron regulation. This indicated that the C-terminal region of OrbS contains elements that 
were able to transduce the presence of iron, and regulate the activity of the sigma factor. 
This C-terminal extension contains four cysteine residues, and was referred to as a cysteine-
rich extension (CRE). Substitution of the four cysteines for alanine encoded an OrbS variant 
that, like the C-terminally truncated variants, was not regulated in the presence of iron. This 
indicated that the four cysteine residues, almost certainly via their thiol groups, were the 
elements within the C-terminal extension that transduced the presence of iron. 
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This regulatory mechanism was investigated further for OrbS and MbaS through a series of 
in vivo promoter reporter analyses and in vitro examination of transcription and RNAP 
holoenzyme reconstitution. These were performed in parallel with variant of each sigma 
factor with cysteine-to-alanine substitutions of the C-terminal cysteine residues with the 
CRE. It was determined that OrbS was regulated both in vivo and in vitro by the presence of 
iron, copper and zinc, and that MbaS was regulated only in vitro by the presence of iron and 
zinc. This meal regulation was shown to be specific to the cysteines of the CRE. 
For the in vitro experiments, concentrations of the metal ions assayed were selected 
empirically at 10 μM or 25 μM. However, these concentrations may not truly reflect the 
concentrations of the metals in nature. The total concentrations of iron and zinc in bacterial 
cells are around 0.2 mM, but much of this is bound by metalloproteins (Outten and 
O'Halloran, 2001). Therefore, the pool of free metal ions in E. coli is estimated to be around 
10-6 to 10-7 M for Fe(II), and 10-15 to 10-16 M for Zn(II) (effectively no free Zn(II) ions in the 
cytoplasm under normal growth conditions) (Outten and O'Halloran, 2001; Williams, 2012). 
So, the concentrations of Fe(II) used are around one order of magnitude greater than found 
in the cell, and the concentration of Zn(II) used is around 10 orders of magnitude greater 
than found in the cell. This raises that the possibility that the concentrations used in ivT and 
BLI assays do not have relevance for the binding of metal the the sigma factors in nature. 
Nonetheless, these simple in vitro systems do not account for the complexity of the cell, and 
the influence other metalloproteins and metal chaperone proteins may have in the bacterial 
cytoplasm and upn the effective concentration of metal ions. Plus, if the influence of iron, 
zinc and copper upon the sigma factors was an artefactual effect due to high concentrations 
of metal, one might expect to see similar levels of sigma factor inhibition in the presence of 
other metal ions, which is not observed. Therefore, despite the concentrations of metal ions 
used in the ivT and BLI experiments being much higher than would be present in a bacterial 
cell, it is still probable that the metal-dependent inhibitory effect upon the sigma factor 
activity is genuine and likely to be at work in nature. 
Through biolayer interferometry assays, a series of binding affinities for MbaS, MbaSCpentaA, 
OrbS and OrbSCtetraA with E. coli core RNAP were generated (Table 5.3). In the absence of 
metal, these interactions had and mean KD values of 3.5 ×10-8 M. Binding affinity for core 
RNAP and sigma factor interactions is limited, and varies somewhat depending on the 
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specific protein pair and the techniques used to derive the data. However, the interaction of 
E. coli core RNAP and σFecI, determined by holoenzyme reconstitution followed by gel 
filtration column chromatography, protein staining and image-based quantification, has a KD 
value of 1.73×10-9 M (Maeda, Fujita and Ishihama, 2000). This represents a 20-fold 
discrepancy of binding affinity between the two KD values. Nonetheless, BLI assays are a 
more accurate method of determining binding kinetic data, and perhaps should be 
considered with greater validity than data generated through methods that are more 
inaccurate and/or modelling. 
Further examination of the binding kinetics values generated in Table 5.3 could provide 
some insights into the inhibitory mechanism of the metal-dependent regulation. It has been 
demonstrated that specific metals inhibit the association of MbaS and OrbS with core RNAP 
via their CREs; this could occur via decreasing the association of the holoenzyme complex, 
or by increasing the dissociation of the holoenzyme complex. In the case of Orbs, regardless 
of the presence of metal, the Kd values remain within the same order of magnitude (around 
5 ×10-4 s-1). However, when Fe(II) or Zn(II) are added, the Ka values decrease by 805-fold and 
1,391-fold, respectively. This indicates that it is the association of OrbS and core RNAP that 
is inhibited by the presence of Fe(II) and Zn(II). In the case of MbaS interacting with core 
RNAP, however, both the association and dissociation constants are altered with the 
addition of Zn(II): the Ka decreases 1,740-fold, and the Kd increases 45-fold, when Zn(II) is 
present compared to when it is not. This could indicate that both the association and 
dissociation of MbaS and core RNAP is affected by the presence of Zn(II), although the 
assocoiation is the more significantly influenced step of the protein-protein interaction. 
Nonetheless, this could suggest subtley different metal-dependent inhibitory mechanisms 
between MbaS and OrbS. 
In conclusion, the research presented in this study has provided evidence that the iron 
starvation (IS) sigma factors OrbS and MbaS contain on-board regulatory domains. These 
domains are able to transduce the presence of specific metal ions. This could represent a 
novel regulatory mechanism of this class of ECF sigma factors. 
Given that both MbaS and OrbS are regulated by iron via Fur, and they regulate the 
transcription of Fe(III)-specific siderophores, it is unclear why this secondary metal-
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dependent regulation mechanism via the CREs exists, and why additional non-iron metal 
ions are able to regulate the sigma factors. Firstly, it suggests that the post-translational 
regulation of sigma factor activity is important and there is a selective advantage for 
maintaining or evolving such a mechanism. Normally, ECF sigma factors have an anti-sigma 
factor to regulate this activity at the protein level. Even PvdS, an IS sigma factor with iron-
dependent transcriptional regulation by Fur, is regulated by the anti-sigma factor FpvR. The 
expression and utilisation of siderophore systems much be a metabolically intensive process 
to warrant this level of stringent control. Perhaps the degradation of MbaS and OrbS within 
the bacterial cell is a relatively slow process, and simply repressing the transcription of the 
sigma factors via Fur is insufficient to repress the transcription of the 
malleobactin/ornibactin apparatus effectively. Secondly, this additional post-translational 
regulation may allow further modulation of the sigma factor activity. Given that iron-
dependent regulation occurs via Fur, alternative metal-dependent regulation could be able 
to occur via the sigma factor’s CREs. These alternative metals could acts proxy stimuli for 
iron limitation, and could be selected for as they provide further detection of metal 
starvation conditions in an example of metal homeostasis. 
 
7.2 Future work 
 
Nonetheless, further elucidation of this regulatory mechanism is required. Data from bio 
layer interferometry experiments, which examined the association of core RNAP with the 
Burkholderia sigma factors, suggests that it is this reconstitution step that is inhibited by the 
presence of the metal ions. However, the association of sigma factor and DNA was not 
specifically examined, and the metal ions could inhibit this association, too. Further bio layer 
interferometry assays, or EMSAs, investigated this interaction could be employed. 
Additionally, because all of the cysteine residues of the CRE were substituted, it is unclear 
what influence the individual cysteines had upon the regulatory activity. Performing these 
experiments with a series of individual or combined cysteine-to-alanine substitutions could 
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explore this further. Moreover, there are additional conserved amino acids residues within 
the CRE. It is conceivable that they, too, may transduce the presence of metal ions. In 
particular, a histidine residue located in region 4.2, and conserved among ECF09 IS sigma 
factors containing a CRE (highlighted in Figure 1.13), and a conserved aspartate residue 
(amino acid position 201 in OrbS, 208 in MbaS), could be capable of coordinating metal ions 
via their imidazole and carboxylate groups, respectively. 
It also appears that the differences in the CREs of MbaS and OrbS influence the metal ions 
that can be transduced. OrbS is regulated in the presence of copper in vivo whereas MbaS is 
not. To examine this further, and truly characterise the CRE as a protein domain, protein 
constructs could be engineered in which the CREs are swapped. This may result in changing 
the specificity of the metal ions that the sigma factors are regulated by. 
This study looked solely at the influence of metal ions upon the activity of the sigma factors 
OrbS and MbaS via their CREs. However, the CRE may respond to other stimuli to affect the 
activity of the sigma factors. For instance, cysteine residues are readily oxidised and 
reduced, and this greatly affects the ability of the side chains to acts as nucleophiles and 
form disulphide bridges. Therefore, redox stress could be another stimulus that regulates 
the activity of OrbS and MbaS through their CREs. 
Most importantly, direct binding of metal ions to the sigma factors MbaS and OrbS has not 
been demonstrated. The binding metal ions to the sigma factors could be inferred from a 
series of experiements. Circular dichroism could be used to demonstrate a shift in secondary 
protein structure upon binding of metal to the sigma factors. This could also be 
demonstrated by isothermal titration calorimetry experiments, which enabes calculation of 
a binding affinity. In the case of iron binding, proteins containing iron-sulphur clusters 
typically produce orange-coloured solutions; this phenomonen could be exploited by 
titrating OrbS/MbaS with iron to form iron-sulphur clusters in vitro, and spectrometrically 
measure the colour change. Alternatively, metal-binding could be measured using NMR 
spectroscopy, with the added nuance that the residues responsible for the binding could be 
determined by 2D-NMR analysis. Mass spectroscopy, specifically ESI-MS, would also identify 
whether metal binding occurs by ascertaining the precise molecular weight; this molecular 
weight would also elucidate the ratio metal ions bound and (in the case of iron-binding) the 
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coordination of the iron-sulphur cluster. A further method of determining the metal-protein 
stoichiometry with high precision is inductively coupled plasma optical emission 
spectroscopy (ICP-OES). Ultimately, the elucidation of the protein structures of OrbS or 
MbaS with bound metal ions would provide considerable data, including identification of 
the metal-coordinating residues and the inactive conformation of the sigma factors. If 
binding of the metal ion by the thiols is accommodated by the formation of a metal-sulphur 
cluster, the coordination of this cluster could also be examined. 
However, to perform these experiements the proteins analysed must be compatible. There 
were significant difficulties in handling the purified OrbS and MbaS proteins. These IS sigma 
factors were prone to denaturation and/or degradation, often precipitating out of solution. 
This would occur at temperatures above 4 OC, at high concentrations above ~1 mg ml-1, and 
in buffers that did not contain high concentrations of glycerol. Given that most of the 
biochemical techniques with the potential to examine metal binding to these sigma factors 
require the proteins to be in solutions at high concentrations/amounts, in compatible 
buffers, and at room temperature or higher, this poses serious difficulties. For this further 
work to be achieved, the purification and handling of the proteins must be developed and 
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Figure A.1. Plasmid map of pBBR1MCS-orbS. 
The locations of each of the following are shown: the orbS gene (red), the chloramphenicol 
resistance-conferring gene cat (blue), the Bordetella bronchiseptica gene encoding the plasmid 
replication protein Rep (purple), the Rep-dependent Bordetella bronchiseptica plasmid replication 
origin oriV (yellow), the cat, lac, T3 and orbS promoters (white), the CAP binding site and lac 
operator (teal), the HindIII and BamHI restriction sites used in plasmid construction, and the binding 




Figure A.2. Plasmid map of pBBR1MCS2-orbS. 
The locations of each of the following are shown: the orbS gene (red), the kanamycin resistance-
conferring gene aph(3’)-II (light green), the Bordetella bronchiseptica gene encoding the plasmid 
replication protein Rep (purple), the Rep-dependent Bordetella bronchiseptica plasmid replication 
origin oriV (yellow), the lac, T3, T7 and orbS promoters (white), the CAP binding site and lac operator 
(teal), the HindIII and BamHI restriction sites used in plasmid construction, and the binding sites for 




Figure A.3. Plasmid map of pBBR1MCS2-mbaS. 
The locations of each of the following are shown: the mbaS gene (red), the kanamycin resistance-
conferring gene aph(3’)-II (light green), the Bordetella bronchiseptica gene encoding the plasmid 
replication protein Rep (purple), the Rep-dependent Bordetella bronchiseptica plasmid replication 
origin oriV (yellow), the lac, T3 and T7 promoters (white), the CAP binding site and lac operator 
(teal), the HindIII and BamHI restriction sites used in plasmid construction, and the binding sites for 




Figure A.4. Plasmid map of pBBR1MCS2-pchE. 
The locations of each of the following are shown: the pchE gene (blue), the kanamycin resistance-
conferring gene aph(3’)-II (light green), the Bordetella bronchiseptica gene encoding the plasmid 
replication protein Rep (purple), the Rep-dependent Bordetella bronchiseptica plasmid replication 
origin oriV (yellow), the lac, T3 and T7 promoters (white), the CAP binding site and lac operator 
(teal), the HindIII and BamHI restriction sites used in plasmid construction, and the binding sites for 





Figure A.5. Plasmid map of pBBR1MCS2-orbSΔP. 
The locations of each of the following are shown: the orbS gene (red), the kanamycin resistance-
conferring gene aph(3’)-II (light green), the Bordetella bronchiseptica gene encoding the plasmid 
replication protein Rep (purple), the Rep-dependent Bordetella bronchiseptica plasmid replication 
origin oriV (yellow), the lac and T3 promoters (white), the CAP binding site and lac operator (teal), 
the HindIII and BamHI restriction sites used in plasmid construction, and the binding sites for 




Figure A.6. Plasmid map of pBBR1MCS2-BCAM0001. 
The locations of each of the following are shown: the BCAM0001 gene (red), the kanamycin 
resistance-conferring gene aph(3’)-II (light green), the Bordetella bronchiseptica gene encoding the 
plasmid replication protein Rep (purple), the Rep-dependent Bordetella bronchiseptica plasmid 
replication origin oriV (yellow), the lac, T3 and T7 promoters (white), the CAP binding site and lac 
operator (teal), the HindIII and BamHI restriction sites used in plasmid construction, and the binding 




Figure A.7. Plasmid map of pBBR1MCS5-orbS. 
The locations of each of the following are shown: the orbS gene (red), the gentamycin resistance-
conferring gene aacC1 (light green), the Bordetella bronchiseptica gene encoding the plasmid 
replication protein Rep (purple), the Rep-dependent Bordetella bronchiseptica plasmid replication 
origin oriV (yellow), the Pc, lac, T3, orbS and T7 promoters (white), the CAP binding site and lac 
operator (teal), the HindIII and BamHI restriction sites used in plasmid construction, and the binding 




Figure A.8. Plasmid map of pBBR1MCS5-mbaS. 
The locations of each of the following are shown: the mbaS gene (red), the gentamycin resistance-
conferring gene aacC1 (light green), the Bordetella bronchiseptica gene encoding the plasmid 
replication protein Rep (purple), the Rep-dependent Bordetella bronchiseptica plasmid replication 
origin oriV (yellow), the Pc, lac, T3 and T7 promoters (white), the CAP binding site and lac operator 
(teal), the HindIII and BamHI restriction sites used in plasmid construction, and the binding sites for 




Figure A.9. Plasmid map of pBBR1MCS5-orbSΔP. 
The locations of each of the following are shown: the orbS gene (red), the gentamycin resistance-
conferring gene aacC1 (light green), the Bordetella bronchiseptica gene encoding the plasmid 
replication protein Rep (purple), the Rep-dependent Bordetella bronchiseptica plasmid replication 
origin oriV (yellow), the Pc, lac, T3, and T7 promoters (white), the CAP binding site and lac operator 
(teal), the HindIII and BamHI restriction sites used in plasmid construction, and the binding sites for 




Figure A.10. Plasmid map of pSRK-Km-furFLAG 
The locations of each of the following are shown: the furFLAG gene (blue, with FLAG epitope residues 
in orange), the kanamycin resistance-conferring gene aph(3’)-II (light green), the Bordetella 
bronchiseptica gene encoding the plasmid replication protein Rep (purple), the Rep-dependent 
Bordetella bronchiseptica plasmid replication origin oriV (yellow), the lacI gene (purple), the lacIq, 
lac, T3, and T7 promoters (white), the CAP binding site and lac operator (teal), the HindIII and BamHI 




Figure A.11. Plasmid map of pET14b-mbaS 
The locations of each of the following are shown: the mbaS gene containing an N-terminal His-tag 
(orange), the ampicillin resistance-conferring gene bla (light green), the plasmid ColE1 replication 
origin ori (yellow), the gene encoding the E. coli regulatory protein Rop (purple), the T7, tet and bla 
promoters (white), the T7 terminator (white), the plasmid pBR322 basis of mobility region bom 
(grey), the thrombin cleavage site (purple), the ribosome binding site (grey), the NdeI and BamHI 




Figure A.12. Plasmid map of pET14b-orbS 
The locations of each of the following are shown: the orbS gene containing an N-terminal His-tag 
(orange), the ampicillin resistance-conferring gene bla (light green), the plasmid ColE1 replication 
origin ori (yellow), the gene encoding the E. coli regulatory protein Rop (purple), the T7, tet and bla 
promoters (white), the T7 terminator (white), the plasmid pBR322 basis of mobility region bom 
(grey), the thrombin cleavage site (purple), the ribosome binding site (grey), the NdeI and BamHI 




Figure A.13. Plasmid map of pRLG770-PmbaH. 
The locations of each of the following are shown: the PmbaH promoter (blue), the ampicillin 
resistance-conferring gene bla (light green), the plasmid ColE1 replication origin ori (yellow), the bla 
promoter (white), the rrnB T1 and T2 terminators (white), the plasmid pBR322 basis of mobility 
region bom (grey), the EcoRI and HindIII restriction sites used in plasmid construction, and the 




Figure A.14. Plasmid map of pEX18Tp-pheS-ΔmbaS. 
The locations of each of the following are shown: the ΔmbaS gene (orange), the trimethoprim 
resistance-conferring gene dhfrIIb (light green), the plasmid ColE1 replication origin ori (yellow), the 
Bps mutant gene pheS (red), the Bth genes encoding MbaH, MbaG, and a hypothetical protein (HP) 
(light blue), the Pc, lac, mbaS and mbaH promoters (white), the rrnB T1 and T2 terminators (white), 
the CAP binding site and lac operator (teal), the conjugal origin of transfer oriT (grey), the BamHI and 




Figure A.15. Plasmid map of pSNUFF3Cm-ΔpchE. 
The locations of each of the following are shown: the ΔpchE gene (orange), the trimethoprim 
resistance-conferring gene dhfrIIb (light green), the chloramphenicol resistance-conferring gene cat 
(blue), the plasmid ColE1 replication origin ori (yellow), the Bps mutant gene pheS (red), the Pc, lac, 
and cat promoters (white), the rrnB T1 and T2 terminators (white), the CAP binding site and lac 
operator (teal), the lacI attenuator region (grey), the conjugal origin of transfer oriT (grey), the I-SceI 
meganuclease restriction site (olive), the BamHI and HindIII restriction sites used in plasmid 




Figure A.16. Plasmid map of pSNUFF3Cm-mbaSCpentaA. 
The locations of each of the following are shown: the mbaSCpentaA gene (orange), the trimethoprim 
resistance-conferring gene dhfrIIb (light green), the chloramphenicol resistance-conferring gene cat 
(blue), the Bth genes encoding MbaH, MbaG, and a hypothetical protein (HP) (light blue), the 
plasmid ColE1 replication origin ori (yellow), the Bps mutant gene pheS (red), the Pc, lac, cat and 
mbaS promoters (white), the rrnB T1 and T2 terminators (white), the CAP binding site and lac 
operator (teal), the lacI attenuator region (grey), the conjugal origin of transfer oriT (grey), the I-SceI 
meganuclease restriction site (olive), the BamHI and HindIII restriction sites used in plasmid 




Figure A.17. Plasmid map of pSHAFT2-Δfur::TpTer. 
The locations of each of the following are shown: the disrupted Δfur gene (orange), the 
trimethoprim resistance-conferring gene dhfrIIb (light green), the chloramphenicol resistance-
conferring gene cat (blue), the ampicillin resistance-conferring gene bla (light green), the E. coli 
plasmid transfer gene traJ (purple), the R6Kγ replication origin ori (yellow), the Pc and bla promoters 
(white), the rrnB T1 and T2 terminators (white), the lac operator (teal), the conjugal origin of 
transfer oriT (grey), the NdeI, XbaI and Acc65I restriction sites used in plasmid construction, and the 
binding sites for relevant DNA primers. 
